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Abstract 
Approximately 1400 HIV-positive women are known to become pregnant in the UK 
each year, the overwhelming majority being from Sub-Saharan Africa.   
The overall question I pose in this thesis is:  how do African women living with HIV in 
the UK engage with HIV services and interventions during and after pregnancy?  The 
question is addressed through a mixed methods approach.  Drawing upon 
epidemiological data from the UK and Ireland's National Study of HIV in Pregnancy 
and Childhood, and primary ethnographic data, I examine key outcomes (not receiving 
antiretroviral therapy during pregnancy, detectable maternal HIV viral load at delivery, 
vertical transmission, late antenatal booking and maternal loss to follow-up from HIV 
care after pregnancy), as well as exploring women's experiences. 
Women from Western Africa and those who had arrived in the UK after conception 
appeared to be at greater risk of poorer outcomes.  Pentecostal beliefs in divine healing, 
although cited by professionals as a potential barrier to HIV care, did not necessarily 
prevent women from engaging with HIV services and interventions.  Instead, a complex 
constellation of cultural and structural factors including stigma and lack of UK 
citizenship rights emerged as a greater challenge to engagement with care.    
Women described good relationships with their multidisciplinary HIV antenatal teams 
that fostered confidence in medical systems.  On the other hand, some reported negative 
experiences, particularly with regards to poor maternity care at the time of delivery and 
difficulties in abstaining from breastfeeding.  
Overall I found that the majority of African women living with HIV in the UK engage 
well with HIV services and interventions during and after pregnancy, resulting in low 
rates of both vertical transmission and loss to follow-up after pregnancy.   This 
highlights women's resilience and determination to engage with HIV care, despite 
challenges, in order to secure the health of their babies.
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1  
            
Introduction 
 
 
Summary 
This thesis explores how African women living with HIV in the UK engage with HIV 
services and interventions during and after pregnancy.  In this introductory chapter I 
provide background to my subject of inquiry.  I start by using a vignette from my own 
clinical practice as an entry point into my work.  I then describe the broader 
epidemiological context of HIV both globally and in the UK before specifically 
focusing on HIV in African communities in the UK.  Following this I provide an 
epidemiological overview of HIV and pregnancy in the UK, before summarising the 
key components of clinical management of pregnancy in the context of HIV.  I proceed 
to outline the rationale behind my work by highlighting the paucity of work in HIV and 
pregnancy that focuses on mothers, and providing a critique of the use of “Black 
African” as an analytic tool to examine difference.  After introducing the research 
questions posed in this thesis, I summarise three key theoretical frames that underpin 
my work.  I then conclude this introductory chapter with an outline of the overall 
structure of the thesis.   
1.1 Pauline1 
 
Several years ago whilst working as a junior doctor in an HIV antenatal clinic in 
London, I met Pauline, a 32-year-old woman from Sierra Leone.  Some months earlier 
she had been diagnosed with HIV during a routine screening blood test in pregnancy.  
When the HIV specialist midwife gave her the diagnosis, it came as a shock and she had 
found it hard to come to terms with it, subsequently failing to attend any further 
antenatal appointments.  She later went on to have a stillbirth as a result of an HIV-
related infection of the placenta.   
 
A few months later she attended the hospital’s general antenatal clinic in the early 
                                                             
1
 Names and some other details have been changed to protect confidentiality. 
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stages of pregnancy.  The midwives, knowing her HIV status, offered her an 
appointment with the HIV specialist midwife.  However, Pauline declined.  She 
believed that the specialist midwife had precipitated her stillbirth by giving her her 
diagnosis.  For Pauline, HIV was a “curse” that the midwife had placed upon her to the 
detriment of her baby.  She did not want to discuss her HIV diagnosis or engage with 
the possibility of taking treatment, instead insisting on attending the general antenatal 
clinic and seeking “healing” through prayer.  At this point Pauline was significantly 
immunocompromised and was at risk of severe opportunistic infections.  Furthermore, 
she had already lost one baby as a result of a potentially reversible HIV-related 
complication. 
This complex situation would usually have been best managed by an HIV antenatal 
specialist team but this was not feasible in view of Pauline’s reluctance to discuss her 
diagnosis with anyone.   At some point, we decided as a team that I would start looking 
after her as an “infection” doctor.  Over the following months Pauline and I made 
tentative steps towards getting to know each other.  We talked about how to make her 
body and immune system “stronger”.  I was careful not to mention the word “HIV”; 
Pauline, for her part, slowly began to open up to the possibility of taking “immune-
boosting” drugs.  During this time I was struck by Pauline’s social isolation.  With no 
friends or family around her, her only source of support was her partner who also 
believed in a spiritual aetiology of HIV, declining HIV-testing himself in favour of 
prayer.  Furthermore she was overwhelmed by her precarious financial situation and 
anxieties about what would happen now that her visa had expired. 
Throughout Pauline’s pregnancy we negotiated a difficult terrain between our differing 
“explanatory models”2 of HIV. However, together we reached a point where her HIV 
was well controlled on HIV medication, despite never discussing HIV explicitly, and 
she delivered a healthy HIV-negative baby girl.  After delivery, Pauline brought her 
daughter in for her routine HIV test and came to the HIV clinic for her own HIV care.  
However a few months later Pauline stopped her medication and her attendance at the 
clinic became more erratic until her visits finally tailed off and we were unable to 
contact her again.  
Towards the end of my fieldwork, a colleague mentioned to me that Pauline had been 
                                                             
2
 Kleinman and colleagues were the first to highlight the role of patients’ and healers’ (used in the 
broadest sense to also refer to biomedical doctors) discordant explanatory systems as a barrier to effective 
delivery of healthcare (Kleinman, et al. 1978). 
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admitted to hospital after years of not being seen.  She had kidney failure as a result of 
advanced HIV infection.  At this point she declined any further treatment, explaining 
that she and her husband were concerned that members of her church might see her 
attending for HIV care.  She discharged herself with the hope of finding a cure through 
prayer.   
Over the past ten years I have seen many women with similarly complicated journeys 
through pregnancy and motherhood.  However Pauline’s story has stayed with me, 
reminding me that HIV in pregnancy is embedded within a complex matrix of 
biomedical, social and cultural factors that are often poorly understood, and prompting 
me to develop the work I present in this thesis.       
1.2 Global epidemiology of HIV 
Since the first reports in 1981 of a cluster of cases of Pneumocystis Carinii pneumonia 
in young gay men in the United States (Centers for Disease Control 1981), HIV has 
become a global epidemic with 34 million people living with HIV worldwide by the end 
of 2011 (UNAIDS 2012).  Although rates of new HIV infections have fallen in recent 
years, the number of people living with HIV globally continues to increase, largely as a 
result of the scale-up of antiretroviral therapy (ART)3 and the consequent decline in 
HIV-related deaths (Ibid.).  In the past decade there has been a twenty-fold increase in 
the coverage of ART worldwide, with more people initiating ART in 2011 than at any 
other time previously (Ibid.). 
Sub-Saharan Africa bears a disproportionate burden of the disease with 23.5 million 
people estimated to be living with HIV by the end of 2011, 69% of the global total, and 
70% of all HIV-related deaths worldwide (Ibid.).   Throughout most of the region the 
number of people newly infected with HIV is now stabilising or declining as a result of 
widespread HIV prevention interventions including condom promotion, male 
circumcision and the use of ART.  Although there has been a rapid expansion in ART 
coverage across the continent, it remains low at 54% (Ibid.).  There are important 
variations in the HIV epidemic within Africa with prevalence4 ranging from less than 
5% in Western and Central Africa to over 20% in Lesotho, Botswana and Swaziland 
(Ibid.). 
                                                             
3
 Antiretroviral therapy is the term for medication used to treat HIV.  There are currently five classes of 
medication available with standard ART comprising three antiretroviral agents from at least two different 
classes.   
4
 The prevalence is the proportion of the population found to have HIV. 
19 
 
The HIV epidemic in Sub-Saharan Africa is predominantly heterosexual, with women 
representing 58% of all people in the region living with HIV.  The preponderance of 
women in the HIV epidemic in Sub-Saharan Africa is due to a number of intersecting 
factors including women’s physiological vulnerability to HIV5 and social determinants 
such as gender inequality, poverty, poor access to education and gender-based 
violence6. 
1.3 Epidemiology of HIV in the UK 
As in other parts of the world, the number of people living with HIV in the UK 
continues to grow (figure 1.1).  However, the HIV epidemic is relatively small with an 
estimated 96,000 people living with HIV in the UK by the end of 2011 of whom 20,200 
(21%) were African-born heterosexual women.  Despite the increasing prevalence of 
HIV, the number of HIV-related deaths and AIDS diagnoses remains stable as a result 
of the widespread availability of highly active antiretroviral therapy (HAART)7 (figure 
1.1).  In the UK, HIV prevalence is elevated both among men who have sex with men 
(MSM) and African-born heterosexual women and men, with the largest numbers of 
people living with HIV coming from these groups (figure 1.2).  
The total number of new HIV infections in the UK in 2011 was 6280.  There has been a 
consistent decline since a peak in 2005 (figure 1.1), mainly due to a decrease in reported 
diagnoses among heterosexuals born in areas of high HIV prevalence.  It is important to 
note that the number of new diagnoses in MSM has increased year on year since 2007, 
with 2011 seeing the highest ever number of new diagnoses among MSM in the UK. 
 
                                                             
5
 Women’s biological vulnerability to HIV acquisition is thought to be secondary to hormonal changes, 
vaginal environmental factors and increased co-infection with other sexually transmitted infections, 
(Quinn, et al. 2005). 
6
 A background paper prepared on behalf of the Salamander Trust providing an excellent overview of 
current knowledge of violence against women in the context of HIV is available at 
http://www.salamandertrust.net/resources/VAPositiveWomenBkgrdPaperMarch2011.pdf (accessed 30 
July 2013). 
7
 HAART is the combination of antiretroviral agents, usually from at least two different classes, to treat 
HIV. 
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Figure 1.1: Annual number of people living with HIV infection and newly diagnosed with 
HIV in the United Kingdom, 1980-2011 
 
 
 
Source: http://www.hpa.org.uk/webc/HPAwebFile/HPAweb_C/1317137200016 (accessed 30 July 2013). 
 
Figure 1.2: Estimated number of people living with HIV (both diagnosed and 
undiagnosed) in the United Kingdom, 2011 
 
 
 
Source: http://www.hpa.org.uk/webc/HPAwebFile/HPAweb_C/1317137200016 (accessed 30 July 2013). 
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Within England there is substantial geographical variation in the HIV epidemic.   The 
prevalence of diagnosed HIV infection in London is much higher than any other region 
in England at 5.4 per 1000, and is more than 2.5 times the prevalence rate in England as 
a whole (Public Health England 2013).  In 2011, new HIV diagnoses in London 
comprised over half of all new diagnoses in England whilst those with living with 
diagnosed infection (n=31,147) represented just under half of all patients accessing HIV 
care in England (Ibid.)    
1.4 HIV in African communities in the UK 
The Black African community8 bears a disproportionate burden of HIV disease in the 
UK with a prevalence of 37 per 1000 persons, over thirty times higher than in the UK 
population overall (Health Protection Agency 2012).   In 2011 HIV prevalence among 
Black African women was 50 per 1000, twice as much as the prevalence in Black 
African men (Ibid.).  Among the 2990 new diagnoses of HIV infection due to 
heterosexual contact, nearly 60% were among Black Africans, the majority of whom 
were born outside the UK (Ibid.).  In earlier years of the HIV epidemic in the UK it was 
believed that the majority of Black Africans acquired their HIV abroad.  However, there 
is evidence that an increasing number of infections are acquired in the UK rather than 
abroad (Rice et al. 2012).   
Nearly a third of people living with HIV in the UK were born in Africa.  There were 
30,700 Africans estimated to be living with HIV in the UK by the end of 2011, two 
thirds of whom were women (figure 1.3).  The majority of Africans newly diagnosed 
with HIV in the UK originate from East Africa, although the epidemic has become more 
diverse over time.  The proportion of Africans diagnosed with HIV who are from East 
Africa has fallen from just under 75% in 2001 to approximately 50% in 2010, whilst in 
the same time period there was a significant increase in diagnoses in West Africans to a 
point in 2010 when almost one in three Africans diagnosed with HIV in the UK were 
West African (Meaghan Kall, Public Health England, personal communication, 25 June 
2012)9.  
                                                             
8
 “Black African” here refers to the ethnic category used in the UK Census since 1991.  It is based on 
self-reported ethnicity as belonging to a Black African group, rather than country of birth.  This is 
discussed in detail later in this chapter.   
9
 The trends in region of birth in Africans diagnosed with HIV in the UK firstly reflects the changing 
geographical distribution of the disease in Africa, which was initially concentrated in Eastern Africa 
earlier in the epidemic before becoming more widespread.  Secondly it reflects underlying changes in 
migration patterns from Africa to the UK (Owen 2009).   
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Studies have shown that African10 patients are more likely than others to present to 
medical services at a later stage of HIV infection, with advanced disease and greater 
immune suppression (Burns et al. 2001, The UK Collaborative Group for HIV and STI 
Surveillance 2005).   This is due to a number of factors including perception of low risk, 
fear of stigma and discrimination, lack of HIV testing in general medical settings and 
anxieties regarding medical bills for HIV care (Burns et al. 2007, Thomas et al. 2010).  
African heterosexual patients are also more likely to be lost to follow-up from HIV care 
than white MSM.  Disengagement from medical services could be due to institutional 
barriers such as lack of entitlement to free care, cultural factors leading to treatment 
concerns (Erwin et al. 1999), or emigration (Rice et al. 2011).  Many Africans living 
with HIV in the UK have a high level of social need (Weatherburn et al. 2003, Ibrahim 
et al. 2008) including financial difficulty (Weatherburn et al. 2003), social isolation 
(Doyal 2009) and insecure immigration status11 (Allan et al. 2005, Cherfas 2006).  The 
medical and social care of HIV-positive asylum seekers may be further disrupted as a 
result of compulsory dispersal12 to areas of the UK which have few HIV and voluntary 
sector services (Creighton et al. 2004).  All of these factors are likely to impact on 
patients’ access to healthcare and may result in them seeking alternative treatment either 
in lieu of, or as an adjunct to, services provided within the NHS (Erwin et al. 1999, 
Thomas 2010). 
1.5 HIV and pregnancy 
Transmission of HIV from a mother to her infant is known as vertical transmission13 
and occurs during pregnancy, during delivery, or postnatally through breastfeeding 
(Newell 1998).  In 2011, 333,000 children were estimated to have newly acquired HIV 
worldwide.  The number of new infections in children in 2011 was substantially lower 
than in 2003 as a result of widespread efforts to prevent vertical transmission (UNAIDS 
2012).  Over 90% of these new HIV infections were in children living in Sub-Saharan 
Africa. Although the number of new infections in children has fallen by 24% since 2009 
                                                             
10
 In this section I draw upon findings from work conducted within both Black African and African-born 
communities, reflecting a lack of consensus on how to explore ethnic disparities in HIV outcomes.  
11
 Throughout this thesis I use secure immigration status to describe being a UK citizen, a recognised 
refugee or having exceptional or indefinite leave to remain.  Anyone not in these categories is defined as 
having insecure immigration status. 
12
 Since 2000 the UK Home Office policy has operated a compulsory dispersal policy where asylum 
seekers are housed on a no-choice basis in locations mainly situated outside of  London and the South 
East region of the UK in an effort to distribute housing, social and financial pressures amongst local 
authorities throughout the country.   
13
 It is also known as mother-to-child transmission (MTCT), however I avoid this terminology in this 
thesis as result of concerns that it assigns blame to mothers, constructing them as “vectors of infection”.  
HIV activists advocate the use of more neutral language that focuses on the event (Dilmitis, et al. 2012).  
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in the region overall (UNAIDS 2012), there is important variation across countries.  The 
vertical transmission rate in Southern Africa, which also has the highest coverage of 
ART for the prevention of vertical transmission14, has declined faster than in Central 
and Western Africa where coverage is much lower (Ibid.).  For the rest of this section I 
will focus on HIV and pregnancy within the UK. 
1.5.1 HIV and pregnancy in the UK  
The overall prevalence15 of HIV among women giving birth in England was 0.22%  in 
2011 (Health Protection Agency 2012) 16.  This is an increase from 2002 when the 
prevalence was 0.15% but it has been stable in recent years at 0.21-0.22% (Ibid.).  
Within England there is substantial geographical variation with regards to the 
prevalence of HIV among women giving birth with London having the highest 
prevalence at 3.5 per 1000, compared with 1.6 per 1000 in the rest of England (Ibid).  
Pregnant women born in Sub-Saharan Africa have the highest prevalence of HIV at 
2.3% compared with 0.05% in women born in the UK and 0.58% in those born in other 
parts of the world17.   
The number of pregnancies in women with diagnosed HIV-infection reported to the UK 
and Ireland’s National Study of HIV in Pregnancy and Childhood (NSHPC) has 
increased 17-fold from 82 in 1990 to over 1400 a year since 200618, with the sharpest 
rise occurring between 1999 and 2003 (Townsend et al. 2008b).   The increase in 
pregnancies reported to women diagnosed with HIV is due to a number of factors 
including the steep rise in heterosexually acquired HIV in the 1990s (Health Protection 
Agency 2006), the introduction of routine antenatal screening for HIV in the early 
2000s, and the introduction of HAART which has improved prognosis in terms of 
women’s survival and reducing the risk of vertical transmission, affording greater 
reproductive opportunity.   This is reflected by the increase in pregnancy rates between 
2000 and 2009 in women attending for HIV care in thirteen UK clinics (Huntington et 
al. 2013), with women of Black African ethnicity being more likely to become pregnant 
than their White counterparts (Ibid.).  Another important contributing factor to the 
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 As discussed later in this section, ART is a cornerstone in the prevention of vertical transmission of 
HIV. 
15
 The proportion of pregnant women found to be HIV-positive through testing newborn infants for the 
presence of HIV antibodies.   
16
 This includes women with diagnosed and undiagnosed HIV infection.  
17
 Data obtained from http://www.hpa.org.uk/webc/HPAwebFile/HPAweb_C/1287144874352 (accessed 
23 September 2013). 
18
 See NSHPC summary slides from July 2013, available at http://www.ucl.ac.uk/nshpc/slides (accessed 
23 September 2013). 
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increase in pregnancies reported in HIV-positive women is the rise in sequential 
pregnancies19, with nearly 50% of pregnancies reported to the NSHPC in 2011 being in 
women who had had a previous reported pregnancy (Tookey 2013).  The proportion of 
women reported as pregnant to the NSHPC who were diagnosed with HIV prior to 
conception has increased from 40% between 2000 and 2003 (Townsend et al. 2008b) to 
just over 80% in 2011 (Byrne et al. 2013), a reflection of both the increase in HIV-
testing in a range of medical settings including antenatal clinics and the rise in second or 
subsequent pregnancies.  Routine antenatal testing for HIV has been highly successful 
with 95% uptake of testing and 95% of women with HIV being diagnosed by the time 
of delivery20.  Diagnosis during pregnancy is often made at an early stage of HIV 
disease, with only 11% of women having symptomatic HIV or AIDS (Townsend et al. 
2008b).  The increase in diagnoses prior to conception has been accompanied by an 
increase in the proportion of women who are on ART at conception to nearly 40% 
(Townsend et al. 2013). 
There have been significant demographic changes in women reported to the NSHPC as 
pregnant over time.  Pregnancies in women reported to have acquired HIV through 
injecting drug use (or from an injecting drug using partner) fell ten-fold from 1990, to 
less than 5% in 2004 to 2006 (Townsend et al. 2008b).  In the same time period, the 
proportion of reported pregnancies that were in women born in Sub-Saharan Africa 
increased significantly from just under 50% in 1990 to nearly 80% in 2004 to 2006 
(Ibid.) and has stabilised at this level since then, reflecting the overall trends in HIV 
epidemiology described earlier in this chapter. 
1.5.2 Clinical management of pregnancy in the context of HIV 
The risk of vertical transmission is estimated to be between 25% and 40% in the 
absence of interventions (Newell et al. 1997).  Important interventions to reduce vertical 
transmission21 include screening for HIV in early pregnancy (Townsend et al. 2008a), 
delivery by elective caesarean section22 (Kind et al. 1998) and the avoidance of 
breastfeeding (Nduati et al. 2000).   The cornerstone of the prevention of vertical 
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 Women having a second or subsequent pregnancy reported to the NSHPC since their HIV diagnosis. 
20
 See NSHPC summary slides from July 2013, available at http://www.ucl.ac.uk/nshpc/slides (accessed 
23 September 2013). 
21
 Important interventions to prevent HIV in childhood also include addressing the broader context of 
women’s reproductive healthcare including the prevention of HIV in people of reproductive age and the 
prevention of unplanned pregnancies (Abrams 2004).  
22
 Although recent data show that rates of vertical transmission in women who have controlled HIV-
infection on ART have been shown to be similar in vaginal deliveries and those by elective caesarean 
section  (Townsend, et al. 2013). 
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transmission of HIV is the use of ART in pregnancy, which has been the major driver in 
the decline of new infections in children globally   Over the past two decades, the use of 
single antiretroviral agents (Connor et al. 1994, Guay et al. 1999) which were the first 
regimens to be found to be effective for the prevention of vertical transmission, has 
been superseded by the use of HAART which has largely contributed to the decline in 
rates of transmission (Cooper et al. 2002, European Collaborative Study 2005, Tonwe-
Gold et al. 2007). 
In the UK there is clear national guidance for the management of HIV in pregnancy 
(figure 1.3).  The approach comprises early and universal screening for HIV in 
pregnancy (National Institute for Health and Clinical Excellence 2008), timely initiation 
of ART, appropriate management of delivery, ART prophylaxis to the infant, and the 
avoidance of breastfeeding (Taylor et al. 2012) .  HAART is the most commonly used 
ART regimen in pregnancy in the UK (Townsend et al. 2008b), with an aim to start 
treatment by week twenty-four of pregnancy at the latest (Taylor et al. 2012) and earlier 
if the mother’s HIV viral load is high (Read et al. 2012).  Pregnant women living with 
HIV are expected to attend antenatal appointments more frequently than women without 
any medical complications, as they require blood test monitoring of response to 
treatment and possible side effects.   The management of HIV in pregnancy is complex 
requiring careful consideration of obstetric, paediatric and HIV-related issues, as well as 
the provision of emotional and social support.  National guidelines therefore 
recommend that antenatal HIV care be delivered by a multidisciplinary team 
comprising, at the very least, an HIV specialist doctor, an obstetrician, an HIV specialist 
midwife and a paediatrician23 (Taylor et al. 2012) .  The combination of the above 
interventions has been successful, resulting in the UK having the lowest vertical 
transmission rate in the world in recent years at 0.5% (Townsend et al. 2013). 
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 The multidisciplinary team often extends beyond this core group to include voluntary and peer support 
professionals, social workers, legal advocates, clinical psychologists, clinical nurse specialists as well as 
others.  
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Figure 1.3: Antenatal management of women living with HIV in the UK 
 
 
Source: (Taylor et al. 2012). 
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1.6 Rationale for my research 
So far in this chapter I have described the changing epidemiology of HIV in the UK, 
placing it in a broader global context.  I have highlighted the disproportionate burden of 
disease borne by African communities living in the UK, especially women, and the 
increasing diversity in terms of African region of birth.  Since the early 1990s there has 
been a rise in the number of pregnancies reported in women living with HIV as a result 
of the introduction of routine antenatal HIV screening and the increased reproductive 
opportunities afforded by the advent of HAART.  In recent years, over 1400 
pregnancies a year in HIV-positive women have been reported to the UK and Ireland’s 
national surveillance programme; the majority in women of Black African ethnicity.  
This epidemiological data allows us to begin to appreciate the importance of pregnancy 
in African women living with HIV as an object of inquiry.  I will now build upon this 
by summarising two other key areas that have informed the development of my work.   
1.6.1 Where is the M in MTCT? 
The global decline in rates of vertical transmission and the current UK rate of 0.05% 
should rightly be hailed as a success.  However, to focus solely on vertical transmission 
risks overlooking other important aspects of pregnancy in the context of HIV.  In their 
1985 paper, Rosenfield and Maine (Rosenfield et al. 1985) posed the following 
question: where is the “M” in MCH?  The authors drew attention to the fact that most 
maternal and child health (MCH) programmes tended to focus upon the child, often 
considering women “only in relation to improving infant outcomes” (Ibid.: 84).   Nearly 
two decades later they revisited this question, this time framing it within the HIV 
epidemic (Rosenfield et al. 2001).  The authors argue that MCH programmes and the 
academic community have focused their attention on the health of infants and 
minimising the risk of vertical transmission whilst overlooking the multiple ways in 
which HIV affects their mothers.  Indeed a cursory search for literature on HIV and 
pregnancy will reveal the preponderance of work on vertical transmission and other 
infant-related outcomes such as preterm delivery and congenital abnormalities.  A 
recent scoping review of reproductive health research in HIV (Loutfy et al. 2012) has 
underlined this neglect of expectant mothers’ health, identifying critical gaps in current 
knowledge on key aspects of HIV and pregnancy including maternal health outcomes, 
optimal methods of infant feeding, and social and psychological aspects of motherhood.  
Access to healthcare and engagement with services is a critical factor in the health of 
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women living with HIV and their children as highlighted by a retrospective review of 
cases of vertical transmission in the UK (National Study of HIV in Pregnancy and 
Childhood (NSHPC) et al. 2007).  This report identified high levels of social need 
among mothers whose children acquired HIV and highlighted the significant role of 
delayed access to services and poor communication between mothers and healthcare 
professionals.  A review of the theoretical underpinnings of current literature on the 
prevention of vertical transmission has revealed a paucity of studies that explore social 
determinants of health such as gender inequality and poverty, arguing for work that 
engages with HIV and pregnancy from a perspective of structural violence24 
(Hampanda 2012).      
1.6.2 Moving beyond the term Black African 
A central aim of public health research, including epidemiology, is to investigate 
differences between populations in order to address health inequality and inform public 
health policy.  In the past two decades, ethnicity has become a key area of interest25 
resulting in a proliferation of studies that explore associations between ethnicity and 
health26.  This work has revealed important health disparities such as increased 
mortality rates in the UK among those born outside the country (Davey-Smith et al. 
2000) and increased rates of hypertension, diabetes and obesity in people of African and 
Asian ethnicities when compared with white Europeans (Landman et al. 2001).  In the 
area of sexual and reproductive health, studies in the UK have shown differences in 
rates of sexually transmitted infection across ethnic groups (Lacey et al. 1997) and 
access to antenatal care in the UK (Rowe et al. 2008, Jayaweera et al. 2010). 
Ethnicity has been defined as “the social group a person belongs to, and either identifies 
with or is identified with by others, as a result of a mix of cultural and other factors 
including language, diet, religion, ancestry, and physical features traditionally 
associated with race” (Bhopal 2004).  Unlike arguably more objective variables such as 
age and sex, ethnicity is a complex and contested social construct that defies objective 
                                                             
24
 The theoretical concept of structural violence will be described in detail later in this chapter. Briefly, it 
refers to the ways in which political, social and cultural structures act to cause harm.   
25
 This increasing focus on ethnicity in health research has its roots in feminist movements of the 1970s 
that highlighted the importance of difference, and a subsequent move towards the inclusion of minority 
groups in research and an understanding of their differences compared with majority groups (Epstein 
2007).  This has coincided with rapid globalisation and unprecedented movements of people 
transnationally with a consequent need to explore differences among groups with varying geographical 
origins, cultures and migration histories. 
26
 In the United States there has been a parallel surge of interest in the associations between race and 
health.  The use of race in American literature has a particular socio-historical origin that is context-
specific and of limited relevance to work in the UK. 
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measurement.  Several authors have highlighted important limitations of the use of 
ethnicity in health research (Bhopal et al. 1998, Aspinall 2002, Bhopal 2004, Mateos et 
al. 2009).  These authors highlight a lack of critical engagement with ethnicity as a 
construct.  Ethnicity is rarely explicitly defined in papers and there is a propensity for it 
to be conflated with race.  Furthermore the lack of a clear consensus regarding ethnic 
categorisation has led to a lack of standardisation in ethnic groups across studies making 
comparison difficult27 and little description of methods used to ascribe ethnicity to 
individuals.  However, perhaps most importantly, ethnicity is often used with little 
justification for it as a focus of interest or explanation of observed differences.  It has a 
tendency to be deployed as an explanatory variable in itself without a discussion of 
whether differences are attributable to biological, environmental, social or cultural 
factors. 
The most commonly used ethnicity categories in the UK are derived from the decennial 
England and Wales census and are described in table 1.1.  Ethnicity was first recorded 
in the 1991 England and Wales Census, with the same categories rapidly adopted 
throughout the public sector before being introduced into the routine monitoring of 
hospital patients in 1995 (Bhopal et al. 1998).   This has resulted in an “uncritical feast” 
on new sources of NHS ethnicity data (Kesby et al. 2003).   The use of census-derived 
ethnicity categories within healthcare is problematic in that it is a “borrowed system of 
classification” (Pfeffer 1998).  It was developed for administrative and political 
purposes with a consultation process pertaining to these uses alone (Gill et al. 1995), not 
to its use in health research.   
The emergence of a distinct “Black African”28 ethnic category in the UK dates back its 
inclusion in the1991 census and relies on an individual’s self-defined ethnicity as 
belonging to a Black African group, rather than being based on country of birth.   It is 
commonly used to denote people of Sub-Saharan African origin and is widely used in 
policy and health research in the UK, assuming the status of “social category” (Aspinall 
et al. 2011).  Black African has become a standardised term in demographic and health 
research in the UK (Ibid.) and studies that disaggregate this category remain rare.  
However its use in health research is problematic for a number of reasons.  As a term 
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 For example, in the work I cite earlier in this section on ethnic disparities in sexual and reproductive 
health a variety of terminology are used including “African”, “Black African” and “Non-UK Black”. 
28
 Throughout this thesis I avoid using capitalised phenotypic descriptions of ethnicity that can reinforce 
colour of skin as dominant markers of identity.  I only used them when citing work that specifically 
deploys these terms.   
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that refers to outmoded notions of phenotypic difference, it can be perceived as 
offensive to some people from African communities (Agyemang et al. 2005) and may 
not be how people would choose to identify themselves (Bhrolcháin 1990).  
Furthermore it is a broad category that pertains to a group of people who were born in, 
or have antecedents in, a continent comprising fifty-five countries and thousands of 
languages and dialects.   The use of Black African as an ethnic category elides vast 
differences in religion, diet, migratory experience, education, language, kinship groups 
and health beliefs (Elam et al. 2001).  Furthermore it does not differentiate between 
first, second and third generation migrants whose experiences and health may differ.  
We know from rare studies that have presented disaggregated data by country of birth 
that there are disparities between groups of Black Africans in the UK in terms of health 
outcomes such as rates of TB and HIV (Aspinall et al. 2011).  The uncritical use of the 
category "Black African" therefore risks obscuring important differences that may be 
used to inform public health policy.   
In this thesis I aim to engage with the concept of ethnicity critically to explore social 
and cultural differences that may contribute to disparities in outcome and experiences of 
pregnancy in HIV-positive African women.  Rather than using the term Black African, I 
use “African" to describe women who were born in Sub-Saharan Africa and have 
defined themselves as being Black African29.  I have disaggregated data by African 
region of birth30, whilst remaining aware that this approach itself has weaknesses as 
regional groupings are based on national borders that were often created in the context 
of colonisation and may have limited anthropological value.  I use African regions of 
birth pragmatically as a heuristic device to explore cultural and social differences 
among African women, conscious that smaller groupings such as country of birth may 
not be feasible for epidemiological analyses and may also risk identification of 
individuals in groups of very small numbers.   
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 Ethnicity data are collected in the NHS by asking patients to record their ethnicity themselves 
according to England and Wales census categories.  Ethnicity cannot be attributed to a patient on their 
behalf by staff. 
30
 These groupings are based on United Nations regional groups and are described in Chapter Three (table 
3.4: 71).   
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Table 1.1: Classification of ethnicity in the 2011 England and Wales Census 
White 
English/Welsh/Scottish/Northern Irish, British 
Irish 
Gypsy or Irish Traveller 
Any other White background 
Mixed/multiple ethnic groups 
White and Black Caribbean 
White and Black African 
White and Asian 
Any other Mixed/multiple ethnic background 
Asian/Asian British 
Indian 
Pakistani 
Bangladeshi 
Chinese 
Any other Asian background 
Black/African/Caribbean/Black British 
African 
Caribbean 
Any other Black/African/Caribbean background 
Other ethnic group 
Arab 
Any other ethnic group 
Source: 2011 Census Programme 2009. 
 
 I also present data disaggregated by duration of residence in the UK, hypothesising that 
this may be associated with immigration problems and poorer access to health services.  
A recent paper in the Lancet states that undocumented migrants face the greatest 
difficulties in accessing health services but that evidence on the links between migration 
and health is lacking due to the absence of migration-related data on health information 
systems (Rechel et al. 2013). Doctors of the World’s31 2013 report of patients accessing 
their services in fourteen cities across Europe (including London), many of whom were 
undocumented migrants and asylum seekers, found high levels of psychosocial need 
(Chauvin et al. 2013).  Over 90% of their patients reported barriers to accessing 
healthcare with nearly 60% describing difficulties in accessing antenatal care.  The main 
obstacles reported included lack of knowledge of healthcare systems, being denied care 
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 Doctors of the World/Médecins du Monde is a global organization which delivers healthcare to 
vulnerable people affected by war, natural disaster, hunger, poverty or exclusion.  See 
http://doctorsoftheworld.org.uk/pages/about-us.   
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and being unable to pay for care.    
Finally, I contextualise my epidemiological findings with qualitative data in order to 
explore underlying mechanisms for observed differences.  I present this thesis as a 
response to the following call to action in a wide-ranging review of literature on sexual 
and reproductive health of migrants in resource-rich settings: 
“Challenges will only be overcome if more studies are conducted with an inter-
disciplinary focus on migrant reproductive health. These should be both quantitative, 
such as epidemiological surveys with an appropriate disaggregation of different migrant 
populations, and qualitative, or ethnographic, in character. While the former would 
enable the collection of new data on migrant populations and thus improve our 
understanding of the reproductive health issues that confront them, the latter would 
deepen our knowledge of the socio-economic, political and cultural forces that 
contribute to reproductive health inequities between specific migrant groups and their 
hosts.” 
(Georgiadis 2008: 22) 
1.7 Research question 
The overarching research question posed in this thesis is: how do African women living 
with HIV in the UK engage with HIV services and interventions during and after 
pregnancy?32  The three specific questions posed are: 
1. Are maternal ethnicity, African region of birth and duration of residence in the 
UK associated with:  
a. Not receiving ART during pregnancy 
b. Detectable maternal HIV viral load at delivery 
c. Vertical transmission of HIV 
d. Late antenatal booking 
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 I use the terms “living with HIV” and “HIV-positive” interchangeably throughout this thesis.  There 
have been important critiques of the term “HIV-positive” that point to the relegation of the individual and 
the removal of agency and a suggestion that it is substituted with “living with HIV” (Dilmitis et al. 2012).  
On the other hand, the term has been employed by many HIV activists since the beginning of the 
epidemic.  My decision to use both reflects this tension and my own uncertainties about finding the ‘right’ 
term.    
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e. Loss to follow-up from HIV care in the year after pregnancy 
2. What are the mechanisms underlying associations between clinical and service 
outcomes, and maternal ethnicity, African region of birth and duration of 
residence in the UK? 
3. What are the experiences of African women living with HIV during and after 
pregnancy? 
Understanding engagement with care during and after pregnancy in HIV-positive 
African women living in the UK involves exploring clinical outcomes; access to 
services; beliefs about illness, health and childbearing; and lived experiences.  To 
explore this complex and multidimensional research question I use a mixed methods 
approach combining quantitative and qualitative methods informed by epidemiology 
and anthropology respectively.  
1.8 Theoretical frames  
Having outlined the rationale for this study and presented my research questions, I will 
now provide a summary of three key theoretical frames that inform my qualitative 
analyses and the synthesis of the quantitative and qualitative data in subsequent 
chapters.  The often interconnected concepts of diaspora and globalisation, structural 
violence, and stigma are important anchors, repeatedly referred to at several points in 
this thesis.  
1.8.1 Diaspora and globalisation 
The term diaspora  is defined by the Oxford English Dictionary as the “dispersion or 
spread of people from their original homeland” (2011).   Classically, the term has been 
associated with the archetypal Jewish and Greek diasporas, its use historically carrying 
with it notions of exile and longing (Butler 2001).   Since the 1980s there has been a 
proliferation in its use, both academically and through people’s self-identification as 
part of diasporic groups, resulting in a degree of conceptual ambiguity (Ibid.).  It is 
important to be clear about the distinct nature of diaspora compared with other 
movements of people.  Although diaspora involves migration, not all migration results 
in diaspora.  Butler identifies the distinct characteristics of diaspora as dispersal to more 
than one destination, a relationship to an actual or imagined homeland, an ethnonational 
consciousness, and a collective history of group dispersal (Ibid.).  The notion of 
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diaspora is a conceptual tool that is context dependent and shifts over time and space 
(Patterson et al. 2000).   The reasons for dispersal, the nature of the relationship with the 
homeland and the host land, and differences within groups (such as class and gender) 
are all integral in shaping diasporic communities.     The use of “African diaspora” 
emerged specifically in the 1950s in reference to shared experiences of those displaced 
by the Slave Trade, but is now commonly used to describe the contemporary global 
migrations of various African communities (Ibid.) who retain relationships with their 
homelands and an ethnonational identification whether that is Yoruba, Nigerian or 
African.   
Related to diaspora, is the concept of globalisation.  One reason for the surge of interest 
in diaspora has been the scale of movement of people fuelled by technological advances 
in transportation and media (Appadurai 1996).  Whereas previous representations of 
space were based on notions of “break, rupture and disjunction” (Gupta et al. 1992), we 
now live in an era of “border crossings” where: 
“old-fashioned attempts to map the globe as a set of culture regions or homelands are 
bewildered by a dazzling array of postcolonial simulacra, doublings and redoublings, as 
India and Pakistan reappear in postcolonial simulation in London, prereveloution 
Tehran rises from the ashes in Los Angeles, and a thousand similar cultural dreams are 
played out in urban and rural settings all across the globe.  In this culture-play of 
diaspora, familiar lines between “here” and “there”, centre and periphery, colony and 
metropole are blurred.” 
(Gupta et al. 1992: 10) 
Notions of strictly bounded communities and geographical-cultural isomorphism no 
longer have purchase, superseded by ideas of deterratorialisation33 and 
interconnectedness (Ibid.) that have challenged the supremacy of the nation-state 
(Appadurai 1996).    However, this mass movement is not confined to people.  
Appadurai sees globalisation a product of global cultural flows in five domains that he 
terms ethnoscapes, technoscapes, financescapes, mediascapes and ideoscapes (Ibid.: 
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 Appadurai describes this condition of the world we live in now as “rhizomic” (1996: 29) borrowing 
from the work of Deleuze and Guattari ([2004] 1980) who argue for the displacement of the defined, 
hierarchical structures of “arborescent” tree and root ontological models in favour of the rhizome which 
foregrounds connection and multiplicity: “ unlike trees or their roots, the rhizome connects any point to 
any other point, and its traits are not necessarily linked to traits of the same nature” (Ibid.: 21). Appadurai 
uses the image of the rhizome to capture the interconnections, disjunctures and rootlessness of the 
contemporary globalised world.  Also see Paul Gilroy’s description of the “Black Atlantic” diaspora as a 
“rhizomorphic and fractal structure” (1993: 4) 
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33), pertaining to flows of people, technology, global capital, information (especially 
electronically) and ideologies respectively.  Rather than being a homogenising force, 
globalisation has created -scapes in which cultural flows are characterised by 
disjuncture and “deeply perspectival” local articulations (Ibid.: 33).    The work 
presented in this thesis draws upon the notion of transnational flows of culture to 
explore how African women are situated within a global interconnected space and how 
this impacts upon their management of HIV within the UK. 
1.8.2 Structural violence 
The concept of structural violence was developed by Johan Galtung in his seminal 1969 
paper on peace and violence (Galtung 1969).  For Galtung, violence extends beyond the 
physical domain and is “present when human beings are being influenced so that their 
actual somatic and mental realizations are below their potential realizations” (Ibid.: 
168).  He makes a distinction between “personal or direct” violence involving a subject 
who commits a violent act, and “structural or indirect” violence.  Structural violence is 
not perpetrated by a subject but is instead “built into the structure and shows up as 
unequal power and consequently unequal life chances” (Ibid.: 171) as a result of the 
uneven distribution of resources and power, and is often not perceived directly.  Galtung 
is careful to emphasise that “in both cases [either personal or structural violence] 
individuals may be killed or mutilated, hit or hurt in both senses of the words, and 
manipulated by means of carrot and stick strategies” (Ibid.: 170).   
Structural violence is a central organising principle in Critical Medical Anthropology34 
with writers such as Philippe Bourgois35 and Nancy Scheper-Hughes36 focusing on how 
the macro-level forces of poverty, racism, gender inequality and political violence come 
to be embodied by people in the form of ill health.  With specific reference to South 
Africa, Didier Fassin has explored how the legacy of Apartheid and the post-Apartheid 
economic and political situation have created conditions in which the HIV-pandemic 
has flourished, leaving its mark disproportionately on the most vulnerable in society 
(Fassin 2007).  Paul Farmer in his work in Haiti, Russia, Rwanda and the United States 
has challenged the notion of individual risk behaviours, showing how increased 
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 The branch of medical anthropology that uses critical theory and an explicit consideration of issues of 
power to explore the associations between social inequality and ill health. 
35
 See Bourgois’ work with crack dealers in East Harlem in which he traces the emergence of the crack 
cocaine economy subculture as “an alternative forum for autonomous personal dignity” in response to 
social marginalisation (1996).  
36
 See Scheper-Hughes’ study of high child mortality, and mothers’ responses to infant death, in the 
context of chronic extreme poverty in a favela in North Eastern Brazil (1993). 
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vulnerability to HIV and poor access to HIV care are predominantly driven by poverty, 
lack of health infrastructure, unequal gender relations, discriminatory practices and 
aspects of national and international policy (Farmer 2004).  
There is therefore a clear precedent for employing the concept of structural violence in 
the analysis of disparities in health, especially in work on HIV.  In this thesis I explore 
how structural violence manifests itself particularly under conditions of diaspora in the 
UK and how it impacts on African women’s utilisation of HIV services.   
1.8.3 Stigma 
The Oxford English Dictionary defines stigma as a mark of disgrace associated with a 
particular circumstance, quality or person” (2011).  Its origins are in the Ancient Greek 
term referring specifically to bodily signs (such as incisions or branding) that were 
“designed to expose something unusual about the moral status of the signifier” 
(Goffman [1990] 1963: 11), although its common usage now extends beyond physical 
manifestations.    Goffman views stigma as “a special discrepancy between virtual and 
actual social identity”37 where someone possesses an “attribute that is deeply 
discrediting” (Ibid.: 13) leading to discrimination “through which we effectively, if 
often unthinkingly, reduce … life chances” (Ibid.: 15).  For Goffman, stigma is 
profoundly relational and is located in the interactions between people, making a 
distinction between those whose stigmatising characteristic is evident or known about, 
the “discredited”, and those whose difference is not apparent or known about, the 
“discreditable” (Ibid.: 14).  The risk of the disclosure of the discreditable attribute is that 
it “spoils” social identity by revealing the discrepancy between virtual and actual 
identity (Ibid.: 31).  The concealment of the discreditable attribute involves the careful 
management of information (Ibid.: 57) in order to “pass” as “normal” (Ibid.: 95), which 
has particular salience in the context of HIV and fears about disclosure of status. 
Goffman’s theory of stigma has been highly influential and is the dominant theoretical 
frame for much health research exploring the impact of stigma, including within HIV.  
Although it provides a useful framework for conceptualising stigma, its focus is on the 
micro-interactions between people.  More recent work by Parker and Aggleton, with 
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 Goffman uses the term "social identity" to describe the composite of structural and personal 
characteristics ascribed to people based on social categories, for example assumptions made on 
discovering someone’s occupation.  However, this identity is “virtual” in that it is imputed from 
normative expectations of a person belonging to that “category” of person and may be discrepant with an 
individual’s true attributes, their “actual social identity” ([1990] 1963: 12).    
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specific reference to HIV and AIDS-related stigma and discrimination, places stigma 
within a wider context of structural forces, attending to issues of power and 
domination38 and highlighting how the “strategic deployment” of stigma serves the 
interests of dominant groups (Parker et al. 2003).   Furthermore, other forces of social 
inequality articulate closely and synergistically with stigma to produce vulnerability 
(Castro et al. 2005)39.   I use Goffman’s theory of stigma and this more recent work on 
the role of power and domination to explore the interpenetration of stigma and structural 
violence as experienced by migrant African women living with HIV in the UK.  
1.9 Structure of this thesis 
The thesis comprises eleven chapters, including this introductory chapter and six 
empirical chapters.  Quantitative and qualitative data are integrated where possible.   
In Chapter Two I locate my research question within existing knowledge of HIV and 
pregnancy in resource-rich settings.  I present a narrative literature review specifically 
focusing on the five key clinical and service-related outcomes explored in this thesis, 
and a review of qualitative literature that explores pregnancy in the context of HIV in 
the UK.   
In Chapter Three I describe the overall mixed methods approach I have used in this 
thesis.  I provide an overview of the mixed-methods model I have adopted in this work, 
before describing in detail the specific methods and analytic approaches used in the 
quantitative and qualitative phases of this study. 
In the first of my empirical chapters, Chapter Four, I draw upon NSHPC data to provide 
a broad epidemiological overview of pregnancy in HIV-positive African women living 
in the UK.  I present data on trends over time in ethnicity of women, maternal African 
region of birth and duration of residence in the UK.   I then present baseline 
demographic and clinical characteristics of women whose pregnancies form the basis of 
analyses in Chapters Five, Seven and Eight.   
In Chapter Five, a mixed methods empirical chapter, I present the results of analyses of 
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 This work is informed by critical theory with particular reference to Foucault’s notion of the inherent 
issues of power in the social production of difference (Foucault 1978), Bourdieu’s concept of symbolic 
violence as “the process by which symbolic systems (words, images, practices) promote the interests of 
dominant groups” (Parker et al. 2003: 18), and hegemony in which dominant groups secure their position 
over subordinate groups consensually via structuring fields of ideology and meaning (Gramsci 1970). 
39
 The authors discuss how HIV-related stigma is often more pervasive in those experiencing poverty, 
gender inequality and racism and that the combined forces of social inequalities and stigma interpenetrate 
to constrain people’s capacity to manage their illness further.   
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NSHPC data investigating the association between maternal ethnicity, region of birth 
and duration of residence in the UK and (i) uptake of ART, (ii) detectable viral load at 
delivery, and (iii) vertical transmission, in African women.   I then draw upon 
ethnographic data to explore women’s experiences of taking, or not taking, ART during 
pregnancy. 
Pentecostal faith and beliefs in divine healing are often cited by professionals as a 
potential barrier to engagement with HIV care.  In Chapter Six I explore the role of 
Pentecostalism in managing illness, with specific reference to HIV, drawing mainly 
upon ethnographic material collected during fieldwork in a diasporic African 
Pentecostal church in London.   I situate illness within a broader cosmological 
framework of spiritual misfortune and explore factors that underpin the popularity of 
Pentecostalism among African migrants in order to challenge misconceptions about 
beliefs in divine healing as irrational.  I conclude by considering whether it acts as a 
barrier to engagement with HIV services and interventions.   
In Chapter Seven, I explore African women’s engagement with and experiences of 
health services during pregnancy, using both quantitative and qualitative data.  I present 
the results of my analyses of epidemiological data investigating the association between 
late antenatal booking and maternal ethnicity, region of birth and duration of residence 
in the UK.  These epidemiological findings are contextualised with ethnographic data 
exploring women’s attitudes towards and experiences of health services.  I conclude by 
drawing upon ethnographic data to specifically explore women’s experiences of 
maternity services at the time of delivery.  
In Chapter Eight, the last of my mixed methods empirical chapters, I explore the 
engagement with HIV services by African women for their own care after pregnancy.   I 
start by using NSHPC data to examine the association between loss to follow-up from 
HIV care after pregnancy and maternal ethnicity, region of birth and duration of 
residence in the UK.  I then contextualise these findings with ethnographic data to 
explore why most women continue to engage with HIV services after pregnancy, and 
why other may find it harder to engage.   
In Chapter Nine I present ethnographic data on infant-feeding decision making in HIV-
positive African women.  I describe the social context in which these decisions are 
made and the profound social impact of not breastfeeding on this group of women.  I 
outline specific difficulties women experience in adhering to national guidelines to 
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abstain from breastfeeding and trace an emergent resistance to these recommendations.   
In Chapter Ten I present a synthesis of my quantitative and qualitative findings with 
reference to the overarching research question and the specific questions posed in this 
thesis.  I highlight how my research has generated new knowledge in key areas and 
conclude with a discussion of the strengths and limitations of my methodological 
approach in this thesis.   
In my final chapter (Chapter Eleven) I highlight the significance of my findings, 
specifically discussing implications for further work and making key recommendations 
for the collection of surveillance data, the delivery of clinical services, and the 
development of wider public policy. 
40 
 
2  
            
Literature Review 
 
Summary 
In this chapter I present a literature review specifically focusing on HIV and pregnancy 
and the five key clinical and service-related outcomes explored in this thesis.  These are 
(i) uptake of ART in pregnancy, (ii) maternal HIV viral load at delivery, (iii) vertical 
transmission of HIV, (iv) timing of antenatal booking among HIV-positive women, and 
(v) loss to follow-up after pregnancy.  I also present a narrative review of qualitative 
literature that explores pregnancy in the context of HIV in the UK.   
2.1 Introduction 
The overarching question posed in this thesis is: how do African women living with 
HIV in the UK engage with HIV services and interventions during and after pregnancy? 
This thesis explores key clinical and service-related outcomes, and their association 
with maternal ethnicity, African region of birth and maternal duration of residence in 
the UK; as well as women’s experiences during and after pregnancy. In this chapter I 
locate my work within existing knowledge of HIV and pregnancy in resource-rich 
settings40.  I present a narrative literature review41 specifically focusing on HIV and 
pregnancy and the five key clinical and service-related outcomes explored in this thesis.  
These are (i) uptake of ART in pregnancy, (ii) maternal HIV viral load at delivery, (iii) 
vertical transmission of HIV, (iv) timing of antenatal booking among HIV-positive 
women, and (v) loss to follow-up after pregnancy.  I also present a narrative review of 
qualitative literature that explores pregnancy in the context of HIV in the UK.   
2.2 Uptake of antiretroviral therapy in pregnancy 
The advent of antiretroviral therapy, most importantly HAART, has resulted in dramatic 
declines in deaths and diagnoses of AIDS (Health Protection Agency 2012), as well the 
prevention of other comorbidity such as cardiovascular disease (Emery et al. 2008).  
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 Studies in resource-poor settings predominate in the field of HIV and pregnancy however findings from 
these studies are rarely generalisable to resource-rich settings such as the UK. 
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 See Appendix iii for the search strategy used for this review.  A systematic review of work on HIV and 
pregnancy was beyond the scope of this thesis.   
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Uptake of ART in the general HIV-positive population with CD4 counts below the 
treatment threshold (<350 cells/mm3) has recently been estimated at just over 90% in a 
clinic population in the UK (Kober et al. 2011).  In the same study, a lower CD4 count 
and a higher viral load were predictive of taking ART (Ibid.).  Risk factors for not 
taking ART include younger age (Kober et al. 2011, Fleishman et al. 2012a), not being 
at an advanced stage of disease (Ezzy et al. 1998) and injecting drug use (Kober et al. 
2011).  Evidence for the effect of gender is conflicting with some studies finding that 
women are less likely to take ART than men (Ezzy et al. 1998, Fleishman et al. 2012a), 
whilst others finding that female gender is associated with increased uptake (Kober et 
al. 2011). Similarly, there is no consensus on the effects of race and/or ethnicity.  A 
systematic review of twenty-six studies between 1984 and 1999 concluded that there 
was evidence of racial and/or ethnic disparities in uptake of ART (Palacio et al. 2002) 
with recent work from the United States also finding that decreased uptake was 
associated with Black race (Fleishman et al. 2012a).  Studies from the UK and Italy 
have found no association between uptake and ethnicity (Elford et al. 2008b), and being 
a migrant (Floridia et al. 2007) respectively. 
ART is the mainstay of prevention of vertical transmission and the use of ART by HIV-
positive pregnant women in resource-rich settings is high42, having increased over time 
(Lansky et al. 1999, Giles et al. 2008, Townsend et al. 2008b, Bailey et al. 2011, 
Townsend et al. 2013).  In the UK, 99% of women diagnosed with HIV received ART 
during pregnancy between 2007 and 2011 (Townsend et al. 2013) with comparably high 
rates of uptake in other parts of Europe (Mayaux et al. 2003, Bailey et al. 2011).  
Studies have identified similar risk factors for non-uptake of ART among pregnant 
women and non-pregnant HIV-infected population.  These include asymptomatic 
disease (Bailey et al. 2011) and substance misuse (Abatemarco et al. 2008, Bailey et al. 
2011, Elenga et al. 2012).  Risk factors specific to pregnancy include being diagnosed 
with HIV late in pregnancy (Mayaux et al. 2003), suboptimal antenatal care (Lansky et 
al. 1999, Mayaux et al. 2003, Abatemarco et al. 2008), preterm delivery (Mayaux et al. 
2003) and lack of partner support of ART use (Kiarie et al. 2003).  Again, the role of 
race and/or ethnicity remains unclear with a study in the US reporting decreased uptake 
in pregnant Black women (Abatemarco et al. 2008) but no disparities in uptake 
according to ethnic group identified within a French cohort of pregnant women 
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 It is important to note that uptake of ART during pregnancy is also high in low and middle-income 
countries although this is not the focus of my thesis (Ekama, et al. 2012, Kinuthia, et al. 2011, 
Kreitchmann, et al. 2012). 
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(Mayaux et al. 2003).   
A recent analysis of UK and Ireland data from the NSHPC between 2005 and 2010 
looked specifically at women who received less than fourteen days of ART prior to 
delivery43 and found that this group had high rates of vertical transmission at 13% 
(Modestini et al. 2012).  The main predictor of sub-optimal ART was being diagnosed 
with HIV during pregnancy.  The authors found no association with being born in 
Africa; they did not look further at differences among African women.  Follow-up 
questionnaires sent to participating clinics identified late antenatal booking, denial of 
HIV status, and refusal of treatment by women as important explanatory factors.  In that 
study eleven women were documented not to have received ART during pregnancy, of 
whom six had been diagnosed at term.  The work presented in this thesis includes all 
eligible pregnancies over a longer time period and is therefore larger in scale.  
Furthermore, it specifically focuses upon the association between not receiving any 
ART during pregnancy and maternal ethnicity, African region of origin and duration of 
residence in the UK.   
2.3 Detectable maternal HIV viral load at delivery 
Maternal HIV viral load at delivery is the most important predictor of vertical 
transmission of HIV (Garcia et al. 1999, European Collaborative Study 2005, Townsend 
et al. 2008a) and control of this is the main mechanism by which ART prevents 
transmission of HIV to the infant (Panel on Treatment of HIV-Infected Pregnant 
Women and Prevention of Perinatal Transmission 2012).   Pregnancy does not appear to 
affect women’s response to ART (Rachas et al. 2013).  Lack of virological suppression 
may indicate sub-optimal response to ART or poor adherence and may result in the 
development of resistant virus44, compromising a woman’s future ART treatment 
options.  In a previous analysis based on combined data from the NSHPC and the 
European Collaborative Study (ECS) between 2000 and 2009, I reported that maternal 
HIV viral load was detectable at delivery in 25% of pregnancies reported in HIV-
positive women (Tariq et al. 2011).  This is comparable to rates of between 19% and 
35% reported in other studies from Europe, the United States and Brazil (Patel et al. 
2007, Baroncelli et al. 2009, Katz et al. 2010, Joao et al. 2012, Rachas et al. 2013). 
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 This study included data from the NSHPC and data from questionnaires sent to NHS HIV antenatal 
clinics.  Approximately 25% of eligible pregnancies were excluded from this study due to non-response 
from clinics for further data. 
44
 HIV drug resistance is the ability of the HIV virus to replicate and mutate in the presence of 
antiretroviral drugs that can lead to failure of certain drug regimens.  
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High maternal HIV viral load early in pregnancy is one of the most important predictors 
of detectable viral load at delivery (Louis et al. 2005, Patel et al. 2007, Floridia et al. 
2010, Joao et al. 2012, Kay et al. 2012, Read et al. 2012), as is duration of ART (Joao et 
al. 2012, Read et al. 2012, Rachas et al. 2013).  The class of ART used in pregnancy 
may play a role with nevirapine-based45 regimes having been shown to result in faster 
rates of viral suppression (Patel et al. 2007, Kay et al. 2012).  There is also evidence that 
a non-nucleoside reverse transcriptase inhibitor46 regime (NNRTI) in a previous 
pregnancy increases the risk of not adequately suppressing the virus (French et al. 2013)  
Other risk factors for detectable viral load at delivery include substance misuse (Katz et 
al. 2010), change in ART regime during pregnancy (Floridia et al. 2010) and preterm 
delivery (O'Shea et al. 1998).  The few studies that have explored behavioural risk 
factors for detectable viral load at delivery have found associations with poor adherence 
to ART (Louis et al. 2005, Weinberg et al. 2009) and non-disclosure to partners 
(Jasseron et al. 2011).   
Very few studies have looked at the effects of ethnicity on maternal viral load at 
delivery.  Two studies, both from Italy, found that migrant women (mainly African) did 
not have an increased risk of detectable viral load at delivery (Floridia et al. 2007, Izzo 
et al. 2011).  Patel et al (2007), in their analysis of ECS data, also found no association 
between ethnicity and detectable viral load at delivery, although they demonstrated 
faster rates of virological suppression in West African women which they hypothesise 
may be due to differences in maternal HIV subtype or host biological factors.  The work 
presented in this thesis is the first study in the UK to explore the association between 
ethnicity and maternal viral load at delivery.  It is also the first study anywhere, to the 
best of my knowledge, to specifically look at differences in virological response among 
pregnant HIV-positive African women according to region of birth and duration of 
residence in the host country.  
2.4 Vertical transmission of HIV 
Transmission of HIV from a mother to her infant can occur before or during delivery, or 
after delivery through breastfeeding47 (Newell 1998).  In the absence of medical 
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 An antiretroviral medication that is commonly used during pregnancy worldwide. 
46
 One of the five classes of antiretroviral medications currently licensed for the treatment of HIV.  This 
class includes the commonly used drug in pregnancy nevirapine.   
47
 The overwhelming majority of cases of vertical transmission in the UK in women diagnosed with HIV 
will be as a result of in-utero or perinatal transmission as breastfeeding is rare in this setting (see Chapter 
Nine). 
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interventions the rate of vertical transmission has been estimated to be between 25% 
and 40% (Newell et al. 1997).  With appropriate medical management the rate of 
transmission can be reduced to less than 2% (Warszawski et al. 2008, Baroncelli et al. 
2009, European Collaborative Study 2010, von Linstow et al. 2010).  Overall in women 
diagnosed with HIV by the time of delivery, the vertical transmission rate in the UK 
between 2007 and 2011 was 0.57%, reaching 0.46% in 2010 (Townsend et al. 2013), a 
dramatic decline from a peak of nearly 20% in 1993 (Duong et al. 1999).  The majority 
of cases of perinatal transmission now occur in women who have had less than two 
weeks of ART or none at all (Modestini et al. 2012), many of these being women 
diagnosed with HIV during labour or after delivery (National Study of HIV in 
Pregnancy and Childhood (NSHPC) et al. 2007).  
Duration of ART is an important determinant of vertical transmission with longer 
duration of ART associated with lower risk of transmission (Bailey et al. 2011, Forbes 
et al. 2012, Townsend et al. 2013).  This is reflected by vertical transmission rates as 
low as 0.19% in women conceiving on ART (Townsend et al. 2013).  As highlighted in 
the previous section, maternal HIV viral load plays a pivotal role in vertical 
transmission.   Recent NSHPC data has highlighted the negligible rate of transmission 
(0.05%) when a woman has a viral load close to delivery of <50 copies/ml (Townsend 
et al. 2013).  Elective caesarean section has also long been an important component in 
the prevention of vertical transmission (Kind et al. 1998, European mode of delivery 
collaboration 1999, International Perinatal HIV Group 1999).  However recent data 
demonstrating rates of vertical transmission of less than 0.5% regardless of mode of 
delivery have led to a shift in practice to planned vaginal delivery in women who are 
virologically suppressed (Boer et al. 2007, Townsend et al. 2008a, Warszawski et al. 
2008, Boer et al. 2010) 
Obstetric factors that may increase the risk of vertical transmission, especially in the 
presence of circulating maternal virus, include premature rupture of membranes 
(Landesman et al. 1996, Kuhn et al. 1999, Tomarken 2001, Garcia-Tejedor et al. 2009), 
and invasive monitoring and other interventions (European Collaborative Study 1992, 
Kind et al. 1998, Garcia-Tejedor et al. 2009).  Several infant-related factors have also 
been associated with an increased risk of HIV transmission including preterm delivery 
(European Collaborative Study 1992, Kuhn et al. 1999, Struik et al. 2008), low 
birthweight (Landesman et al. 1996, Garcia-Tejedor et al. 2009), twin pregnancy 
(Scavalli et al. 2007) and female sex (Piwoz et al. 2006, Brahmbhatt et al. 2009).   
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Maternal risk factors for vertical transmission identified in the literature include 
maternal seroconversion during pregnancy (Struik et al. 2008), low maternal CD4 count 
at delivery (Landesman et al. 1996, Ioannidis et al. 2001, European Collaborative Study 
2005, Garcia-Tejedor et al. 2009),  certain viral subtypes (Renjifo et al. 2001), 
coexistent infections (Mwapasa et al. 2006, Gupta et al. 2011), substance misuse 
(Landesman et al. 1996, Peters et al. 2008), non-HAART regimens (Siegfried et al. 
2011) and treatment interruption during pregnancy (Martino et al. 2009).  With regards 
to ethnicity and/or race, studies from France and the UK have not demonstrated an 
association between maternal ethnicity and vertical transmission (Jasseron et al. 2008, 
Townsend et al. 2008a), whilst increased transmission was seen in White women 
compared to Black and Hispanic women in a New York cohort (Peters et al. 2008).  
There have been no studies to date that have examined the effects of African region of 
birth or duration of residence in the host country on the risk of vertical transmission.   
2.5 Late antenatal booking48 
Antenatal care plays an important role in maternal and infant health (Bergsjø et al. 
1997), providing a woman with information and support to make decisions about her 
pregnancy .  Guidelines from both the UK and Ireland state that all women should have 
their first antenatal care appointment, known as “antenatal booking”, by ten to thirteen 
weeks’ gestation (National Institute for Health and Clinical Excellence 2008, 
Department of Health 2009).  In 2010-2011, it was estimated that just over 30% of 
women in England had their booking appointment at thirteen weeks’ gestation or 
beyond49.  
Low maternal socioeconomic status (Brown 1989, Essex et al. 1992, Melnikow et al. 
1993, Beeckman et al. 2010), young maternal age (Essex et al. 1992, Blondel et al. 
1998, Delvaux et al. 2001), not having a stable partner (Delvaux et al. 2001) and 
multiparity (Essex et al. 1992, Blondel et al. 1998) have all been identified as risk 
factors for late booking in studies from the United States and Europe.  Studies 
specifically from the UK have identified similar risk factors (Simpson et al. 1980, Lewis 
1982, Florey et al. 1994, Kupek et al. 2002, Rowe et al. 2008, Redshaw et al. 2010).   
Maternal non-white ethnicity and migrant status have been shown to play an important 
role in late presentation to antenatal care.  Studies in England have demonstrated an 
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 Some of this material appears in Tariq et al 2012a . 
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 See NHS Maternity Statistics for 2010-2011 (provider level analysis tables) available at 
http://www.hscic.gov.uk/pubs/maternity1011 (accessed 23 September 2013). 
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association between late antenatal booking and black ethnicity (Rowe et al. 2008, 
Redshaw et al. 2010), and both being from a minority ethnic group and having been 
born outside of the UK (Redshaw et al. 2010).  Immigration status is a further 
associated factor with a study from Switzerland reporting an eleven-fold higher risk of 
delayed prenatal care in undocumented migrant mothers compared with mothers with 
legal residency (Wolff et al. 2008).  Similar associations between ethnicity or migrant 
status, and late booking have been reported in numerous other studies from the UK and 
elsewhere (Simpson et al. 1980, Chisholm 1989, Petitti et al. 1990, Essex et al. 1992, 
Melnikow et al. 1993, Delvaux et al. 2001, Kupek et al. 2002, Alderliesten et al. 2007, 
Park et al. 2007, Beeckman et al. 2010, Chote et al. 2011, Korinek et al. 2011).  A 
systematic review of quantitative and qualitative literature on the use of antenatal care 
by “non-Western” women in industrialised Western countries has identified poor 
knowledge of healthcare systems, language difficulties, previous poor experience of 
healthcare, institutional barriers, lack of social support and recent migration as 
important explanatory factors (Boerleider et al. 2013) 
Late initiation of antenatal care is associated with poor maternal and infant outcomes 
(Quick et al. 1981, Florey et al. 1994, Van Hanegem et al. 2011).  A report from the 
UK’s Confidential Enquiry into Maternal and Child Health (CEMACH) found that 
antenatal booking beyond twelve weeks gestation was more common in women whose 
pregnancies had resulted in a stillbirth or neonatal death (2009)50.  Late booking may 
carry even greater risks in the context of HIV infection as effective prevention of 
vertical transmission is dependent upon early screening for maternal HIV infection, 
prompt initiation of ART, planning of infant delivery and timely support for women in 
making decisions about feeding their infant.   There are few data on the presentation to 
antenatal care of women living with HIV.  A small study from London found that a 
greater proportion of women living with HIV presented late to antenatal care compared 
with the local general obstetric population (Parisaei et al. 2007).  One of the few studies 
exploring ethnicity and antenatal care in women living with HIV revealed that African 
migrants living in France were more likely to initiate antenatal care late than French-
born women (Jasseron et al. 2008).    In terms of HIV-related outcomes, suboptimal 
antenatal care51 has been found to be associated with a decreased uptake of ART 
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 It is important not to assume a causal link as women with socio-demographic risk factors for poor 
maternal and child health outcomes are also probably more likely to present late for care during 
pregnancy.   
51
 Either late booking or fewer visits, or both.   
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(Lansky et al. 1999, Mayaux et al. 2003, Abatemarco et al. 2008) and an increased risk 
of both detectable viral load at delivery and vertical transmission (Wilson et al. 2004, 
Denoeud-Ndam et al. 2013).  There have been no previous studies in the UK 
specifically investigating antenatal care access in women with HIV, and very few 
studies internationally exploring the association between initiation of antenatal care and 
maternal ethnicity, region of birth and duration of residence in the host country, in 
women living with HIV. 
2.6 Loss to follow-up after pregnancy in women living with HIV  
Current standards of care for people living with HIV issued by the British HIV 
Association state that >95% of people known to have HIV should have accessed clinical 
services within the past twelve months (British HIV Association 2012).  Regular 
attendance for HIV care is important as it allows for monitoring of HIV and treatment-
related side effects, provision of ART, access to reproductive and sexual health care, 
and provision of psychological and social support.   
A national study of loss to follow-up52 among adults attending HIV services in England, 
Wales and Northern Ireland between 1998 and 2006 found that 10% of adults attending 
for care in one year failed to attend in the following year (Rice et al. 2011); 5% never 
returned, a further 4% attended at some point later and less than 2% had died (Ibid.).  A 
smaller study of patients attending a London clinic between 1997 and 2005 found that 
one in five of their patients never returned for HIV care (Gerver et al. 2010).  However, 
both of these studies were limited by lack of information on emigration.  A recent audit 
of adults in England, Wales and Northern Ireland with diagnosed HIV found that of 
2255 patients who did not access care in 201153, one in four had left the UK (Clay 
2013). Taking into account emigration, reporting errors and death, the authors estimate 
that at most 2.6% of people with diagnosed HIV who remained in the UK did not access 
care in 2011 (Ibid.).  Factors associated with disengagement from care include female 
gender, younger age, recently diagnosed HIV and not being on ART (Gerver et al. 2010, 
Rice at al. 2011, Clay 2013).  Clay (2013) also identifies stigma, poverty and women’s 
responsibilities as sole carers for children as important barriers to accessing ongoing 
HIV care.  A consistent finding across UK studies is the association between black 
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 There is no consensus in the literature on how to define loss to follow-up, which makes it difficult to 
compare across studies.  Broadly, loss to follow-up is a measure of how many patients fail to maintain 
engagement with HIV care.  A range of measures are used across studies based mainly based on either 
varying periods of time since last clinic visit or number of visits over a defined period.  
53
 This audit was based on those who were known to have accessed care in 2010.  
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African ethnicity and loss to follow-up ART (Gerver et al. 2010, Rice at al. 2011, Clay 
2013).  The association between poorer retention in HIV care and non-White ethnicity 
and/or race has also been reported in studies from other parts of Europe and the United 
States (Fleishman et al. 2012b, Hall et al. 2012, Helleberg et al. 2012, Thierfelder et al. 
2012, Rebeiro et al. 2013).  
HIV antenatal and PMTCT (prevention of mother-to-child transmission) programmes 
offer an opportunity to engage women in long-term HIV care.  However, pregnant 
women and new mothers share many of the risk factors identified above as barriers to 
engagement in care.  Few studies have explored loss to follow-up after pregnancy in 
women living with HIV. The majority have been conducted in resource-poor settings, 
revealing rates of attrition of between 20% and 83% (Panditrao et al. 2011, Ferguson et 
al. 2012, Clouse et al. 2013).  Factors associated with disengagement with care after 
pregnancy include late antenatal booking (Panditrao et al. 2011), institutional barriers 
(Ferguson et al. 2012), lower educational level (Panditrao et al. 2011), poverty 
(Panditrao et al. 2011), not being on ART (Coria et al. 2012), concerns about HIV 
disclosure and stigma (Bwirire et al. 2008, Chinkonde et al. 2009), and lack of support 
especially from partners (Bwirire et al. 2008, Chinkonde et al. 2009, Gilles et al. 2011).  
Data from resource-rich settings are extremely limited.    Among a cohort of HIV-
positive women in Paris, a quarter did not attend for their own HIV care two years after 
delivery of their child, although they did return for appointments for their child (Lemly 
et al. 2007).  The only study that has looked at postnatal loss to follow-up in the context 
of HIV in the UK is an audit of thirty-nine women in a North London hospital showing 
that 65% of women did not access HIV care within three months post-partum 
(Saulsbury et al. 2004).  Recent data from the NSHPC has revealed that two fifths of 
women with a second pregnancy reported to the NSHPC had presented with a low CD4 
count in that pregnancy, with 5% presenting with symptomatic HIV or AIDS (French et 
al. 2012), suggesting sub-optimal HIV follow-up after pregnancy in a proportion of 
HIV-positive women.     
2.7 Experiences of pregnancy in HIV-positive women in the UK 
There is a paucity of qualitative research exploring pregnancy in the context of HIV 
infection in the UK, with the majority of existing studies originating in either Sub-
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Saharan Africa54 or the United States55.  Only six studies have explored pregnancy 
and/or motherhood in the context of HIV in the UK (see table 2.1).  These studies were 
conducted in a variety of settings and vary in their methodological approaches and 
theoretical frames.  Only two studies specifically focus on migrant African women 
living in the UK (Doyal et al. 2005, Treisman et al. 2013), and only two explore HIV-
positive women’s experiences of health services during pregnancy (Naftalin et al. 2010, 
Kelly et al. 2012b). 
A landmark 2005 study conducted with HIV-positive African women (many of whom 
were mothers), revealed the exigencies of everyday life as a migrant African woman 
living with HIV in London with poverty and poor housing very common (Doyal et al. 
2005).  Those without residency status in the UK also faced the pervasive fear of 
deportation and the frustration of not being able to travel back to their home countries to 
visit family.  Almost all the women in this study described fear of disclosure of their 
HIV-status, resulting in a restriction of social interaction including their ability to 
engage with support services.  Health services are therefore a centrally important 
resource for migrant women living with HIV, not only providing medical care but also 
addressing social and psychological needs.  
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 For example see Cooper at al’s work from South African on reproductive decision-making among HIV-
positive men and women in South Africa which highlights the importance of parenthood, especially 
motherhood, in conforming to hegemonic gender identities (2007).  Carol Long’s monograph on HIV-
positive motherhood in South African is also important, emphasising the experiences of disruption and 
dissonance in the context of HIV-positive motherhood and women’s overwhelming fear for the health of 
their children (2009).  
55
 Key references from the US emphasise the strong desire for motherhood in the context of HIV, and the 
role of parenthood in providing meaning (D'Auria, et al. 2006, Kirshenbaum, et al. 2004). See also 
Sandelowski’s (2003) metasynthesis of qualitative findings on HIV and motherhood, which highlight the 
“work” involved in protecting children from HIV infection and preserving a positive maternal identity.   
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Table 2.1: Summary of qualitative studies on HIV and pregnancy in the UK 
Authors Focus of study Recruitment Number of 
participants 
Participant characteristics Methods 
Doyal and 
Anderson 
(2005)* 
How migrant African HIV positive 
ǁoŵeŶ’s liǀes are shaped ďy 
gender, migration and 
seropositivity 
Women attending NHS 
HIV services in London 
62 All Sub-Saharan Black African; 
diagnosed HIV>6 months; not 
necessarily pregnant 
Questionnaire and semi-structured 
interviews using life history 
approach 
Wilson (2007) The interplay between identity 
and illness in HIV-positive 
mothers  
Women attending 
voluntary organisations 
in Scotland 
12 All White British/European, 
diagnosed HIV<1995; six with history 
of injecting drug use 
Semi-structured interview using 
grounded theory and narrative 
approach 
Carter 
(unpublished 
MSc thesis, 
2009) 
The social impact of HIV in 
pregnancy 
Women attending HIV 
support organisations 
in London 
7 Six Sub-Saharan African; previous 
pregnancy since diagnosis 
Open-ended interview with 
content analysis 
Naftalin, 
Moore et al. 
(2010) 
How HIV influences decisions 
regarding conception and 
pregnancy 
Women attending NHS 
HIV services in South 
East England 
8 Five Sub-Saharan African; currently 
pregnant or previous pregnancy since 
HIV diagnosis,  
Semi-structured interviews with 
thematic analysis 
Kelly, Alderdice 
et al. (2012a, 
2012b) 
Reproductive decision-making 
and experience of pregnancy and 
childbirth following HIV diagnosis 
HIV-affected women 
and men attending 
regional HIV unit in 
Northern Ireland 
15 Combination of Sub-Saharan African, 
Asian and Caucasian; HIV-positive or 
partners of people living with HIV; 
trying to conceive or pregnant 
Unstructured interviews using a 
narrative approach 
Treisman, Jones 
et al. (2013) 
How UK-based African women 
perceive, make sense of, and 
manage an HIV diagnosis during 
pregnancy and after delivery 
Women who had 
attended or were 
attending an antenatal 
support group in 
London for HIV-positive 
African women  
12 African, experience of being 
diagnosed with HIV during pregnancy 
Semi-structured interviews with 
interpretative phenomenological 
analysis (IPA) approach 
*This study is included as although its focus was not specifically pregnancy, motherhood emerges as a central theme.  
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The centrality of motherhood in constructing female identity and achieving normality is 
emphasised in many studies (Doyal et al. 2005, Naftalin et al. 2010, Kelly et al. 2012b).  
Motherhood provides an important reason to live (Doyal et al. 2005, Wilson 2007, 
Naftalin et al. 2010, Kelly et al. 2012a) but is disrupted in the context of HIV (Kelly et 
al. 2012a), with women experiencing themselves as a potential source of danger to their 
children (Wilson 2007, Kelly et al. 2012a).  Widespread and deep-rooted anxieties 
about vertical transmission of HIV (Naftalin et al. 2010, Kelly et al. 2012a) result in 
women being highly motivated to take ART and engaging well with care, many finding 
solace in medical interventions that reduce the risk of transmission to their babies 
(Naftalin et al. 2010, Kelly et al. 2012b).  However, women often find the interventions 
difficult (Naftalin et al. 2010) with the avoidance of breastfeeding identified as 
particularly challenging due to the cultural importance of breastfeeding and fears about 
bonding (Treisman et al. 2013).   Fear and experiences of stigma predominate in these 
studies with women often anxious about disclosing to support networks, resulting in 
careful management of information (Carter 2009, Kelly et al. 2012b) and social 
isolation (Carter 2009).  Healthcare providers therefore become an important source of 
support (Naftalin et al. 2010, Kelly et al. 2012b), with continuity of care with a 
specialist team highly valued (Kelly et al. 2012b).  However, this trust in healthcare 
systems can be compromised by negative experiences such as lack of compassion, poor 
knowledge and discriminatory attitudes from key professionals (Wilson 2007, Kelly et 
al. 2012b). 
Key qualitative and theoretical texts that inform the qualitative analyses in this thesis 
are presented in the relevant chapters (Five to Nine), as is the convention in 
ethnographic writing, in order to create a dialogue between my findings and existing 
work.    
2.8 Conclusions 
Little is known both internationally and within the UK on key service-related outcomes 
among pregnant women living with HIV such as initiation of antenatal care and loss to 
follow-up after pregnancy.  Furthermore, the impact of ethnicity, and the potential 
heterogeneity within broad ethnic groups, has been relatively overlooked when 
exploring both key clinical and service-related outcomes including uptake of ART 
during pregnancy, maternal viral load at delivery and antenatal booking. 
Only six qualitative studies to date have engaged with experiences of pregnancy and 
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motherhood among women living with HIV in the UK (see table 2.1).  Only two of 
these focused upon African migrant women (Doyal et al. 2005, Treisman et al. 2013), 
and only one of these specifically explored pregnancy (Treisman et al. 2013).  The 
degree of analytic depth and theoretical engagement varies across these six studies and 
one of them remains unpublished.  None of these studies take an ethnographic approach 
and all are based exclusively on some variation of interviews.  Furthermore there is no 
explicit focus in these studies on macro-level factors such as poverty and public policy, 
which are likely to constrain women’s agency when seeking care and are often 
overlooked (Hampanda 2012)56. 
The work presented in this thesis attempts to bridge this gap in existing knowledge on 
HIV and pregnancy by exploring maternal outcomes in African women and their 
association with ethnicity, region of birth and duration of residence in the UK.  The 
epidemiological findings are contextualised with ethnographic research exploring 
women’s experiences during and after pregnancy, with a particular focus on the broader 
structural factors that may constrain women’s engagement with HIV care.  The 
combination of both quantitative and qualitative methods in a single study to explore 
pregnancy in HIV-positive women has not been undertaken before, presenting an 
opportunity to gain new knowledge and to explore methodological boundaries. 
Key points 
 There are few studies internationally, and none from the UK, that explore 
antenatal booking and loss to follow-up after pregnancy in HIV-positive women. 
 Data on the impact of ethnicity, region of birth and maternal duration of 
residence on outcomes on clinical and service-related outcomes in pregnancy are 
lacking. 
 There are very few qualitative studies that engage with the lived experience of 
pregnancy and motherhood in HIV-positive women in the UK, especially among 
African women who are the largest group. 
 There is a paucity of literature pertaining to HIV and pregnancy that explores the 
impact of structural factors on women’s engagement with HIV care. 
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 Hampanda notes in her review of literature on the prevention of vertical transmission (2012) that the 
majority of studies to date have focused on individual level constructs, such as psychological models of 
health beliefs and behaviour, to the exclusion of a theoretical engagement with structural inequalities such 
as gender and poverty. 
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3  
            
Methods 
 
Summary 
In this chapter I describe the overall mixed methods approach I have used in this thesis.  
I start by introducing mixed-methods research as a methodological57 approach, moving 
on to describe the mixed-methods model I have adopted in my work.  I then describe in 
detail the specific methods and analytic approaches 58used in the quantitative and 
qualitative phases of this study59.     
3.1 Mixing methods 
In the previous chapter I situated this thesis within existing knowledge on HIV and 
pregnancy, particularly focusing on literature pertaining to migrant women and women 
from minority ethnic communities.  This narrative review encompassed literature from 
both quantitative and qualitative research traditions, highlighting the role both 
approaches play in understanding the complex role of ethnicity and migration in 
pregnancy in HIV-positive women.  The narrative review sets the stage for this chapter 
in which I describe the overall mixed methods approach I have used in this thesis.  
The overarching research question posed in this thesis is: how do African women living 
with HIV in the UK engage with HIV services and interventions during and after 
pregnancy?  The three specific questions posed are: 
1. Are maternal ethnicity, African region of birth and duration of residence in the 
UK associated with:  
a. Not receiving ART during pregnancy 
b. Detectable maternal HIV viral load at delivery 
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 I use the term methodology to describe the body of practices, the underlying philosophy and the 
fundamental assumptions of a research approach.  I use methods to describe the specific techniques 
deployed to collect and analyse data. 
58
 Some of this material appears in Tariq, et al. 2012b . 
59
 I will describe the quantitative methods before the qualitative methods.  This is a reflection of the 
chronological structure of my research rather than an indication of priority of methods.  The quantitative 
and qualitative aspects of the study both carry equal weight in the overall thesis.   
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c. Vertical transmission of HIV 
d. Late antenatal booking 
e. Loss to follow-up from HIV care in the year after pregnancy 
2. What are the mechanisms underlying associations between clinical and service 
outcomes, and maternal ethnicity, African region of birth and duration of 
residence in the UK? 
3. What are the experiences of African women living with HIV during and after 
pregnancy? 
Understanding engagement with care during and after pregnancy involves exploring 
clinical outcomes; access to services; beliefs about illness, health and childbearing; and 
lived experiences.  The complex and multidimensional nature of the phenomena studied 
disrupts a simple dichotomy of quantitative and qualitative methodologies.  Instead, I 
have deployed a mixed methods approach, using quantitative and qualitative methods to 
answer the specific questions posed in this thesis in order to gain a breadth and depth of 
understanding African women’s engagement with HIV services and interventions 
during and after pregnancy.   
3.1.1 Mixed methods as a methodological paradigm60  
The most widely accepted definition of mixed methods research, and the one that I use 
in this thesis, is research that “focuses on collecting, analysing, and mixing both 
quantitative and qualitative data in a single study or a series of studies” (Creswell et al. 
2007: 5).  Mixed methods research is a broad umbrella term for a wide spectrum of 
study designs which vary in terms of methodological priority (the emphasis placed on 
each method) and the sequence in which methods are deployed (Creswell et al. 2007)61.  
The central premise of mixed methods research is “that the use of quantitative and 
qualitative approaches in combination provides a better understanding of research 
problems than either approach alone” (Creswell et al. 2007: 5).   
There has been extensive debate on the validity of mixed methods as a methodological 
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 Some of this material appears in Tariq, et al. 2013. 
61
 Quantitative and qualitative methods can be deployed sequentially or concurrently, and the level of 
integration between the approaches within a single study can vary greatly. 
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approach. Drawing upon Thomas Kuhn’s notion of paradigms ([1996] 1962) 62, 
methodological purists believe that quantitative and qualitative methodologies cannot be 
combined as they are founded upon fundamentally conflicting ontologies and 
epistemologies.   This rigid enforcement of paradigmatic boundaries has been countered 
by the mixed methods research community with a number of arguments63.  In the past 
twenty years, mixed methods has emerged as a distinct methodology in its own right 
with the development of its own notation system (Morse 1991) and a description of 
typologies (Greene et al. 1997).  The establishment of a major international conference 
of mixed methods research, the publication of key textbooks (Tashakkori et al. 2003, 
Creswell et al. 2007) and the launch of the Journal of Mixed Methods Research in 2007, 
have been instrumental in the growing visibility of mixed methods approaches.  The 
increasing recognition and acceptance of mixed methods by researchers within health-
related fields is reflected by the growing numbers of published studies that use this 
approach (O'Cathain et al. 2007).  Mixed methods research is now accepted as an 
innovative and useful approach in addressing complex questions and meeting the 
demands for sophisticated evidence in health research. 
Quantitative research is traditionally associated with a positivist stance and a belief that 
reality can be measured and observed objectively. Most commonly, it sets out to test an 
a priori hypothesis and is therefore conventionally described as deductive. Strengths of 
quantitative research include its procedures to minimise confounding and its potential to 
generate generalisable findings if based on samples that are both large enough and 
representative. It remains the dominant paradigm in health research. However this 
deductive approach is less suited to generating hypotheses about how or why things are 
happening, or explaining complex social or cultural phenomena.  
Qualitative research most often comes from an interpretive framework and is usually 
informed by the belief that there are multiple realities shaped by personal viewpoints, 
context and meaning. Qualitative approaches are usually described as inductive as 
questions are often open-ended with the analysis allowing hypotheses to emerge from 
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 Kuhn’s notion of paradigms is the set of practices and foundational beliefs held by a disciplinary 
community at a point in time, which are fundamentally incommensurable with others. 
63
 Many mixed methods researchers have drawn from the American philosophical tradition of pragmatism 
arguing that for a move beyond paradigm boundaries towards an assessment of methodological 
approaches based on their capacity to successfully address a research question.  On the other hand some 
mixed methods researchers embrace the differences inherent in methodological paradigms, using them 
dialectically and seeing the tensions as potential spaces to generate insight (Greene, et al. 1997).  Others 
argue that the boundaries drawn between qualitative and quantitative approaches are arbitrary and 
exaggerated, stating that both seek to generate data to describe and address questions, and that both 
approaches have inherent biases that they seek to minimise  (Paley, et al. 2011). 
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data. Qualitative research can generate robust theory that is applicable to contexts 
outside of the study area in question, helping to guide practitioners and policy-makers 
(Murphy et al. 1998).  However, for research that aims to directly impact on policy and 
practice, the findings of qualitative research can be limited by the small samples sizes 
that are necessary for in-depth exploratory work and the consequent lack of 
generalisabilty.   
Mixed methods research therefore has the potential to harness the strengths and 
counterbalance the limitations of each approach and can be especially powerful when 
addressing multifaceted questions such as those posed in this thesis. 
3.1.2 Mixed methods in the context of this PhD 
As discussed earlier in this chapter, this thesis seeks to explore the complex, 
multidimensional nature of engagement with HIV care during and after pregnancy 
among African women living with HIV in the UK.  The three specific research 
questions encompass clinical outcomes, access to services, and beliefs and experiences, 
necessitating a mixed methods approach.   
In this thesis I combine epidemiological and anthropological methods.  I have used a 
sequential explanatory model with a quantitative phase followed by a qualitative phase 
(Tashakkori et al. 2003, Creswell et al. 2007)64.  My overall study design is summarised 
in figure 3.1 and a Gantt chart of the quantitative and qualitative components is 
presented in table 3.1.  The first phase was quantitative, comprising analysis of national 
surveillance data.  This was followed by a qualitative phase which sought to explain and 
contextualise the findings from the first phase whilst highlighting other important 
aspects of women’s experience.  This qualitative phase comprised semi-structured 
interviews and participant observation.  
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 Sequential explanatory mixed methods study designs have been well described in the literature.  These 
designs comprise a quantitative phase where data are collected and analysed, followed by a qualitative 
phase where data are collected and analysed in order to explain and elaborate upon findings from the 
quantitative phase.   
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Figure 3.1: Mixed methods design for this study 
 
 
QUANT, quantitative; QUAL, qualitative 
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Table 3.1: Gantt chart of quantitative and qualitative components of study (October 2009 – September 2012) 
 
 October 2009 – September 2010 October 2010 – September 2011 October 2011 – September 2012 
 Q 1 Q2 Q3 Q4 Q 1 Q2 Q3 Q4 Q 1 Q2 Q3 Q4 
Quant NSHPC             
SOPHID             
Qual SSIs             
B&S             
TCPM             
Q, quarter; Quant, quantitative; Qual, qualitative; NSHPC, National Study of HIV in Pregnancy and Childhood; SOPHID, Survey of Prevalent HIV Infections Diagnosed; SSIs, 
semi-structured interviews; B&S, Body & Soul fieldwork; TCPM, Triumph of Christ Pentecostal Ministry fieldwork
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Each dataset was kept analytically distinct and analysed using appropriate techniques.  I 
moved between the datasets at the analysis stage to use findings from each analysis to 
identify key areas to be explored in the other datasets (Moran-Ellis et al. 2006).  Linking 
also occurred at the interpretation stage, when results from the quantitative and 
qualitative analyses were compared, contrasted and combined (Sandelowski 2000).  
This has resulted in a thesis in which quantitative empirical chapters are interwoven 
with qualitative ones, three of which present fully integrated analyses (Chapters Five, 
Seven and Eight), concluding with chapters that synthesise findings from both 
approaches to answer the overarching research question (Chapters Ten and Eleven).   
Although mixed methods are increasingly recognised within health research, methods 
such as secondary analysis of surveillance datasets and ethnography are rarely used in 
the context of mixed methods research with quantitative surveys, intervention studies 
and semi-structured interviews predominating (O'Cathain et al. 2007).  It has been 
argued that anthropological approaches can provide “interpretive enrichment” (Béhague 
et al. 2008), providing a depth of understanding of the mechanisms by which 
epidemiological associations emerge.  This is especially important as “epidemiology 
moves away from studying only biological phenomena towards exploring societal 
patterns and context, where causal pathways are likely to be longer, complex, diverse, 
and even cyclical” (Ibid.: 1705).  By combining quantitative and qualitative approaches 
in this study my aim was to not only identify disparities in clinical outcomes and access 
to care, but to also understand how these disparities are produced, whilst exploring 
aspects of pregnancy in the context of HIV that women themselves found important.  
This would not have been possible using one methodological approach alone.   
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3.2 Quantitative methods - overview of datasets 
The quantitative phase of this study comprises secondary analysis of epidemiological 
data from the National Study of HIV in Pregnancy and Childhood (NSHPC), the UK 
and Ireland’s active surveillance programme for HIV in pregnancy.  The analysis of loss 
to follow-up after pregnancy uses a matched dataset comprising NSHPC data and data 
from the Survey of Prevalent Infections Diagnosed (SOPHID), a cross sectional survey 
coordinated by Public Health England (PHE) of all individuals diagnosed with HIV 
attending for HIV care in the UK.  In this section I will describe these datasets in greater 
detail. 
3.2.1 National Study of HIV in Pregnancy and Childhood (NSPHC) 
The NSHPC, coordinated at University College London (UCL) Institute of Child Health 
(ICH), is a comprehensive population-based active surveillance programme that aims to 
include all women with diagnosed HIV who are pregnant or give birth in the UK and 
Ireland65.  It was established in 1986 and currently has information on approximately 
15,500 pregnancies reported between 1990 and 2011.  It operates two voluntary 
quarterly parallel reporting schemes (figure 3.2) consisting of: (i) quarterly notification 
of all pregnancies and pregnancy outcomes among women with HIV on standardised 
forms66 by approximately 240 National Health Service (NHS) maternity units in the UK 
and Ireland, and (ii) notification of children born to HIV infected mothers via the 
monthly reporting of rare conditions of childhood to the British Paediatric Surveillance 
Unit (Nicoll et al. 2000)67.  Laboratory sources also contribute and some reports are 
directly obtained from specialist paediatric units looking after large numbers of children 
living with HIV.  No names are requested or recorded and data collected include 
maternal date of birth, maternal country of birth, maternal ethnicity, date of arrival in 
UK, maternal source of infection, estimated date of delivery (EDD) or date of birth of 
infant, pregnancy outcome, delivery complications, maternal and infant HIV treatment, 
maternal clinical HIV stage, infant congenital abnormalities, and maternal CD4 counts 
and viral loads.  Duplicate reports are deleted and records are linked by demographic 
data for previous pregnancies in the same mother.  Major data queries detected at data 
entry are checked with NHS respondents.  During the period of my PhD work, data 
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 See http://www.ucl.ac.uk/nshpc/ for further details of NSHPC.  
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 NSHPC reporting forms are included in Appendix iv. 
67
 The British Paediatric Surveillance Unit was jointly set up by the Royal College of Paediatrics and 
Child Health, the Institute of Child Health and the Public Health England (formerly the Health Protection 
Agency) to conduct active surveillance of rare conditions
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were managed in Access 2003 and there were a series of checking mechanisms within 
Access and on export into Stata 11.2 (Stata Corporation, College Station, Texas, USA) 
to maintain data quality.   
The NSHPC has national coverage and all women with diagnosed HIV-infection are 
eligible for inclusion.  It is an active reporting system with a response rate of over 90% 
by NHS maternity units and it operates parallel obstetric and paediatric reporting 
schemes, ensuring that case ascertainment remains high.  Uptake of HIV-testing in 
pregnancy has been over 80% since 2000 (Townsend et al. 2006) and was 97% in 2011 
(Health Protection Agency 2012). A comparison with other sources of population 
surveillance data for HIV suggests that over 90% of HIV infections in pregnancies 
resulting in a live birth are diagnosed before or during pregnancy (Health Protection 
Agency 2009).  Therefore, almost all pregnant women living with HIV in the UK will 
be diagnosed by the end of their pregnancy and should be reported to the NSHPC.  
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Figure 3.2: Reporting structure of the National Study of HIV in Pregnancy and Childhood 
(NSHPC) 
 
 
Source: Adapted from Townsend (2009) 
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3.2.2 Survey of Prevalent HIV Infections Diagnosed (SOPHID)  
The Survey of Prevalent HIV Infections Diagnosed (SOPHID) is a cross-sectional 
survey of all individuals aged fifteen and over with diagnosed HIV infection who attend 
for NHS HIV care in England, Wales and Northern Ireland within a calendar year 
(Smith et al. 2010). It was introduced in 1995 and is coordinated by Public Health 
England (PHE, formerly the Health Protection Agency).  Scottish data are collected 
separately in Scotland by Health Protection Scotland and incorporated into UK data.  
The survey is conducted twice a year in London68 and annually outside London.  
Providers of HIV care are asked to compile a list of all individuals who have attended 
for HIV-related care. Data collected include: date of birth, sex, site of care, route of 
infection, ethnicity, date last seen (or date of death), and clinical markers.  These 
anonymised data are transferred securely to PHE with duplicates identified and 
removed, and records pertaining to the same individual linked over time.   SOPHID 
aims to provide estimates of prevalence of diagnosed HIV infection in the UK, as well 
as an epidemiological profile.  As it is based on reports of people attending for HIV-
related care, it is also used to plan and commission services, allocate funding and target 
national intervention programmes.   Under-reporting to SOPHID is unlikely to be 
common as PHE actively follows up NHS sites that are under-reporting (Rice et al. 
2011).  Furthermore, there is a strong financial incentive for units to report to SOPHID 
as funding allocation for local HIV services are based on SOPHID estimates (Ibid.).   
3.2.3 Record linkage between NSHPC and SOPHID 
One of the objectives in this thesis is to explore the associations between loss to follow-
up from HIV care after pregnancy and maternal ethnicity, African region of birth and 
duration of residence in the UK.  The NSHPC does not collect data on women after 
pregnancy and SOPHID does not record pregnancy.  It was therefore necessary to 
create, for the first time, a combined dataset using NSHPC and SOPHID data69.   This 
allowed me to explore whether a woman reported to the NSHPC as pregnant in a given 
year attended for HIV care anywhere in England, Wales and Northern Ireland in the 
year following pregnancy70. 
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 For the purposes of SOPHID the survey of London includes Brighton, Hastings and Eastbourne. 
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 I am indebted to Cuong Chau, database manager for SOPHID and other colleagues at PHE for 
developing a matching strategy, and for implementing the matching algorithm and providing me with a 
list of matched records.  I also acknowledge the role of my colleague Clare French at the NHSPC who 
collaborated closely with me on the creation of a joint dataset. 
70
 This analysis is presented in Chapter Seven. 
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Women known by the NSHPC to be pregnant between 1999 and 2009 were matched to 
the SOPHID dataset by year of pregnancy71.  A hierarchical matching strategy was 
implemented using limited identifiers collected in both the NSHPC and SOPHID such 
as sex, date of birth, residential information, country of birth and date of HIV diagnosis.  
Potential matches were identified by matching on female gender and date of birth in 
both NSHPC and SOPHID.  Matches were then confirmed by matching across datasets 
using postcodes (or part postcodes) and other variables such as country of birth and date 
of diagnosis (table 3.2). 
Country of birth is not collected by SOPHID and was obtained through linking of 
records between SOPHID and the HIV and AIDS New Diagnoses and Deaths database 
(HANDD) 72. Deaths in women reported to have been pregnant to the NSHPC were also 
identified through linking of records to HANDD. Potential duplicate reports were 
identified and excluded from analysis.  Pregnancies in women reported from Scotland to 
the NSHPC or reports to SOPHID from Scotland were also excluded as prior to 2008 
Scottish reports to SOPHID were not linked over time, and it is therefore difficult to 
establish links between records in the same patient prior to 2008.   
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 Women attending for HIV care during pregnancy should be reported to both the NSHPC and SOPHID 
in the same calendar year.  Therefore residential details should be similar. 
72
 The HIV and AIDS New Diagnoses and Deaths database at PHE collects information on new HIV 
diagnoses, first AIDS diagnoses and deaths in HIV infected individuals through voluntary reports by 
laboratories and clinicians in England, Wales and Northern Ireland.  Records were linked to SOPHID 
through demographic data and soundex codes (an indexing system for encoding surnames).  See 
http://www.hpa.org.uk/web/HPAweb&HPAwebStandard/Page/1201094588891 (accessed 13 July 2013).  
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Table 3.2: Matching algorithm to create joint dataset from the National Study of HIV and 
Pregnancy and Childhood (NSHPC) and Survey of Prevalent HIV Infections Diagnosed 
(SOPHID) 
Match 
level 
Sex Date of 
birth 
Residential postcode to be 
matched with SOPHID 
Other variables to be 
matched with SOPHID 
1 ✓ ✓ Full/part PC (PS+) at Notification 
 
 
2 ✓ ✓ Full/part PC (PS+) at Delivery 
 
 
3 ✓ ✓ Part PC (PS) at Notification 
 
 
4 ✓ ✓ Part PC (PS) at Delivery 
 
 
5 ✓ ✓ Part PC (PD) at Notification 
 
Country of birth 
6 ✓ ✓ Part PC (PD) at Delivery 
 
Country of birth 
7 ✓ ✓ Part PC (PD) at Notification 
 
Site of treatment 
8 ✓ ✓ Part PC (PD) at Delivery 
 
Site of delivery 
9 ✓ ✓ Part PC (PD) at Notification Date of HIV diagnosis +/- 
30 days  
10 ✓ ✓ Part PC (PD) at Delivery Date of HIV diagnosis +/- 
30 days  
PS+ (postcode sector plus) = full postcode minus the last character e.g. NW9 5E 
PS (postcode sector) = full postcode minus the last 2 characters e.g. NW9 5 
PD (postcode district) = 1st half of postcode e.g. NW9 
 
 
3.2.4 Limitations of matching NSHPC and SOPHID datasets 
There are limitations in matching records across two large national epidemiological 
datasets.  As SOPHID and NSHPC do not share a unique identifier, the matching 
algorithm described in the previous section (which employed a series of increasingly 
fuzzy identifiers) was used.  This matching strategy was successful in that nearly 90% 
of NSHPC records were matched to a corresponding record in SOPHID.  Not being 
matched across the datasets was associated with reporting area (probably a function of 
SOPHID being conducted twice yearly in London and annually elsewhere, giving 
London centres greater opportunity to collect data) and earlier time period.  Women 
from Southern Africa and those who arrived in the UK after conception were also more 
likely not to be matched which may be because this was a more mobile population73 or 
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 Women may have moved between pregnancy (the postcode reported to NSHPC) and attendance for 
HIV care (the postcode reported to SOPHID). 
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because these women were more likely not to have ever attended for care.  There was 
no evidence of an association between ethnicity and a NSHPC record being matched 
with one in SOPHID.   
A recent audit on loss to follow up in the general adult HIV-positive population in the 
UK found that one in five people not linked to SOPHID had in fact attended for care in 
the UK (Clay 2013).  The authors conclude that the reasons why some patients 
attending for HIV care in the UK are not captured in SOPHID are unclear (Ibid.). As 
discussed earlier, under-reporting to SOPHID is unlikely to be a major factor due to the 
financial implications.  Coding errors in variables in the NSHPC or SOPHID, such as 
gender, date of birth or residential information, would result in a non-match and an 
over-estimate of the proportion of women who were lost to follow-up.  Furthermore, 
changes in date of birth or residential postcode (which occurs in the context of 
undocumented migration and highly mobile populations) would also prevent matching.    
Some women who were not matched may have disengaged from care after pregnancy 
and therefore would not be reported to SOPHID, leading to underestimation of loss to 
follow-up.  To address this I coded all pregnancies that were not matched as lost to 
follow-up and repeated all multivariable analyses to explore the effects on estimates 
(Chapter Eight) .   
3.3 Quantitative methods - analysis of NSHPC datasets 
My quantitative analyses, presented in Chapters Four, Five, Seven and Eight, are based 
on the Q87 NSHPC dataset, which comprises data collected by the NSHPC up until the 
end of June 201174.   I created my own dataset from this by checking existing variables 
and removing variables that were not required for my analyses.  I regrouped some of the 
existing variables according to my own requirements and removed records according to 
the exclusion criteria described in section 3.3.1.  For the specific purposes of this study I 
created exposure variables from existing data that have not been used in previous 
NSHPC analyses.  These were maternal ethnicity (comprising white British and African 
categories as opposed to ethnic categories based on the England and Wales Census), 
maternal African region of birth, and maternal duration of residence in the UK.  
Furthermore I created two new outcome variables (maternal viral load at delivery and 
timing of antenatal booking) that have not previously been explored within the NSHPC.  
This involved merging raw data from the NSHPC Access database into the Q87 dataset.  
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 The most up to date dataset available at the completion of the quantitative phase of my PhD research. 
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Finally, I created a range of variables to explore loss to follow-up after pregnancy for 
the first time in UK national surveillance datasets.  I was closely involved in the 
matching process between NSHPC and SOPHID and was responsible (with my NSHPC 
colleague Clare French) for merging the matched SOPHID dataset with the Q87 
NSHPC dataset.   
3.3.1 Exclusion criteria  
All pregnancies reported to the NSHPC in the UK were eligible for inclusion in the 
study if the year of delivery or estimated date of delivery (EDD) was between 1990 and 
2010.  Pregnancies before 1990 were excluded as there were little data recorded on 
them.  Pregnancies with a delivery date or EDD in 2011 were excluded as these 
pregnancies were mainly ongoing by the completion of analyses and data on these 
pregnancies were therefore incomplete.   Data from Ireland were excluded, as the focus 
of this thesis is pregnancies in African migrant women living with HIV in the UK.  
Health and social care policy, which is likely to impact women’s access and experience 
of healthcare, differs between the UK and Ireland.  Furthermore the qualitative phase of 
this study was conducted within the UK and findings cannot be extrapolated to inform 
understanding of clinical outcomes and access to care in Ireland. 
The dataset was further restricted by the following criteria (also see figure 3.3): 
1. If the report was “retrospective”.  Retrospective reports are in pregnancies 
originating early in the NSHPC study period that were reported a considerable 
time after a woman had delivered, regardless of whether a woman was 
diagnosed before or after delivery.  These reports (292) often lacked detailed 
data on maternal demographics and the majority pertained to pregnancies with 
an EDD before 1990. 
2. If the report pertained to a twin or triplet who was not the first-born.  This avoids 
duplicate inclusion of the same mother in the same pregnancy in analyses. 
3. If the reported pregnancy resulted in a child born outside the UK or Ireland.  
These reports have very little maternal data reported and may reflect care 
received outside the UK. 
4. If maternal ethnicity and country of birth were missing as they are main 
exposure variables of interest for the quantitative analyses in this thesis. 
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Figure 3.3: Restriction of the main study dataset (NSHPC) 
 
 
EDD, estimated date of delivery; COB, country of birth 
 
 
The dataset was further restricted for the analyses of the five key outcomes: late 
antenatal booking, not receiving ART during pregnancy, detectable maternal HIV viral 
load at delivery, vertical transmission of HIV and loss to follow-up from HIV care in 
the year after pregnancy.  Pregnancies were included if year of delivery or EDD was 
after 2000.  This corresponds with wider use of HAART in pregnancy and more 
consistency in clinical practice and laboratory monitoring than in the previous decade.  
Furthermore, the majority of pregnancies reported to the NSHPC were during this time 
period (12,193/13,676; 89%).  Pregnancies were also excluded in analyses of key 
outcomes if the mother was diagnosed with HIV after delivery as the clinical and 
service-related outcomes explored in this thesis relate to HIV care and interventions 
received during pregnancy.  The 286 women diagnosed after delivery75 would not have 
had the opportunity to access this.  Further exclusion criteria specific to each analysis 
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 These are different from the aforementioned “retrospective” reports as they all pertain to pregnancies 
where maternal HIV diagnosis was after delivery. 
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are presented in table 3.3 and discussed in detail in the relevant chapters. 
3.3.2 Definition of key exposure variables 
This thesis sets out to explore the association between key clinical and service-related 
outcomes, and maternal ethnicity, African region of birth and maternal duration of 
residence in the UK.  I now describe these key exposure variables in detail.  For each of 
the following variables, I completed missing values from data reported in other 
pregnancies reported to the NSHPC in the same woman when possible.   
Maternal ethnicity 
Maternal ethnicity in the Q87 dataset was based on recorded ethnicity on notification 
forms.  This was most likely to be based on self-reported ethnicity on hospital records.  
Where missing, maternal ethnicity was recorded as the same as infant ethnicity (if 
reported, and if the infant was not of mixed ethnicity).  Ethnicity categories reported to 
the NSHPC correspond to England and Wales Census ethnic classification. As 
discussed in Chapter One, UK census categories were not developed or validated for 
public health research.  Furthermore these broad ethnicity categories may not capture 
differences between those who migrate to the UK, and those born in the UK who have 
descended from African backgrounds.  The focus of this thesis is migrant women and 
therefore maternal ethnicity in the analyses presented in this thesis is based on reported 
ethnicity (categorised according to England and Wales Census classification) and 
maternal country of birth.  I categorised as women as “African” if they were of Black 
African ethnicity and were born in Sub-Saharan Africa76.  “White British” pertains to 
women of White ethnicity who were born in the UK.  All analyses except for the 
description of demographic trends (Chapter Four) comprise only pregnancies in white 
British and African women due to small numbers in the other ethnic groups. 
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 Women of mixed, white or other ethnicities who were born in Sub-Saharan Africa were not included in 
this group as they are likely to have different migratory experiences due to cultural, political and 
socioeconomic differences.   
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Table 3.3: Analysis specific exclusion criteria 
Analysis (Chapter) Time period 
(EDD/year of delivery) 
Exclusions Outcome Outcome 
missing 
n (%) 
Number in 
analysis 
Time trends in ethnicity, 
African region of origin 
and duration of residence 
in the UK (4) 
1990-2010 Non first-born twins/triplets. N/A N/A (numbers 
vary) 
Uptake of ART in 
pregnancy (5) 
2000-2010 Non- first born twins/triplets. TOPs, 
miscarriages, ectopic pregnancies. 
No ART in pregnancy         217 (2.6) 9214 
Viral load at delivery (5) 2000-2010 All outcomes except live births. 
Twin pregnancies. 
No HAART in pregnancy. 
Detectable HIV viral 
load at delivery  
1285 (17.6) 7290 
Infant HIV status (5) 2000-2010 All outcomes except live births. 
Twin pregnancies. 
Vertical transmission  1177 (13.9) 7277 
Timing of antenatal 
booking (7) 
2008-2010 Non first-born twins/triplets. TOPs 
and ectopic pregnancies. 
Pregnancies in women who arrived 
in UK after conception. 
Late antenatal 
booking 
874 (26.1) 2481 
Follow-up after 
pregnancy (8)  
2000-2009 Non first-born twins/triplets. 
Pregnancies notified in Scotland. 
Pregnancies in women who moved 
abroad during pregnancy. 
Failure to return for 
HIV care in the 
calendar year after 
pregnancy 
749 (10.4) 7235 
EDD, estimated date of delivery; N/A, not applicable; TOP, termination of pregnancy; ART, antiretroviral therapy; HAART, highly active antiretroviral therapy.
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Maternal African region of birth 
I based maternal African region of birth on reported country of birth and grouped 
according to United Nations classification of Sub-Saharan African regions:  Eastern, 
Western, Southern and Middle Africa (table 3.4).  I accept that boundaries of countries 
and regions in Sub-Saharan Africa are somewhat arbitrary with origins in colonial 
history and that they may not correspond to cultural groups.  However in the absence of 
more useful information such as languages spoken, I use these groupings as a heuristic 
device to explore heterogeneity within African women in terms of reasons for 
migration, economic circumstances and culture.   
 
Table 3.4: United Nations geographical sub-regions (Sub-Saharan Africa) 
United Nation Region Countries  
Eastern Africa 
 
Burundi, Comoros, Djibouti, Eritrea, Ethiopia, Kenya, 
Madagascar, Malawi, Mauritius, Mayotte, Mozambique, 
Réunion, Rwanda, Seychelles, Somalia, Uganda, United Republic 
of Tanzania, Zambia, Zimbabwe 
Southern Africa Botswana, Lesotho, Namibia, South Africa, Swaziland 
Western Africa BeŶiŶ, BurkiŶa Faso, Cape Verde, Cote d’Iǀoire, Gaŵďia, GhaŶa, 
Guinea, Guinea-Bissau, Liberia, Mali, Mauritania, Niger, Nigeria, 
Saint Helena, Senegal, Sierra Leone, Togo 
Middle Africa Angola, Cameroon, Central African Republic, Chad, Congo, 
Democratic Republic of the Congo, Equatorial Guinea, Gabon, 
Sao Tome and Principe 
Source: http://unstats.un.org/unsd/methods/m49/m49regin.htm (accessed 06 May 2011). 
 
 
Maternal duration of residence in the UK  
I defined duration of residence in the UK for African women as the length of time in 
years between reported date of entry to the UK and estimated date of conception.  I 
estimated conception date to be the date of the last menstrual period, which I defined as 
day 280 before EDD.  If EDD was unavailable, then it was estimated by subtracting 
gestation in days from infant date of birth. There is no clear consensus within 
epidemiological literature as to how to categorise duration of residence with authors 
deploying different measures and groupings (Jayaweera et al. 2010, Teitler et al. 2012, 
Urquia et al. 2012).  Due to a large proportion of missing data on duration of residence 
in the UK (36.7%) I categorised women in broad groups, which were based on the 
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median duration of residence in the UK (four years).  I hypothesised that women who 
had migrated to the UK after conception may be a particularly vulnerable group in 
terms of access to healthcare and grouped these women separately.  Duration of 
residence was therefore grouped as follows: “≥4 years”, “< 4 years (before conception)” 
and “since conception”. 
3.3.3 Data management 
The five outcome variables are described in detail in the relevant chapters.  I defined 
and categorised other key potential confounding variables as follows. 
Maternal age corresponded to maternal age at delivery in years and I categorised it as 
“<25”, “25-34” and “≥35”.  These groupings correspond with known obstetric risk in 
younger and older women.  Maternal injecting drug use was a binary variable (“yes” or 
“no”) and was defined as whether the mother’s likely infection route was injecting drug 
use or not.  I defined year as year of birth or EDD and treated it as a categorical 
variable.   
I grouped first recorded HIV viral load in pregnancy in RNA copies/ml into three 
categories according to accepted clinical cut-off points (“undetectable”, “50-10,000”, 
“≥10,000”), which corresponds to undetectable, moderate, and high HIV viral loads.  
“Undetectable” viral load was defined as viral load <50 copies/ml.  I grouped first 
recorded HIV CD4 count in pregnancy in cells/mm3 into three categories (“≥350”, 
“200-349”, “<200”), which reflects mild, moderate and advanced immunosuppression 
and corresponds to the threshold for initiation of antiretroviral therapy (ART)77.  
Gestational age was based on completed weeks of gestation and grouped into two 
categories (“≥37 weeks”, “<37 weeks”), which corresponds to term and preterm 
delivery.  This also allowed for censoring at thirty-eight weeks due to routine elective 
caesarean section at thirty-eight weeks for the prevention of vertical transmission.   
I defined type of highly active antiretroviral therapy (HAART)78  as “NRTI only” 
(nucleoside reverse transcriptase inhibitor only), “NNRTI-based” (non-nucleoside 
reverse transcriptase inhibitor based), “PI-based” (protease inhibitor-based) and 
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 Current UK guidelines advise the initiation of ART at a CD4 count of <350 cells/mm3 (Williams, et al. 
2012) CD4 count<200 is evidence of advanced immunosuppression and is associated with an increased 
incidence of opportunistic infection.   
78
 HAART being classified as a treatment combination of three of more antiretrovirals agents. 
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“NNRTI and PI-based” (exposure to both PI and NNRTI)79.  Duration of ART at 
delivery was measured in weeks and I categorised it as “on HAART at conception”, 
“12-40 weeks”, “2-11 weeks”, “<2 weeks” and “none”.   
I examined all data for improbable values and these values were checked against written 
records and amended accordingly or coded as missing.  I also checked the dataset for 
duplicate entries, which I subsequently removed. 
3.3.4 Missing data 
Data were checked for missing values on exposure variables, the five key outcomes (not 
receiving ART in pregnancy, detectable viral load at delivery, vertical transmission of 
HIV, late antenatal booking and loss to follow-up) and potential confounding variables.  
Records with missing exposure and outcome data were excluded from analysis for the 
exposure and outcome of interest80.  Records with missing data on confounding 
variables were also dropped from the final multivariable models.  Clinical and 
demographic characteristics of pregnancies with missing data were compared with 
pregnancies with data recorded using the χ2 test to investigate potential bias.   
The NSHPC is an active surveillance programme which depends on respondents’ 
reporting of information about pregnancies.  Data were inevitably missing for many 
variables, however on the whole this was minimal.  In terms of the key exposure 
variables, data on ethnicity and maternal country of birth were missing in only 0.8% and 
1.5% of 11,090 eligible pregnancies81 respectively.  Given these small proportions, 
missing data are unlikely to bias estimates significantly.   
Data on maternal duration of residence in the UK were much less complete. After 
excluding 1464 pregnancies in women who had been born in the UK, 36.7% of 
pregnancies did not have maternal duration of residence in the UK reported.   
Missingness was associated with diagnosis during pregnancy, outcome other than live 
birth and earlier gestational age at delivery (all p<0.001) suggesting that this may be due 
to lack of opportunity to record this information.  The mechanism for missing data on 
maternal duration of residence in the UK is likely to be missing not at random (MNAR) 
                                                             
79
 This excludes newer classes of antiretroviral agents such as integrase inhibitors and CCR5-receptor 
antagonists. However, these agents were very rarely used at the time of analysis in 2011. 
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 Except for the analysis of maternal HIV viral load at delivery where an imputed variable was used 
(Chapter Seven). 
81
 Pregnancies reported between 2000 and 2010 in women who were of Black African, white or unknown 
ethnicity and who were diagnosed with HIV prior to the end of pregnancy.   
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(Donders et al. 2006).  That is, the probability of maternal duration of residence being 
missing is likely to be dependent on both the actual missing value (how long a woman 
has been resident in the UK)82 and other reported factors such as whether HIV was 
diagnosed before or during pregnancy, gestation at delivery and pregnancy outcome. 
(figure 3.5).  
As a first step, missing date of entry into the UK was completed from previous 
pregnancies reported to the NSHPC where available.  Date of entry into the UK is not 
available in other large HIV datasets such as SOPHID, HANDD and UK Collaborative 
HIV Cohort (UK CHIC)83.  I therefore considered a number of further approaches to 
handle missing data in this variable.  I discounted Multiple Imputation by Chained 
Equations (MICE)84 (Rubin 1987) as the fraction of missing information (FMI)85 was 
>35%.  Furthermore the number of imputed datasets should exceed FMI which for the 
purposes of my analyses would be >37 imputed datasets which is computationally 
difficult.   The structure of my dataset was complex with a mix of categorical and 
continuous data (mainly non-normally distributed), which would be difficult to model, 
and a set of variables (such as maternal ethnicity and date of entry into the UK) that 
need to remain constant in the case of sequential pregnancies in the same woman during 
an imputation process.  Most importantly, however, is the likelihood that the mechanism 
of missingness was MNAR, in which case MICE would not be reliable.  Following 
discussion with the MRC Biostatistics Unit in Cambridge86 it became apparent that 
MICE was not an appropriate approach in handling missing duration of residence in the 
NSHPC dataset.  Other statistical approaches such as inverse probability weighting 
were beyond the scope of my PhD and would also be unreliable if data were MNAR.   I 
was therefore limited in my ability to address the large proportion of missing data on 
maternal duration of residence in the UK and restricted my analyses to pregnancies 
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 This is hard to predict as duration of residence may not be reported in women who have been in the UK 
for a longer period of time as it is not considered relevant, or it may not be overlooked in women who 
have recently arrived in the UK (who are likely to also be newly diagnosed with HIV) due to more 
pressing factors to address during pregnancy. 
83
 This is a cohort study comprising over 47,200  patients from some of the largest HIV clinical centres in 
the UK which pools routinely collected clinical and demographic data.  See UK Chic website for further 
information at http://www.ukchic.org.uk/.  
84
 MICE is an approach used to handle missing data involving the creation of several datasets where 
missing values are imputed based on a model specified by the analyst.  Analysis is then conducted on 
each of the imputed datasets and the parameter estimates combined.  This method is increasingly used and 
recognised as a more robust method of handling missing data although it has important limitations.  
85
 FMI approximates to the proportion of missing information in a variable. MICE models are not reliable 
with FMI>20%. 
86
 The MRC Biostatistics Unit at Cambridge has particular expertise in MICE with members of their team 
having written the MICE commands for Stata and providing regular teaching on missing data and 
imputation techniques.   
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where this was reported.  This is likely to introduce bias but it is difficult to predict in 
what way87. 
With regards to key outcomes, data on whether a woman received ART in pregnancy 
was recorded well with data available in nearly 98% of pregnancies. Approximately 
14% of records had missing data on infant HIV status.  Again, this was strongly 
associated with later year of report (2007-2010) and largely reflects delays in reporting 
final laboratory results of infants’ HIV-antibody tests.  Previous sensitivity analyses 
have shown that missing infant HIV-status is likely to have a minimal effect on vertical 
transmission estimates for UK data (Townsend et al. 2008a).  Analyses exploring 
antenatal booking were restricted to pregnancies after 2008 by necessity as this was 
when booking date started to be routinely collected by the NSHPC, with smaller 
numbers included in this analysis than others presented in this thesis.   Data on antenatal 
booking were not available in over a quarter of eligible pregnancies.  Missing data were 
associated with reporting region and may reflect variations in reporting practice.  They 
were also associated with miscarriage, severe prematurity and continuing pregnancies 
suggesting a lack of opportunity to record booking date.  There was no association 
between missing booking date and ethnicity, African region of origin or duration of 
residence in the UK.  Although I cannot exclude the possibility of bias being introduced 
by missing data in this analysis it appears unlikely.    
The proportion of missing data on maternal viral load at delivery was much higher than 
other outcome variables at 43.7%88.  An imputed viral load variable was used if the last 
viral load in pregnancy was undetectable in an effort to reduce this and a further 1904 
values were added using this approach89.  This reduced the proportion of missing viral 
load at delivery data to 17.6%.  All analyses were performed using the non-imputed and 
imputed variable with little difference in results apart from reducing confidence 
intervals, which increases confidence in the validity of the model using imputed values.  
An important predictor of missing delivery viral load was earlier year of report, which is 
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 For example, women with shorter duration of residence in the UK may have been less likely to have 
date of entry into the UK reported, and would be excluded from analyses.  These women may also have 
poorer outcomes, which would not be reflected in my analyses.   
88
 This is likely to be largely due to maternal viral load samples not being sent in the twenty-eight days 
prior to delivery or seven days subsequent (the time frame I use in my analyses for viral load at delivery).   
89
 The proportion of missing viral load data was higher in pregnancies where the first viral load in 
pregnancy was undetectable compared with those where it was detectable (57.1% vs. 47.1%, p<0.001).  
See Chapter Five for a detailed description of the use of this imputed variable in this analysis. 
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likely to reflect changes in clinical practice in virological monitoring over time90.  
Missing delivery viral load data was also associated with arriving in the UK after 
conception, possibly indicating decreased access to services.  It may also be that these 
women were more likely to have a detectable viral load, which would have led to an 
underestimation of the association between viral load at delivery and duration of 
residence in the UK.     
3.3.5 Statistical methods 
Data were analysed using Stata 11.2 (Stata Corporation, College Station, Texas, USA).    
For analyses of trends I used the Bonferroni correction (Bland et al. 1995) which 
accounts for multiple comparisons within a group by adjusting the statistical 
significance level used for each test, minimising the chance of spurious positive results.  
For a given outcome, a Chi-square test was performed to compare pregnancies across 
different ethnicity, African region and duration of residence groups.  These groups were 
then compared for each outcome using univariable and multivariable logistic regression 
models to estimate odds ratios and adjusted odds ratios, with 95% confidence intervals.   
A priori confounders were included in final multivariable models91.  Other variables 
were included if their inclusion improved model fit.  This was assessed using likelihood 
ratio tests, with a significance level of p<0.05.  Approximately 26% (3535/13,676) of 
pregnancies reported to the NSHPC between 2000 and 2010 were in women who had 
had a previous reported pregnancy.  It may not be appropriate to treat sequential 
pregnancies in the same woman as independent pregnancies as there are likely to be 
maternal-level factors not captured by the NSHPC, such as adherence to ART, that exert 
an effect on pregnancies in the same woman.  To account for potential clustering at a 
maternal level in sequential pregnancies where appropriate for some outcomes I used 
robust standard errors (Kirkwood et al. 2003)92.  
                                                             
90
 Between 2000 and 2010, the importance of viral load monitoring was increasingly recognised with the 
first specific guidance recommending maternal HIV viral at 36 weeks’ gestation and at delivery in 2005 
(Hawkins, et al. 2005). 
91
 Year of delivery or EDD was included as an a priori confounder in all analysis to allow for changes in 
clinical practice and measurement tools over time.  Other a priori confounders are described in the 
relevant chapters. 
92
 Standard statistical approaches, which are based on an assumption that observations in a dataset are 
independent of each other, may not be appropriate for clustered data, that is if observations in a cluster are 
more similar to each other than observations in the rest of the dataset.  Examples of this include repeated 
measures (or pregnancies in the case of my own research) in the same patient, multiple measures (such as 
observations on both eyes in one patient), and study designs where individuals are grouped (such as 
cluster randomised trials).  In these cases a variety of approaches can be used to allow for clustering.  
Having considered approaches such as random effects models, I decided that robust standard errors were 
the most appropriate technique to handle clustering in my dataset.  Robust standard errors are based on 
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3.3.6 Ethical considerations 
The NSHPC has London Multi-Centre Research Ethics Committee approval 
(MREC/04/2/009).  SOPHID does not require ethical approval as it fulfils a surveillance 
purpose (Tariq et al. 2012b).  Public Health England (formerly the Health Protection 
Agency until April 2013) is registered under the Data Protection Act 1998 (registration 
number Z7749250) to handle data for diagnostic, public health and other purposes.  It is 
also registered under Section 251 of the Health and Social Care Act 2001 and has 
approval from the Patient Information Advisory Group (PIAG) and the National 
Information Governance Board for Health and Social Care (NIGB) to handle data for 
purposes that include surveillance and the control of disease, even where specific 
patient consent has not been given93 . 
An important ethical consideration to be taken into account during the quantitative 
phase of this study was the grouping of pregnancies according to maternal country of 
birth.  I do not present data by maternal country of birth in this thesis as in some cases 
there were small numbers of women from certain countries (less than five) which may 
lead to these women being identified by healthcare professionals94.  Instead data on 
maternal country of birth are grouped and presented as African region of birth as 
described earlier.   
                                                                                                                                                                                  
the variability in the data, rather than that assumed by statistical models, and adjust the standard error 
accordingly.   
93
 See Public Health England's website for further details on surveillance and confidentiality 
(http://www.hpa.org.uk/Topics/InfectiousDiseases/InfectionsAZ/Surveillance/SurveillanceAndConfidenti
ality/, accessed 26 September 2013). 
94
 This could have been addressed by restricting analyses to pregnancies in women born in Uganda, 
Nigeria, Zimbabwe, South Africa and Zambia (the largest groups) but this would exclude other groups of 
women and shift the focus of this thesis to women from these countries rather than African migrant 
women more broadly.  
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3.4 Qualitative methods 
The second phase of the mixed-methods research presented in this thesis uses an 
ethnographic approach to understand the experiences during and after pregnancy of 
African migrant women living in London.  Ethnographic methods are relatively under-
utilised in health research (Savage 2000, Lambert et al. 2002, Mulhall 2003).   
Ethnography has its roots in social anthropology and the work of key figures such as 
Malinowski ([2010] 1954), Boas ([1986] 1928) and Mead ([2001] 1928). There is no 
clear consensus as to what defines ethnography (Hammersley et al. 2007), however 
ethnographic research is distinguished from other forms of qualitative approaches by its 
explicit focus on the understanding of cultural phenomena within groups of people 
using a range of methods.  Traditionally the cornerstone of ethnographic research has 
been participant observation involving a researcher’s prolonged immersion and 
participation in the daily lives of people in a group (Ibid.).  The combination of 
observations, informal conversation, formal interviews, and analysis of documents and 
other cultural resources can facilitate a multidimensional understanding of cultural 
phenomena that may not be possible with methods such as formal interviews alone 
(Reeves et al. 2008).   
My decision to use an ethnographic approach in my work was informed by my previous 
training as a medical anthropologist which gave me both a methodological and 
intellectual plane in which to orientate myself.  By using an ethnographic approach I 
aimed to gain a depth of understanding of pregnancy in African migrant women living 
with HIV that does not currently exist within the literature.  Previous qualitative studies 
in the UK on HIV and pregnancy, although yielding important insights95, have been 
based solely on semi-structured or in-depth interviews with women and their health care 
providers.  By using a variety of methods (including participant observation), grounding 
myself within anthropological literature and seeking a deep engagement with cultural 
data on traditional themes of interest in anthropology such as religion, pollution and 
taboo, and marginality, I have sought to reflect the world of my participants whilst 
critically engaging with key theoretical constructs that emerged (Golden-Biddle et al. 
1993). My aim has been to provide a detailed account and ethnographically-informed96 
analysis of what it is to be an HIV-positive pregnant African woman living in London.   
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 This literature is summarised and reviewed in the previous chapter. 
96
 By this I mean focusing on cultural data such as religion, taboo and marginality and grounding my 
analysis in relevant ethnographic and theoretical work. 
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My ethnographic approach (which is described in detail in later sections) comprised 
mainly semi-structured interviews with pregnant African women living with HIV and 
those involved in their care, and participant observation in London in NHS clinics, a 
Pentecostal church and a charity that supports families affected by HIV.  This work was 
supported and contextualised by attendance at professional meetings and conferences 
and analysis of documents and other media where relevant.   
3.4.1 Locating my field 
The focus of this thesis is pregnant African women living with HIV.  This is not a 
natural cultural group with regular interaction, making an ethnographic field, in the 
traditional sense, difficult to locate.  Historically ethnographic research has been based 
on work within a single site.  However, it is increasingly recognised that this approach 
may not be suited to questions asked within a contemporary postmodern society.  
Marcus (1995) traces the emergence in the past three decades of multi-sited 
ethnography in response to the transformation of the global cultural economy.  As 
discussed in Chapter One, the world we live in challenges previous notions of world 
systems, discontinuous spaces and the “isomorphism of space, place and culture” 
(Gupta et al. 1992: 7). This is an era of interconnected space with transnational 
circulations of economic, cultural and symbolic capital as well as unprecedented flows 
of people across borders97.  “Cultures” and “peoples” can no longer be “plausibly 
identified as spots on the map” (Ibid: 10), and ethnography that fails to attend to this 
risks replicating static notions of culture.  Multi-sited ethnography attempts to engage 
with this transformation of space by acknowledging that meaning is created in various 
interconnected sites of activity (Marcus 1995)98.   
African migrant women living with HIV in London are a heterogeneous group 
comprising women of different ethnicities, linguistic communities, religions, migration 
experiences and social circumstances.  Some will have been diagnosed with HIV many 
years ago; whilst for others their HIV diagnosis will be much more recent.  This is a 
group of women who are scattered across one of the largest cities in the world, 
sometimes without stable housing, with no obvious focal convergent point.  To borrow 
from Paul Farmer, they are “splintered groups of people bound together by a shared lab 
                                                             
97
 Eloquently captured in Appadurai’s notion of –scapes as discussed in Chapter One (Appadurai 1996). 
98
 This multiplicity of meaning extends beyond geographical space, into considerations of subjectivity 
and an understanding of the value of multiple vantage points in avoiding naïve and romanticised 
representations of subjects. Donna Haraway’s essay on situated knowledge and the value of  “partial 
perspective” is an important reference here (1988).    
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result” (Farmer 2004: 71).  Furthermore, HIV is a highly stigmatising condition and one 
that women may go to great lengths to hide.   
The rhizomic99 nature of HIV-positive African women’s lives in London demanded a 
multi-sited approach to fieldwork.  Rather than locating women in a single naturally 
occurring site (which was not feasible) I decided to “follow the people” (Marcus 1995: 
106) and go to places where women may go.  This was primarily NHS HIV antenatal 
clinics, as they are one of the few spaces where women may feel that they can openly 
acknowledge their HIV-positive status.  However, I also “followed” women into other 
sites that shaped their day-to-day experiences, such as a London-based HIV charity and 
a Pentecostal church on the outskirts of the city.  In doing so, I hoped to not only 
encounter pregnant African women living with HIV but also those around them who are 
involved in producing what it means to be pregnant, HIV-positive and African in 
London.  These other actors included healthcare professionals, charity professionals, 
church pastors, community members and other groups of people living with HIV.   
The practice of multi-sited ethnography is not straightforward in that it involves the 
constant repositioning of oneself as an ethnographer with shifting allegiances, 
commitments, and roles (Marcus 1995).   During the course of my own work I found 
myself rapidly cycling through the roles of anthropologist, doctor, colleague, volunteer 
and friend; many of these concurrently.  However, I see this constant repositioning of 
myself in the field as akin to using a set of different camera lenses, allowing me to gain 
a multiperspectival view of my research question. 
3.4.2 Introducing my field 
London is the most populous city In Europe with a population of 8.2 million, of whom 3 
million were born outside of the UK, a 54% increase since 2001100.  It is the most 
ethnically diverse area in England and Wales with 40% of people living in London from 
a minority ethnic group (Ibid.).   Just over 13% of people residing in London are of 
Black African101 ethnicity, compared with 3% in England and Wales as a whole (Ibid.).   
African migration to the UK dates back to Roman times when African soldiers served in 
Roman legions and increased during the seventeenth and eighteenth centuries during the 
                                                             
99
 See Chapter One for a discussion of Appadurai’s use of the term rhizome to capture the 
deterritorialisation and interconnectedness of the contemporary globalised world.   
100
 Data obtained from Table KS201EW of the 2011 Census for England and Wales available at 
http://www.ons.gov.uk/ons/datasets-and-tables/index.html (accessed 06 August 2013). 
101
 This includes people born in the UK and abroad. 
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transatlantic slave trade.  London, as one of Britain’s main trading ports along with 
Liverpool and Bristol, was a focal point in African slave migration during this time 
(Grillo et al. 2008).  The mid-twentieth century saw a dramatic increase in migration to 
the UK from Britain’s former colonies and Commonwealth states, in response to 
favourable immigration policies designed to attract migrant workers to rebuild the post-
war British economy.  Although this levelled off with the introduction of immigration 
restrictions in the 1960s, migration to the UK from Sub-Saharan Africa for economic 
and political reasons has continued.   
London also has the highest HIV prevalence in the UK, with thirty of the city’s Local 
Authorities having a high prevalence of diagnosed HIV (>2 per 1000 persons), and 
eighteen of these having the highest prevalence rates in the country (Public Health 
England 2013).  Over 31,000 people living in London with diagnosed HIV accessed 
care in 2011, representing just under 50% of all people accessing HIV care in the UK 
(Ibid.).  Furthermore, the five NHS centres that report the greatest numbers of 
pregnancies in women diagnosed with HIV are all in London102.   
As the most ethnically diverse city in the UK with a sizable African population and 
large numbers of people accessing HIV care, and also my home for over thirteen years, 
London was an ideal site for my fieldwork.   
As discussed earlier, my ethnographic research was not confined to a single site; rather 
it encompassed several sites across the city.  Firstly I recruited pregnant African women 
living with HIV and healthcare professionals in three specialist NHS HIV antenatal 
clinics in London, choosing to recruit from more than one centre in order to maximise 
the chances of recruiting and to reflect the diversity of clinical practice and clinic 
populations in London.  These three sites are among the five hospitals reporting the 
largest numbers of pregnancies in HIV infected women in the UK between 2000 and 
2010103, each centre looking after approximately forty to fifty pregnant HIV-positive 
women each year.  They are in boroughs (Hackney, Newham and Lambeth) of great 
ethnic diversity104, and also substantial deprivation with all three classified as among the 
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 Data from the Q87 NSHPC dataset with reports up to and including June 2011.    
103
 Data from the Q87 NSHPC dataset with reports up to and including June 2011. 
104
 All three hospitals are in boroughs that are ethnically diverse, with the proportion of the population 
who are Black African approximately 11% to 12%.  Data obtained from 2011 England and Wales Census 
table KS201EW available at http://www.ons.gov.uk/ons/datasets-and-tables (accessed 24 September 
2013). 
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thirty most deprived local authorities in England105 (figure 3.4).  All the antenatal clinics 
were based within NHS hospitals, which are bound by Department of Health regulations 
to provide maternity services, including antenatal care, to all women free of charge 
regardless of residency status (Department of Health 2011)106.   
Homerton University Hospital is in Hackney in East London, a borough which is the 
second most deprived in the UK by multiple indices of deprivation (Leeser 2011).  The 
hospital was opened in 1986 and sees over 322,000 patients a year.  Its HIV department 
currently looks after over 850 patients (Jane Anderson, Homerton University Hospital 
NHS Foundation Trust, personal communication, 28 September 2012), of whom over 
half are women of reproductive age and three quarters are first-generation Africans107.  
Newham University Hospital opened in 1983 and is in the borough of Newham, also in 
East London.  It was thrust into the spotlight in 2012 as the host borough for the 2012 
Olympics and has been the site of rapid regeneration.  However the borough remains 
extremely socioeconomically deprived and is ranked third in the UK in terms of 
deprivation (Leeser 2011).  Over 900 patients access the hospital’s HIV services a year, 
of whom nearly 60% are women and 70% are African (Rebecca O’Connell, Barts 
Health NHS Trust, personal communication, 22 August 2013).    African HIV-positive 
patients attending for care in clinics in East London face significant economic and 
social hardship in comparison to other ethnic groups, with 50% having insecure 
immigration status and 40% not having enough money to cater for their basic needs 
(Ibrahim et al. 2008).  My final NHS site was St Thomas’ Hospital, one of the oldest 
hospitals in London with its modern incarnation opening in 1896.  It is situated in 
Lambeth in South London, a borough ranked twenty-ninth on multiple indices of 
deprivation (Leeser 2011).  It has one of the largest HIV clinic populations in the UK 
(approximately 3000 patients) of whom over a quarter are Black African and nearly a 
third are female (Annemiek de Ruiter, Guys and St Thomas’ NHS Foundation Trust, 
personal communication, 23 July 2013). 
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 As measured by multiple indices of deprivation which combine a number of indicators pertaining to 
economic, social and housing issues (see https://www.gov.uk/government/organisations/department-for-
communities-and-local-government/series/english-indices-of-deprivation, accessed 17 July 2013). 
106
 People who are not “ordinarily resident” in the UK (which includes those without secure immigration 
status) are liable to be charged for healthcare apart from that which is deemed immediately necessary and 
treatment of communicable diseases (Department of Health 2011). 
107
 Data obtained from http://www.homerton.nhs.uk/our-services/sexual-health/csshh-centre-for-the-
stud11731067065572/ (accessed 17 July 2013).   
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Figure 3.4: Multiple deprivation indices mapped onto London with study recruitment sites  
 
 
 
 
 
 
 
 
 
 
 
     
     Source: http://casa.oobrien.com/booth/ (accessed 18 July 2013).
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Specialist HIV antenatal clinics were held once a week at each centre, although they 
operated differently in each site.  In one hospital the HIV specialist doctor and midwife, 
together with the obstetrician, ran a clinic at the same time and shared patients between 
them.  In other centres, the HIV specialist doctor saw the patient separately within the 
hospital’s HIV department, with women attending the main antenatal department for 
their antenatal care.  Each of the three centres had a dedicated HIV antenatal 
multidisciplinary team comprising an HIV specialist doctor (with an interest in HIV and 
pregnancy), an HIV specialist midwife and a paediatrician.  Two of the teams had an 
obstetrician with a specialist interest in HIV.  One team also included a social welfare 
advisor to provide patients with support around housing, finance and immigration. 
I interviewed twenty-four women during the course of my fieldwork, of whom all but 
one were recruited from these three NHS sites108.  Their ages ranged from 26 to 41years 
(median 34 years).    They came from twelve countries in Africa and had been in the 
UK from a few months up to 20 years (median 7.5 years); with thirteen having secure 
immigration status.  The majority had come to study or for work but five had fled 
political persecution.  Over half had been educated to degree level and all but one spoke 
English as a first or second language.  Ten of the twenty-four women were unemployed 
when I interviewed them and five described poor quality or temporary housing.  Fifteen 
were in relationships at the time with five describing recent experiences of intimate 
partner violence109.  The vast majority described themselves as religious, mainly 
Christian with ten describing themselves as Pentecostal. 
The subject of faith, especially Pentecostalism was a recurrent theme in interviews with 
women and was cited as a barrier to accessing care by healthcare and charity 
professionals.  This prompted me to conduct a six-week period of participant 
observation at the Triumph of Christ Pentecostal Ministry (TCPM)110, a Pentecostal 
church on the outskirts of London.  I specifically chose to attend TCPM as it had been 
mentioned in interviews by a number of women and I describe the church in greater 
detail in Chapter Six. 
Finally, I spent a total of twenty months volunteering at Body & Soul, an award-
winning London-based charity that has been supporting children and families affected 
                                                             
108
 See Appendix v for participant characteristics. 
109
 Defined as the physical, sexual, or psychological harm by a current or former partner or spouse.  See 
http://www.who.int/violence_injury_prevention/violence/world_report/factsheets/en/ipvfacts.pdf , 
accessed 17 July 2013).  
110
 I refer to the church by a pseudonym throughout this thesis.  
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by HIV since 1996111.  It provides workshops, peer support, one-to-one support, and 
counselling and alternative therapies to over 150 members, mainly from London but 
also from other parts of the UK, in a purpose-built site in central London.     
3.4.3 Situating myself in my field 
My ethnographic field is the city in which I have lived for nearly fourteen years, all of 
that time in Hackney in East London, close to one of my collaborating NHS sites.  I 
have also worked as doctor since 1999.  Ten of those years have been spent working in 
the field of HIV and Sexual Health, mainly in East London.  During my fieldwork I 
continued to work as an HIV clinician at one of the sites where I was conducting my 
research (Homerton University Hospital).  I therefore entered the field with personal 
experience of living in East London and significant professional experience of working 
with people living with HIV, primarily African migrant women.  With regards to my 
fieldwork in NHS sites this was an asset.  It gave me in-depth knowledge of HIV and 
pregnancy, a familiarity with the language and set-up of the clinics, and a wide range of 
professional networks to draw upon during the study.  On the other hand I may have 
overlooked some aspects of HIV and pregnancy, given my familiarity with clinical 
services and settings.    
On a personal level, I am a thirty-seven year old second-generation UK-born Asian 
female doctor who has never had children, conducting research with first-generation 
African HIV-positive migrant mothers, many of whom faced significant social and 
economic hardship.  Within the statement above are similarities and differences, which I 
have endeavoured to keep in mind throughout the research process. 
3.4.4 Semi-structured interviews 
Interviews are ubiquitous not only in qualitative research but also in contemporary 
society (Atkinson et al. 1997) and are accepted as a natural and effective method of 
gaining knowledge.  It is important to critically engage with interviewing as a method in 
itself and challenge the assumption that “what is said is […] a reflection of what is ‘out 
there’ rather than […] an interpretation which is jointly produced by interviewer and 
respondent” (Briggs 1986: 3).  The presupposition that interviews are a neutral method 
capable of capturing a direct representation of experience fails to account for the fact 
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 Further information about Body & Soul is available on their website at 
http://www.bodyandsoulcharity.org/.  
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that what is produced in an interview is an account of the respondent’s experience. 
Interviews are a “speech event” (Ibid:2), subjected to “communicative ideologies” 
(Briggs 2007) in terms of communicative norms and the intended audience.  
Furthermore, accounts are shifting and context dependent and sometimes not 
immediately accessible to the respondent themselves.  These accounts are dialogic, 
constructed by interviewer and respondent, and are therefore shaped by power and 
interest on both sides.  
Whilst it is important to acknowledge the epistemological challenges presented by 
interviews, they remain an important and useful entry point into people’s experiences, 
and were a key method by which I collected data on women’s experiences during and 
after pregnancy112.    
Between October 2010 and October 2011 I interviewed twenty-four African women 
living with HIV.  All but one were pregnant at the time I first interviewed them113.  
Almost all women were recruited from three specialist NHS HIV antenatal clinics in 
London114.  I conducted initial face-to-face interviews (nineteen) in a private room in 
the hospital site with an interpreter present if required115.  Topics covered included 
experiences of pregnancy; attitudes towards medical interventions; experiences of 
healthcare during pregnancy; and stigma and discrimination116.  The interview 
framework was open-ended allowing for new topics to emerge during conversations and 
over the course my fieldwork.   I arranged follow-up interviews after birth with the 
twenty-three women whom I had interviewed during pregnancy, of whom fourteen were 
interviewed postnatally117.  The follow-up interview occurred at a convenient time for 
my participants, up to one year after delivery, although I was unable to contact some 
women and others declined (figure 3.5).  Topics included experiences of delivery; 
experiences of infant feeding; support at home after delivery; and engagement with HIV 
                                                             
112
 In my use of interviews as a predominant method of data collection I have been influenced by the 
work of Emily Martin on Baltimore women’s understanding of reproductive processes (1987) and Linda 
Blum on breastfeeding in North America (1999). 
113
 I approached one woman whilst pregnant but she chose to defer her interview until after delivery due 
to poor health towards the end of her pregnancy. 
114
 One interview was conducted with a woman I met whilst volunteering at an HIV charity.   
115
 One initial interview was conducted at a participant's house.  Only one interview was conducted with 
an interpreter. 
116
 See Appendix vi for the interview guide. 
117
 Serial interviews can result in the development of increased trust between researcher and participant, 
facilitating more open discussion (Murray, et al. 2009).  Furthermore, given that the transition between 
pregnancy and motherhood is a dynamic time, I felt that serial interviews might better capture this 
changing experience (Ibid.).   
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services after delivery118. 
 
I conducted four of the initial interviews by telephone when women stated a preference 
for this.  Six of the postnatal interviews were also conducted by telephone due to 
women’s difficulty in attending for an interview when caring for a newborn infant.   
The pre-eminence of face-to-face interaction in anthropological fieldwork has been 
challenged as other modes of communication such as mobile phones have become 
integral to contemporary life (Sunderland 1999). Whilst useful in engaging hard to 
reach groups such as mothers with young children (Musselwhite et al. 2007), telephone 
interviewing brings its own challenges such as maintaining respondent involvement, 
understanding accents, not having access to non-verbal communication and 
encountering difficult disclosures.  However, on balance I found very little difference in 
the accounts produced by telephone and face-to-face.  All face-to-face and telephone 
interviews were recorded on a digital voice recorder where possible, except for when a 
woman felt uncomfortable with this.  In these two cases, I took extensive 
contemporaneous written notes. 
I wanted to reflect a breadth of experience of pregnancy in the context of HIV and 
therefore attempted to recruit women from a range of African countries who had been in 
the UK for varying lengths of time.  This allowed me to compare experiences across 
groups.  I also included women who had been diagnosed before and during their current 
pregnancy.  Some of my sampling was guided by initial quantitative results in order to 
explore emerging findings119.   
For interviews conducted within NHS clinics, I asked healthcare professionals to 
identify and approach African women attending for HIV antenatal care who might be 
suitable for the study.   I based myself on site when the HIV antenatal clinics were 
running in order to be available to discuss the project further and provide women who 
were interested with an information sheet120.   If a woman wished to participate we 
found a convenient time for her to come back to the hospital to be interviewed, before 
which I obtained written informed consent121.  
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 See Appendix vi for the interview guide. 
119
 For example, the quantitative analysis revealed that Western African women were less likely to 
receive ART during pregnancy and I therefore sought to interview greater numbers of women from 
Western African countries to explore this in greater detail.    
120
 See Appendix vii for an example of a participant information sheet. 
121
 See Appendix viii for an example of a participant consent form. 
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Figure 3.5: Recruitment and follow-up of interview participants 
 
 
 
 
 
 
 
 
 
 
 
* 1 woman was recruited and interviewed postnatally face-to-face 
   ftf, face-to-face interview; tel, telephone interview; ltfu, lost to follow-up 
 
I also conducted interviews with four healthcare professionals involved in the care of 
pregnant women living with HIV at the collaborating NHS clinics.  They comprised two 
consultants in HIV medicine, one HIV specialist midwife and one specialist nurse in 
genitourinary medicine.  Interviews were also conducted with two professionals from 
voluntary sector organisations with experience of supporting African women living with 
HIV.  These participants were identified through my knowledge of local voluntary 
sector organisations and professional networks.  The purpose of interviewing health 
care and charity professionals was to elicit their experience of providing care to this 
group of women and to identify what they saw as barriers to accessing care.  In total I 
conducted forty-four interviews with HIV-positive African women and professionals 
working with them, over a fourteen-month period between 2010 and 2011. 
   
In her 1987 ethnography of the cultural representation of reproduction in the United 
States, Emily Martin acknowledges that interview-based studies sometimes forego “the 
rich, multi-layered texture of life” that is experienced through traditional modes of 
fieldwork (1987: 9).  Furthermore, my interviews occurred mainly in clinical spaces 
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filled with medical paraphernalia and were conducted primarily in English122.  Like 
Martin (Ibid.), I have attempted to address this potential lack of depth by immersing 
myself in my field as fully as possible.  During my fieldwork I continued to work as an 
HIV clinician in one of the collaborating clinics and as a volunteer at an HIV charity, 
keeping a record of my observations and informal exchanges with colleagues in order to 
inform my analysis.     
3.4.5 Participant observation 
I undertook participant observation in three different sites during the qualitative phase 
of this study.   
Antenatal clinics 
Firstly, I conducted ad-hoc participant observation in the HIV antenatal clinics I 
collaborated with, one of which was based in the hospital in which I continued to work 
as an HIV clinician.  This mainly comprised observing and reflecting upon 
consultations (including some of my own) and conversations with clinical colleagues.  
In two of the clinics I worked with I was also invited to attend the pre-clinic meeting 
where patients and management plans were discussed at length within the 
multidisciplinary team.    I recorded my thoughts and observations as written field 
notes, and although they do not appear in this thesis (to preserve confidentiality) they 
were integral in shaping my understanding of the research question. 
Body and Soul 
I also volunteered at an HIV charity (Body & Soul) between April 2010 and December 
2011.  During this time I worked with the “Adults’ Group”, assisting with serving food 
and coordinating the running of group sessions.  There were very few pregnant women 
attending the service during the study period and it was not feasible to engage people in 
lengthy conversations as they were often attending for specific meetings or workshops.  
Despite these limitations, volunteering at Body & Soul gave me important insights into 
the lives of HIV-positive people and how HIV was discussed outside of a clinical 
environment.   It has also been invaluable in forging networks to disseminate my work 
to people living with HIV and gain feedback on my findings.   I recorded my thoughts 
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 All women were offered the use of an interpreting service however all but one preferred to conduct the 
interview in English (many stating that this was their first language).  However, I am conscious that for 
some women certain cultural concepts may not have been easily translatable into English. 
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and observations as written field notes immediately after a session ended.  Again, 
although very little data from my fieldwork at Body & Soul appear formally in this 
thesis, my thinking about HIV in the lives of African migrants has been shaped by my 
observations and experiences there. 
Pentecostal church 
The most consolidated period of ethnographic fieldwork I undertook in the course of 
this research was between July and September 2011, when I conducted nearly forty 
hours of participant observation in the Triumph of Christ Pentecostal Ministry.  Over 
the course of six weeks, I attended daily church services including one all night prayer 
vigil, keeping extensive written field notes and voice memos on a digital voice recorder.  
This was complemented by watching footage of TCPM church services broadcast on 
satellite television, and conducting in-depth audio-recorded interviews with two 
members123 of the congregation and a local pastor (who also worked as a specialist 
nurse in genitourinary medicine) who was familiar with the church.    
This period of fieldwork was brief by necessity given the time constraints of a three-
year mixed-methods PhD and has particular limitations when compared with the 
prolonged periods of immersion typical of most anthropological research124.  A longer 
period of ethnographic fieldwork would have resulted in a deeper understanding of the 
church and increased access to members of the congregation and clergy.  The brevity of 
the fieldwork was a necessary compromise.  However it remains useful and has 
generated important insights into the interaction between Pentecostal faith and HIV in 
the daily lives of African migrants in the UK.   
3.4.6 Analysis of qualitative data 
I employed a professional transcription company to transcribe all interviews, and I 
quality checked a proportion of transcriptions throughout the qualitative phase to ensure 
accuracy.  I used the Qualitative Data Analysis (QDA) software NVivo 9.0 (QSR 
International Pty Ltd., 2010) to manage interview data.  QDA software allows the 
storage, classifying, sorting and linking of data, which can improve efficiency and 
efficacy in analysis (Bazeley et al. 2013), however it is important to note that it does not 
                                                             
123
 Both of these interviews were recorded on a digital voice recorder having gained written informed 
consent from participants and then transcribed verbatim.   
124
 Traditional views of ethnographic research requiring extended periods of time in the field have been 
challenged as the role of innovative and pragmatic approaches such as brief ethnography has become 
increasingly recognised (Green, et al. 2009). 
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have any analytical function itself.     I undertook a thematic analysis of interview data, 
using the constant comparative method usually associated with grounded theory (Pope 
et al. 2000).   This is an inductive process where each transcript is read several times 
and sections of the text coded within the database.  Coded text are then compared and 
linked across all the interviews if they capture a similar theme, leading to the 
development of broader key categories.   I paid particular attention to the context of 
coded text by reading transcripts in their entirety several times, rather than focusing on 
small sections of coded text in isolation.  I also sought out data, which did not appear to 
fit into the emerging thematic framework, in order to deepen my understanding.  As 
well as these inductive codes, I devised some a priori codes from the quantitative phase 
of the study, allowing me to interrogate the qualitative data to generate insights into my 
quantitative findings.   
I made extensive written field notes during ethnographic fieldwork conducted at both 
Body & Soul and the Pentecostal church.  I hand-coded these field notes rather than 
transcribing them and entering them into NVivo as this was time efficient.  I used a 
manual index system to organise this data.  I began with open coding, a process where 
codes are identified from the data without restriction, later developing broader thematic 
categories using the constant comparative method described above. 
Throughout the qualitative phase I discussed the interpretation of my data with other 
anthropological colleagues, including one of my supervisors, and several doctoral and 
post-doctoral students with ethnographic experience of either Pentecostalism in London 
or HIV and pregnancy.  I also presented my emergent findings to colleagues in HIV 
departments and patient groups.  This allowed me to receive feedback on my analysis 
and also gave me increased confidence in my interpretation of the data. 
3.4.7 Ethical considerations 
The qualitative phase of the study has ethical approval from City University Research 
Ethics Committee for qualitative research conducted outside NHS sites (ref PhD/09-
10/10)125.   It also has approval from the West London Research Ethics Committee for 
the overall qualitative phase, including research conducted with NHS staff and patients 
(ref 10/10707/49)126. 
                                                             
125
 See Appendix ix for ethical approval from City University Ethics Committee. 
126
 See Appendix x for ethical approval from the West London Research Ethics Committee on behalf of 
NHS sites. 
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I obtained written consent from all participants I interviewed and ensured that I revisited 
this in subsequent interviews.  I emphasised to women recruited through NHS clinics 
that participation was independent of any care received and that declining to be 
interviewed would have no negative repercussions.  I did not approach any woman I 
have looked after in a clinical capacity.  I have given pseudonyms to all my participants 
in this thesis127 and omitted or changed details that may render them identifiable.   
I also obtained written consent from Body & Soul on behalf of their members and 
regularly ensured that members were aware of my presence as a researcher.  I was 
unable to secure written consent from the Pentecostal Church for participation 
observation.  I was not able to arrange a meeting with the senior Pastor and assistant 
pastors were unwilling to consent on his behalf128.  The church clergy were aware of my 
presence at services as a researcher exploring health and healing within the church129 
and were provided with an information sheet130.  As I was not asked to leave I assumed 
assent and instead sought written consent from individual church members before 
conducting interviews.  After discussion with City University’s research ethics 
committee, I present findings from this part of my fieldwork in this thesis with 
identifiable data omitted or changed to protect the identity of the church and those 
within it. 
3.4.8 Conclusions 
The overarching question posed in this thesis is: how do African women living with 
HIV in the UK engage with HIV services and interventions during and after pregnancy?  
Answering this question involves engaging with clinical outcomes, access to services, 
beliefs and lived experiences.  To achieve an understanding of the multidimensional 
nature of the pregnancy in the context of HIV in this group of women I have used a two 
phase mixed methods research approach combining epidemiological and 
anthropological methods.  In the first phase (quantitative) I analysed data on 
approximately 10,000 pregnancies from the National Study of Pregnancy in HIV and 
Childhood, the UK and Ireland’s comprehensive surveillance programme for HIV in 
pregnancy.  I also matched data from the NSHPC and another national epidemiological 
                                                             
127
 I have chosen to use common names from the countries my participants were from (rather than codes 
or numbers) in order to preserve narrative flow. 
128
 I also had concerns that, given his authority, had the pastor consented on behalf of the congregation 
individual church members would feel under pressure to participate.   
129
 The brief nature of my fieldwork precluded discussions of sensitive topics such as HIV. 
130
 See Appendix xi for examples of participant information sheets. 
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dataset (SOPHID) in order to explore loss to follow-up after pregnancy.  In the second 
phase I conducted multi-sited ethnographic fieldwork in London to explore HIV-
positive migrant African women’s experiences of pregnancy and early motherhood.  My 
methods mainly comprised semi-structured interviews with twenty-four pregnant 
African women living with HIV (and those involved in their care), and participant 
observation in a number of sites including a Pentecostal church.  Where possible the 
findings from the quantitative and qualitative analyses will be presented and interpreted 
together in this thesis to achieve a deeper understanding of how African HIV-positive 
women engage with services during and after pregnancy than would be possible by 
drawing upon either epidemiological or ethnographic data alone.   
Key Points 
 The overarching research question in this thesis is: how do African women 
living with HIV in the UK engage with HIV services and interventions during 
and after pregnancy?  This question encompasses clinical and service-related 
outcomes as well as the experiences of pregnant African women living with 
HIV. 
 A mixed methods approach (combining quantitative and qualitative methods in 
the same study) is suited to understanding this type of complex, multi-
dimensional phenomena. 
 In this thesis I use a combination of epidemiological and anthropological 
methods. 
 In the quantitative phase I analysed data from the National Study of HIV in 
Pregnancy and Childhood, the UK and Ireland’s comprehensive national 
surveillance programme for HIV in pregnancy, and from the Survey of Prevalent 
HIV Infections Diagnosed. 
 In the qualitative phase I conducted multi-sited ethnographic research in London 
comprising semi-structured interviews and participant observation.  
 The quantitative and qualitative datasets have been kept analytically distinct.  
However during analyses I have moved between the two datasets and also linked 
them at the interpretation stage in order to achieve integration. 
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Pregnancy and HIV in African migrant women  
living in the UK: epidemiological overview 1990 - 2010 
 
Summary 
In this first empirical chapter of my thesis, I draw upon NSHPC data to provide, for the 
first time, a broad overview of HIV and pregnancy in the UK with specific reference to 
African women.  I present updated data on trends in ethnicity of women whose 
pregnancies were reported to the NHSPC between 1990 and 2010.  Previous analyses of 
NSHPC data have not explored trends in pregnancies in African women in detail.  Here 
I explore trends in maternal African region of birth and duration of residence in the UK, 
both nationally and within reporting regions, between 1990 and 2010.  Finally I focus 
on pregnancies reported in white British and African women between 2000 and 2010, 
which form the basis of analyses presented in Chapters Five, Seven and Eight, 
presenting baseline demographic and clinical characteristics.  This epidemiological 
overview of pregnancy in HIV-positive African women living in the UK will provide 
context for the presentation of quantitative and qualitative data in the subsequent 
chapters.   
4.1 Introduction  
As described in Chapter One, there have been changes in the epidemiology of HIV over 
the past three decades.  Heterosexually acquired HIV infection has increased both 
worldwide and within the UK.  In the UK, heterosexual Black African women now 
comprise the second largest group of people living with HIV, after men who have sex 
with men; a reflection of the global burden of disease still shouldered by Sub-Saharan 
African countries.  In Chapter One I highlighted the sharp increase in the UK in the 
number of pregnancies in women with diagnosed HIV-infection, the majority being in 
women of Black African ethnicity (Townsend et al. 2008b).  In this chapter I provide an 
epidemiological overview of pregnancy and HIV in the UK with specific reference to 
African women.  I first present data on trends in maternal ethnicity, African region of 
birth and duration of residence in the UK at the time of conception between 1990 and 
95 
 
2010.  I then present baseline demographic and clinical characteristics of African and 
white British women who were reported as pregnant between 2000 and 2010131, as they 
form the basis of analyses presented in Chapter Five, Seven and Eight. 
4.2 Trends over time  
There were 13,676 pregnancies reported to the NSHPC in 10,141 women between 1990 
and 2010.  The annual number of reported pregnancies increased from 58 in 1990 to 
1351 in 2010, the majority (12193/13676; 89%) reported between 2000 and 2010.  
Between 1990 and 2010 three quarters of pregnancies in the UK reported to the NHSPC 
(10,191/13,676) were in African women.   The number and proportion of African 
women (of Black African ethnicity and born in Sub-Saharan Africa)132 increased 
significantly between 1990 and 2006 (figure 4.1 and table 4.1).    The number and 
proportion stabilised between 2007 and 2010 but African women remained by far the 
largest group numerically.  Of note there was a significant increase in women of both 
Caribbean and “Other” ethnicities (comprising Asian, mixed and other ethnicities) 
throughout the study period (both ptrend<0.001), although their proportions remained 
small.  
Between 1990 and 2010, 10,191 pregnancies were reported in African women.  More 
than half  (6300/10,191; 62%) were in women born in Eastern Africa133 with Western 
African women the second largest group (2102/10,191; 20.6%) during this time period.  
Women from Southern and Middle African constituted much smaller groups at 7.3% 
and 10.2% respectively.   Over 60% (6278) of pregnancies in African women were in 
women born in Zimbabwe, Uganda, Nigeria, South Africa or Zambia (table 4.2), with 
Zimbabwean women being the largest group of these five countries.
                                                             
131
 This time period corresponds with wider use of HAART in pregnancy and more consistency in clinical 
practice and laboratory monitoring than in the previous decade.   
132
 Previous analyses of NSHPC data have used “Black African” as an ethnicity category without 
specifying place of birth.  The overwhelming majority of Black African women reported to the NSHPC 
were born in Sub-Saharan Africa.  Between 1990 and 2010, 10,634 pregnancies reported to the NSHPC 
were reported in Black African women, of whom 10,191 (95.8%) were born in Sub-Saharan Africa (data 
from the Q87 NSHPC dataset with reports up to and including June 2011. 
133
 See Chapter 3 (table 3.4: 71) for definitions of United Nations geographical region categories.   
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Figure 4.1: Trends in maternal ethnicity in pregnancies reported to the NSHPC (proportions), 1990-2010 (n=13,676) 
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     Table 4.1: Trends in maternal ethnicity in pregnancies reported to NSHPC by time period, 1990 – 2010 
 
 
*p-value for trend over time for each category compared with others combined using logistic regression.  †All significance levels with α=0.05 set at p<0.01  
(Bonferroni correction).  
 
 Time period n (column %)  
 1990-93 1994-96 1997-99 2000-03 2004-06 2007-10 Total (row) p-value*† 
White British 108 (27.8) 97 (23.5) 115  (16.9) 291  (10.6) 330 (8.70) 520  (9.2) 1461 <0.001 
African  246 (63.4) 269 (65.1) 464 (68.0) 2053 (74.4) 2906 (76.6) 4253 (75.4) 12191 <0.001 
Black British 7 (1.8) 6 (1.5) 16 (2.4) 76 (2.8) 76 (2.0) 121 (2.2) 302 0.817 
Black Caribbean 0 (0.0) 4 (1.0) 14 (2.1) 78 (2.8) 95 (2.5) 121 (2.1) 307 <0.001 
Other  27 (7.0) 37 (9.0) 73 (11.9) 260 (9.4) 387 (10.2) 626 (11.1) 1409 0.003 
Total (column) 388 413 682 2758 3794 5641 13676  
98 
 
Table 4.2: Maternal country of birth in pregnancies reported to NSHPC, 1990-2010 
(restricted to the ten African countries contributing the greatest number of pregnancies, 
n=8175) 
Country Number of pregnancies (%) 
Zimbabwe 2811 (34.4) 
Uganda 1227 (15.0) 
Nigeria 1070 (13.1) 
South Africa 645 (7.9) 
Zambia 525 (6.4) 
Ghana 473 (5.8) 
Congo 437 (5.3) 
Malawi 358 (4.4) 
Kenya 349 (4.3) 
Cameroon 280 (3.4) 
 
The number of reported pregnancies increased over time in women from all African 
regions (table 4.3).  Women from Eastern Africa remained the largest group throughout 
the study period but the proportion of pregnancies reported in women from this region 
significantly decreased from 87.1% (27/31) in 1990 to 62.0% (623/1005) in 2010 
(ptrend<0.001, figure 4.2).  The number of women from Southern Africa (almost entirely 
South African) increased from 1 (0.4%) to 65 (6.5%) during this period (ptrend<0.001, 
figure 4.2), as did the number of women from Middle Africa (from 3 in 1990 to 82 in 
2010, ptrend<0.001, figure 4.2).  However, the most striking change was in the number of 
pregnancies reported in Western African women from only one reported pregnancy in 
1990 (3.2%) to 235 (23.4%) in 2010 (ptrend<0.001, figure 4.2).   
Over 60% of pregnancies in African women were in women born in Zimbabwe, 
Uganda, Nigeria, South Africa and Zambia (table 4.2).  Numbers of pregnancies in 
women born in each of these five countries increased between 1990 and 2010.  
However the proportions have changed over time with a predominance of Ugandan 
women earlier in the time period and an increasing proportion of Zimbabwean, and to a 
lesser extent Nigerian, women from the late 1990s onwards (figure 4.3).
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Table 4.3: Trends in maternal African region of birth in pregnancies reported to NSHPC by time period, 1990 – 2010 
 
    
*p-value for trend over time for each category compared with others combined using logistic regression.  †All significance levels with α=0.05 set at p<0.01  
(Bonferroni correction).  
 
                                                Time period n (column %)  
 1990-93 1994-96 1997-99 2000-03 2004-06 2007-10 Total (row) p-value*† 
Eastern African 215 (87.4) 200 (74.4) 323  (69.6) 1287  (62.7) 1709 (58.8) 2566  (60.3) 6300  <0.001 
Southern African  1 (0.4) 2 (0.7) 12 (2.6) 145 (7.1) 259 (8.9) 329 (7.7) 748  <0.001 
Western African 13 (5.3) 30 (11.2) 71 (15.3) 369 (18.0) 629 (21.6) 990 (23.3) 2102 0.817 
Middle African 17 (6.9) 37 (13.8) 58 (12.5) 252 (12.3) 309 (10.6) 368 (8.7) 1041 <0.001 
Total (column) 246 269 464 2053 2906 4253 10191  
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Figure 4.2: Trends in maternal African region of birth in pregnancies reported to the NSHPC (numbers), 1990-2010  
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Figure 4.3: Trends in maternal African country of birth in pregnancies reported to the NSHPC (proportions), 1990-2010 (restricted to top five countries, 
n=6278) 
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Duration of residence in the UK was measured from the mother’s documented date of 
arrival in the UK to estimated date of conception of the reported pregnancy.  Analyses 
were restricted to first pregnancies reported to the NSHPC in African women134.  Date 
of arrival in the UK was not reported in 3023 (40.0%) pregnancies135; therefore the 
following analysis is based on 4543 pregnancies.   
The median duration of residence in the UK at conception of first reported pregnancy to 
the NSHPC for African women was 2.9 years (interquartile range [IQR]:  0.8, 5.7 
years).  Of the 575 pregnancies in women who had arrived in the UK after conception, 
only a small proportion (12.9%) were in women known to have been diagnosed with 
HIV prior to the reported pregnancy.  Median duration of residence varied across 
African regional groups as shown in table 4.4 (p Kruskal-Wallis<0.001, table 4.4), with 
women from Eastern Africa having resided in the UK the longest and those from 
Middle African the shortest period of time.  Among all African women, the median 
maternal duration of residence in the UK at time of conception increased from 2.3 years 
(IQR: 2.3, 2.5 years) in 1990 to 6.3 years (IQR: 2.3, 8.7 years) in 2010, with a sharp 
decrease in 1999 but a steady increase from 2002 onwards (figure 4.4)136. 
Table 4.4: Duration of residence in the UK at conception by maternal African region of 
birth 
Maternal African region of birth  Median duration of residence in the UK in years* 
Eastern Africa 3.5 (IQR: 1.3, 6.1)  
Southern Africa  1.8  (IQR: 0.4, 4.0) 
Western Africa 2.4  (IQR: 0.4, 5.2) 
Middle Africa 1.6  (IQR: 0.1, 4.8) 
IQR, interquartile range; * pKruskal-Wallis<0.001 
                                                             
134
 Sequential pregnancies were not included as duration of residence would be correlated with time 
between pregnancies and would partly be a measure of this. 
135
 Missing data on maternal duration of residence in the UK is discussed in Chapter Three (73-74).  
136
 It is important to be aware that the proportion of data missing on maternal duration of residence in the 
UK reached up to 95% in some of the years preceding 2000 which means estimates earlier in the study 
period are likely to be less reliable.  All analyses using maternal duration of residence in the UK 
presented in this thesis are restricted to pregnancies reported between 2000 and 2010 when the proportion 
of missing data was consistently below 45%.  
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Figure 4.4: Median maternal duration of residence in the UK or Ireland at time of 
conception for African women (restricted to first reported pregnancy to NSHPC), 1990-
2010 
 
 
 
4.3 Trends by geographical reporting area 
Between 1990 and 2010, over half (4854/8793) of pregnancies in African women were 
reported by London centres137.  However, a substantial number (3664; 41.7%) of reports 
came from the rest of England (table 4.5).  Wales, Scotland and Northern Ireland 
reported the smallest number of pregnancies in African women, with white women 
predominating in these areas. There was variation among reporting areas with regards to 
maternal African region of birth as shown in table 4.5.  London reported the greatest 
number of pregnancies in women from Western, Middle and Eastern Africa, although a 
large number of pregnancy reports in Eastern African women originated from the rest of 
England.  English centres (not including London) also reported the largest number of 
pregnancies in Southern African women (368; 59.2%), although substantial numbers 
were also reported by centres in London. There were differences in duration of 
residence at the time of conception for African women across the UK as summarised in 
table 4.5, with women whose pregnancies were reported by London centres having been 
in the country longer than those reported by centres in Wales, Scotland and Northern 
                                                             
137
 Due to small numbers of reports in women from other ethnicities this analysis is restricted to women 
of white British and African ethnicity. 
p<0.001 
R
2
=0.66 
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Ireland.   
Between 1990 and 2010 there were also changes in the maternal ethnic composition of 
pregnancies reported to the NSHPC within each reporting area (Figure 4.5).  London 
saw a rise in reports in African women from the early 1990s, with the sharpest increase 
between 2000 and 2003.  The rest of England also reported an increasing number of 
pregnancies in African women, mainly between 2000 and 2010.  Wales, Scotland and 
Northern Ireland has seen a similar pattern but on a much smaller scale, with reports of 
pregnancies in African women outnumbering those in white British women for the first 
time in recent years.  
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Table 4.5: Maternal ethnicity, African region of birth and maternal duration of residence in the UK at conception, by geographical reporting area in the 
UK, 1990-2010 
 
 
 
 
 
 
 Reporting region n (column%) 
 London England (non-London) Wales, Scotland and 
Northern Ireland 
Total p-value   
Ethnicity (n=10033)      
White British             287 (5.6) 668 (15.4) 285 (50.9) 1240  
African 4854  (94.4) 3664 (84.6) 275  (49.1) 8793 <0.001* 
Total 5141 4332 560   
African region of birth (n=8793)      
Eastern Africa 2682 (55.3) 2589 (70.7) 170 (61.2) 5441  
Southern Africa             218 (4.5) 368 (10.0) 36 (13.1) 622  
Western Africa 1416 (29.2) 365 (10.0) 45 (16.4) 1826  
Middle Africa 538 (11.1) 342 (9.3) 24 (8.7) 904 <0.001* 
Total 4854 3664 275 8793  
Median duration of residence in the UK (years) 3.4 (IQR: 1.0, 6.5)  2.4 (IQR: 0.6, 4.8)  1.4 (IQR: 0.1, 4.1)  <0.001¶ 
IQR, interquartile range; *p-value obtained using χ2test; ¶p-value obtained using Kruskal-Wallis test. 
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Figure 4.5: Maternal ethnicity in pregnancies reported to NSHPC by geographical 
reporting area, 2000-2010 
a) London 
 
 
 
 
 
 
 
 
 
b) England (outside London)
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c) Wales, Scotland and Northern Ireland*  
 
 
 
 
 
 
 
 
 
*Note that y-axis scale is ten-fold lower than in figures 4.5a and 4.5b. 
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4.4 Baseline characteristics of pregnancies reported to NSHPC 2000-2010 
I will now focus on pregnancies reported to the NSHPC between 2000 and 2010 in 
women of white British or African ethnicity who were diagnosed with HIV prior to the 
end of their pregnancy, as they form the basis of all subsequent quantitative analyses in 
this thesis.  This time period corresponds with wider use of highly active antiretroviral 
therapy (HAART) in pregnancy and more consistency in clinical practice and laboratory 
monitoring than in the previous decade.  As highlighted earlier in this chapter, this is 
also when the majority of pregnancies were reported to the NSHPC (12193/13676; 
89%).   
There were 10,100 pregnancies reported to the NSHPC in 7657 women between 2000 
and 2010, including 175 twin or triplet pregnancies.  Since 2000 there were 8626 live 
births, 93 stillbirths, 531 miscarriages and 339 terminations of pregnancy138.  Data on 
pregnancy outcome were not available for 176 continuing pregnancies at the time of 
analysis.  Less than 1% of pregnancies were in women infected with HIV-2 virus 
(33/9865)139.   
Approximately 1% (94/10,100) of pregnancies were in women who were reported to 
have acquired HIV through injecting drug use (table 4.6).  The median maternal age at 
delivery was 31.2 years (IQR: 27.4, 35.0 years).  In over 90% (9137/9761) of 
pregnancies, women received ART during pregnancy; with the majority (8189/9658; 
85%) receiving HAART140.  Comparing pregnancies in white British and African 
women (table 4.6), a greater proportion of Africans were diagnosed during pregnancy 
and had an initial CD4 count <200 cells/mm3 (both p<0.001).  A slightly higher 
proportion of African women had vaginal deliveries (p<0.001) whilst preterm delivery 
in this group was less common than in the white British group (p<0.01). 
                                                             
138
 Data on termination of pregnancy and miscarriage are not accurate as they are often poorly reported by 
respondents to the NSHPC. 
139
 Pregnancies in women with HIV-2 infection were included in all analyses.  
140
 HAART being classified as a treatment combination of three or more antiretroviral agents. 
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Table 4.6: Baseline characteristics of pregnancies by maternal ethnicity (n=10100) 
 
Characteristics † Total Ethnicity n (col %) 
White British 
(n=1118) 
African 
(n=8982) 
p-value* 
Maternal age at delivery  
<25 
25-34 
шϯϱ 
 
      1313 (13.7) 
      5884 (61.3) 
      2401 (25.0) 
 
     325 (29.9) 
     531 (48.8) 
     232 (21.3) 
 
  988 (11.6) 
4765 (65.0) 
2169 (25.5) 
 
<0.001 
IDU 
No  
Yes 
 
   10006 (99.1) 
             94 (0.9) 
 
  1027 (91.9) 
        91 (8.1) 
 
    8979 (100.0) 
           3 (0.0) 
 
<0.001 
Timing of HIV diagnosis 
Before pregnancy 
During pregnancy 
 
5959 (59.2) 
4107 (40.8) 
 
728 (65.1) 
390 (34.9) 
 
5231 (58.5) 
3717 (41.5) 
 
<0.001 
Earliest HIV viral load
¶
  
(copies/ml)  
Undetectable 
50-10000 
шϭϬϬϬϬ 
 
 
2908 (36.6) 
3050 (38.4) 
1990 (25.0) 
 
 
319 (36.3) 
324 (36.9) 
236 (26.9) 
 
 
2589 (36.6) 
2726 (38.6) 
1754 (24.6) 
 
 
0.385 
Earliest CD4
¶
  (cells/mm
3
)  
шϯϱϬ 
200-349 
<200 
 
5016 (57.3) 
2540 (29.0) 
1203 (13.7) 
 
654 (69.8) 
220 (23.5) 
            63 (6.7) 
 
4362 (55.8) 
2320 (29.7) 
1140 (14.6) 
 
<0.001 
ART during pregnancy 
Yes 
No 
 
9137 (93.6) 
    624 (6.4) 
 
1013 (93.3) 
            73 (6.7) 
 
8124 (93.7) 
551 (6.4) 
 
0.638 
Duration of ART  
On ART at conception 
12-40 weeks 
2-11 weeks 
<2 weeks 
 
2958 (35.4) 
3262 (39.1) 
1949 (23.4) 
   178 (2.1) 
 
304 (32.7) 
407 (43.7) 
205 (22.1) 
             15 (1.6) 
 
2654 (35.8) 
2855 (38.5) 
1744 (23.5) 
163 (2.2) 
 
0.017 
Mode of delivery  
Elective CS 
Emergency CS 
Vaginal 
 
4398 (50.9) 
2038 (23.6) 
2210 (25.6) 
 
572 (58.2) 
194 (19.7) 
217 (22.1) 
 
3826 (49.9) 
1844 (24.1) 
1993 (26.0) 
 
<0.001 
Gestational age (weeks)
¶¶
     
ш ϯ7  
< 37 
 
7404 (85.9) 
1211 (14.1) 
 
806 (82.7) 
169 (17.3) 
 
6598 (86.4) 
1042 (13.6) 
 
0.002 
† Numbers vary due to missing data. * p-value obtained using χ2test. ¶ First reported value in pregnancy.    
¶¶ Restricted to live and still births.  Col, column; IDU, likely route of HIV acquisition was maternal 
injecting drug use; ART, antiretroviral therapy; CS, Caesarean Section. 
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Looking at the 8992 pregnancies in African women there were differences according to 
maternal African region of birth (table 4.7).  Women from Eastern Africa were older 
(p<0.001).  HIV diagnosis was more commonly made during pregnancy in pregnancies 
in Southern and Western African women (p<0.001) and therefore a greater proportion 
of these women were not on ART at conception and had a detectable initial viral load in 
pregnancy (both p<0.001), although the greatest proportion of pregnancies where ART 
was not received was in women from Middle Africa.  There was no significant 
association between African region of birth and initial CD4 count in pregnancy (p>0.5). 
Data were available on duration of residence in the UK at conception in 5813 of 8982 
pregnancies in African women between 2000 and 2010 (table 4.8).  Women who had 
arrived in the UK after conception were younger than those who had been in the UK for 
a longer period of time (p<0.001).  Diagnosis of HIV was more commonly made during 
pregnancy in pregnancies in this group and consequently they were less likely to be on 
ART at conception.  Women who had been in the UK for less than four years, including 
those who arrived after conception, were more likely to have a lower initial CD4 count 
and a detectable initial viral load than those who had been in the UK for longer (all 
p<0.001).  ART was not received during pregnancy in a greater proportion of 
pregnancies in women who had arrived in the UK after conception (p<0.05), and there 
was a higher proportion of elective caesarean sections in this group (p<0.001), likely as 
a result of shorter duration of ART and consequent concerns around risk vertical 
transmission.
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Table 4.7: Baseline characteristics of pregnancies by maternal African region of origin (n=8982) 
 Characteristics† Maternal African region of birth (col %)  
p-value*  Eastern Africa Southern Africa Western Africa Middle Africa 
Maternal age at delivery  
<25 
25-34 
шϯϱ 
 
       527 (10.2) 
     3203 (61.8) 
     1457 (28.1) 
 
93 (14.5) 
435 (67.8) 
114 (17.8) 
 
219 (12.0) 
1217 (66.5) 
393 (21.5) 
 
149 (17.5) 
498 (58.5) 
205 (24.1) 
 
<0.001 
Timing of HIV diagnosis 
Before pregnancy 
During pregnancy 
 
3381 (62.7) 
2014 (37.3) 
 
316 (44.2) 
399 (55.8) 
 
962 (49.5) 
982 (50.5) 
 
572 (64.0) 
322 (36.0) 
 
<0.001 
Earliest HIV viral load
¶
 
(copies/ml)  
Undetectable 
50-10000 
шϭϬϬϬϬ 
 
 
1664 (39.1) 
1579 (37.1) 
1010 (23.8) 
 
 
166 (29.9) 
235 (42.3) 
154 (27.8) 
 
 
467 (30.0) 
673 (43.3) 
415 (26.7) 
 
 
292 (41.4) 
239 (33.9) 
175 (24.8) 
 
 
<0.001 
Earliest CD4
¶ 
(cells/mm
3
)  
шϱϬϬ 
200-249 
<200 
 
2597 (55.1) 
1413 (30.0) 
701 (14.9) 
 
352 (56.7) 
183 (29.5) 
86 (13.9) 
 
997 (57.9) 
489 (28.4) 
236 (13.7) 
 
416 (54.2) 
235 (30.6) 
117 (15.2) 
 
0.521 
ART during pregnancy 
Yes 
No 
 
4939 (94.2) 
303 (5.8) 
 
641 (93.6) 
44 (6.4) 
 
1741 (92.7) 
137 (7.3) 
 
803 (92.3) 
67 (7.7) 
 
0.039 
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Table 4.7: Baseline characteristics of pregnancies by maternal African region of origin continued 
 
 Characteristics† Maternal African region of birth (col %)  
p-value*  Eastern Africa Southern Africa Western Africa Middle Africa 
Duration of ART  
Before conception 
12-40 weeks 
2-11 weeks 
<2 weeks 
 
1787 (39.5) 
1676 (37.1) 
970 (21.5) 
88 (2.0) 
 
152 (26.8) 
243 (42.9) 
164 (28.9) 
8 (1.4) 
 
432 (26.9) 
687 (42.8) 
437 (27.2) 
50 (3.1) 
 
283 (39.2) 
249 (34.5) 
173 (24.0) 
17 (2.4) 
 
                <0.001 
Mode of delivery  
Elective CS 
Emergency CS 
Vaginal 
 
2395 (51.6) 
1053 (22.7) 
1194 (25.7) 
 
305 (51.7) 
137 (23.2) 
148 (25.1) 
 
773 (46.4) 
462 (27.7) 
432 (25.9) 
 
353 (46.2) 
192 (25.1) 
219 (28.7) 
 
<0.001 
Gestational age (weeks)
¶¶
 
ш ϯ7  
<37 
 
4001 (86.6) 
621 (13.4) 
 
508 (86.0) 
83 (14.0) 
 
1438 (86.2) 
231 (13.8) 
 
651 (85.9) 
107(14.1) 
 
0.930 
† Numbers vary due to missing data. * p-value obtained using χ2test. ¶ First reported value in pregnancy. ¶¶ Restricted to live and still births.   
Col, column; ART, antiretroviral therapy; CS, Caesarean Section. 
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Table 4.8: Baseline characteristics of pregnancies by maternal African region of origin (n=5813) 
Characteristics† Maternal duration of residence in the UK at conception (col %)  
p-value * шϰ years <4 years  (before conception) Since conception 
Maternal age at delivery  
<25 
25-34 
шϯϱ 
 
    184 (6.4) 
1655 (57.6) 
1033 (36.0) 
 
365 (16.0) 
1560 (68.5) 
352 (15.5) 
 
100 (23.0) 
285 (65.7) 
49 (11.3) 
 
<0.001 
Timing of HIV diagnosis 
Before pregnancy 
During pregnancy 
 
2299 (77.2) 
680 (22.8) 
 
1113 (47.0) 
1255 (53.0) 
 
66 (14.4) 
394 (85.7) 
 
<0.001 
Earliest HIV viral load 
(copies/ml)  
Undetectable 
50-10000 
шϭϬϬϬϬ 
 
 
1134 (44.5) 
878 (34.4) 
538 (21.1) 
 
 
573 (29.3) 
830 (42.4) 
553 (28.3) 
 
 
68 (21.5) 
147 (46.4) 
102 (32.2) 
 
 
<0.001 
Earliest CD4 count 
(cells/mm
3
)  
шϱϬϬ 
200-249 
<200 
 
 
1625 (59.2) 
776 (28.3) 
344 (12.5) 
 
 
1139 (52.5) 
681 (31.4) 
349 (16.1) 
 
 
210 (53.2) 
118 (29.9) 
67 (17.0) 
 
 
<0.001 
ART during pregnancy 
Yes 
No 
 
2763 (94.8) 
152 (5.2) 
 
2174 (93.8) 
144 (6.2) 
 
412 (91.2) 
40 (8.9) 
 
0.007 
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Table 4.8: Baseline characteristics of pregnancies by maternal African region of origin continued 
Characteristics† Maternal duration of residence in the UK at conception (col %)   
p-value * шϰ years <4 years  (before conception) Since conception 
Duration of ART  
Before conception 
12-40 weeks 
2-11 weeks 
<2 weeks 
 
1315 (50.4) 
873 (33.5) 
395 (15.2) 
24 (0.9) 
 
495 (24.3) 
921 (45.2) 
584 (28.7) 
36 (1.8) 
 
30 (8.0) 
119 (31.7) 
179 (47.7) 
47 (12.5) 
 
         <0.001 
Mode of delivery  
Elective CS 
Emergency CS 
Vaginal 
 
1188 (46.6) 
643 (25.2) 
720 (28.2) 
 
1051 (50.7) 
503 (24.2) 
521 (25.1) 
 
235 (55.6) 
91 (21.5) 
97 (22.9) 
 
0.002 
Gestational age (weeks)
¶¶
 
ш ϯ7  
<37 
 
2206 (86.5) 
343 (13.5) 
 
1810 (87.2) 
265 (12.8) 
 
367 (87.0) 
55 (13.0) 
 
0.789 
† Numbers vary due to missing data. * p-value obtained using χ2test. ¶ First reported value in pregnancy. ¶¶ Restricted to live and still births.   
Col, column; ART, antiretroviral therapy; CS, Caesarean Section. 
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4.5 Conclusions 
The number of pregnancies reported in the UK in women diagnosed with HIV increased 
dramatically between 1990 and 2006, although numbers have plateaued to 
approximately 1400 pregnancies a year since then.  The number of reports in African 
women increased substantially over this time period with three quarters of all 
pregnancies reported annually to the NSHPC since 2002 being in African women.  This 
is due to a combination of increasing prevalence of HIV in Sub-Saharan Africa, 
increasing migration from Africa to the UK (Owen 2009)141 and the advent of routine 
antenatal HIV screening in the late 1990s (Townsend et al. 2006).  The number of 
pregnancies reported in African women has stabilised since 2006, partly reflecting the 
plateauing of immigration to the UK (including from Commonwealth nations) in recent 
years (Rienzo et al. 2012).   
Centres in London reported the largest number of pregnancies in HIV-positive women, 
the overwhelming majority being in African women.  However, outside London the 
number of pregnancies reported to the NSHPC has also increased over time, again 
mainly in African women.  The increasing numbers of pregnancies reported to the 
NSHPC in African women across the UK is likely to be due to a combination of the 
routine dispersal of asylum seekers away from the South East of England since the 
implementation of the 1999 Immigration and Asylum Act in 2000142 (Stewart 2012) as 
well as widespread HIV antenatal screening being rolled out across the UK.   
The greatest number of reported pregnancies in African women diagnosed with HIV 
was in women from Eastern Africa.  This is unsurprising given that many Eastern 
African countries (such as Uganda, Tanzania, Kenya and Zimbabwe) are current or 
former members of the Commonwealth of Nations and have well established links with 
the UK.  In the 1990s the majority of pregnancies in African women that were reported 
to the NSHPC were in Ugandans, probably a reflection of forced migration due to the 
Ugandan Civil War and the concentration of the early HIV epidemic in Eastern Africa.  
In recent years, Zimbabwean women predominate, reflecting the surge of Zimbabweans 
seeking political asylum in the UK in the late 1990s and early 2000s as a result of the 
                                                             
141
 Also see data from the 2001 and 2011Census for England and Wales available at 
http://www.ons.gov.uk/ons/rel/census/2011-census/key-statistics-for-local-authorities-in-england-and-
wales/sty-non-uk-born-population.html (accessed 23 September 2013). 
142
 Since 2000 the UK Home Office policy has operated a compulsory dispersal policy where asylum 
seekers are housed on a no-choice basis in locations mainly situated outside of the South east of the UK 
and London in an effort to distribute housing, social and financial pressures amongst local authorities 
throughout the country.   
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political instability in Zimbabwe since the mid-1990s (Owen 2009).    More broadly, 
there has been a diversification in terms of region of birth among African women 
reported to the NSHPC since the late 1990s.    The number of pregnancies in women 
from Eastern Africa increased from 1990 to 2010, although the overall proportion 
declined.  In the same time period the number of pregnancies in women from Western 
Africa (predominantly Nigeria) increased to a point where nearly one in four HIV-
positive women reported as pregnant to the NSHPC were from western African.  This 
echoes the diversification in African region of birth of the HIV seen in Black Africans 
in the general adult HIV-positive population in the UK between 2001 and 2010 
(Meaghan Kall, Public Health England, personal communication, 25 June 2012).  This 
reflects migration patterns to England and Wales in that there has been a greater 
increase in numbers of residents in England and Wales who were born in Western and 
Central Africa compared with those born in Southern and Eastern Africa143.  In later 
years, with increasing sequential pregnancies, it may also reflect underlying differential 
fertility patterns among African women (French et al. 2011). 
Between 1990 and 2010 the median duration of residence at conception among African 
women increased.  This trend towards increasing duration of residence at the time of 
conception may be a result of increasingly stringent UK immigration policy since the 
late 1990s (Somerville 2007).  It is also important to note that early in the study period 
there was little availability of ART.  African women migrating to the UK in the early 
1990s (who were likely to have acquired HIV prior to migration) would not have had 
access to effective treatment and therefore would have been less likely to survive to 
have a long interval between arrival in the UK and becoming pregnant.  
Chapters Five, Seven and Eight of this thesis focus on pregnancies reported to the 
NSHPC between 2000 and 2010.  Looking briefly at this group, we see that it was more 
common for African women to have been diagnosed with HIV during their reported 
pregnancy than it was for white British women.  In particular, African women who had 
arrived in the UK after conception, as well as women from Southern and Western 
Africa, were more likely to have been diagnosed during pregnancy.  As a result only a 
small proportion of these women were on ART at conception and hence they were more 
likely to have a detectable initial HIV viral load in pregnancy.  Those who arrived in the 
                                                             
143
 Data from 2001 England and Wales Census available from table UV08 at 
http://www.ons.gov.uk/ons/datasets-and-tables/index.html (accessed 23 September 2013) and data from 
2011 England and Wales Census available from table QS213EW at 
http://www.nomisweb.co.uk/census/2011/qs213ew (accessed 23 September 2013).   
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UK after conception were also more likely to have had an elective caesarean section, 
probably reflecting shorter duration of ART and lack of virological suppression towards 
the end of pregnancy.  In the following chapter I explore the use of ART among African 
women living with HIV in greater detail. 
Key Points 
 African women were the largest group of women reported to the NSHPC 
between 1900 and 2010, with London reporting the largest numbers of pregnant 
African women living with HIV. 
 Eastern Africans (initially Ugandan and more recently Zimbabwean) were the 
largest group of African women reported to the NSHPC, however there have 
been recent increases in other groups, most notably Western Africans (mainly 
Nigerians).  This echoes trends in the general adult HIV-positive population and 
mainly reflects trends in African migration to the UK since the early 1990s.  
 Over time, African women have been resident in the UK for a longer period of 
time at the time of conception. 
 Over the past ten years, an increasing number of pregnancies in African women 
has been reported outside of London.   
 Demographic and clinical differences have been seen among African women, 
with Southern and Western African women more likely to be diagnosed with 
HIV during pregnancy, as were those who had arrived in the UK after 
conception. 
 The findings in this chapter highlight the changing epidemiology of HIV and 
pregnancy among African women and suggest that there may be differences in 
terms of clinical outcomes within this broad ethnic group. 
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5        
Using antiretroviral therapy in pregnancy 
 
Summary 
A central component in the management of HIV in pregnancy is the use of ART.  In this 
mixed methods chapter I use data from the NSHPC to examine the relationship between 
maternal ethnicity, African region of birth and duration of residence in the UK, and the 
following key indicators: (i) not receiving ART during pregnancy (ii) detectable 
maternal HIV viral load at delivery and (iii) vertical transmission of HIV.    I then 
present ethnographic data, based mainly on interviews with pregnant women and their 
healthcare providers, in order to explore women’s experiences of taking, or not taking, 
ART during pregnancy.   Through the dialogic movement between quantitative and 
qualitative findings, I aim to provide a multidimensional account of the processes that 
shape African women’s use of ART during pregnancy.  
5.1 Introduction 
The overarching research question posed in this thesis is: how do African women living 
with HIV in the UK engage with HIV services and interventions during and after 
pregnancy?   In Chapter One I outlined the changing epidemiology of HIV in the last 
three decades, with an increase in heterosexually acquired infection in the UK and a rise 
in the number of pregnancies in HIV-positive women in the UK.  I also highlighted the 
paucity of literature on HIV and pregnancy that engages with outcomes other than those 
that directly affect the infant.  Furthermore I discussed the lack of work to date that 
explores the impact of ethnicity, and the heterogeneity within ethnic groups, on 
pregnancy and motherhood in the context of HIV.  This is a notable lacuna since 
African women represent over three quarters of HIV-positive women reported as 
pregnant in the UK each year and that there has been a diversification in African 
women’s region of birth (as described in Chapter Four).  
A central component in the management of HIV in pregnancy is the use of antiretroviral 
therapy (ART). The clinical indications for ART in pregnancy in the UK are relatively 
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straightforward (Taylor et al. 2012).  All women diagnosed with HIV are advised to take 
ART during pregnancy to prevent vertical transmission of the virus.  Some women will 
have been on treatment for some time for their own health and will therefore continue 
on the same medication regime throughout their pregnancy.  Others will start treatment 
during pregnancy for their own health, either because they are at risk of an opportunistic 
infection or their CD4 count has fallen below the threshold for starting treatment, as 
well as for the prevention of vertical transmission.   A third group of women will not 
require treatment for their own health and the only indication for ART will be for the 
prevention of vertical transmission.    Regardless of the situation, most women will be 
advised to be on treatment by fourteen to twenty-four weeks of pregnancy at the latest 
(Ibid.).  Therefore, within this group of women taking ART there are important 
differences according to women’s experience of taking ART and the clinical reasons 
underlying their treatment.  Already we can begin to make out a complexity that belies 
the apparent straightforwardness of clinical guidelines.   
Furthermore, there are important dichotomies that lie at the heart of treating HIV during 
pregnancy.  Women living with HIV are advised to take medication to safeguard the 
health of their child during pregnancy, the very time in which most women are advised 
to exercise caution when ingesting any substance whether that be food or medication.  
This leads us to ask: what does it mean to take ART during pregnancy, and is African 
women’s use of ART shaped by ethnicity, African region of birth and duration of 
residence in the UK?   
5.2 Epidemiological data on uptake of antiretroviral therapy 
Uptake and adherence to ART is the cornerstone of treatment of HIV in pregnancy in 
order to reduce maternal HIV viral load in the blood and genital secretions, therefore 
minimising the risk of vertical transmission.  Furthermore, if a woman has a 
compromised immune system ART is the key to restoring immune-function and 
safeguarding long-term health. In this section I explore the association between uptake 
of ART and: (i) maternal ethnicity, (ii) maternal African region of birth, and (iii) 
maternal duration of residence in the UK at conception (for African women).  The 
analysis of uptake of ART excluded ectopic pregnancies and pregnancies resulting in 
termination or miscarriage, as it would be unlikely that there would have been an 
indication or opportunity to take ART.   ART referred to any antiretroviral medication 
whether monotherapy, dual therapy or HAART. Potential confounding variables 
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included maternal age, history of injecting drug use, reporting region, timing of HIV 
diagnosis and gestational age.  Robust standard errors were used to account for possible 
clustering of maternal-level effects in women who had more than one pregnancy.  
Uptake of treatment was defined as whether a woman was reported to have received 
treatment with ART at any point during her pregnancy and was categorised as “yes” or 
“no”144.  
5.2.1 Results 
There were 9214 eligible pregnancies with a delivery date or expected delivery date 
between January 2000 and December 2010.  This analysis is based on 8997/9214 
(97.6%) pregnancies with data available on uptake of ART in 7228 women145.  
Demographic and clinical characteristics of the study population are presented in table 
5.1.  Nearly 90% (88.8%) of pregnancies were in women who were of African ethnicity.  
Overall, in 2.6% (233/8997; 95% confidence interval [CI]: 2.3%, 2.9%) of pregnancies 
women were not reported to have received ART; this did not differ significantly 
between white British and African women (p>0.5, table 5.1). 
In almost 30% (67/233) of pregnancies where women were not reported to have 
received ART, this was because she was documented as having declined treatment.  Of 
those who didn’t receive ART during pregnancy, a greater proportion of African women 
declined treatment (64/205; 31.2%) compared with white British women (3/28; 10.7%; 
p<0.05).  Women born in Western Africa (22/62; 35.5%) and Middle Africa (14/26; 
50.0%) were more likely to decline treatment than those from Eastern Africa (27/100; 
27.0) and Southern Africa (1/15; 6.7%; p<0.05).  Small numbers precluded any further 
meaningful statistical analysis.   
The percentage of pregnancies where the mother had not received ART during 
pregnancy fell from 11.4% in 2000 to 1.1% in 2010 (χ2trend test p<0.001, figure 5.1).   
Over 90% (7839/8672) of women who took ART during pregnancy took HAART with 
731 (8.4%) taking monotherapy and 102 (1.2%) taking dual therapy.   
On univariable analysis there was an association between not receiving ART in 
pregnancy and younger maternal age at delivery, the route of maternal HIV acquisition 
being injecting drug use (IDU), HIV diagnosis during the reported pregnancy, higher 
                                                             
144
 This excluded pregnancies in which women received only intrapartum ART.   
145
 Some women had more than once pregnancy reported to the NSHPC. 
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initial HIV viral load in pregnancy, preterm delivery and pregnancy earlier in the study 
period (all p<0.05, table 5.1). There was no association between uptake of ART and 
either earliest CD4 count or reporting area (p>0.1). 
Just under 3% (28/1007; 2.8%) of women of white British ethnicity did not receive 
ART during pregnancy; similar to the percentage of African women (205/7990, 2.6%; 
odds ratio (OR) 0.92; 95% CI: 0.62, 1.37; p>0.1, table 5.2).  After adjusting for year, 
history of IDU, timing of HIV diagnosis and gestation at delivery, the odds of not 
receiving ART in African women remained similar to that in white British women 
(adjusted odds ratio (AOR 0.84); 95% CI: 0.53, 1.34; p>0.1, table 5.2). 
Restricting the analysis to African women, 2.1% (100/4779) of Eastern African women 
did not receive ART during pregnancy.  A greater proportion of Western African 
(62/1748; 3.6%) and Middle African (28/799; 3.5%) women did not receive ART 
during pregnancy (both p<0.05, table 5.3).  After adjusting for year, timing of diagnosis 
and gestation at delivery, Middle African women’s odds of not receiving ART were 
similar to those of women from Eastern Africa (AOR 1.47; 95% CI: 0.82, 2.63; p>0.1; 
table 5.3).  However, after adjusting for the same factors, the odds of not receiving ART 
during pregnancy remained increased in Western African women compared with those 
from Eastern Africa (AOR 1.77; 95% CI: 1.19, 2.63; p<0.01, table 5.3).  There are 
differences in median duration of residence in the UK at conception according to 
African region of birth146.  I explored the effects of duration of residence in the UK on 
the association between Western African ethnicity and not taking ART by including it 
in the multivariable model.  The odds of not taking ART in pregnancy remained 
increased for Western African women although this was now of borderline significance, 
possibly as a result of smaller numbers (AOR 1.54; 95% CI: 0.94, 2.52; p=0.088). 
Among African women, a greater proportion of those who had arrived in the UK after 
conception had not received ART during pregnancy (7.4%; 33/444) than those who had 
been in the UK for less than 4 years (2.2%; 46/2142) and those who had been in the UK 
for ≥ 4 years (2.0%; 53/2653).  In fact, on multivariable analysis adjusting for maternal 
age, year, timing of HIV diagnosis and gestation at delivery, African women who had 
arrived in the UK after conception had over twice the odds of not receiving ART during 
pregnancy compared with those who had been in the country for ≥ 4  years (AOR 2.31; 
95% CI: 1.31, 4.08; p<0.05, table 5.4). 
                                                             
146
 See Chapter Four (table 4.4: 102). 
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Table 5.1: Characteristics of women with pregnancies reported to the NSHPC by receipt 
of antiretroviral therapy, 2000-2010 
 
 
 
ART,  
n (row %) 
n=8764 
No ART, 
 n (row %) 
n=233 
p-value* 
 
Ethnicity, n=8997 
White British 
African 
 
979 (97.2) 
7785 (97.4) 
 
28 (2.8) 
205 (2.6) 
 
0.686 
Maternal age at delivery, n=8613 
<25 years 
25-34 years 
шϯϱ years 
 
1147 (96.5) 
5199 (97.6) 
2063 (98.4) 
 
42 (3.5) 
128 (2.4) 
34 (1.6) 
 
0.002 
Year of EDD/delivery, n=997 
2000-2003 
2004-2006 
2007-2010 
 
1818 (94.4) 
2737 (97.4) 
4209 (98.8) 
 
108 (5.6) 
73 (2.6) 
52 (1.2) 
 
<0.001 
IDU, n=8997 
No 
Yes 
 
8686 (97.5) 
78 (91.8) 
 
226 (2.5) 
7 (8.2) 
 
0.001 
Timing of HIV diagnosis, n=8975 
Before conception 
During pregnancy 
 
5129 (98.5) 
3613 (95.9) 
 
77 (1.5) 
156 (4.1) 
 
<0.001 
Reporting areas, n=8611 
London  
England (not London) 
Scotland, Wales, NI 
 
4053 (97.2) 
3916 (98.0) 
436 (97.5) 
 
115 (2.8) 
80 (2.0) 
11 (2.5) 
 
0.081 
Timing of antenatal booking, n=2554 
1
st
 trimester 
2
nd
/3
rd
 trimester 
 
1243 (99.1) 
1282 (98.6) 
 
11 (0.9) 
18 (1.4) 
 
0.226 
Earliest HIV viral load
¶
, copies/ml, 
n=7482 
чϱϬ 
51-10000 
>10,000 
 
 
2692 (99.3) 
2844 (98.1) 
1844 (98.5) 
 
 
19 (0.7) 
55 (1.9) 
28 (1.5) 
 
 
<0.001 
Earliest CD4 count
¶
, cells/µl, n=8074 
шϯϱϬ 
200-249 
<200 
 
4539 (98.0) 
2294 (98.5) 
1097 (98.6) 
 
92 (2.0) 
36 (1.6) 
16 (1.4) 
 
0.272 
Gestation at delivery, n=8358 
шϯ7 ǁeeks 
<37 weeks 
 
7176 (97.9) 
1165 (96.8) 
 
158 (2.2) 
39 (3.2) 
 
0.020 
*Obtained using χ2 test.  ¶ First reported value in pregnancy. ART, antiretroviral therapy; EDD, expected 
date of delivery; IDU, likely route of HIV acquisition was maternal injecting drug use; NI, Northern 
Ireland. 
123 
 
Figure 5.1: Trends over time in women not receiving ART during pregnancy, 2000-2010 
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 Table 5.2: Univariable and multivariable analysis of the association between ethnicity and not receiving antiretroviral therapy during pregnancy 
  Univariable analysis Multivariable analysis, n= 8518 
 No ART/N (%) OR (95% CI) p-value AOR (95% CI) p-value 
Ethnicity 
White British 
African 
 
28/1007 (2.8) 
205/7990 (2.6) 
 
1.00 
0.92 (0.62,1.37) 
 
 
0.686 
 
1.00 
0.84 (0.53,1.34) 
 
 
0.465 
Maternal age at delivery 
<25 years 
25-34 years 
шϯϱ years 
 
42/1189 (3.5) 
128/5327 (2.4) 
34/2097 (1.6) 
 
1.00 
0.67 (0.47,0.96) 
0.45 (0.28,0.71) 
 
0.003 
  
Year of EDD/delivery 
2000-2003 
2004-2006 
2007-2010 
 
108/1926 (5.6) 
73/2810 (2.6) 
52/4261 (1.2) 
 
1.00 
0.45 (0.33,0.61) 
0.15 (0.15,0.29) 
 
<0.001 
 
1.00 
0.37 (0.26,0.53) 
0.27 (0.18,0.40) 
 
 
<0.001 
<0.001 
IDU 
No 
Yes 
 
226/8912 (2.5) 
7/85 (8.2) 
 
1.00 
3.45 (1.57,7.56) 
 
0.008 
 
1.00 
3.06 (1.04,8.97) 
 
 
0.042 
Reporting areas 
London  
England (not London) 
Scotland, Wales, NI 
 
115/4168 (2.8) 
80/3996 (2.0) 
11/447 (2.5) 
 
1.00 
0.72 (0.54,0.96) 
0.89 (0.48,1.66) 
 
0.080 
  
Timing of HIV diagnosis 
Before conception 
During pregnancy 
 
77/5206 (1.5) 
156/3769 (4.1) 
 
1.00 
2.88 (2.18,3.79) 
 
<0.001 
 
1.00 
2.46 (1.74,3.47) 
 
 
<0.001 
Timing of antenatal booking 
1
st
 trimester 
2
nd
/3
rd
 trimester 
 
11/1254 (0.9) 
18/1300 (1.4) 
 
1.00 
1.59 (0.75,3.37) 
 
0.224 
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Table 5.2 continued 
  Univariable analysis Multivariable analysis 
 No ART/N (%) OR (95% CI) p-value AOR (95% CI) p-value 
Gestation at delivery  
шϯ7 ǁeeks 
<37 weeks 
 
158/7334 (2.2) 
39/1204 (3.2) 
 
1.00 
1.52 (1.07,2.17) 
 
0.027 
 
1.00 
1.50 (1.04,2.16) 
 
 
0.032 
  OR, odds ratio; AOR, adjusted odds ratio: EDD, expected date of delivery; IDU, likely route of HIV acquisition was maternal injecting drug  
  use; NI, Northern Ireland. 
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Table 5.3: Univariable and multivariable analysis of the association between African region of birth and not receiving antiretroviral therapy during 
pregnancy (restricted to African women) 
 Univariable analysis Multivariable analysis, n=7548 
 No ART/N (%) OR (95% CI) p-value AOR (95% CI) p-value 
African region of birth 
Eastern Africa 
Southern Africa 
Western Africa 
Middle Africa 
 
100/4779 (2.1) 
15/644 (2.3) 
62/1748 (3.6) 
28/799 (3.5) 
 
1.00 
1.12 (0.65,1.94) 
1.73 (1.25,2.83) 
1.71 (1.11,2.61) 
 
 
0.684 
0.001 
0.014 
 
1.00 
 0.91 (0.45,1.82) 
1.77 (1.19,2.63) 
1.47 (0.82,2.63) 
 
 
0.784 
0.005 
0.200 
Maternal age at delivery 
<25 years 
25-34 years 
шϯϱ years 
 
31/894 (3.5) 
116/4841 (2.4) 
30/1985 (1.6) 
 
1.00 
0.68 (0.46,1.02) 
0.45 (0.27,0.74) 
 
0.008 
 
 
 
Year of EDD/delivery 
2000-2003 
2004-2006 
2007-2010 
 
92/1680 (5.5) 
67/2515 (2.7) 
46/3795 (1.2) 
 
1.00 
0.47 (0.34,0.65) 
0.21 (0.15,0.30) 
 
<0.001 
 
1.00 
0.38 (0.26,0.56) 
0.26 (0.17,0.41) 
 
 
<0.001 
<0.001 
IDU 
No 
Yes 
 
205/7987 (2.6) 
        0/3 (0) 
 
 
 
 
 
 
 
 
 
Reporting areas 
London  
England (not London) 
Scotland, Wales, NI 
 
105/3959 (2.7) 
69/3419 (2.0) 
5/252 (2.0) 
 
1.00 
0.76 (0.56,1.03) 
0.74 (0.30,1.84) 
 
0.184 
  
Timing of HIV diagnosis 
Before conception 
During pregnancy 
 
63/4559 (1.4) 
142/3409 (4.2) 
 
1.00 
3.10 (2.30,4.19) 
 
<0.001 
 
1.00 
2.55 (1.73,3.76) 
 
 
<0.001 
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Table 5.3 continued 
  Univariable analysis Multivariable analysis 
 No ART/N (%) OR (95% CI) p-value AOR (95% CI) p-value 
Timing of antenatal booking 
1
st
 trimester 
2
nd
/3
rd
 trimester 
 
10/1088 (0.9) 
15/1196 (1.3) 
 
1.00 
1.37 (0.61,3.06) 
 
0.440 
  
Gestation at delivery  
шϯ7 ǁeeks 
<37 weeks 
 
137/6532 (2.1) 
34/1036 (3.3) 
 
1.00 
1.58 (1.08,2.32) 
 
0.024 
 
 
1.00 
1.60 (1.09,2.35) 
 
 
0.016 
OR, odds ratio; AOR, adjusted odds ratio: EDD, expected date of delivery; IDU, likely route of HIV acquisition was maternal injecting  
drug use; NI, Northern Ireland. 
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Table 5.4: Univariable and multivariable analysis of the association between maternal duration of residence in the UK at conception and not receiving 
antiretroviral therapy during pregnancy (restricted to African women) 
 Univariable analysis Multivariable analysis, n=5018 
 No ART/N (%) OR (95% CI) p-value AOR (95% CI) p-value 
Duration of residence in UK 
ш ϰ years 
< 4 years (before conception) 
Since conception 
 
53/2653 (2.0) 
46/2142 (2.2) 
33/444 (7.4) 
 
1.00 
1.08 (0.72,1.60) 
3.94 (2.52,6.16) 
 
 
0.717 
<0.001 
 
1.00 
0.70 (0.41,1.20) 
2.31 (1.31,4.08) 
 
 
0.193 
0.004 
Maternal age at delivery 
<25 years 
25-34 years 
шϯϱ years 
 
20/595 (3.4) 
81/3190 (2.5) 
17/1261 (1.4) 
 
1.00 
0.75 (0.46,1.23) 
0.39 (0.20,0.76) 
 
0.009 
 
1.00 
0.90 (0.52,1.56) 
0.54 (0.26,1.13) 
 
 
0.706 
0.101 
Year of EDD/delivery 
2000-2003 
2004-2006 
2007-2010 
 
60/1114 (5.4) 
44/1682 (2.6) 
28/2443 (1.2) 
 
1.00 
0.47 (0.32,0.70) 
0.20 (0.13,0.32) 
 
<0.001 
 
1.00 
0.45 (1.31,4.08) 
0.23 (0.28,0.71) 
 
 
0.001 
<0.001 
IDU 
No 
Yes 
 
132/5238 (2.5) 
0/1 (0) 
 
 
 
 
 
 
 
 
 
Reporting areas 
London  
England (not London) 
Scotland, Wales, NI 
 
74/2880 (2.6) 
41/2006 (2.0) 
3/157 (1.9) 
 
1.00 
0.79 (0.54,1.16) 
0.74 (0.23,2.37) 
 
0.453 
  
Timing of HIV diagnosis 
Before conception 
During pregnancy 
 
43/3044 (1.4) 
89/2190 (4.1) 
 
1.00 
2.96 (2.05,4.27) 
 
<0.001 
 
1.00 
2.46 (1.74,3.47) 
 
 
<0.001 
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Table 5.4 continued 
 Univariable analysis Multivariable analysis 
 No ART/N (%) OR (95% CI) p-value AOR (95% CI) p-value 
Timing of antenatal booking 
1
st
 trimester 
2
nd
/3
rd
 trimester 
 
9/699 (1.3) 
7/761 (0.9) 
 
1.00 
0.71 (0.26,1.92) 
 
0.500 
  
Gestation at delivery  
шϯ7 ǁeeks 
<37 weeks 
 
90/4358 (2.1) 
25/660 (3.8) 
 
1.00 
1.87 (1.19,2.93) 
 
0.010 
 
1.00 
1.86 (1.19,2.90) 
 
 
0.007 
OR, odds ratio; AOR, adjusted odds ratio: EDD, expected date of delivery; IDU, likely route of HIV acquisition was maternal injecting drug  
use; NI, Northern Ireland.
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5.3 Epidemiological data on detectable maternal HIV viral load at 
delivery 
Lack of maternal virological suppression at delivery is the main mechanism for vertical 
transmission and can be due to either sub-optimal response (as a result of 
pharmacokinetics of ART during pregnancy, interactions with other medication or 
maternal drug resistance) or poor adherence147 to medication.  In this section I explore 
the association between detectable maternal HIV viral load at delivery and: (i) maternal 
ethnicity, (ii) maternal African region of birth, and (iii) maternal duration of residence 
in the UK at conception (for African women).   
Analysis of viral load at delivery was restricted to live singleton births in women who 
received HAART during pregnancy.  Stillbirths were excluded due to the possibility of 
maternal co-infections, such as syphilis, that may increase HIV viral load.   Pregnancies 
in women taking mono/dual antiretroviral therapy were excluded, as these regimes 
would not be expected to result in virological suppression.  HAART was defined as a 
regimen of three or more antiretroviral drugs.  Type of HAART was categorised as: 
nucleoside reverse transcriptase inhibitor (NRTI) only, non-nucleoside reverse 
transcriptase inhibitor (NNRTI)-based, protease inhibitor (PI)-based, and HAART 
including both NNRTIs and PIs. Robust standard errors were used to account for 
possible clustering of maternal-level effects in women who had more than one 
pregnancy. 
Viral load at delivery was defined as the closest reported maternal HIV viral load to 
delivery measured between twenty-eight days before and seven days after delivery.   
Delivery viral load was categorised as undetectable or detectable; ‘undetectable’ was 
defined as ≤50 copies/ml.   
Maternal age, history of injecting drug use, first viral load in pregnancy, first CD4 count 
in pregnancy and HAART regime were considered as confounders in analyses.  
Duration of HAART was considered as a potential confounder in the analyses of viral 
load at delivery and both ethnicity and African region of origin.  Duration of HAART 
was not included in the analysis of viral load at delivery and maternal duration of 
                                                             
147
 I use the term ‘adherence’ throughout this thesis rather than ‘compliance’.  Adherence in this context is 
widely understood to mean a person’s ability to take ART as prescribed.  It has much more common 
usage in the field of HIV medicine than compliance and implies a degree of agency and choice in taking 
medication (Mykhalovskiy, et al. 2004). 
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residence in the UK at conception as it was thought to be on the causal pathway148.   
Due to the high proportion of missing viral load data in pregnancies (3189/7290, 
43.7%), an imputed variable was used.  If delivery viral load was missing but the last 
reported viral load during pregnancy (at any time point) was undetectable, then delivery 
viral load was imputed as undetectable.  This was based on an assumption that women 
on HAART in pregnancy who achieved virological suppression would remain 
undetectable until delivery149.  To ensure validity, a sensitivity analysis was conducted 
by running all multivariable analyses using both the imputed and non-imputed150 
delivery viral load data. 
5.3.1 Results 
There were 7290 eligible pregnancies in women on HAART during the study period.  
This analysis is based on 6005/7290 (82.4%) pregnancies in 4991 women with available 
data on HIV viral load at delivery based on the imputed dataset.  Again, the 
overwhelming majority of pregnancies were in African women (5362/6005; 89.3%).  
Other demographic and clinical characteristics of the study population are presented in 
table 5.5.    
Using the non-imputed delivery viral load variable, HIV viral load at delivery was 
detectable in 28.8 % of pregnancies (1181/4101).  A further 1904 values were imputed 
by assuming that viral load at delivery was undetectable if the last viral load in 
pregnancy (regardless of when this was taken in pregnancy) was undetectable.  Using 
this imputed value, HIV viral load was detectable in almost 20% of pregnancies 
(1181/6005; 95% CI: 18.7%, 20.7%).  This proportion fell from 29.2% in 2000 to 
14.3% in 2010 (χ2trend test p<0.001, figure 5.2).    
                                                             
148
 Its inclusion would introduce the possibility of over-adjustment (Schisterman, et al. 2009). 
149
 A recent US study found that nearly 90% of women who were virologically suppressed on HAART 
earlier in pregnancy maintained virological suppression until delivery suggesting that this assumption was 
reasonable (Katz, et al. 2010). 
150
 Excluding the 3189 pregnancies where delivery viral load was missing.  
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Table 5.5: Characteristics of women on HAART with pregnancies reported to the NSHPC 
by HIV viral load at delivery, 2000-2010 (based on imputed dataset) 
 
 
 
Undetectable VL,  
n (row %) 
n=4824 
Detectable VL,  
n (row %) 
n=1181 
p-value* 
 
 
Ethnicity, n=6005 
White British 
African 
 
532 (82.7) 
4292 (80.0) 
 
111 (17.3) 
1070 (20.0) 
 
0.105 
Maternal age at delivery, n=6005 
<25 years 
25-34 years 
шϯϱ years 
 
515 (71.7) 
2958 (79.9) 
1351 (85.2) 
 
203 (28.3) 
743 (20.1) 
235 (14.8) 
 
<0.001 
Year of EDD/delivery, n=6005 
2000-2003 
2004-2006 
2007-2010 
 
640 (72.4) 
1510 (78.9) 
2674 (83.4) 
 
244 (27.6) 
404 (21.1) 
533 (16.6) 
 
<0.001 
IDU, n=6005 
No 
Yes 
 
4793 (80.4) 
31 (75.6) 
 
1171 (19.6) 
10 (24.4) 
 
0.445 
Earliest HIV VL
¶
, copies/ml, n=5404 
чϱϬ 
51-10000 
>10,000 
 
2195 (95.9) 
1467 (81.3) 
800 (61.1) 
 
95 (4.2) 
338 (18.7) 
509 (38.9) 
 
<0.001 
Earliest CD4 count
¶
, cells/µl, n=5875 
шϯϱϬ 
200-249 
<200 
 
2773 (84.4) 
1397 (79.4) 
565 (68.1) 
 
513 (15.6) 
362 (20.6) 
265 (19.4) 
 
<0.001 
Type of HAART, n= 6005 
NRTI only 
NNRTI-based 
PI-based 
NNRTI/PI based 
 
83 (89.3) 
1766 (85.7) 
2682 (77.6) 
293 (74.7) 
 
10 (10.8) 
296 (14.4) 
776 (22.4) 
99 (25.3) 
 
<0.001 
Duration of HAART, n=5923 
On ART at conception 
12-40 weeks 
2-11 weeks 
<2 weeks 
 
2045 (92.4) 
2080 (82.8) 
629 (58.2) 
13 (11.1) 
 
169 (7.6) 
431 (17.2) 
452 (41.8) 
104 (88.9) 
 
<0.001 
* Obtained using χ2 test. ¶ First reported value in pregnancy. VL, viral load; EDD, expected date of 
delivery; IDU, likely route of HIV acquisition was maternal injecting drug use; HAART, highly active 
antiretroviral therapy; NRTI, nucleoside reverse transcriptase inhibitor; NNRTI, non-nucleoside reverse 
transcriptase inhibitor; PI, protease inhibitor. 
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Figure 5.2: Trends over time in HIV viral load at delivery in women on HAART during 
pregnancy, 2000-2010 
 
 
In univariable analysis there was an association between detectable viral load at delivery 
and younger maternal age at delivery, higher earliest antenatal viral load, lower earliest 
antenatal CD4 count, HAART regime and shorter duration of ART (all p<0.001, table 
5.5).  
Nearly 20% (1070/5362) of African women had a detectable HIV viral load at delivery 
compared with 17.3% of white British women (111/643; OR 1.19; 95% CI: 0.96, 1.48; 
p>0.05, table 5.6).  After adjusting for year, earliest antenatal viral load, earliest 
antenatal CD4 count, HAART regime and duration of ART, there was still no evidence 
of a difference between African women and white British women (AOR 1.08; 95% CI: 
0.82, 1.41; p>0.1, table 5.6).  A similar odds ratio was obtained when the multivariable 
analysis was repeated using the non-imputed delivery viral load variable (AOR 1.03; 
95% CI: 0.77, 1.37; p>0.1). 
Restricting the analysis to African women, a significantly higher proportion of Southern 
African women (22.7%; 96/423) and Western African women (23.0%; 270/1172) had a 
detectable delivery viral load compared with women from Eastern Africa (18.5%; 
p<0.05, table 5.7).  After adjusting for year, earliest viral load, earliest CD4 count, 
HAART regime and duration of ART, there was no evidence of an association between 
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Southern or Western African region of birth and detectable viral load at delivery (both 
p>0.1; table 5.7).  Similar odds ratios were obtained when repeating the multivariable 
analysis using the non-imputed delivery viral load variable for both Southern African 
women (AOR 1.03; 95% CI: 0.74, 1.44; p>0.1) and Western African women (AOR 
1.05; 95% CI: 0.77, 1.46). 
Among African women, a much higher percentage of those who had arrived in the UK 
after conception had a detectable HIV viral load at delivery  (43.0%; 110/256) than 
those who had been in the UK for less than 4 years (19.5%; 283/1450) and those who 
had been in the UK for ≥ 4 years (15.9%; 313/1969).  This group had four times the 
odds of having a detectable viral load at delivery compared with those who had been in 
the country for ≥ 4 years (OR 3.99; 95% CI: 3.03, 5.25; p<0.001, table 5.8).  After 
adjusting for year, earliest viral load, earliest CD4 count, HAART regime and duration 
of HAART, the odds of having a detectable viral load at delivery were still over twice 
as high for women arriving in the UK after conception than those who had been in the 
UK for ≥ 4 years (AOR 2.29; 95% CI: 1.61, 3.26: p<0.001, table 5.8).   
On repeating the multivariable analysis using the non-imputed viral load variable, there 
was little difference in the odds ratio (AOR 2.03: 95% CI: 1.40, 2.95; p<0.001).  I 
hypothesised that the effects of shorter duration of residence in the UK on viral load at 
delivery were mainly mediated by duration of ART i.e. if a woman arrived after 
conception she would have been likely to have less opportunity to start ART in a timely 
fashion, a critical predictor of viral load at delivery.  I therefore repeated the analysis 
adjusting for duration of ART, to investigate whether this was an important mediating 
factor.   I found that although the adjusted odds ratio was attenuated, there remained 
increased odds of having a detectable viral load in the group of women arriving in the 
country after conception (AOR 1.49: 95% CI: 1.02, 2.18; p<0.05). 
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Table 5.6: Univariable and multivariable analysis of the association between ethnicity and detectable HIV viral load at delivery (based on imputed dataset) 
 Univariable analysis Multivariable analysis, n=5280 
 Detectable VL/N (%) OR (95% CI) p-value AOR (95% CI) p-value 
Ethnicity 
White British 
African 
 
111/643 (17.3) 
1070/5362 (20.0) 
 
1.00 
1.19 (0.96,1.48) 
 
 
0.100 
 
1.00 
1.08 (0.82,1.41) 
 
 
0.583 
Maternal age at delivery 
<25 years 
25-34 years 
шϯϱ years 
 
203/718 (28.3) 
743/3701 (20.1) 
235/1586 (14.8) 
 
1.00 
0.64 (0.53,0.76) 
0.44 (0.36,0.55) 
 
<0.001 
  
Year of EDD/delivery 
2000-2003 
2004-2006 
2007-2010 
 
244/884 (27.6) 
404/1914 (21.1) 
533/3207 (16.6) 
 
1.00  
0.70 (0.58,0.84) 
0.52 (0.44,0.62) 
 
<0.001 
 
1.00 
0.72 (0.54,0.95) 
0.69 (0.53,0.89) 
 
 
0.004 
0.005 
IDU 
No 
Yes 
 
1171/5964 (19.6) 
10/41 (24.4) 
 
1.00 
1.32 (0.65,2.70) 
 
0.458 
  
Earliest viral load
¶
, copies/ml 
чϱϬ 
51-10000 
>10,000 
 
95/2290 (4.2) 
338/1805 (18.7) 
509/1309 (38.9) 
 
1.00 
5.32 (4.20,6.75) 
14.70 (11.64,18.57) 
 
<0.001 
 
1.00 
4.76 (3.44,6.59) 
14.32 (10.18,20.14) 
 
 
<0.001 
<0.001 
Earliest CD4 count
¶
, cells/µl 
шϯϱϬ 
200-249 
<200 
 
513/3286 (15.6) 
362/1759 (20.6) 
265/830 (31.9) 
 
1.00 
1.40 (1.21,1.63) 
2.54 (2.13,3.01) 
 
<0.001 
 
1.00 
1.11 (0.92,1.34) 
1.88 (1.48,2.37) 
 
 
0.266 
<0.001 
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Table 5.6 continued 
 Univariable analysis Multivariable analysis 
 Detectable VL/N (%) OR (95% CI) p-value AOR (95% CI) p-value 
Type of HAART 
NRTI only 
NNRTI-based 
PI-based 
NNRTI/PI based 
 
10/93 (10.8) 
296/2062 (14.4) 
776/3458 (22.4) 
99/392 (25.3) 
 
1.00 
1.39 (0.71,2.71) 
2.40 (1.24,4.65) 
2.80 (1.40,5.62) 
 
<0.001 
 
1.00 
1.14 (0.42,3.04) 
2.19 (0.83,5.78) 
2.15 (0.92,1.34) 
 
 
0.800 
0.113 
0.140 
Duration of HAART  
On HAART at conception 
12-40 weeks 
2-11 weeks 
<2 weeks 
 
169/2214 (7.6) 
431/2511 (17.2) 
452/1081 (41.8) 
104/117 (88.9) 
 
1.00 
2.51 (2.08,3.03) 
8.70 (7.13,10.60) 
96.80 (53.3,175.95) 
 
<0.001 
 
1.00 
0.53 (0.40,0.72) 
2.15 (1.58,2.93) 
15.37 (7.26,32.52) 
 
 
<0.001 
<0.001 
<0.001 
¶ First reported value in pregnancy. VL, viral load; OR, odds ratio; AOR, adjusted odds ratio: EDD, expected date of delivery; IDU, likely route of HIV acquisition was maternal 
injecting drug use; HAART, highly active antiretroviral therapy; NRTI, nucleoside reverse transcriptase inhibitor; NNRTI, non-nucleoside reverse transcriptase inhibitor; PI, 
protease inhibitor. 
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Table 5.7: Univariable and multivariable analysis of the association between African region of birth and detectable HIV viral load at delivery (restricted to 
African women, based on imputed dataset) 
 Univariable analysis Multivariable analysis, n=4712 
 Detectable VL/N (%) OR (95% CI) p-value AOR (95% CI) p-value 
African region of birth 
Eastern Africa 
Southern Africa 
Western Africa 
Middle Africa 
 
600/3248 (18.5) 
96/423 (22.7) 
270/1172 (23.0) 
104/519 (20.0) 
 
1.00 
1.30 (1.01,1.65) 
1.32 (1.12,1.55) 
1.11 (0.88,1.40) 
 
 
0.038 
0.001 
0.396 
 
1.00 
1.08 (0.78,1.48) 
1.09 (0.88,1.35) 
1.17 (0.87,1.58) 
 
 
0.646 
0.426 
0.309 
Maternal age at delivery 
<25 years 
25-34 years 
шϯϱ years 
 
159/538 (29.6) 
691/3384 (20.4) 
220/1440 (15.3) 
 
1.00 
0.61 (0.50,0.75) 
0.43 (0.34,0.54) 
 
<0.001 
  
Year of EDD/delivery 
2000-2003 
2004-2006 
2007-2010 
 
221/780 (28.3) 
371/1711 (21.7) 
478/2871 (16.7) 
 
1.00  
0.70 (0.58,0.85) 
0.51 (0.42,0.61) 
 
<0.001 
 
1.00 
0.67 (0.51,0.89) 
0.66 (0.51,0.87) 
 
 
0.005 
0.003 
IDU 
No 
Yes 
 
1070/5361 (20.0) 
0/1 (0) 
 
 
 
 
  
Earliest viral load
¶
, copies/ml 
чϱϬ 
51-10000 
>10,000 
 
91/2034 (4.5) 
305/1618 (18.9) 
453/1161 (39.0) 
 
1.00 
4.96 (3.88,6.33) 
13.66 (10.73,17.39) 
 
<0.001 
 
1.00 
4.51 (3.22,6.33) 
13.54 (9.49,19.33) 
 
 
<0.001 
<0.001 
Earliest CD4 count
¶
, cells/µl 
шϯϱϬ 
200-249 
<200 
 
448/2860 (15.7) 
335/1615 (20.7) 
255/782 (32.6) 
 
1.00 
1.41 (1.20,1.65) 
2.61 (2.18,3.12) 
 
<0.001 
 
1.00 
1.11 (0.91,1.35) 
1.98 (1.55,2.52) 
 
 
0.318 
<0.001 
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Table 5.7 continued 
 Univariable analysis Multivariable analysis 
 Detectable VL/N (%) OR (95% CI) p-value AOR (95% CI) p-value 
Type of HAART 
NRTI only 
NNRTI-based 
PI-based 
NNRTI/PI based 
 
10/76 (13.2) 
270/1863 (14.5) 
698/3064 (22.8) 
92/359 (25.6) 
 
1.00 
1.12 (0.57,2.20) 
1.95 (1.00,3.81) 
2.27 (1.12,4.61) 
 
<0.001 
 
1.00 
0.98 (0.35,2.72) 
1.93 (0.71,5.29) 
1.83 (0.64,5.25) 
 
 
0.972 
0.199 
0.261 
Duration of HAART  
On HAART at conception 
12-40 weeks 
2-11 weeks 
<2 weeks 
 
162/1991 (8.1) 
383/2218 (17.3) 
404/974 (41.5) 
97/107 (90.7) 
 
1.00 
2.36 (1.94,2.86) 
8.00 (6.52,9.82) 
109.51 (56.01,214.12) 
 
<0.001 
 
1.00 
0.50 (0.37,0.68) 
1.96 (1.43,2.70) 
17.45 (7.85,38.79) 
 
 
<0.001 
<0.001 
<0.001 
¶ First reported value in pregnancy. VL, viral load; OR, odds ratio; AOR, adjusted odds ratio: EDD, expected date of delivery; IDU, likely route of HIV acquisition was 
maternal injecting drug use; HAART, highly active antiretroviral therapy; NRTI, nucleoside reverse transcriptase inhibitor; NNRTI, non-nucleoside reverse transcriptase 
inhibitor; PI, protease inhibitor. 
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Table 5.8: Univariable and multivariable analysis of the association between maternal duration of residence in the UK at conception and detectable HIV 
viral load at delivery (restricted to African women, based on imputed dataset) 
 Univariable analysis Multivariable analysis, n=3319 
 Detectable VL/N (%) OR (95% CI) p-value AOR (95% CI) p-value 
Duration of residence in UK 
ш ϰ years 
< 4 years (before conception) 
Since conception 
 
313/1969 (15.9) 
283/1450 (19.5) 
110/256 (43.0) 
 
1.00 
1.28 (1.07,1.53) 
3.99 (3.03,5.25) 
 
 
0.006 
<0.001 
 
1.00 
0.83 (0.67,1.03) 
2.29 (1.61,3.26) 
 
 
0.094 
<0.001 
Maternal age at delivery 
<25 years 
25-34 years 
шϯϱ years 
 
100/384 (26.0) 
457/2308 (19.8) 
149/980 (15.2) 
 
1.00 
0.70 (0.55,0.90) 
0.51 (0.38,0.68) 
 
<0.001 
  
Year of EDD/delivery 
2000-2003 
2004-2006 
2007-2010 
 
152/540 (28.2) 
252/1204 (20.9) 
302/1929 (15.7) 
 
1.00  
0.68 (0.54,0.85) 
0.47 (0.38,0.59) 
 
<0.001 
 
1.00 
0.59 (0.43,0.82) 
0.45 (0.32,0.62) 
 
 
0.002 
<0.001 
IDU 
No 
Yes 
 
706/3672 (19.2) 
0/0 (0) 
 
 
 
 
  
Earliest viral load
¶
, copies/ml 
чϱϬ 
51-10000 
>10,000 
 
58/1405 (4.1) 
213/1138 (18.7) 
306/810 (37.8) 
 
1.00 
5.35 (3.95,7.23) 
14.10 (10.46,19.01) 
 
<0.001 
 
1.00 
4.47 (3.25,6.15) 
11.48 (8.32,15.85) 
 
 
<0.001 
<0.001 
Earliest CD4 count
¶
, cells/µl 
шϯϱϬ 
200-249 
<200 
 
307/1975 (15.5) 
220/1113 (19.8) 
168/535 (31.4) 
 
1.00 
1.34 (1.11,1.62) 
2.49 (2.00,3.10) 
 
<0.001 
 
1.00 
0.99 (0.79,1.25) 
1.47 (1.11,1.96) 
 
 
0.959 
0.007 
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Table 5.8 continued 
 Univariable analysis Multivariable analysis 
 Detectable VL/N (%) OR (95% CI) p-value AOR (95% CI) p-value 
Type of HAART 
NRTI only 
NNRTI-based 
PI-based 
NNRTI/PI based 
 
7/56 (12.5) 
190/1326 (14.3) 
444/2029 (21.9) 
65/261 (24.9) 
 
1.00 
1.17 (0.52,2.62) 
1.96 (0.88,4.36) 
2.32 (1.00,5.38) 
 
<0.001 
 
1.00 
0.90 (0.34,2.38) 
1.58 (0.61,4.08) 
1.76 (0.64,4.82) 
 
 
0.831 
0.346 
0.275 
¶ First reported value in pregnancy. VL, viral load; OR, odds ratio; AOR, adjusted odds ratio: EDD, expected date of delivery; IDU, likely route of HIV acquisition was 
maternal injecting drug use; HAART, highly active antiretroviral therapy; NRTI, nucleoside reverse transcriptase inhibitor; NNRTI, non-nucleoside reverse transcriptase 
inhibitor; PI, protease inhibitor. 
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5.4 Epidemiological data on vertical transmission of HIV 
As discussed in Chapter Two, annual rates of vertical transmission in the UK have been 
low at approximately 1% since 2000 as a result of the introduction of routine antenatal 
HIV testing, the use of ART in pregnancy, appropriate management of delivery and the 
avoidance of breastfeeding.  In this section I explore the association between vertical 
transmission and: (i) maternal ethnicity, (ii) maternal African region of birth, and (iii) 
maternal duration of residence in the UK at conception (for African women).  The 
analysis of vertical transmission was restricted to singleton live births.  No women 
delivered more than one HIV-infected child between 2000 and 2010 and therefore 
robust standard errors were not required for this analysis.   
Infant infection status was classified as uninfected or infected on the basis of reported 
polymerase chain reaction (PCR) or HIV antibody results151.    
Potential confounders considered in the following analysis included maternal age, 
history of injecting drug use, duration of ART, CD4 count at delivery, gestational age at 
delivery, mode of delivery and infant sex.  Viral load at delivery was not included in the 
analysis despite being a recognised risk factor for vertical transmission as it was likely 
to be on the causal pathway.  I hypothesised that adherence was the main mediating 
factor between all exposure variables and vertical transmission and that viral load at 
delivery would mediate the relationship between adherence (which is unmeasured in 
this dataset) and vertical transmission.  
5.4.1  Results 
There were 8454 eligible singleton live births between January 2000 and December 
2010, of which 85.5% (7227) had available data on infant HIV status.  These reports 
pertained to 5839 women.  Similarly to previous analyses, approximately 90% of births 
(6429/7227) were to African women.  Other demographic and clinical characteristics of 
the study population are presented in table 5.9.    
The overall rate of vertical transmission during the study period was 1.1% (78/7277; 
                                                             
151
 An infant is “presumed infected” on the basis of one positive PCR result and “confirmed infected” if a 
further PCR result is positive, or if HIV antibody is detected beyond eighteen months of age.  An infant is 
“presumed uninfected” if a PCR test is negative after one month of age and “confirmed uninfected” after 
a negative PCR result beyond three months of age or a negative HIV antibody test after eighteen months 
of age (Townsend, et al. 2008a).  For the purposes of this analysis “presumed negatives” were categorised 
as not infected and “presumed positives” were categorised as infected, as infant status changes rarely 
unless transmission occurs via breast milk.  
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95% CI:  0.8%, 1.3%).  The vertical transmission rate fell over time from 2.6% in 2000 
to a low of 0.3% in 2009 (χ2trend test p<0.05, figure 5.3).   The rate increased to 1.3% in 
2010 due to time lag in reporting of infant HIV status where infected children are likely 
to be reported earlier than non-infected infants (Pat Tookey, UCL Institute of Child 
Health, personal communication, 20 September 2012)152.     
In univariable analysis vertical transmission was associated with lower CD4 count at 
delivery, shorter duration of ART, preterm delivery and the infant being female153 (all 
p<0.05, table 5.9). The vertical transmission rate in African women was 1.1% (73/6429) 
and not significantly different from the rate in white British women (0.6%; 5/848; 
p>0.1, table 5.10).    After adjusting for year, duration of ART and CD4 count at 
delivery African ethnicity was still not a significant risk factor (AOR 2.41; 95% CI: 
0.74, 7.85; p>0.1, table 5.10).  There was no significant difference between rates of 
vertical transmission among the different African region of birth groups (p>0.1, table 
5.11) and odds ratios adjusted for year, duration of ART, CD4 count at delivery and 
infant sex were similar (all p>0.1, table 5.11). 
Among African women there was a difference in vertical transmission rates according 
to maternal duration of residence in the UK at conception.  The vertical transmission 
rate in those who arrived in the country after conception was 2.9% (10/347) compared 
with 1.0% (19/1840) in those who had been in the UK for <4 years and 1.0% in those 
who had been in the country longer (29/2113; p>0.1; table 5.12).  After adjusting for 
year, uptake of ART and CD4 count at delivery, maternal arrival in the UK after 
conception remained a risk factor, albeit with borderline significance (AOR 2.56; 95% 
CI: 0.98, 6.68; p=0.055; table 5.12).    
I hypothesised that the effects of shorter duration of residence in the UK on vertical 
transmission were mainly mediated by duration of ART and therefore repeated the 
analysis also adjusting for duration of ART.  As expected, maternal arrival in the UK 
after conception was no longer a significant risk factor for vertical transmission after 
adjustment for duration of ART (AOR 1.19; 95% CI: 0.43, 3.32; p>0.1).  This would 
suggest that the effect of shorter maternal duration of residence was almost entirely 
mediated by duration of ART. 
                                                             
152
 Recent analysis of NSHPC data which has more complete information on the infection status of 
infants has shown a rate of VT of 0.5% in 2010-2011 (Townsend at al.: 2013).   
153
 Infant of female sex is a recognised associated factor in the literature (see Chapter Two: 44).  
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Table 5.9: Characteristics of women with pregnancies reported to the NSHPC by infant 
HIV status, 2000-2010 
 
 
 
 
Uninfected,  
n (row %) 
n=7199 
Infected,  
n (row %) 
n=78 
p-value* 
 
 
Ethnicity, n=7277 
White British 
African 
 
843 (99.4) 
6356 (98.9) 
 
5 (0.6) 
73 (1.1) 
 
0.147 
Maternal age at delivery, n=7268 
<25 years 
25-34 years 
шϯϱ years 
 
1002 (98.7) 
4481 (98.9) 
1708 (99.2) 
 
13 (1.3) 
51 (1.1) 
13 (0.8) 
 
0.336 
Year of EDD/delivery, n=7277 
2000-2003 
2004-2006 
2007-2010 
 
1645 (98.4) 
2541 (98.8) 
3012 (99.3) 
 
26 (1.6) 
31 (1.2) 
21 (0.7) 
 
0.016 
IDU, n=7277 
No 
Yes 
 
7125 (98.9) 
74 (100.0) 
 
78 (1.1) 
0 (0.0) 
 
0.368 
CD4 count at delivery, cells/µl, n=6349 
шϯϱϬ 
200-249 
<200 
 
3942 (99.2) 
1684 (99.1) 
662 (97.8) 
 
30 (0.8) 
16 (0.9) 
15 (2.2) 
 
0.002 
Duration of ART, n=6685 
On ART at conception 
12-40 weeks 
2-11 weeks 
<2 weeks 
None 
 
1990 (99.9) 
2702 (99.4) 
1648 (98.5) 
126 (93.3) 
145 (87.9) 
 
3 (0.2) 
16 (0.6) 
26 (1.6) 
9 (6.7) 
20 (1.1) 
 
<0.001 
Gestation at delivery, n=7176 
шϯ7 ǁeeks 
<37 weeks 
 
6236 (99.1) 
864 (98.2) 
 
60 (1.0) 
16 (1.8) 
 
0.019 
Mode of delivery, n=7234 
Elective CS 
Emergency CS 
Vaginal  
 
3773 (99.2) 
1654 (98.8) 
1729 (98.6) 
 
32 (0.8) 
21 (1.3) 
25 (1.4) 
 
0.107 
Sex of infant, n= 7273 
Male 
Female 
 
3642 (99.2) 
3553 (98.7) 
 
30 (0.8) 
48 (1.3) 
 
0.033 
*Obtained using χ2 test. EDD, expected date of delivery; IDU, likely route of HIV acquisition was 
maternal injecting drug use; ART, antiretroviral therapy; CS, caesarean section. 
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Figure 5.3: Trends over time in vertical transmission of HIV during pregnancy, 2000-2010 
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Table 5.10: Univariable and multivariable analysis of the association between ethnicity and vertical transmission of HIV 
 Univariable analysis Multivariable analysis, n=6259 
 VT/N (%) OR (95% CI) p-value AOR (95% CI) p-value 
Ethnicity 
White British 
African 
 
5/848 (0.6) 
73/6429 (1.2) 
 
1.00 
1.94 (0.78,4.81) 
 
 
0.117 
 
1.00 
2.41 (0.74,7.85) 
 
 
0.145 
Maternal age at delivery 
<25 years 
25-34 years 
шϯϱ years 
 
13/1015 (1.3) 
51/4532 (1.1) 
13/1721 (0.8) 
 
1.00 
0.88 (0.48,1.62) 
0.59 (0.27,1.27) 
 
0.314 
  
Year of EDD/delivery 
2000-2003 
2004-2006 
2007-2010 
 
26/1671 (1.6) 
31/2572 (1.2) 
21/3034 (0.7) 
 
1.00  
0.77 (0.46,1.30) 
0.59 (0.27,1.27) 
 
0.015 
 
1.00 
1.16 (0.62,2.17) 
0.92 (0.46,1.84) 
 
 
0.642 
0.807 
IDU 
No 
Yes 
 
78/7203 (1.1) 
0/74 (0) 
 
 
 
 
  
Duration of ART  
On ART at conception 
12-40 weeks 
2-11 weeks 
<2 weeks 
No treatment 
 
3/1993 (0.2) 
16/2718 (0.6) 
26/1674 (1.6) 
9/135 (6.7) 
20/165 (12.1) 
 
1.00 
3.93 (1.14,13.50) 
10.47 (3.16,34.64) 
47.38 (12.67,177.19) 
91.49 (26.87,311.51) 
 
<0.001 
 
1.00 
3.80 (1.10,13.07) 
9.33 (2.76,31.54) 
43.94 (11.30,170.83) 
100.12 (26.81,373.91) 
 
 
0.034 
<0.001 
<0.001 
<0.001 
CD4 count at delivery, cells/µl 
шϯϱϬ 
200-249 
<200 
 
30/3972 (0.7) 
16/1700 (0.9) 
15/677 (2.2) 
 
1.00 
1.25 (0.68,2.30) 
2.98 (1.59,5.56) 
 
0.006 
 
1.00 
1.20 (0.64,2.24) 
2.82 (1.47,5.40) 
 
 
0.567 
0.002 
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Table 5.10 continued 
 Univariable analysis Multivariable analysis 
 VT/N (%) OR (95% CI) p-value AOR (95% CI) p-value 
Gestation at delivery  
шϯ7 ǁeeks 
<37 weeks 
 
60/6296 (1.0) 
16/880 (1.8) 
 
1.00 
1.92 (1.10,3.36) 
 
0.030 
 
 
 
 
 
Mode of delivery 
Elective CS 
Emergency CS 
Vaginal  
 
32/3805 (0.8) 
21/1675 (1.3) 
25/1754 (1.4) 
 
1.00 
1.50 (0.86,2.60) 
1.70 (1.01,2.89) 
 
0.109 
  
Sex of infant 
Male 
Female 
 
30/3672 (0.8) 
48/3601 (1.3) 
 
1.00 
1.64 (1.04,2.59) 
 
0.032 
  
VT, vertical transmission; OR, odds ratio; AOR, adjusted odds ratio: EDD, expected date of delivery; IDU, likely route of HIV acquisition was maternal injecting drug use; 
ART, antiretroviral therapy; CS, caesarean section. 
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Table 5.11: Univariable and multivariable analysis of the association between African region of birth and vertical transmission of HIV (restricted to 
African women) 
 Univariable analysis Multivariable analysis, n=5541 
 VT/N (%) OR (95% CI) p-value AOR (95% CI) p-value 
African region of birth 
Eastern Africa 
Southern Africa 
Western Africa 
Middle Africa 
 
46/3900 (1.2) 
2/492 (2.0) 
18/1408 (1.3) 
7/629 (1.1) 
 
1.00 
0.34 (0.08,1.41) 
1.08 (0.63,1.88) 
0.94 (0.42,2.10) 
 
 
0.138 
0.771 
0.885 
 
1.00 
0.36 (0.08,1.55) 
1.04 (0.56,1.92) 
0.82 (0.33,2.05) 
 
 
0.170 
0.905 
0.670 
Maternal age at delivery 
<25 years 
25-34 years 
шϯϱ years 
 
10/770 (1.3) 
49/4109 (1.2) 
13/1542 (0.8) 
 
1.00 
0.92 (0.46,1.82) 
0.65 (0.28,1.48) 
 
0.456 
  
Year of EDD/delivery 
2000-2003 
2004-2006 
2007-2010 
 
24/1448 (1.7) 
29/2292 (1.3) 
20/2689 (0.7) 
 
1.00  
0.76 (0.44,1.31) 
0.44 (0.24,0.81) 
 
0.022 
 
1.00 
1.05 (0.55,1.99) 
0.83 (0.41,1.70) 
 
 
0.889 
0.611 
IDU 
No 
Yes 
 
73/6426 (1.1) 
0/3 (0) 
 
 
 
 
  
Duration of ART  
On ART at conception 
12-40 weeks 
2-11 weeks 
<2 weeks 
No treatment 
 
3/1769 (0.2) 
15/2380 (0.6) 
23/1491 (1.5) 
9/123 (7.3) 
19/141 (13.5) 
 
1.00 
3.73 (1.08,12.92) 
9.22 (2.76,30.78) 
46.47 (12.41,174.02) 
91.68 (26.76,314.09) 
 
<0.001 
 
1.00 
3.58 (1.03,12.44) 
8.43 (2.47,28.81) 
42.82 (10.89,168.47) 
114.87 (30.14,437.80) 
 
 
0.045 
0.001 
<0.001 
<0.001 
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Table 5.11 continued 
 Univariable analysis Multivariable analysis 
 VT/N (%) OR (95% CI) p-value AOR (95% CI) p-value 
CD4 count at delivery, cells/µl 
шϯϱϬ 
200-249 
<200 
 
27/3422 (0.8) 
16/1560 (1.0) 
15/639 (2.3) 
 
1.00 
1.30 (0.70,2.43) 
3.02 (1.60,5.71) 
 
0.006 
 
1.00 
1.28 (0.67,2.44) 
3.01 (1.55,5.87) 
 
 
0.444 
0.001 
Gestation at delivery  
шϯ7 ǁeeks 
<37 weeks 
 
55/5594 (1.0) 
16/751 (2.1) 
 
1.00 
2.19 (1.25,3.86) 
 
0.011 
 
 
 
 
 
Mode of delivery 
Elective CS 
Emergency CS 
Vaginal  
 
30/3303 (0.9) 
19/1511 (1.3) 
24/1577 (1.5) 
 
1.00 
1.39 (0.78,2.48) 
1.69 (0.98,2.89) 
 
0.156 
  
Sex of infant 
Male 
Female 
 
26/3227 (0.8) 
47/3198 (1.5) 
 
1.00 
1.84 (1.13,2.97) 
 
0.011 
 
1.00 
1.96 (1.13,3.42) 
 
 
0.018 
VT, vertical transmission; OR, odds ratio; AOR, adjusted odds ratio: EDD, expected date of delivery; IDU, likely route of HIV acquisition was maternal injecting  
drug use; ART, antiretroviral therapy; CS, caesarean section. 
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Table 5.12: Univariable and multivariable analysis of the association between duration of residence in the UK at conception and vertical transmission of 
HIV (restricted to African women) 
 Univariable analysis Multivariable analysis, n=3922 
 VT/N (%) OR (95% CI) p-value AOR (95% CI) p-value 
Duration of residence in UK 
ш ϰ years 
< 4 years (before conception) 
Since conception 
 
20/2113 (1.0) 
19/1840 (1.0) 
10/347 (2.9) 
 
1.00 
1.09 (0.58,2.06) 
3.11 (1.44,6.69) 
 
 
0.780 
0.004 
 
1.00 
1.30 (0.63,2.65) 
2.56 (0.98,6.68) 
 
 
0.478 
0.055 
Maternal age at delivery 
<25 years 
25-34 years 
шϯϱ years 
 
8/511 (1.6) 
31/2747 (1.1) 
10/1038 (1.0) 
 
1.00 
0.72 (0.33,1.57) 
0.61 (0.24,1.56) 
 
0.593 
  
Year of EDD/delivery 
2000-2003 
2004-2006 
2007-2010 
 
16/974 (1.6) 
18/1533 (1.2) 
15/1789 (0.8) 
 
1.00  
0.71 (0.36,1.40) 
0.51 (0.25,1.03) 
 
0.171 
 
1.00 
1.05 (0.47,2.35) 
0.92 (0.39,2.15) 
 
 
0.909 
0.841 
IDU 
No 
Yes 
 
49/4295 (1.1) 
0/1 (0) 
 
 
 
 
  
Uptake of ART 
Yes 
No 
 
37/4168 (0.9) 
12/94 (12.8) 
 
1.00 
16.34 (8.22,32.47) 
 
<0.001 
 
1.00 
18.24 (7.34,45.29) 
 
 
<0.001 
CD4 count at delivery, cells/µl 
шϯϱϬ 
200-249 
<200 
 
16/2385 (0.7) 
14/1114 (1.3) 
10/423 (2.4) 
 
1.00 
1.88 (0.92,3.87) 
3.59 (1.62,7.95) 
 
0.009 
 
1.00 
1.94 (0.93,4.02) 
3.41 (1.51,7.71) 
 
 
0.077 
0.003 
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Table 5.12 continued 
 Univariable analysis Multivariable analysis 
 VT/N (%) OR (95% CI) p-value AOR (95% CI) p-value 
Gestation at delivery  
шϯ7 ǁeeks 
<37 weeks 
 
38/3777 (1.0) 
11/480 (2.3) 
 
1.00 
2.31 (1.17,4.55) 
 
0.026 
 
 
 
 
 
Mode of delivery 
Elective CS 
Emergency CS 
Vaginal  
 
20/2156 (0.9) 
11/1032 (1.1) 
18/1089 (1.7) 
 
1.00 
1.15 (0.55,2.41) 
1.79 (0.95,3.41) 
 
0.202 
  
Sex of infant 
Male 
Female 
 
18/2161 (0.8) 
31/2132 (1.5) 
 
1.00 
1.76 (0.98,3.15) 
 
0.054 
  
VT, vertical transmission; OR, odds ratio; AOR, adjusted odds ratio: EDD, expected date of delivery; IDU, likely route of HIV acquisition was maternal injecting 
drug use; ART, antiretroviral therapy; CS, caesarean section. 
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5.5 Summary of epidemiological analyses 
I have found no evidence of an association between ethnicity and uptake of ART in 
pregnancy, detectable HIV viral load at delivery and vertical transmission.  This is 
consistent with previous studies (Mayaux et al. 2003, Jasseron et al. 2008, Townsend et 
al. 2008a, Floridia et al. 2010, Izzo et al. 2011, Modestini et al. 2012).   However, I have 
found disparities among African women.  Western African women were more likely not 
to receive ART in pregnancy than women from Eastern Africa, although it is important 
to remember that this is a very small proportion of Western African women (3.5%).  
They were also more likely to have declined ART in pregnancy, along with those from 
Middle Africa.   
The most striking differential was among women who had arrived in the UK after 
conception when compared with those who had been in the UK for those who had been 
in the UK for four years or longer154.  Women who had arrived in the UK after 
conception were twice as likely to not receive ART in pregnancy, to have a detectable 
HIV viral load at delivery and to transmit HIV to their infants155.   
5.6 Ethnographic data 
The quantitative results I have presented provide us with some useful entry points into 
the complexities of ART use during pregnancy.   The overwhelming majority of women 
living with HIV (regardless of ethnicity, country of origin or duration of residence in the 
UK) take ART during pregnancy, mainly successfully, with 80% achieving virological 
suppression at delivery and very few instances of transmission to infants, suggesting 
both that women generally adhere to prescribed ART, and that it is effective. 
But what of the small numbers of women who don’t receive ART?  It seems unlikely 
that healthcare professionals would limit access to ART in certain groups of pregnant 
women given that treatment is advised for all HIV-positive women in pregnancy.     I 
                                                             
154
 The high proportion of missing data on maternal duration of residence in the UK raises concerns about 
bias.  However, reassuringly the proportions of women who did not receive ART during pregnancy, who 
had a detectable viral load at delivery and whose pregnancy resulted in an infected infant were similar in 
the groups with and without data on maternal duration of residence (all p>0.1). 
155
 When adjusting for duration of ART, the association between duration of residence in the UK and 
detectable viral load at delivery was attenuated but remained statistically significant.  This was not the 
case for the association between vertical transmission and duration of residence in the UK, which was no 
longer significant after adjusting for duration of ART.    This difference is likely to be due to the very 
small numbers of infected infants in the dataset and the limited power to detect differences in analyses of 
vertical transmission.  It may also suggest that the effect of shorter duration of residence on vertical 
transmission was mediated entirely by duration of ART, whereas the effect on viral load at delivery may 
be more sensitive to other factors such as adherence (even in the absence of ART the risk of vertical 
transmission is 25% whereas poor adherence often leads to virological failure).   
 152 
am particularly interested in why Western African women were most likely not to 
receive ART during pregnancy (with over a third of those not receiving ART declining 
treatment), although I am mindful that this represents a very small number of women.  
Furthermore, the quantitative results prompt us to ask why African women who migrate 
to the UK during their pregnancy are more likely to exhibit poor use of ART as 
evidenced by the increased likelihood of not receiving treatment, and increased rates of 
detectable viral load at delivery and vertical transmission156.  Although biological 
differences, such as pharmacokinetics and drug resistance, cannot be discounted it 
seems unlikely that that these would be the mechanisms by which duration of residence 
in the UK would lead to differentials in virological suppression.   
For the remainder of this chapter I will draw upon data from my ethnographic research 
to tease out the complex processes involved in taking, or not taking, ART during 
pregnancy.  Specifically, I will explore what enables the overwhelming majority of 
women to take ART during pregnancy, and what may underlie the disparities identified 
in West African women and women who migrate to the UK during pregnancy. 
5.6.1 The notion of compliance 
Within biomedical discourse, to take ART as prescribed is to adhere to ART.  As 
discussed earlier, adherence is closely related to the notion of compliance, albeit with a 
subtle nod to issues of agency and choice. Whatever the distinctions, both concepts 
concern the degree to which a patient follows medical advice.   Traditional sociological 
critiques of compliance have emphasised the negative consequences of biomedical 
authority in either constructing an ideology of compliance where non-compliance is 
seen as deviant (Trostle 1988) or failing to acknowledge other aspects of experience that 
may inform a person’s decision to take medication (Conrad 1985).  Inherent in these 
critiques is the desire to decentre biomedical perspectives, and instead foreground the 
views of patients.   
This body of work has been important in reframing notions of compliance to take into 
account patient agency.  However, the preoccupation with biomedicine157 as a 
                                                             
156
 I have shown earlier in this chapter that the increased risk of vertical transmission in this group is 
likely to be due to shorter duration of ART and the consequent risk of lack of virological suppression by 
delivery.   
157
 I use the term biomedicine to refer to systems of healing that are derived from biological and natural 
sciences.  Other systems of healing may include complementary medicine, traditional medical practice 
and religious healing. 
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repressive regime158 may limit analytic engagement with compliance as it pertains to the 
realities of living with HIV in the twenty-first century (Mykhalovskiy et al. 2004)159.  
The somewhat myopic view of compliance as patients being compelled to follow 
medical advice tends to privilege non-compliance as the object of interest, taking as its 
departure point an assumption that not taking medication is an act of agency.  Whilst 
this may be true, what is missing from this argument is a consideration of the reasons 
why patients may want to take treatment.  Furthermore these older critiques of 
compliance tend to focus on either doctors or patients (or both), and originate in an era 
which predated the global commodification and popularity of biomedicine and the 
plethora of extra-clinical sites where medical knowledge is constructed (Mykhalovskiy 
et al. 2004).    
As an HIV clinician, I have seen at first-hand how ART has radically transformed the 
lives of people living with HIV, affording near-normal life expectancy in a state of good 
health.  The AIDS-ravaged bodies that populate the ethnographies of Paul Farmer in 
Haiti (2004) and Didier Fassin in South Africa (2007) have rarely been a feature of my 
work due to the widespread availability of ART in the UK.  The potential of ART to 
transform lives is perhaps nowhere more evident than in pregnancy.  Where once HIV-
positive motherhood was plagued by the agonies of vertical transmission and death, 
ART’s impact on maternal health and the prevention of vertical transmission has now 
fostered a sense of optimism and hope.  However ART is not without its constraints, 
requiring commitment to a daily (and sometimes complex) medication regimen and the 
acceptance of possible side effects.  The consequences of poor adherence to medication 
are progression of HIV disease, the development of ART resistance and, in the case of 
pregnancy, vertical transmission.  It is therefore unsurprising that adherence is a focal 
point of interest in clinical practice.  Certainly in most departments I have worked, 
weekly meetings have been set aside for the sole purpose of discussing why patients are 
“failing”160 on treatment, with lengthy explorations of patients’ adherence “issues”.      
Although the language of failure may at first suggest a framing of non-compliance as 
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 This argument is mainly informed by Foucault’s genealogy of modern medicine in which he traces the 
diffuse power that underpins the construction of the human body as a ‘knowable’ site by experts (doctors) 
(Foucault [2003] 1963). 
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 In their work on the use of ART by people living with HIV in Toronto in the late 1990s, Mykhalovskiy 
et al. reveal that adherence is not an example of biomedical disciplinary power; rather it is a complex 
technology that is constructed in multiple interlocking sites both within and outside of the clinic.   
Furthermore, the authors describe how healthcare professionals and biomedical researchers actively 
engage with the social reasons behind poor adherence and seek to individualise treatment in order to 
enable their patients to take their medication effectively, rather than compelling them to comply.  
160
 Failure in this context means that a patient on treatment has a detectable viral load. 
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deviance, my experience does not bear this out.  Clinical discussions about adherence 
are predominantly multidisciplinary (comprising doctors, nurses, pharmacists, 
psychologists and social workers) and are multi-dimensional, engaging with a wide 
range of possibilities ranging from side effects to interactions between staff and patients 
to a patient’s health beliefs.  These discussions rarely blame patients, and instead focus 
on ways to work with individual patients to understand why adherence may be 
challenging.  Some patients may be reluctant to take ART for a variety of reasons and 
these views, although as a clinician sometimes hard to accept, are generally respected.  
In contradistinction, treatment is rarely withheld from those who require it and wish to 
take it161. 
Therefore, we can see that in order to understand adherence to ART during pregnancy, 
we need to broaden discussions beyond non-compliance and the disciplinary power of 
doctors and engage with the possibility that patients wish to take medication and that 
constraints may lie both within and outside the domain of biomedicine.    
5.6.2 Antiretroviral therapy as a generative tool 
Motherhood plays a central role in the lives of many African women living with HIV in 
the UK, whether they have a child or not.  Smith and Mbakwem (2007) discuss the 
cultural imperative in Nigeria to have children, describing how childbearing is seen as a 
fundamental contribution to community.  In Whyte’s ethnography of the management 
of misfortune by the Nyole in Eastern Uganda (1997), one of the greatest misfortunes is 
infertility: 
“An individual is not a complete social person until he or she is married and can begin 
the process of forming a new household.” 
(Whyte 1997: 54) 
In each of these contexts, parenthood is a social requirement.  It is intrinsic to one’s 
transition into adulthood and fulfils an important role in the flourishing of society; a 
social and biological reproduction.   
African women feel the weight of this expectation, even having moved to the UK.  
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 A recent amendment to the Health and Social Care bill, which came into effect from October 2012, has 
overturned previous legislation that instructed the withholding of free HIV treatment from non-UK 
citizens and undocumented migrants.  In practice, this was rarely enforced by clinicians, although not 
openly discussed (Department of Health 2012a) . 
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Living in the transnational space of diaspora does not erase internalised cultural 
expectations of motherhood.  Close links to African kin and communities, both within 
the UK and abroad, reinforce the need to fulfil one’s role as a woman by becoming a 
mother.  Procreation was a central preoccupation at the Pentecostal church in which I 
conducted fieldwork with large sections of services appealing to the Lord to bless the 
congregation with “fruits of the womb”162.  Many African women living with HIV share 
this similar cultural universe with regards to procreation.  Being childless is greeted 
with suspicion, with women held accountable in the earthly and spiritual realms as 
described by the following participant: 
They think you’re barren [...] you’re wild, you dress improperly, you party, you’ve had 
relationships. They will think all of that. If a person has been having problems of her 
womb [...]  they have also a lot of stories behind it [...]  they can even call you [a] witch. 
(Stella) 
Many women, when discussing their initial response to their HIV diagnosis, talked of 
how it had symbolised the end of their life.  Most had migrated from settings where 
ART was not widely available.  They had seen, or at least heard of, family and 
acquaintances die of AIDS-related illness.  Prior to their diagnosis, few had seen women 
with HIV become mothers.  Being HIV-positive in the UK afforded them access to 
ART and a chance to live, both biologically and socially.  ART therefore becomes an 
important route through which to achieve a culturally prescribed female identity, and it 
was no surprise that all the pregnant women I encountered had taken or were taking 
ART163.  It allowed them to entertain the possibility that they might survive, be healthy 
and produce a healthy child.  Smith and Mbakwem (2007), in their study of adults 
receiving ART in Southeastern Nigeria, write of the importance of ART in people’s 
“life projects”; that is, in a life that is expected to be defined by marriage and 
childbearing, ART becomes a means of achieving normality.  ART allowed many of my 
participants to fulfil their “life project” to become a mother, avoiding the stigma of 
being a childless woman and suspicion as to the reasons why.  It allowed them to “pass” 
as though they were HIV-negative (Goffman [1990] 1963). 
However, women were not merely performing to cultural scripts.  As in previous studies 
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 This is discussed in greater detail in Chapter Six. 
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 Of course, this is a self-selecting sample of women who were engaged in HIV antenatal care at NHS 
clinics or HIV support services.  Women who were poorly engaged with care, or who did not wish to take 
ART, were unlikely to consent to participation.  
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from the US (Richter et al. 2002, Sandelowski et al. 2003, Kirshenbaum et al. 2004, 
Sanders 2008), pregnancy frequently gave women a renewed sense of purpose and 
meaning in their lives in the wake of an HIV diagnosis.   Femi, who was expecting her 
first child, expressed the heightened importance of becoming a mother after receiving 
her HIV diagnosis a year earlier, framing motherhood in terms of legacy: 
Being HIV positive, you just have this impending feeling of doom and then you’re also 
like ‘OK, I need to have something of myself still remaining on this earth before I go’. 
(Femi) 
For others, their diasporic journey had been characterised by loss and exile.  Many had 
left children behind with family as they forged new lives in the UK.  Some had 
maintained contact by telephone or internet, but the constraints of poverty or their 
immigration status prevented them from being able to be with their children.  
Furthermore, their HIV diagnosis was a further barrier due to anxieties about access to 
ART in their home countries.  In an unenviable double bind, a new baby provided some 
balm and an opportunity to mother again.  For others, the situation was even starker.  
Mariama had fled Guinea due to political persecution, having been subjected to extreme 
physical and sexual violence in a military prison.  She had been smuggled out of the 
country by a friend, leaving her seven-year-old son with her parents.  She no longer 
knew their whereabouts.  The promise of a new baby provided some degree of 
consolation: 
That’s why when I was pregnant I was praying to God, like God give me a boy again 
because I miss my son so much.  It helps me think about my son, when I see him I think 
like I’m seeing another one. [It makes me] very happy. 
Sandelowski (2003), in a metasynthesis of qualitative work in the US, divides the 
“work” of motherhood in the context of HIV into two domains.  The first pertains to the 
preservation of a positive maternal identity.  Thus far, I have explored how this is 
specifically elaborated within an African diasporic setting in the UK.  The second 
domain refers to the protection of the child from HIV.   Every woman in my study cited 
this as the most important motivation in taking ART during pregnancy, even if some 
had been reluctant to take ART or poorly adherent prior to their pregnancy.  Many could 
not understand why a woman would not take ART during pregnancy: 
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They maybe don’t cherish what is in their belly.  You have to cherish your baby.  
Because right now, the baby’s innocent.  You can’t transfer your sickness to the baby, 
you have to take it. 
(Effia) 
ART is imbued with affective properties.  It is a vehicle by which you can “transfer” 
love to your baby, ensuring their health.  The assumption is that by not taking ART, you 
fail to protect your baby, “spoiling” your identity as a good mother.  The many 
conversations I have had with clinical colleagues over the years, as a clinician and as a 
researcher, serve to underline this.  Women who do not take ART during pregnancy, or 
who do not have good adherence, are of particular concern to the clinical team, mainly 
because of the risk of vertical transmission.  The situation provokes a great deal of 
anxiety and often results in intensive monitoring of the mother’s clinical situation and 
further discussions about the risk a woman may pose to her child in other ways such as 
withholding ART prophylaxis from the baby after delivery or breastfeeding.   
ART therefore serves multiple functions in the context of maternal HIV infection.  
Beyond its pharmacological actions in sustaining a woman’s health and preventing 
vertical transmission, ART has important transformative powers (Whyte et al. 2002)164.  
Antiretrovirals can be seen as “potent symbols and tokens of hope” (Ibid.: 5), providing 
the means to generate a positive identity as a fully-fledged adult, as a woman, and as a 
good mother. 
5.6.3 Illness within a healthscape 
The dichotomy between ‘Western’ and ‘non-Western’ medical systems looks 
increasingly tenuous in a globalised world.  Medical technologies have widespread 
purchase and the $300 billion global pharmaceuticals market165 is evidence of the 
unbridled commodification of medicines.  Biomedicine is now widely accepted 
throughout the world.  It is seen as effective, especially in areas of high morbidity and 
mortality where antibiotics and vaccination have had a tangible effect on people’s lives.  
It also has many practical advantages such as ease of access and not requiring the 
significant degree of interpersonal effort required in other systems such as divination 
                                                             
164Susan Whyte and colleagues describe the key features of medicines as including the “powers to 
transform…they are supposed to do something, to change the body in a discernable way” and that these 
“transformative powers can be put to different purpose” (2002: 5). 
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 See http://www.who.int/trade/glossary/story073/en/index.html (accessed 15 September 2012). 
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(Whyte 1997)166.   Furthermore, it carries prestige due to its association with “powers of 
modernity, distant centres of advanced technology, and professional expertise” 
(Ibid.:229).  Biomedicine has demonstrated great capacity in penetrating other medical 
systems.  In many settings, traditional medicines have been transformed from outdated 
preparations to hi-tech coated tablets in blister packs, emulating biomedicine in an effort 
to compete in the medicine market (Cocks et al. 2000, Bode 2006).  Biomedicine’s 
widespread popularity and success in penetrating markets and other medical systems 
makes it an exemplar of globalisation.   It is difficult to know where to situate medical 
systems within Appadurai’s "-scapes" described in Chapter One as they largely 
incorporate aspects of technology, finance, information and ideology (1996).  To this 
end, I offer the neologism healthscape in an attempt to capture the transnational flow of 
medical knowledge (not just biomedical) and technologies.  As in Appadurai’s 
“ethnoscapes” and “financescapes”, healthscapes are multiperspectival and globally 
connected, with specific local articulations.    
The African women in my study exist within a healthscape where biomedicine is not an 
alien technological innovation.  This is partly because they are predominantly a group 
of well-educated women who have come from affluent and urbanised backgrounds in 
Africa.  Hospitals were described as relatively easy to access at home in Africa, and 
their status as members of the elite frequently meant that they would preferentially seek 
hi-tech and modern interventions167.  All the women I interviewed had experience of 
biomedicine in Africa prior to migration, and many described previous pregnancies 
where they had delivered in hospitals in their home countries.  Some travelled regularly 
between their African and London homes and therefore experienced biomedicine much 
more directly as an interconnected space.   For example, Effia had been diagnosed with 
HIV during her pregnancy when she had attended an antenatal clinic in Ghana with 
fevers, and was promptly commenced on ART.  Shortly after, she left Accra to join her 
husband in London as they both felt that she would receive more specialised care in the 
UK.  As it transpired, Effia’s doctors in London did not make any changes in her 
medication.   She felt that the clinic in London was more efficient, respected her 
confidentiality and gave her access to free ART, but these operational differences in 
local systems did not detract from Effia’s overall experience of HIV medicine as a 
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 In her work on how misfortune is addressed in Eastern Uganda Whyte contrasts divination, with its 
reliance on complex negotiations between kin, with other remedial measures such as biomedicine that 
require less interpersonal effort.    
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 My questions on the use of traditional or herbal medicines whether in the UK or Africa, were often 
greeted with bewilderment or mild exasperation; a salutary lesson on my own ethnographic naivety.   
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transnational interconnected practice.  For many women, their diasporic vantage point 
within the healthscape gave them an acute awareness of the differences in biomedical 
systems between here and there: 
 I have to take this opportunity though.   There are other people in our countries or in 
other countries; they're dying without [ART]. 
(Marie) 
Although other authors have documented gratitude as a motivation for taking ART in 
pregnancy (Doyal et al. 2005, McDonald et al. 2011), my participants’ views of ART as 
opportunity were uniquely shaped by living in diaspora.  Many had come from, and 
maintained strong links with, settings where ART was not widely available, having 
borne witness to countless AIDS related deaths as a result of the global inequities in 
ART distribution168.     With this in mind, women felt that access to ART in the UK 
provided them with an opportunity that must be grasped. 
So, for these women, biomedicine was an important and familiar resource.  When 
discussing their condition, they often employed biomedical terms in lengthy 
explanations about the importance of the “immune system”, “CD4 counts”, “levels of 
virus” and being “undetectable”169.  However, far from being a model imposed on 
women by staff at their clinics, the construction of the HIV-positive body as a biological 
body was also shaped by women’s interactions with electronic media, when looking for 
information on ART and HIV in pregnancy, and extra-clinical sites such as Body & 
Soul170.  It is also important to note that, according to UK surveillance data171 and my 
ethnographic data172, the majority of women living with HIV who become pregnant are 
diagnosed with HIV prior to their pregnancy.  Having often lived with HIV for some 
time, many were well versed in biomedical understandings of HIV and the body. 
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 Although ART coverage for the prevention of vertical transmission in Sub-Saharan Africa has 
increased significantly from 15% in 2005, it remained 41% in 2010 with coverage in West and Middle 
Africa reported to be 27% (UNAIDS 2011). 
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 As I demonstrate later in this chapter, this does not mean that women don’t retain co-existing models 
of illness. 
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 Common workshop themes included modes of action of ART and the interpretation of HIV blood test 
results.  These sessions were often extremely popular with members who were eager to learn about HIV 
and new developments of medication.  In fact, the only workshops that rivalled these in popularity were 
the ones that addressed disclosure of HIV status to sexual partners, suggesting that understanding the 
biological processes of HIV and finding a way to be HIV-positive in a relationship were central concerns 
for people living with HIV. 
171
 See Chapter Four (table 4.6: 109). 
172
 See table of participant characteristics (Appendix v). 
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These women were therefore oriented towards a biomedical system, at least in terms of 
HIV and pregnancy, and were willing to engage with clinical staff.  In each of the three 
hospitals, women received HIV care during pregnancy from a team that included, at the 
very least, a HIV specialist doctor and midwife.  They were reviewed in pregnancy at 
least once a month (which is more frequent than outpatient appointments in adults who 
are not pregnant) and may have up to a few hours at a time with various members of the 
clinical team.  Contrary to my expectations, most women did not find the increased 
frequency and duration of appointments intrusive.  Most described the care they 
received from their HIV clinical team during pregnancy in positive terms, valuing the 
time they had been given to have treatment explained and their concerns about side 
effects and toxicity addressed.  They also appreciated the continuity in their care as, 
rather unusually for current antenatal care in the UK, they were able to see the same 
midwife and clinician at each visit.  Engagement with a core group of specialist and 
highly experienced staff over regular appointments, fostered relationships with doctors 
and midwives that were founded upon trust and confidence, resulting in women feeling 
reassured about taking ART during pregnancy.   
Relationships with the HIV antenatal team were generally imbued with affective 
properties that defined how women saw their interactions with staff, many recalling 
names of key healthcare professionals they had met in previous pregnancies with a 
couple of women discussing how they had “followed” their HIV doctor to another unit 
when they had transferred to another job.  Many women saw their relationships with the 
HIV team as being characterised by care on a more holistic level.  They described being 
supported not only with clinical aspects of HIV and pregnancy, but emotionally and 
socially in terms of practical assistance with money, housing and immigration.  In the 
1980s, Cecil Helman highlighted the importance of context in doctor-patient 
consultations, describing how the course of illness was often shaped by factors outside 
the consultation room (Helman 1984).  More recently, Anne-Marie Mol has framed this 
philosophically within what she terms the “logic of care” (2008).  Mol contrasts the 
logic of care with its hegemonic counterpart, the “Logic of Choice” which constructs 
patients as individual consumers who must make their own choices about their health 
and take responsibility for poor decisions.  The logic of care, on the other hand, 
understands that people do not experience illness as individuals, may find choice in the 
context of distress challenging, and may be constrained by a variety of factors in their 
ability to exercise their choices.  Within the logic of care, healthcare professionals work 
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flexibly with patients to find ways in which they can live with illness better.  It is: 
“A language in which the main emphasis is not on autonomy and the right to decide for 
oneself, but on daily life practices and attempts to make these more liveable through 
inventive doctoring.  In care-specific terms, care is bad when people are being 
neglected.  When there is not enough time to listen.  When physical parameters are 
isolated from their context; when patients’ daily lives are not taken into consideration.” 
(Mol 2008: 84) 
In the strong relationships forged between professionals and patients, and staff’s 
willingness to engage with the realities of women’s lives, we can see evidence of the 
logics of care operating within the HIV antenatal clinic and acting as an enabling factor 
in adherence to ART: 
Everybody takes care of you; they smile at you all the time […] it gives you more power 
to come again to take your medication. 
(Fatima) 
5.6.4 The work of ART 
Although all the women I interviewed took ART during pregnancy, for many this 
presented a number of challenges.  Very few reported that this impacted on their 
adherence; yet I knew from discussions with healthcare professionals that a number of 
them had not achieved virological suppression, suggesting poor adherence.   Opening 
up a conversation about poor adherence with pregnant women proved to be very 
difficult.  This can perhaps be better understood if we recall the complex ways in which 
taking ART in pregnancy is bound up with the generation of a positive identity as both a 
woman and mother.  It also suggests that despite the good relationships that are forged 
within the HIV clinic between staff and women, there remains a power structure in 
which women feel they may be ‘disciplined’ by staff for “failing” on ART.  
Conrad’s seminal study of compliance in the context of epilepsy (1985) highlights the 
analytic limitations of attributing poor compliance solely to doctor-patient interactions 
or patient’s health beliefs, emphasising the importance of engaging with adherence in 
the context of patient’s lives.  Many women experienced nausea, vomiting, fatigue and 
abdominal pain.  In pregnancy it was often hard for women and their healthcare 
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professionals to distinguish whether these symptoms were due to pregnancy or side 
effects of medication.  These bodily symptoms were a source of great anxiety, with 
many women acutely aware of the need for excellent adherence to minimise the risk of 
vertical transmission: 
It’s really really hard because you get heartburn with pregnancy itself so when I take 
my medication it comes out and I struggle to take more.  Before I was pregnant and I 
was taking medication there was never any problem [...]  It stressed me out because if 
the medication comes out then my CD4 and viral load will be up and I thought ‘Oh my 
God, it’s going to hurt the baby if I’m not taking my medication properly.’ 
(Mehret) 
For others, the presence of side effects was a sign that ART could be harming their 
baby.  Although on the whole women felt reassured by their doctors and midwives who 
emphasised the low risk of toxicity of ART to their baby, many described a residual 
anxiety about the potential for the medication to cause harm.   For them, ART was an 
ambiguous substance with beneficial and toxic properties; a pharmakon173 capable of 
preventing vertical transmission but also of causing damage to their unborn child.  This 
is hardly surprising given that most pregnant women, outside the context of illness, are 
advised to avoid medication and are heightened to the possibility of noxious substances 
that could harm their baby whether it is alcohol, food, or cigarettes174.   
Another theme that emerged was that of experimentation, in that some women felt that 
staff were not certain about drug dosage or efficacy and had to ‘experiment’ to find the 
correct regimen.   This fear is not unfounded given the history of unethical HIV-drug 
trials in pregnancy across Africa in the 1990s (Fassin 2007)175 and that the only licensed 
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 The word pharmaceutical, as highlighted by Derrida (1981), derives from the Greek pharmakon which 
has a dual meaning as both remedy and poison.   
174
 See the recent paper published on behalf of the Royal College of Obstetrics and Gynaecology, which 
warns expectant mothers of the risk of exposure to a host of commonly encountered household chemicals 
(Royal College of Obstetricians and Gynaecologists 2013).  This is discussed in greater detail in Chapter 
Eight.   
175
 Fassin traces the long history of unethical research practice during the HIV epidemic in Africa.  
Specifically in the context of pregnancy, fifteen of sixteen studies investigating the prevention of vertical 
transmission, most funded by the United Sates National Institute of Health but conducted within Sub-
Saharan Africa, used a placebo-group when trialing new agents in pregnancy despite evidence of the 
efficacy of zidovudine in preventing transmission in the landmark ACTG076 trial.  During the same time 
period, studies conducted in North America did not use a placebo arm, instead giving control groups 
zidovudine.  These early studies in Africa deliberately exposed children to the natural risk of HIV 
infection in the quest for achieving results as fast as possible (Fassin 2007: 90).  
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antiretroviral medication in pregnancy is zidovudine176.   The overriding concern for 
most women was that ART would result in physical deformity meaning that foetal 
ultrasound imaging took on particular importance: 
Before I was HIV-positive I never really cared.  I just wanted to look at how the baby 
moved.  But now I read everything in detail.  Normal heart, legs, skin…and I make sure 
that all those parts are normal because now I am more paranoid.  It’s like a 
reassurance that there’s one worry that is taken out.  
(Faith) 
Other authors have charted the rise of foetal ultrasound use in pregnancy and its role in 
constructing a ‘knowable’ pregnant body and reinforcing the clinical gaze (Shaw 
2012)177.  Ultrasound imaging has become the norm during pregnancy in hospital 
settings and is popular among pregnant mothers, partly due to its symbolic association 
with technological modernity and expertise, and also the currency of the visual image in 
contemporary culture (Georges 1996).  For women who have HIV, ultrasound scanning 
carries extra salience; they are exposing their babies to medication that they fear may 
cause physical deformity to their baby.  This (coupled with a constellation of symptoms 
that might be due to pregnancy, to ART, or to HIV), results in women mistrusting their 
own readings of their pregnant bodies.  The combination of HIV, ART and pregnancy 
have rendered their bodies unreliable, laden with symptoms and signs that need to be 
monitored, interpreted and scanned by medical experts.   
We know that the management of chronic illness entails management and “work” 
(Corbin et al. 1985, Sandelowski et al. 2003).  The women in my study engaged in 
antiretroviral work; struggling to take ART in the face of mysterious symptoms, fears 
about toxicity, fears that ART may not be effective and mistrust of their own bodies.  
An ultrasound image of a healthy baby and the safe arrival of their child went some way 
to providing relief but these fears often continued until the final confirmation that their 
baby was HIV-antibody negative at eighteen months of age.  Others remained anxious 
and guilty that illnesses their children developed as they grew older were due to in-utero 
exposure to ART, demonstrating that antiretroviral work is not a time-bounded 
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 There is a global consensus that other antiretroviral medications are safe in pregnancy among HIV 
professionals, however pharmaceutical companies have not obtained licenses for use in pregnancy due to 
logistical difficulties in running clinical trials in pregnant women and cost implications. 
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 Again, these critiques are heavily influenced by the work of Foucault on the development of modern 
medicine and its construction of the body as a site of knowledge and power (Foucault [2003] 1963). 
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phenomenon but a process that extends beyond pregnancy far into motherhood. 
5.6.5 Bare lives 
One of the most pervasive barriers to the uptake of treatment is stigma.  HIV has 
culturally been constructed as a highly stigmatising condition due to its association with 
non-normative sexuality, perceived aberrant behaviour, infectiousness and death.  
Goffman defines stigma as an “attribute that is deeply discrediting” ([1990] 1963).    
My fieldwork revealed that many Western Africans felt that HIV-related stigma was 
more pronounced within their communities than other African communities  
The funny thing in Africa, especially in my country [Guinea], is that when they know 
you have this, even your baby can’t come close to you.  It’s not like in Uganda, or in the 
rest of East Africa, because they know there 80% are in this situation – but in West 
Africa, there are not a lot of people who have it.  So when you have it you can’t have 
anyone that come close to you.  Even your mum, or your brother, or your sister, or your 
kid, no one will come close to you. 
(Mariama) 
HIV-related stigma is a product of cultural, historical and socioeconomic factors.  
Genberg et al (2009) have found an association between lower prevalence of HIV and 
higher levels of stigma and discrimination.  Higher levels of stigma were also reported 
in countries with lower nationwide coverage of ART (Ibid.)
178
.   Lower prevalence 
results in less contact and experience of those living with HIV, and less opportunity to 
develop a sense of normality regarding HIV.  In low prevalence settings HIV may also 
be concentrated in certain minority groups, prompting people to link HIV with 
stigmatising characteristics found within these groups.  Furthermore, the lack of a 
visible ART programme reinforces the belief that HIV is an invariably fatal disease 
(Genberg et al. 2009).  In this context, stigma flourishes
179
.   
HIV often carries no visible stigmata, allowing people to pass as HIV-negative should 
they wish to.  Much work is involved in managing information in order to present an 
                                                             
178
 Of note, the prevalence of HIV in Nigeria was estimated to be 3.7% in 2011 compared with 7.2% in 
Uganda and 17.3% in South Africa.  Country specific estimates obtained from 
http://www.unaids.org/en/regionscountries/countries/ (accessed 23 September 2013).  
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 Two studies each from different regions of Nigeria have highlighted the coupling of HIV and 
pessimistic outcomes and the particular prominence of moralising discourses on HIV, suggesting that this 
is due to a combination of lower prevalence rates (Winskell, et al. 2011) and the widespread influence of 
Evangelical Christianity (most notably Pentecostalism) which constructs HIV as divine punishment for 
sin (Smith 2003). 
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HIV-negative self, thus avoiding a potentially discreditable attribute from becoming 
discrediting.    Coming to hospital for appointments, storing and taking medication and 
possible side-effects of ART (such as rashes) can compromise women’s work in trying 
to pass as HIV-negative.  Their fears about disclosure were well founded given the 
many instances I came across of discrimination, abandonment, and emotional and 
physical abuse.  This work in presenting an HIV-negative self was further complicated 
by structural factors experienced as a result of migration such as inadequate housing, 
which meant that many women were sharing living spaces with family members or 
strangers and had limited space to be able to store and take ART in privacy.   
The daily work of taking ART was even more pronounced for those with insecure 
immigration status180.  We have already seen in the analysis of surveillance data that 
women who arrived in the UK during their pregnancy were at higher risk of not taking 
ART, having a detectable viral load at delivery and transmitting HIV to their baby.  
New migrants are notably under-represented in my fieldwork181, however ten of the 
twenty-four women I interviewed reported that they had insecure immigration status. 
Their experiences are likely to be shared by many women who have recently arrived in 
the UK (who often also have insecure immigration status) and are therefore illustrative.  
Within this group of women, destitution and food insecurity were part of everyday life, 
many of them unable to work due to restrictive immigration policies182.  On an 
instrumental level, lack of food made taking ART very difficult as it resulted in women 
experiencing nausea and abdominal pain.  Women’s lives were dominated by their 
immigration status and the consequential poverty and housing crises that this brought.  
Some had been housed by the National Asylum Support Service183, however this 
accommodation was often temporary and of poor standard.  Others were forced to 
depend on friends, family and sometimes violent partners, setting in motion a chain of 
further vulnerability.  In this context of chronic and extreme material insecurity, HIV 
                                                             
180
 Secure immigration status is defined as being a UK citizen, a recognised refugee or having exceptional 
or indefinite leave to remain. Anyone not in these categories is defined as having insecure immigration 
status. 
181
 I was only able to interview one woman who had arrived in the UK after conception, partly a reflection 
of the general trend towards longer duration of residence at conception (Chapter 4: figure 4.4: 103) and 
also the fact the women who arrived in the UK after conception often  presented late in pregnancy and 
were newly diagnosed with HIV, and therefore not in a position to participate in a study.   
182
 Since 2002 asylum seekers have been denied the right to work unless they have waited for over twelve 
months for an initial decision regarding their asylum application.  People who have been refused asylum 
(after appeal) and those who are in the UK without any documentation have no permission to work 
legally (see http://www.parliament.uk/briefing-papers/SN01908, accessed 22 July 2013). 
183
 The section of the UK Border Agency which is responsible for supporting and housing asylum seekers 
whilst a decision is being made about their asylum application. 
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and ART fall lower and lower in a woman’s “hierarchy of needs” (Maslow 1943)184.  
Their suffering was compounded by fears of compulsory dispersal to other areas of the 
UK and being removed from what little support network they may have, and fears of 
being deported back to Africa where access to ART remains uncertain in many settings.  
Even within the UK, women’s access to ART was far from guaranteed with one woman 
having been sent hospitals bills of over £20,000 for her treatment during pregnancy185.   
Add to this the likelihood that for women who have recently arrived in the UK their 
HIV diagnosis is new, and the situation soon becomes intolerable.  One woman was 
uncompromising in her assessment: 
 the ones with [secure immigration] status live longer than the ones without. 
This complex set of factors that constrain some women’s access to care or uptake of 
ART encapsulates Galtung’s concept of structural violence (1969)186.  The forces of 
poverty, inadequate housing, gender inequality and immigration law combine and 
become embodied by women through disparities in engagement with HIV care (Farmer 
et al. 2006)187.  Building upon Famer’s work on structural violence and HIV, I want turn 
to the Italian philosopher Giorgio Agamben (1998) and his use of the Roman figure of 
law Homo Sacer188.  Political institutions have biopolitical power to create subjects who 
are neither human nor divine, their lives without worth and at risk of being killed with 
impunity (akin to Homo Sacer).  Those who reside in this “zone of indistinction [are] 
between man and beast, nature and culture” (Ibid.: 109)189.  They are reduced to a “bare 
                                                             
184
 This is highlighted by a recent systematic review of housing status and the health of people living with 
HIV (Aidala, et al. 2012). 
185
 This was in direct contravention of UK law, which stipulated that all pregnant women receive free 
HIV treatment as part of “immediately necessary” maternity services to prevent vertical transmission 
(Department of Health 2010).  
186
 In Chapter One I introduced the concept of structural violence as a theoretical frame for this thesis. 
187
 Of interest here is Catherine Kingfisher’s work on the gendering of welfare decline in the West 
(Kingfisher 2002).  Within the contemporary neoliberal economic landscape, those who cannot work and 
participate in the public realm of the marketplace (such as single mothers) are stripped of personhood and 
deemed “normative strangers” (Ibid. 22).  State welfare institutions and discourses surrounding them 
serve to police these boundaries, often reinforcing subjugated positions.   In the same edited volume Ruth 
Lister (Ibid.) traces the emergence of “problem” lone mothers in the UK from the Thatcher-era to the 
New Labour project.  Lister describes lone mothers as a “lightening conductor for a number of political 
concerns centering on family “breakdown”, gendered labor market trends, “welfare dependency”, and 
welfare spending”" (Ibid.: 127).   Post New Labour and in the age of austerity, I would argue that the 
prominent anti-immigrant rhetoric that dominates contemporary British politics is evidence that 
immigrants, especially asylum seekers, have now assumed a similar role.   
188
 The accursed man who may be killed, without the killer being seen as a murderer, but not sacrificed. 
Homo Sacer is a figure that stands apart from society, disinvested of civic rights.   
189
 See also Joao Biehl’s “zones of social abandonment” in his ethnography of Vita, a Brazilian asylum 
for abandoned people which includes those with mental illness, the homeless and those in extreme 
poverty (Biehl 2005).    Vita is  “the end station on the road of poverty; it is the place where living beings 
go when they are no longer considered people” (Ibid.: 2).  State institutions, society and family abdicate 
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life”; a biological life stripped of value and without recourse to political recognition.  
Without the security of British citizenship, some women are subjected to a political 
system that denies them food, shelter, safety and sometimes healthcare.  In this creation 
of “bare lives”, a series of structurally violent acts are enacted that serve as possibly the 
biggest barrier to some African women taking ART.  
5.7 Conclusions 
In this chapter I have used a combination of national surveillance and ethnographic data 
to explore the use of ART by migrant African women in the UK during pregnancy.  The 
findings in this thesis are largely reassuring.  The majority of women take ART during 
pregnancy, with 80% achieving virological suppression by delivery and very few cases 
of vertical transmission each year.  Women are committed to taking ART during 
pregnancy, using it as an important tool in the generation of a positive maternal and 
female identity.  Furthermore, ART’s position within a transnational healthscape where 
biomedicine is popular and widely accessed means that it is not an alien technological 
innovation within African diasporic settings.  Women’s confidence in taking ART is 
further bolstered by their interactions with the HIV antenatal team who deploy “the 
logics of care” (Mol 2008).   
However, taking ART entails struggle for some women, requiring antiretroviral work to 
overcome fears about side effects, toxicity and efficacy.  Women from Western Africa 
appear to be at greater risk of not taking ART during pregnancy than other regional 
groups which may be a product of high levels of HIV-related stigma that operate within 
many African communities, but most notably those from Western Africa.  
The most vulnerable group in terms of taking ART are women who have arrived in the 
UK during pregnancy (many of them who are likely to have insecure immigration 
status).   They were at greatest risk of not taking ART, not achieving virological 
suppression by delivery and transmitting HIV to their infants, although again the vast 
majority of women in this group had good clinical outcomes.  Without UK citizenship, 
some of these women are exposed to multiple structurally violent acts, rendering their 
lives “bare”, marked by indigence, fear and lack of political recognition.  Through the 
resulting disparity in their capacity to take ART, an important minority of African 
women living with HIV (and their unborn infants) come to embody structural violence.  
                                                                                                                                                                                  
responsibility for those placed in Vita, who are stripped of personhood and thereby subjected to extreme 
physical and psychological neglect and trauma.   
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Key points 
 Between 2000 and 2010 over 95% of pregnant women in the UK diagnosed with 
HIV received ART; 80% achieved virological suppression by delivery and the 
rate of vertical transmission was approximately 1%. 
 The use of ART was, in part, facilitated by women’s strong desire to take ART 
to achieve culturally sanctioned roles as mothers and good relationships with 
HIV antenatal specialist teams characterised by "care". 
 Women from Western Africa were more likely than other regional groups not to 
receive ART during pregnancy, although the proportion remained small (3.6%).  
This may be partly due to high levels of HIV-related stigma within Western 
African communities.    
 Women who had arrived in the UK during their pregnancy (who were also likely 
to have had insecure immigration status) were the most vulnerable group in 
terms of use of ART. For some of these women, lack of UK citizenship may 
manifest as extreme social and economic marginalisation, impacting adversely 
on their use of ART. 
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6  
      
Pentecostalism and divine healing among  
African migrants living in London 
 
 
Summary 
Religion, especially Pentecostal Christianity, was described by many women during 
interviews as an important resource in managing HIV, whilst at the same time being 
cited by professionals as a potential barrier to engagement with HIV care.  In this 
qualitative chapter I draw upon data from ethnographic fieldwork in a diasporic 
Nigerian church in London and interviews with pregnant women living with HIV 
attending NHS clinics to explore the role of Pentecostalism in managing illness, placing 
it in a broader cosmological framework of spiritual misfortune.  I explore how these 
beliefs function to mediate suffering and examine the factors that underpin the 
popularity of new Pentecostal movements among migrant African communities in 
London.  I then describe the nature of Pentecostal beliefs surrounding illness, with 
specific reference to HIV, before considering whether they act as barrier to engagement 
with HIV services and interventions.  
6.1 Introduction        
At the edges of the city, in a sprawling industrial state just off the dual carriageway, 
stood a non-descript red-bricked building with a tall corrugated iron roof.  The building 
itself looked run-down, with flaking paint and woodwork discoloured by mould.  The 
dilapidation was offset by large gold lettering spelling “T.C.P.M” on the front of the 
building.  To the side of this hung a banner inviting people to “Experience the greatness 
of God’s power”. 
Within half an hour a stream of people began to file into the back of the building.  A 
man behind me tapped me on the shoulder, asking me how I was and explaining that 
this was his first time here.  “Me too”, I said, as he turned to greet a friend.  He 
explained that he used to go to a different church but that he had heard that this place 
was different.  This church was “bringing miracles”.  “Yes”, said his friend, “This is 
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where to be”. 
(Entry from my field diary, 27 July 2011: 3) 
In Chapter Five I explored the use of ART during pregnancy by African women living 
with HIV in the UK.  This mixed methods analysis demonstrated high uptake of ART, a 
good rate of virological suppression and very few cases of vertical transmission, mainly 
facilitated by good relationships with staff and women’s desire to safeguard the health 
of their babies.   Looking at differences between groups of African women, analysis of 
NSHPC data revealed that women from Western Africa were less likely to receive ART 
in pregnancy, although absolute numbers were very small.  My own clinical experience, 
coupled with discussions with colleagues over several years, had suggested that 
Western African women were a particularly difficult group of patients to engage with 
HIV services and interventions such as ART.   In the previous chapter I discussed the 
role of high levels of HIV-related stigma within Western African communities as a 
barrier to the use of ART.   Another barrier commonly cited by healthcare and charity 
professionals during my fieldwork and my clinical work was the perceived widespread 
belief in divine healing.  This was closely identified with African diasporic Pentecostal 
churches and seen as most pronounced among patients from West Africa.  Initial 
findings from a study recently undertaken by the African Health Policy network190 have 
highlighted the prevalence of claims of “faith healing” in some churches across the UK 
(Stevenson et al. 2013). This has been set against a background of growing media 
interest in divine healing and HIV.  During my fieldwork two national news channels 
reported cases of HIV-related deaths attributed to advice from pastors at a London-
based Pentecostal ministry who were alleged to have made claims about curing HIV 
through prayer alone191.  Furthermore, concerns have been raised about broadcasts by 
“miraculous signs and wonders ministries” on religious satellite channels in which 
people are claimed to have been “healed” of cancer and HIV.  This has resulted in the 
broadcast regulator Ofcom subjecting some television channels to disciplinary 
                                                             
190
 The African Health Policy Network is a UK-based policy organisation addressing the health and well-
being needs of Africans in the UK.  
191
 See reports by BBC News London on alleged deaths attributed to the practice of faith healing at the 
Synagogue, Church of All Nation (SCOAN) by BBC News London on 18 October 2011 
http://www.bbc.co.uk/news/uk-england-london-14406818 (accessed 23 September 2013) and Sky News 
on 26 November 2011 http://news.sky.com/story/903211/faith-healing-and-hiv-shatilas-story (accessed 
23 September 2013).  As recently as 16 August 2013, BBC News UK were reporting incidences in the 
UK of young people living with HIV in London and breastfeeding HIV-positive mothers who were 
declining ART in favour of faith healing http://www.bbc.co.uk/news/uk-23729684 (accessed 23 
September 2013).   Similar media interest has been shown by the media in the United States with a 
recently published article on Pentecostal and faith healing in the context of HIV leading to cessation of 
ART (Lahey 2013). 
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proceedings and a directive that all future claims about divine healing are accompanied 
by encouragement to seek medical advice192.   
Previous studies in London have shown that Africans living with HIV are largely 
religious (Ridge et al. 2008, Fakoya et al. 2012), the majority from non-Catholic 
Christian denominations with almost one in three people stating a belief that faith alone 
could “cure” HIV (Fakoya et al. 2012).  Twenty-two of the twenty-four women I 
interviewed during my study described themselves as religious, mainly Christian 
(twenty); of whom ten were Pentecostal.  Many women described the importance of 
their faith in managing life with HIV and references to “miraculous cures” were 
common.  Some commented on the particular importance of Pentecostal faith in 
Western Africa, with one Nigerian woman remarking that Nigerians were very 
“superstitious” and “put all their hopes in God” to “heal them”.    Most work to date has 
demonstrated that religion plays an important role in the lives of those living with 
HIV193, serving as a coping resource rather than a barrier to engagement with 
services194.  However, there is evidence that that the role religion in the lives of Africans 
living with HIV in the UK is complex and contradictory with moralising discourse 
about HIV in church settings sometimes leading to discrimination and internalised 
feelings of shame (Chinouya et al. 2005, Doyal et al. 2005). 
Bar some notable exceptions  (van Dijk 1997, Hunt et al. 2001, Hunt 2002, Adogame 
2004, Harris 2006), Pentecostalism in African migrant populations in resource-rich 
countries remains a relatively overlooked area of study. Work in this area has tended to 
focus on material culture such as the use of anointing oils (Botticello 2009), ritual and 
belief (Adogame 2004, Harris 2006), or the role of churches in forging diasporic 
identities (Hunt 2001, van Dijk 1997).  The construction of health and illness within 
Pentecostal cultures has not been explored in great detail.  Adogame (2007) remains the 
only scholar to have explored the role of African Pentecostal churches in confronting 
HIV, although this ethnographic research was conducted mainly within Nigeria rather 
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 See the press statement by a church organisation that attended this meeting, which highlights the 
tensions between the right to religious expression and the need to meet UK broadcasting standard 
http://www.cte.org.uk/Articles/353604/Churches_Together_in/News_Events/News/Black_Church_leader
s.aspx (accessed 16 September 2013).   
193
 Religion has been shown to improve wellbeing in those living with HIV (Ridge, et al. 2008) and 
reduced levels of depression and anxiety (Polzer Casarez, et al. 2008, Braxton, et al. 2007). 
194
 Quantitative work conducted in London have not demonstrated an association between religiousness, 
and uptake of or adherence to ART (Tariq, et al. 2010, Fakoya, et al. 2012). 
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than focusing on the diaspora itself195.      
In summary there is a dearth of work exploring the day-to-day lives of migrant Africans 
living with HIV, especially within a UK setting, despite growing concerns amongst 
healthcare and charity professionals about the impact of divine healing on engagement 
with HIV care especially among Western Africans.   Media representations of divine 
healing in the context of HIV in the UK have tended to portray churches as exploitative 
and believers as irrational, conforming to a wider pattern of “media sensationalisation” 
that trades on “exoticised images of African and African-derived religions” (Adogame 
2004: 515).  Influenced by the work of Dan Sperber, I seek to engage with these 
“apparently irrational beliefs” (1985: 37)196.   
In this chapter I present the first study within the UK to specifically explore the role of 
Pentecostal faith in the lives of migrant Africans living with HIV.  I wish to challenge 
dominant stereotypes about churches such as TCPM within healthcare settings and the 
mainstream British media, highlighting both the benefits and challenges it presents to 
those living with HIV and those involved in their care.  I draw primarily upon material 
gathered during six weeks of fieldwork between July and September 2011 at the 
Triumph of Christ Pentecostal Ministry (TCPM)197, a Nigerian Pentecostal church on 
the outskirts of London, during which I regularly attended church services and extended 
prayer vigils.  My analysis is supplemented by data from in-depth interviews with two 
members of TCPM’s congregation and a content analysis of literature published by the 
church.  I also refer to findings from my qualitative interviews with pregnant African 
women living with HIV attending NHS clinics.   
Firstly I describe Pentecostal cosmology as exemplified by the TCPM in order to situate 
beliefs about illness (including HIV) within a broader cosmological framework that 
                                                             
195In his work on the Redeemed Christian Church of God (RCCG), one of the most successfully 
globalised Pentecostal churches in the world, Adogame explores how misfortune is addressed through the 
notion of spiritual warfare in which adherents are implored to counter demonic attacks on a wide variety 
of ills such as sickness, (including HIV), poverty and infertility through a rich constellation of religious 
practices.   Although, Adogame recognises the challenges presented by the RCCG’s claims to cure those 
living with HIV, he is careful to emphasise how the narrative of healing engenders hope and allows 
people to cope with a highly stigmatised condition, thereby performing “ important religious, social and 
therapeutic […] functions” (Adogame 2007: 482).  
196An invitation to slay a dragon during his own fieldwork in Ethiopia prompts Sperber to explore 
“apparently irrational beliefs”.  He rejects intellectualist approaches that view irrational beliefs as 
mistaken and resulting from a lack of information or understanding, and symbolist approaches that posit a 
non-literal meaning.  Importantly, Sperber also critiques the classical anthropological position of 
cognitive relativism in which all beliefs are valid in their own cultural context, arguing that it has little 
theoretical and empirical basis in cognitive psychology.   Instead he explores the cognitive role of this 
form of thinking in processing abstract open-ended concepts.  
197
 Throughout this thesis I use a pseudonym to protect the identity of this church. 
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addresses misfortune.   I then discuss the factors that underpin the popularity of new 
Pentecostal movements among migrant African groups in London and explore how 
Pentecostal beliefs function to mediate suffering.  The exploration of both broader 
Pentecostal cosmology and factors in Pentecostalism’s widespread appeal among 
African migrants is critical to understanding the role of Pentecostalism in the lives of 
people living with HIV and challenging any preconceptions of their irrationality.    I 
conclude by considering whether Pentecostal beliefs serve as a barrier to engagement 
with HIV services and interventions.  
6.2 Overview of Pentecostalism 
In a review of the globalisation of Pentecostal Christianity, the anthropologist Joel 
Robbins writes that “there is little standardization in social scientific usages of terms 
such as Pentecostal and charismatic” (Robbins 2004: 119).  The taxonomy of this 
variant of Christianity is complex and shifting, and many terms used by scholars also 
have widespread lay usage that are specific to local contexts (Robbins 2004, Anderson 
2010).  However, it is possible to identify certain core features shared by many of these 
churches, allowing us to use the term “Pentecostalism” heuristically whilst recognising 
the diversity of churches that it may encompass (Robbins 2004, Anderson 2010).  In 
this chapter, I use Pentecostalism to refer to the form of Christianity in which believers 
emphasise a direct personal experience of God, founded upon baptism in the Holy Spirit 
by which spiritual gifts (charisms), such as speaking in tongues (glossolalia), healing 
and prophesising are bestowed upon adherents198.   It is this “shared emphasis on 
ecstatic experiences that are available to all believers” that Robbins states characterises 
Pentecostalism (2004: 122). 
The roots of contemporary Pentecostalism lie in eighteenth century Protestant 
Evangelism in the UK and North America and its emphasis on religious conversion and 
a highly emotionally-charged style of preaching (Kay 2011), although it is the 
Charismatic revivals in the early twentieth century that are the main antecedents of 
                                                             
198
 It is beyond the scope of this chapter to review the theological underpinning of Pentecostalism.  The 
term is derived from the Day of the Pentecost and it is founded upon a literal interpretation of the Bible 
with particular emphasis on the Acts of the Apostles in the New Testament and passages describing the 
supernatural manifestations of the Holy Spirit (Kay 2011).  These passages describe collective 
experiences of the Holy Spirit which are egalitarian and available to all culminating in glossolalia,, a 
powerful demonstration of the Holy Spirit’s overwhelming capacity to empower believers to achieve 
things that they could not previously do. Other key passages in the New Testament relate to divine 
healing, prophecy and the importance of proselytising.   
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contemporary Pentecostalism199.  Pentecostalism (and similar Charismatic Christian 
movements), with its focus on missionary work and emphasis on spiritual power, was 
particularly successful during colonial expansion in Africa in the nineteenth century, 
leading to the establishment of many African churches of this tradition.  
Pentecostalism’s engagement with a spiritual realm, divine healing and relative lack of 
formal liturgy were consonant with many pre-existing African religious modes of 
worship (Anderson 2001, Harris 2006, Kay 2011).  At the turn of the twentieth century, 
nascent desires for self-expression amongst many Africans led to a breakaway from 
traditional European missionary churches and the formation of African Independent 
Churches (AICs) with African leadership and the incorporation of older African 
religious elements to a greater or lesser extent (Anderson 2001)200.   
Since the 1970s a new type of Pentecostalism has gained popularity in Africa, 
especially Western Africa201.  These new churches deliberately set themselves apart 
from AICs, instead taking their inspiration from Euro-American Pentecostal leaders and 
their liturgical style (Meyer 1998b).  These churches predominantly appeal to a young 
and aspirational burgeoning African middle class and promulgate individualism, 
professionalism and an intertwining of spiritual and economic success, together known 
as the “Prosperity Gospel” (van Dijk 1997).  Often headed up by intensely charismatic 
leaders with flamboyant displays of wealth, material success is perceived as a 
manifestation of God’s power and favour.  These new Pentecostal churches, many 
originating in Africa with headquarters based in enormous megachurches202, have a 
                                                             
199
 In the late 19th century, the Holiness movement within Methodism began to develop a form of 
religious practice that emphasised the supernatural and experiential aspects of Christianity, in particular 
faith healing and speaking in tongues.    At the turn of the twentieth century, a series of seemingly 
unconnected religious revivals appeared to spring up around the world.  One of the most important was 
the Asuza Street revival (1906-1909) led by William Seymour, an African-American son of slaves.   
From the outset, the Asuza Street revival was noted for its racial, gender and social class mixing.  It was 
characterised by intensely enthusiastic worship, accompanied by singing, clapping and public testimonies 
which themselves are likely to have had roots in African-American slave religions.  This style of worship 
and the emphasis on religious phenomena such as glossolalia and divine healing has been a major 
influence on contemporary Pentecostalism.   It also influenced more historically mainstream Christian 
denominations, leading to the development of Charismatic Movements within Catholicism and 
Anglicanism in the 1960s (Robbins 2004, Kay 2011). 
200
 Many of these churches such as Spirit Churches in Ghana and Aladura  in Nigeria emphasise spiritual 
power and manifestations of the Holy Spirit.  See Meyer (2004) for a detailed overview of the history of 
Pentecostal movements in African and the transition from AICs to contemporary Pentecostalism. 
201
 Hunt and Lightly, in their ethnography of an RCCG church in West London, describe the broader 
social and economic conditions that favoured the rapid growth of modern Pentecostal churches in Nigeria.  
Churches espousing material success, individualism and hard work flourished in the 1980s following 
widespread state corruption, the collapse of Nigeria’s oil economy and the subsequent state Structural 
Adjustment Programme which resulted in severe economic hardship throughout the country (2001). 
202
 Such as the Redeemed Christian Church of God’s Redemption Camp in Lagos (see 
http://rccg.org/index.php/about-us-2/history/, accessed 14 August 2013) and the Winners’ Chapel’s Faith 
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strongly international outlook (van Dijk 1997, Coleman 2000) seeing the global stage as 
an opportunity to evangelise and successfully establishing ministries all over the world.    
The rapid growth of this new form of African Pentecostalism in the past forty years has 
been fuelled by neoliberalism, technological innovation, mass-media and the 
widespread globalised social imaginary (Meyer 2010)203.  Furthermore, 
Pentecostalism’s relative lack of fixed doctrine, its egalitarianism and its operation 
outside of a centralised religious structure, gives it an inherent flexibility to adapt to 
local contexts whilst maintaining a global identity.  
In 2005 it was estimated that there were just under one million Pentecostal Christians in 
the UK attending approximately 2200 Pentecostal churches with increasing attendances 
especially by people from minority ethnic groups204 (Evangelical Alliance UK 2008).  It 
is hard to know with accuracy how many Pentecostal churches of African origin exist in 
London in 2013. The Redeemed Christian Church of God (RCCG) has over 100 
branches in London alone205.  What is certain is that the Pentecostal landscape in 
London is composed of a rapidly evolving constellation of churches from different 
traditions, albeit sharing some of the core Charismatic features described earlier, 
ranging from older Charismatic and AICs to the newer Pentecostal churches either 
founded in Africa or in the UK and attracting mainly African adherents.  
6.3 The Triumph of Christ Pentecostal Ministry 
6.3.1 Overview of the Triumph of Christ Pentecostal Ministry 
The Triumph of Christ Pentecostal Ministry (TCPM) was founded in 2005 and is a 
relatively new church compared to more established and well known ministries in the 
UK such as the RCCG and the Winner’s Chapel, both of which were founded in Nigeria 
before establishing branches internationally.  In contrast the TCPM, like the London-
based Kingsway International Christian Centre (KICC) before it206, was founded in 
                                                                                                                                                                                  
Tabernacle in Ogun State also in Western Nigeria  (see http://domi.org.ng/aboutus/timeline, accessed 14 
August 2013), both of which are able to accommodate over 100,000 worshippers. 
203
 The notion of the social imaginary was developed by Charles Taylor who describes it as “the way 
ordinary people “imagine” their social surroundings. […] it is often carried in images, stories, and legends 
[…] the social imaginary is the common understanding that makes possible common practices and a 
widely shared sense of legitimacy” (2002: 106). 
204
 Information obtained from English Church Census 2005 available at 
http://www.eauk.org/church/research-and-statistics/english-church-census.cfm, accessed 26 September 
2013. 
205
 See the RCCG website for further details of the church at www.rccg.org. 
206
 See the KICC website for further information on the church at http://www.kicc.org.uk. 
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London, primarily attracting adherents from the West African diaspora207.  The TCPM 
belongs to the new movement of Pentecostal churches as outlined earlier.  It has few 
ties to older, more Africanist churches, instead borrowing its style heavily from 
contemporary American evangelical Christianity.  It has an explicitly international 
orientation, reflected by its satellite broadcasting of church services and organisation of 
international conferences, and a focus on the Prosperity Gospel espousing material, 
physical and spiritual success.  Furthermore it presents itself as a place of contemporary 
worship, adopting digital technology such as downloadable church literature for e-
readers and apps for smart phones, thus appealing to a young, mobile and aspirational 
audience.   
The TCPM, like other similar churches, was founded outside a traditional ecclesiastical 
structure by one man, Pastor Emmanuel208.  The story of Pastor Emmanuel’s conversion 
to Pentecostalism and the subsequent creation of the ministry is a core part of TCPM’s 
identity, with fragments of the story recounted in church literature, on its website and 
during sermons.  His conversion narrative follows a conventional format found within 
Pentecostalism as described by Coleman in his study of Swedish Pentecostals (2000).  
Interestingly, it most closely resembles that of David Oyedepo, the founder of the 
Winner’s Chapel who is widely regarded as one of the most successful Pentecostal 
pastors in Nigeria with a huge international ministry and an estimated net worth of $150 
million (Nsehe 2011)209.  Pastor Emmanuel’s conversion narrative involves a failed 
migration project resulting in financial loss and family dishonour on his return to 
Nigeria, followed by a “vision” from the Holy Spirit prophesising the creation of a new 
ministry in London.  This was accompanied by other “spiritual gifts” including the 
power to heal210, leading ultimately to great success in the form of marriage, children 
and the founding of his own ministry.  The Pastor’s conversion narrative highlights key 
preoccupations within the congregation of TCPM in London: failed migration projects 
(van Dijk 1997); the struggle for material wealth; healing from sickness; and marriage 
and reproduction.  Furthermore, it encapsulates Pentecostal cosmology, foregrounding 
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 The predominance of African adherents within these churches is well-recognised.  For instance, Hunt 
describes the ethnic composition of the RCCG church in which he conducted fieldwork as 96% 
“African”, with 90% describing themselves as “Nigerian” (Hunt et al. 2001).  
208
 All names are pseudonymised. 
209
 Oyedepo founded his ministry in 1981when suffering similar economic misfortune and describes 
conversion after receiving “visions” from the Holy Spirit imploring him to “liberate the world from all 
oppression of the devil through the preaching of faith”.  Spiritual discourse and preaching style within the 
TCPM echoes that of Oyedepo’s.  See http://www.davidoyedepoministries.org (accessed 23 February 
2013). 
210
 In his biography in church literature, Pastor Emmanuel makes specific reference to an occasion when 
he “resurrected” a man who had died of an HIV-related illness.  
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the power of the Holy Spirit to bestow supernatural gifts such as visions and healing.     
Since its foundation in 2005 the TCPM has grown into a national ministry with four 
branches throughout the UK including two in London, and claims on its website to be  
one of the fastest growing churches in Europe.   It has a successful business portfolio 
comprising shops, religious conference organisation, and most importantly a media 
empire that includes print publication of church literature, television and radio studios, 
and a satellite television channel hosting broadcasts from other ministries 
internationally.  These businesses provide an important stream of income supplementing 
tithes, financial contributions from the congregation that are viewed as a Biblical 
requirement211.  The TCPM’s broadcast media arm allows it to position itself 
successfully within the global mediascape (Appadurai 1996).  It is able to extend its 
evangelising beyond the confines of its churches and transcend national boundaries, 
allowing it to pursue its mission of becoming an international ministry.  The 
broadcasting of church services has been a successful strategy in that many members of 
TCPM’s congregation were drawn to the church from a wide area in South East 
England, often at the expense of other churches, after watching broadcasts of healing 
services that established its reputation as a place where “miracles happen”212.   
6.3.2 The Triumph of Christ Pentecostal Ministry, Greater London  
The work I present in this chapter is based on fieldwork conducted in the TCPM’s 
oldest and largest congregation attracting up to four hundred members to weekday 
services and over a thousand at weekends and twice-monthly night vigils.  The 
congregation is based in TCPM’s main headquarters occupying several sites on an 
industrial estate on the outskirts of London. The TCPM occupies several buildings in 
the area, two of which are used for church services.  Both church spaces were formerly 
secular spaces that have been sacralised by the church; one a former sports hall in which 
daily services are held, and the other a large office block that is the site of the hugely 
popular Sunday services and all night vigil213 .   Neither of the TCPM’s church spaces 
were purpose-built for religious use, and both eschew the ornamentation that is 
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 This model of expansion, although unusual within more established denominations of Christianity, is 
not unusual within the new wave of Pentecostalism, and echoes that of Sweden’s Word of Life church 
(Coleman 2000). 
212
 This is in contrast to membership of the RCCG, which is often forged through existing networks of 
family, friends and acquaintances (Hunt 2002).   
213
 The sacralisation of urban space is not uncommon within the new wave of Pentecostalism and is 
sometimes met with hostility such as the local protests launched in South London against the KICC’s 
purchase of a former bingo hall for religious use (Lidbetter 2009). 
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commonly found in churches of other Christian denominations (figure 6.1).  The church 
interiors are large, sparsely furnished and functional spaces, able to accommodate 
hundreds and even thousands of attendees (figure 6.2).  The focal point is the stage on 
which services are delivered, which are surrounded by broadcast technology including 
camera rigs, large plasma-screens, speakers and microphones, a reminder of the vital 
role played by broadcast media in the constitution of new Pentecostal churches’ identity 
and mode of worship (Coleman 2000, Meyer 2006). 
The church operates one-to-one counselling with the Pastor, a Bible study group, a 
women’s group, a men’s group, a group for single people, a children’s group and a 
welfare department designed to provide practical support to those requiring financial or 
legal assistance.  However, its focal point is the daily deliverance services that last up to 
four hours, with longer services on weekends and fortnightly night vigils. Most church 
services are conducted by Pastor Emmanuel who is described in the church’s literature 
as “endowed by God with an unusual anointing for healing, miracles, extraordinary 
breakthroughs and deliverance”214.  Services follow a predictable format, typical of 
many churches of this kind, with prayers (often in tongues), followed by gospel songs 
by the church choir and then a sermon by Pastor Emmanuel that often focuses upon 
“miracles, signs and wonders”.  The services conclude with an invitation to members of 
the congregation to come forward for anointing with blessed oil or healing by the 
Pastor.    
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 A direct quote from the Pastor’s biography that is printed on the cover of TCPM magazines. 
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Figure 6.1: The Triumph of Christ Pentecostal Ministry Greater London, small church 
hall* 
 
 
Figure 6.2: The Triumph of Christ Pentecostal Ministry Greater London, interior of small 
church hall* 
 
*All photographs taken by Shema Tariq, September 2011 
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6.4 Cosmology of the Triumph of Christ Pentecostal Ministry  
6.4.1  Spiritual realm 
The world as conceived by TCPM, like other Pentecostal churches, is populated by a 
panoply of unseen spiritual forces (Meyer 1998a, Adogame 2004, Harris 2006): 
“It is impossible for us to see spirit beings.  They are like the wind; present but cannot 
be seen.  We only feel the wind and destruction it causes […] why am I talking about 
satanic beings?  Firstly because they are the ones that are responsible for our captivity 
and secondly because we need to subdue them in order for us to be delivered.” 
(Extract from TCPM publication on deliverance, 2009) 
The Pentecostal spiritual realm differs from that of other Christian denominations in its 
emphasis on carefully elaborated demonic forces as well as the more familiar divine 
entities such as God, Jesus and the Holy Spirit.  This explicit acknowledgement and 
engagement with the spiritual realm has been described as consonant with indigenous 
beliefs in a variety of settings in African and the diaspora215 and is an important factor 
in the success of many Pentecostal and Charismatic churches.  For instance, Engelke 
describes the widespread beliefs in evil spirits and use of n’angas (traditional healers) 
by weChishnu Masowe Apostolics216 in Zimbabwe.  As a result, local churches that 
reflect the reality of evil spirits are viewed more favourably than mission churches, 
which often deny their existence: 
“The problem with foreign churches – by which the weChishnu mean mission churches 
which have refused to recognize African culture – is that they deny the existence of 
spirit mediums, witches, avenging spirits and the like […] Foreign churches cannot 
address the spiritual problems of Africans because they deny the roots of such 
problems.” 
(Engelke 2004: 93) 
The TCPM typifies Pentecostal churches in its construction of a universe populated by 
                                                             
215
 Harris in her ethnography of a Yoruba Aladura church discusses the overlap between Yoruba notions 
of spiritual power and interlinked spirit and material worlds (2006).  Both Engleke in his work with 
Apostolics in Zimbabwe (2004) and Meyer in her work with Ghanaian Pentecostalists (1998) highlight 
the importance of the recognition by churches of indigenous belief systems that centre on evil spirits.   
216
 The Apostolic church is a prominent Pentecostal church in South Africa, Zimbabwe and parts of 
Central Africa.   
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the divine forces of God and malevolent spiritual agents, which are recast as agents of 
the Devil.  This construction of a dual cosmological space comprising interpenetrating 
spiritual and material worlds (Adogame 2004) allows for the possibility that ritual 
action appealing to forces within the spiritual realm will enact transformation in the 
material world:   
“By the authority of Jesus Christ you can end your troubles.  All it will take is your faith 
and your tongue.  Stand up and charged with faith, command the thorns in your flesh to 
burn to ashes […] You will be amazed how easily these thorns will listen to your voice 
of faith.” 
(extract from TCPM publication on deliverance, 2009) 
However, the relationship between the TCPM and indigenous belief systems is 
complex.  It cautions against “being enticed by evil powers” in seeking solutions from 
“palmistry, astrology and sorcery”217, warning that “if you ever gain from evil powers, 
you become an evil person yourself”.  On the other hand, traditional preoccupations of 
diviners and healers such as curses brought on by kin218, have been appropriated, 
diabolised and subjected to the power of God: 
“In the name of Jesus, I command you 
Every chain will be broken, 
In the name of Jesus 
Every curse from my family, from my wife, from my village, from my farm, 
I renounce you. 
Family curses, parental curses, ancestral curses, generational curses, spiritual curses, 
I destroy you in the name of Jesus.” 
(Extract of TCPM prayer, 30 August 2011) 
In this TCPM prayer, curses that would be familiar to many in TCPM’s congregation 
are reframed as the work of Satan, with the past acknowledged as having the power to 
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 See also Meyer (1998) on Ghanaian Pentecostal churches’ demonisation of traditional religions, which 
are accused of occult practices. 
218
 See Auslander on Ngoni witchfinding in Zambia where mothers and grandmothers were accused of 
destroying both biological and socioeconomic reproduction  (1993).  Also see Whyte’s accounts of 
divination in Eastern Uganda, which predominantly focus upon relatives as agents of misfortune (1997). 
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create disturbance in the present219.   
The spiritual world therefore has a tangible presence within the lives of those at TCPM.  
Demonic forces are believed to be “universal beings; they are not restricted to a 
particular place on the face of the earth” (extract from TCPM publication on 
deliverance, 2009).  They have “a mandate to perpetuate evil” (ibid.) and are seen as the 
cause of all personal misfortune:   
“The children you never had, the husband that proved elusive all through your fruitful 
years, the promotion that never came, the job and education that never came, the house 
that was repossessed, the salary that was denied you etc. could have been stolen and 
kept from you by the devil.” 
(Extract from TCPM publication on deliverance, 2009) 220 
The reach of these demonic forces extends far beyond the private sphere with Pastors at 
the TCPM accusing the Devil of being the “puppet-master” behind youth knife crime in 
London and on the global stage of being the cause of a reported ambush on American 
troops in Afghanistan by the Taliban, describing their subsequent escape as a “miracle” 
of God. The Pentecostal world is therefore a polarised one, set up as a battle between 
good and evil spiritual forces on a global scale.  Similarly to rhetoric described within 
the RCCG (Hunt 2001, Adogame 2007)221, motifs of warfare abound within the TCPM.  
Militarised language is a core feature of services as the congregation are urged to “enter 
into spiritual warfare” with “spiritual invisible bullets” using “power”, “force” and “the 
word of God as a sword to fight demons and make them bleed in the spiritual realm”, 
with explicit parallels drawn between this spiritual war and the physical battlegrounds 
in contemporary conflicts (extract from TCPM publication on deliverance, 2009).   This 
is a totalising system of meaning in which all misfortune is ascribed to supernatural 
causes, and where good fortune is especially vulnerable to attack. The onus is on each 
member of TCPM to use the Lord as a “shield” to protect themselves from evil spirits, 
and to engage in a range of rituals in order to “keep their miracle”, whether that be 
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 Meyer discusses Pentecostal attitudes towards the “past” in her work on Ghanaian Pentecostalists 
(1998).  Deliverance is preoccupied with securing freedom from the influence of both the immediate past 
and an individual’s “sins”, and their “ancestral past” through which they are punished for sins committed 
by previous generations.   
220
 The prominence of concerns regarding marriage, fertility and career success have been described 
among Pentecostals in London (Hunt 2002) and Zimbabwe (Engelke 2004).   
221
 The idiom of spiritual warfare is common across Pentecostalism.  See Csordas’ description of 
deliverance rituals within Charismatic Renewal Movement in the United States (1997).   
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health, employment, marriage, fertility or immigration papers222.    
6.4.2 Deliverance 
A key ritual practice through which spiritual warfare is enacted is deliverance, which is 
described as: 
“…freedom or liberty or redemption […] When it is said that somebody needs 
‘deliverance’, it means by implication that the person in question is not free.  He or she 
may be in bondage or in captivity against his or her wish.  It implies also that captives 
or victims of bondage are not able to free themselves from the grip of their captors, even 
though they may be desperately willing to be set free.” 
(extract from TCPM publication on deliverance, 2009) 
Church services are filled with references to bondage and the severing of ties, with the 
congregation regularly asked to physically enact the “chopping” of the spiritual chains 
that bind them.  Deliverance occurs spontaneously within church services or through the 
laying on of hands by the Pastors, and through one-to-one counselling sessions with 
Pastors.  It also requires commitment outside the confines of the church with fasting and 
intense prayer “delivering” individuals from the influence of “satanic beings” that are 
responsible for this “captivity”.  Through these ritual acts individuals can achieve 
deliverance, thereby freeing themselves from the malevolent influence of the Devil on 
their lives in order to “possess [their] miracle”.  However, deliverance is not an isolated 
event in an adherent’s religious life. Rather, it is an enduring practice in which people 
actively participate to secure their freedom amidst the constant threat of evil spirits, 
recalling Csordas’ notion of “incremental efficacy” (Csordas 1997: 72)223.   The world 
as constructed by TCPM, as is the case in other Pentecostal churches, is inherently 
threatening, populated by unseen “enemies” who will continually try and “steal” your 
destiny (extract from TCPM publication on deliverance, 2009).  Safeguarding 
deliverance therefore places great demands on adherents, requiring lengthy attendances 
at church services several times a week and incurring significant financial costs in the 
form of regular tithes, travel costs and the repeated purchase of religious material such 
                                                             
222
 These were the most commonly cited issues in TCPM services, literature and promotional material. 
223
 Csordas describes ritual healing among adherents to the Charismatic Renewal Movement in the US as 
unfolding over time.  He states that “miracles of spontaneous and total healing” are rare and that healing 
mainly occurs through consistent engagement with the healing process, including in daily practice outside 
the confines of formalised ritual.  For Csordas, this is a product of Charismatic healing’s mode of action 
which is to transform the self, a process that is fundamentally indeterminate and open-ended (1997: 72).   
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as church publications and ritual objects224. 
6.4.3 Power of the Word 
A central component of deliverance and religious practice more broadly at TCPM is the 
Word of God225.   The Word of God is central in TCPM church services.  The sparsely 
decorated church interior (figure 6.2) reflects the rejection of external stimuli in favour 
of the development of a close personal relationship with God through words in the form 
of intense prayer.  As described earlier, the most prominent feature in the church halls is 
the array of broadcast technology, designed to amplify and transmit God’s Word to the 
congregation and beyond.  Biblical readings, highly charismatic preaching and 
“testimonies” (personal accounts of deliverance relayed by members to the 
congregation) dominate church services and are used to effect transformation in 
people’s lives.  This is exemplified by the range of “Action Prayers” at the TCPM 
which are thought to be especially “powerful prayer points” to be used to secure 
success: 
“With my tongue, I clear every obstacle on my way in Jesus name. 
With my tongue, I clear every barrier against my increase in Jesus name. 
My tongue is anointed to rule therefore I say that I rule over my enemies in the mighty 
name of Jesus Christ.” 
(Extract from TCPM publication on the power of words, 2009) 
An important manifestation of God’s Word within the TCPM is glossolalia  (speaking in 
tongues).  It is a core feature of Charismatic and Pentecostal churches and is defined by 
Virginia Hine in her seminal paper on glossolalia as “a form of unintelligible 
vocalization which has non-semantic meaning to the speaker, and is interpreted in the 
Bible as a divinely inspired spiritual gift” (1969: 211)226.  Initially appearing chaotic 
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 For example at TCPM commonly used objects were prayer cloths, blessed oil and blessed cordial.   
225
 Csordas also highlights the importance of ritual language in the Charismatic Renewal (prophecy, 
prayer, teaching and through sharing of religious experience) which are a “rhetorical means of ordering 
experience and directing attention” and words with highly specific religious meaning which “play a role 
in orientational self-processes [anticipating] the situational consequences of participants’’ actions and 
[implying] strategies for action” (1997: 22).  Engelke’s work with the weChishnu Masowe Apostolics in 
Zimbabwe also identifies the central role of the spoken word in forging a connection to God.  However it 
is a church that prides itself, in its own words, as being “the Christians who don’t read the Bible”, instead 
drawing upon performative religious language which “collapses the distance between God and the 
congregation in both spatial and temporal terms” (Engelke 2004: 87). 
226
 “But the manifestation of the Spirit is given to every man to profit withal.  For to one is given the 
Spirit the word of wisdom; to another the word of knowledge by the same Spirit; to another faith by the 
same Spirit; to another the gifts of healing by the same Spirit; to another the working of miracles; to 
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and disorientating, there was an underlying discipline and patterning of vocalisations in 
individuals at the TCPM despite its apparent “urgency and spontaneity” (Coleman 
2000: 134)227.  Members were primed during services to expect to receive the gift of 
tongues from the Holy Spirit and were surrounded by others speaking in tongues, thus 
shaping a charismatic habitus.  Furthermore, it was expected to be performed within set 
parameters and at defined points of the service228.  Glossolalia serves a range of 
purposes for members of TCPM.  It is a marker of baptism within the Holy Spirit, it 
facilitates a close personal relationship with God, it is a direct channel for prayer and it 
can be a source of comfort and joy229: 
it [speaking in tongues] began another open door of my spiritual world with God […] I 
mean you feel good […] praying in English is using your mind to pray but praying in 
tongues it’s just kind of coming from within you. 
(Sarah, member of TCPM congregation) 
Sarah (above) described speaking in tongues as part of her day-to-day life rather than a 
ritual practice reserved for church, often using it to facilitate a fast connection with God.  
Far from being an esoteric ritual practice, glossolalia is therefore embedded within 
people’s quotidian lives, enabling immediate access to spiritual power outside of church 
and providing a rich and portable source of religious self-efficacy.   
6.4.4 Spiritual power 
Harris, in her study of a Yoruba Aladura church in London, highlights spiritual power 
as the “central organising principle” within Pentecostalism (2006: 58).  The world of the 
TCPM is suffused with spiritual power.  Religious discourse is filled with references to 
“fire”, “prayer bombs” and “breakthroughs” with prayer, fasting and speaking in 
                                                                                                                                                                                  
another prophecy; to another discerning of spirits; to another diverse kinds of tongues; to another the 
interpretation of tongues.” (Corinthians 12: 7-10, Holy Bible: King James Version).    
227
 In contrast to previous notions of glossolalia as a process available to anyone willing to “adopt a 
passive attitude about controlling speech” (Mansell Pattison cited in Hine, 1969: 220), Csordas also views 
it as an active process which initially involves intentional active utterance of “whatever nonsense 
syllables she [adherent] can formulate” (Csordas, 1994: 273).  Both Csordas (1994) and Coleman (2000) 
highlight the role of past experience and a specific religious predisposition in the manifestation of the 
phenomenon.   
228
 Those who fail to perform by speaking in tongues at an inappropriate point in the service are perceived 
to be “drunk on the spirit” and admonished.   
229
 See also Hine’s observation that Pentecostals involved in the “tongue movements” described a range 
of positive emotions including increased capacity to love, patience and increased self-confidence (1969: 
216).   
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tongues functioning to harness God’s power in order to secure deliverance230.  This 
transformative power of God’s Word also extends to material objects as TCPM 
members draw upon a range of ritual blessed objects blessed by the Pastor including oil, 
water, cordial and prayer cloths231.    These preparations and objects are then placed 
upon their bodies or ingested, facilitating an embodiment of the Word and God’s power: 
The oil is the symbol of the Holy Spirit – the active part of God.  You can take cooking 
oil that you fry an egg in, you pray on it and it becomes a supernatural power.  You put 
it on you and it becomes a symbol of the Holy Spirit in you. 
(Sarah, member of TCPM congregation) 
These ritual objects are used as part of deliverance to collapse the distance between God 
and the bodies of the congregation.  They are also used widely outside of church as a 
way of accessing God’s power in other spaces, another demonstration of the flexibility 
and portability of Pentecostal religious practice.   
Intertwined with spiritual power within the TCPM is the notion of “fruitfulness” which 
refers to both material and spiritual success.  The language of “fruitfulness” dominates 
the church’s discourse with repeated references to “abundance”, “supernatural harvest” 
and the planting of “seeds” (tithes) that will grow and deliver spiritual breakthroughs.  
Therefore spiritual power is channelled for a specific purpose within the TCPM; that is 
to bring about fruitfulness whether that be success in business, the bearing of children or 
immigration matters. 
In summary, the cosmology of the TCPM is typical of Pentecostal churches in that it 
constructs a world where the spiritual and material realms interpenetrate and where 
individuals live in constant threat from satanic spirits. Deliverance is centred upon the 
power of God’s Word and ritual practice, forming a rich armoury that member of the 
church can draw upon as they engage in ongoing spiritual warfare to free themselves 
from demonic forces that may be negatively impacting their lives in any sphere. 
6.5 The promise of transformation 
The TCPM is growing in popularity with new branches being established across the 
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 This is perhaps best encapsulated by the church’s mascot, the eagle, “a bird that can fly on extremely 
high places.  A bird of power” (extract from monthly TCPM publication, December 2010). 
231
 In her ethnography of a Nigerian Pentecostal church in London, Botticello describes how faith is 
reinforced by “tangible forms that materialize the intangibility of God and his Word” (2009: 82).  These 
“tangible forms” range from food to a variety of other ritual preparations such as oil, water and soap. 
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country and an expansion of its congregation.  This reflects a global resurgence in 
Pentecostalism, which is now the most rapidly growing denomination of Christianity 
with at least 500 million Pentecostal Christians worldwide (Pew Forum on Religion & 
Public Life 2006), many of whom live in resource-poor settings.  This leads us to ask: 
what attracts adherents to Pentecostalism in the face of diminishing congregations 
within other Christian denominations and the perceived increasing secularisation of 
society? 
In section 6.4.1 I touched upon the resonance of Pentecostalism with indigenous 
spiritual ontologies, which some authors see as central to the global success of 
Pentecostalism especially within Africa (Kalu 2003)232.  However, this was not how my 
participants framed their decision to attend Pentecostal churches.  Robbins argues that 
approaches emphasising “cultural continuity”, risk overlooking a core aspect of 
Pentecostal belief and practice: 
“For when one takes seriously what Pentecostals understand themselves to be doing, 
one discovers that most often they are trying to change.  They are involved, that is, in 
personal and collective projects of discontinuity framed very much in Christian terms.” 
(Robbins 2003: 230) 
Robbins identifies the notion of discontinuity, or “rupture” as an important analytic 
entry point in the study of global Pentecostalism (Ibid.).  In her work with Ghanaian 
Pentecostals, Birgit Meyer describes her participants’ preoccupation with making “a 
complete break with the past” (Meyer 1998a)233.  However, inherent in the discourse of 
“separation” and “breaking bonds” within the TCPM is the quest for transformation, 
highlighted by its central motto: “Your story is changing”.  In this section, I argue that it 
is the notion of transformation that is key to understanding how Pentecostalism 
becomes “a central category of cultural practice in which lived lives embody an 
evolving religious understanding of the ultimate meaning of life” (Kalu 2003: 88). 
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 Both Harris (2006) and Adogame (2004), in their work on Pentecostal practice in the African diaspora, 
foreground the overlap between Yoruba indigenous cosmologies and the spiritual realm constructed 
within Pentecostalism.   
233
 For the Ewe Pentecostals in Ghana, breaking with the past involves deliverance from evil spirits, many 
of who originate in the past in the form of generational curses, and also severing of ties to kin in order to 
live as a “modern individual” without obligations to an extended clan (Meyer 1998: 336).  However 
several authors highlight the ambiguity of rupture in Pentecostalism in that it involves remembering and 
taking seriously the very things Pentecostalists seek to break away from (Robbins 2003, Meyer 1998, 
Engelke 2004).  This is encapsulated by the acknowledgement of indigenous practices such as divination 
but their recasting as the work of the devil and the engagement in ongoing spiritual battle against them.   
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In his 2004 review article on global Pentecostalism, Joel Robbins discusses the 
preponderance of theories of “deprivation and anomie” in sociological analyses of 
contemporary Pentecostalism (Robbins 2004).  These theories seek to explain the 
attraction of Pentecostalism to socially marginalised groups, emphasising its roots in the 
early twentieth century as a movement attracting migrants and those from lower social 
classes.  To those mired in poverty and other types of social suffering, Pentecostalism 
offers a transcendent escape, providing hope for a transformation of circumstances 
(Ibid.)234.  As the TCPM states, “God invites the heavy-laden to come to Him so that he 
can give them rest” (Extract from TCPM publication on deliverance, 2009).  In addition 
to spiritual salvation, the TCPM can be distinguished from non-Pentecostal churches by 
its explicit engagement with the day-to-day difficulties of life as a migrant African such 
as unemployment, poverty, poor health and relationship difficulties235.  Its newly 
established social welfare department locates it firmly in the quotidian lives of its 
members’, providing assistance in matters ranging from immigration issues to 
destitution to the development of business opportunities236 in order to effect a material 
transformation.  Furthermore it cultivates an entrepreneurial orientation as demonstrated 
by church literature espousing self-development and employment success, borrowing 
heavily from the discourse of self-help237.  With the success of migration projects 
paramount to the economic survival of kin, the promise of success and prosperity is of 
central importance (Van Dijk 1997). 
The TCPM provides a tightly knit community and a ritual practice that is highly 
structured and time-consuming but also enjoyable, with members describing it as “a 
kind of spiritual party” that is “lively” and “energetic” compared with other “sombre” 
and “routine” churches.   It also facilitates a sense of belonging to a larger collectivity, 
both within London and beyond.  Meyer describes Pentecostalism as a “globalising 
religious project” partly founded upon its imaginary of the world and its outreach and 
spread (Meyer 2010: 114).  A defining characteristic of churches such as the TCPM is 
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 Robbins writes “To the deprived, those who feel they are not getting their lot in life, [Pentecostalism] 
offers ecstatic escape, hope for millennial redress, and an egalitarian environment in which everyone is 
eligible for the highest religious rewards (i.e. salvation and gifts of the Spirit)” (2004: 124). 
235
 This is highlighted in Van Dijk’s ethnography of the Ghanaian Pentecostal diaspora in the 
Netherlands.  He describes the role of Pentecostalism in the forging of diasporic identities through prayers 
to secure successful migration projects, assistance with unemployment and legal status, and the provision 
of a “safe, personalistic network in the host country” (1997: 15).   
236
 Examples of material assistance given by the TCPM included the provision of funds to one of my 
participants with no recourse to public funds for the funeral of her stillborn baby, and the promotion of 
members’ businesses through a church conference in August 2011.   
237
 For instance in one “devotional guide” chapter titles include “Embrace encouragement”, “Project 
boldly”, “Plan wisely” and “Value yourself” (from TCPM “Daily Devotional Guide”, August 2011).   
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their international orientation.  TCPM’s imaginary of the world extends far beyond the 
confines of its branches in the UK.  It maintains close links with the United States 
through its connections with American evangelists, and with West Africa (particularly 
Nigeria) through the regular flow of pastors, members and money across continents.  
Furthermore its successful position on the global stage through its highly adept use of 
digital and broadcast media have allowed it to reach an audience that extends 
throughout the world.  The TCPM is therefore not a geographically bounded 
community, but is instead one that inhabits a transnational sacroscape (Tweed 2008)238, 
providing familiarity in terms of beliefs, practice, food, dress and language whilst at the 
same time specifically orientating itself towards the difficulties and aspirations of those 
in the diaspora. 
As well as offering the promise of transformation of material circumstances, the church 
offers the potential to transform the self239.    Firstly, the ritual of deliverance offers a 
space in which members can articulate their problems, objectifying them as demonic 
forces, thus facilitating a clearer mapping of intrapsychic suffering240.  Furthermore in 
its preoccupation with the past, rupture and renewal, Pentecostal practice may also offer 
a space in which adherents can reflect upon and bridge the gap between old and new 
ways of being (Meyer 1998a: 339)241.  Above all, religious belief at TCPM is a deeply 
embodied process with ritual practices such as receiving anointing oil and glossolalia, 
being experienced as deeply satisfying and often resulting in feeling “uplifted” and the 
relief of suffering242.  This embodied sense of transformation powerfully reinforces 
belief (Harris 2006) and when embedded within a network of shared practice leads to 
the formation of a charismatic habitus that predisposes adherents to the transformative 
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 Tweed borrows from Appadurai’s notion of “global cultural flows” and the notion of –scapes (1996) in 
order to specifically capture transnational religious flows in his ethnography of Cuban Catholics in 
Miami.   
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 The work of Thomas Csordas on the phenomenology of faith healing within the Charismatic Catholic 
Renewal Movement in the United States describes clearly the  role of faith healing in addressing 
psychological suffering and pain (1997).     
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 Csordas writes of deliverance” “if the cosmological effect […] is to objectify evil spirits, the 
psychological effect is to formulate a problem which had previously eluded the patient.  The 
identification of multiple spirits sets the stage for describing how spirits are interacting within the person, 
and thus provides a parapsychodynamic idiom for dealing with psychological conflicts” (1997 178).  
241
 Also of interest here is Dan Sperber’s work on the cognitive basis of religious belief in which he 
suggests that semi-propositional representational beliefs (“fuzzy” concepts which we don’t fully grasp 
such as love or God, as opposed to factual beliefs) “gives us the means to process information […] which 
exceeds our conceptual capacities” (1985: 53).   
242
 Some members described relief from physical ailments after practices such as healing or anointing.  
Csordas attributes this to an alteration of “somatic modes of attention” (1997: 67) in which adherents’ 
orientation to physical symptoms are reconfigured.  He cites the example of a man with chronic back pain 
who experienced a marked reduction in symptoms after faith healing, partly as a result of a renewed 
vigilance for onset of symptoms in order to offer prophylactic prayer (Ibid.: 68).   
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efficacy of deliverance and healing, as eloquently summarised by Csordas: 
“The sense of the divine other is cultivated by participation in a coherent ritual system.  
This ritual system is embedded in, and helps to continually create, a behavioural 
environment in which participants embody a coherent set of dispositions or habitus.  
These are the elements that constitute the webs of significance – or of embodied 
existence in which the sacred self comes into being.  To be healed is to inhabit the 
Charismatic world of sacred self.” 
(Csordas 1997: 24) 
6.6 Medication, miracles and HIV 
“I have been suffering for years now and I decided to go for a test, at the hospital, it was 
confirmed that I had tested positive to HIV and I screamed as I thought it was the end of 
my life […] I became a recluse because of this and most of the time, I kept to myself 
[…] I came for counselling and I didn’t mention to the Pastor I had this disease.  He 
blessed oil and Ribena for me and encouraged me that as long as I believe, God will 
terminate whatever sickness in my body. I became joyous and found myself enjoying 
every deliverance session for the week […] After one month, I noticed that I felt good 
within myself, I became more confident and I had the peace of God that surpasses all 
understanding.  This kept me going and all my friends noticed the change in me […] I 
noticed I had more strength even after I had stopped the medication the doctors gave to 
me […] Church, I have to tell you the good news I have been to three different hospitals 
for test and glad to tell you that Jesus has washed all my sins away as all the three tests 
came out negative!  As I speak now I am so happy because God has delivered me and a 
man is even knocking asking me to marry him.” 
(Extract from TCPM “Daily Devotional Guide”, December 2010) 
So far in this chapter I have outlined the cosmological framework in which misfortune 
is addressed within the TCPM through the ritual practice of deliverance and I have 
explored the appeal of Pentecostalism using the notion of transformation.  The extract 
above, entitled “My terminal sickness is gone, thanks to God of the TCPM”, now brings 
me back to the central concern of this chapter.  How is illness, especially HIV, 
addressed within Pentecostal churches such as the TCPM, and do Pentecostal beliefs 
serve as a barrier to engagement with HIV services and interventions?   
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Recovery from illness is one of the greatest and most desired transformations within the 
TCPM, and is a central preoccupation of members as demonstrated by the number of 
“testimonies”, like the one above, describing divine healing243.  Testimonies, public 
accounts by members of “miracles” they have experienced through deliverance and 
healing, form a large bulk of the main Sunday service at TCPM and are the main focus 
of television broadcasts244.  Members are strongly encouraged to recount their 
experiences of transformation not only to the rest of the congregation but also to others 
that they meet: 
“It will be very unkind and ungrateful of you to keep the miraculous story of your 
deliverance to yourself.  You should let others know, so that they may also pluck up 
enough courage to try God.”  
(Extract from TCPM publication on deliverance, 2009) 
Of the fifty-two testimonies I witnessed at TCPM services, just under a third (16) were 
related to health and illness.  Along with testimonies about financial and employment 
success (14) and marriage and fertility (12), they were by far the most common subjects 
of testimonies in the church, reflecting the main targets of prayer within the TCPM 
namely marriage, fertility, immigration papers, financial success and health.     
Accounts of divine healing ranged from recoveries from serious injury and illness such 
as suspected cancer to the speedy resolution of relatively trivial ailments such as chest 
infections. Although I never witnessed an instance of healing during a church service, 
members discussed cases frequently and many described healing in their own lives 
manifesting in alleviation of physical symptoms.     
Earlier in this chapter I described how misfortune is embedded within a larger moral 
universe defined by the spiritual battle between God and evil spirits.     Deliverance 
aims to release adherents from the influence of malign spirits in order to enact 
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  It is important to clarify the difference between deliverance and healing.  Deliverance refers to being 
set free from the influence of evil spirits.  Healing pertains specifically to the restoration of physical 
health whereas deliverance aims to secure spiritual wellbeing, although as discussed previously this can 
result in material transformation including healing.   
244
 Testimonies serve a number of important functions within Pentecostalism.  On an individual level, 
they are an opportunity for believers to further strengthen their personal relationship with God and give 
thanks for blessings received thus securing continued good favour.  They contribute to the shaping of a 
charismatic habitus, providing an exemplar of embodiment and performance of Pentecostal Christianity.  
Finally, accounts of “miracles” at services are important evangelising tools as they are disseminated in the 
wider world through word of mouth and broadcast and print media.  They have been instrumental in 
building the TCPM’s reputation as a place of “amazing miracles [and] things you have never seen” as 
many members were initially drawn to the church either through hearing accounts of “miracles” from 
friends or watching testimonies on satellite television.   
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transformation in the “physical, spiritual, financial, matrimonial and emotional realms” 
(from TCPM service, 02 August 2011).  Illness, like any other type of misfortune, is 
thought to ultimately have a spiritual aetiology necessitating deliverance.   Direct 
comparisons are made between healing within the church and biomedicine, with the 
Pastor borrowing heavily from biomedical terminology describing Jesus as “the greatest 
physician” and the church as a “spiritual operating table” (TCPM service, 02 August 
2011).  Indeed, the superiority of God’s power over biomedicine is made explicit in 
assertions such as “no one has God’s pharmacy” (TCPM service, 02 August 2011), and 
the recounting of numerous cases of doctors’ failures to treat illnesses which were 
subsequently healed within the church.  This is partly due to biomedicine’s inability to 
engage with spiritual aetiology: 
“Unlike your General Practitioner who can attend to your medical problems to the 
exclusion of your other problems […] if we are afflicted medically, God would not only 
deliver us medically, but emotionally, spiritually and otherwise.” 
(Extract from TCPM publication on deliverance, 2009) 
Furthermore, God’s treatment is free making it accessible to all, especially the 
dispossessed: 
“In some parts of the world where hospital treatment is not free, patients can be left in 
hospital corridors pending when their families can come up with the required funds for 
their treatment […] God’s deliverance costs nothing [...]  God’s system is the only one 
for the down-and-out who have no hope in the world’s system.” 
(Extract from TCPM publication on deliverance, 2009) 
As described earlier, the Pentecostal world is one that is inherently insecure and 
vulnerable to evil forces, and members of the church are cautioned against mistrusting 
God’s power.  “Negative reports” from a doctor could be the “Devil’s report” designed 
to instil fear and leave one open to demonic possession producing “sickness, diseases, 
weakness, failure” (Extract from TCPM publication on the power of words, 2009).  
However, despite the weight of expectation and spiritual imperative to pursue a divine 
solution to illness, at no time did I witness explicit directives by Pastors at the TCPM to 
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their congregation to reject biomedicine245.    
I now wish to return to African women living with HIV in the UK, especially those who 
are pregnant, to understand the role churches such as TCPM may play in their lives.  
The hours devoted to prayers for “fruits of the womb” reveal how motherhood is 
constitutive of female identity within the church, with women who are unable to bear 
children commonly thought to be suffering from a spiritual affliction.  For many 
women, being HIV-positive and not having children is doubly stigmatising and impacts 
on their sense of identity as women.  Marriage, fertility and health are among the most 
prominent targets for miraculous healing within TCPM and the church therefore 
promises to deliver HIV-positive women from two assaults on their sense of self, HIV 
and childlessness, offering hope that they may be able to perform culturally sanctioned 
social roles.  Once pregnant, regardless of HIV-status, the church becomes a sanctuary 
for expectant mothers where various rituals are enacted in order to ensure safe delivery 
of a healthy baby.  For many women, pregnancy and early motherhood in the context of 
HIV is characterised by fear for their children’s health246.  The promise of divine 
protection within TCPM therefore provides particular succour as described by Rhoda, 
an HIV-positive member of TCPM: 
All the pregnant women come to the front [of the church] and you put anointing oil on 
you […] I believed that it’s protection if there was evil forces against me and stuff like 
that […] I was at peace and I thought that nothing would happen to this baby. 
(Rhoda, member of the TCPM congregation) 
Furthermore, there are explicit references during services and within church literature to 
divine healing of HIV, although this is often in the context of healing of a range of 
common illnesses including “diabetes, leukaemia, bowel cancer, insomnia, depression 
and high cholesterol” (TCPM service, 16 August 2011).  Some participants had heard of 
or had met people with HIV who had been healed by God: 
One lady just came [to church] and said she was diagnosed with HIV […] I said to 
myself ‘One day He will heal me like that lady’ [...] She prays and prays and all those 
things. So one day she went to a doctor for a test. The results came back; they said 
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 Having not had one-to-one spiritual counselling I cannot exclude the possibility that members were 
advised to stop medication individually. 
246
 Women's concerns about risks of transmission of HIV to their baby or possible toxicity of ART are 
discussed in Chapter Five. 
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‘what is going on?’ And they did [the HIV test] again and confirm that she’s HIV free. 
(Marie) 
For people living with HIV, the greatest of transformations would be a cure, or as one 
woman put it “a total healing”.  This would mean release from a highly stigmatising 
chronic illness with its attendant demands including long term medication and anxieties 
about survival.    
Clifford Geertz writes that religion acts to create order from disorder when: 
“a tumult of events which lack not just interpretations but interpretability – threatens to 
break in upon man: at the limits of his analytic capabilities, at the limits of his powers of 
endurance, and at the limits of his moral insight.” 
(Geertz [2010] 1973: 100) 
Religion may play an especially important bridging role in “limit situations” (Tweed 
2008: 137) when people find themselves at the threshold of embodied existence, such as 
during illness.  An HIV-positive diagnosis can be a “limit situation”, throwing life into 
“tumult” and not readily interpretable.  For many women interviewed, their HIV 
diagnosis had prompted a deep reflection on mortality, pushing them towards the 
threshold between life and death.  Pentecostal belief and the promise of healing allowed 
them to mediate this space between the possible and impossible.  Again, the central 
concept here is transformation, as women undertake spiritual healing in order to break 
with a past defined by their HIV-status. Furthermore, the belief in the spiritual aetiology 
of HIV places the locus of agency beyond oneself, as well as providing the framework 
for understanding this “limit situation”247.  As migrant women living with HIV who are 
marginalised on many levels, attributing HIV to spiritual forces provides the means to 
absolve themselves of blame for a highly stigmatising disease that is subjected to 
particularly moralising discourse, and in doing may foster self-worth.   
The belief in divine healing therefore functions as a source of great hope and strength in 
confronting the daily challenges of living with HIV.  Some women spoke of how 
pastors assured them that prayer would eventually lead to divine healing; however they 
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 Harris describes this as “external causation” and notes how it is an important aspect of both Yoruba 
and Pentecostal cosmology: “External causation offers a logical explanation for apparently random 
misfortune, integrating malaise into a system of meaning that fends off feelings of inadequacy, and lack 
of self-worth.  Foreign perils are encompassed by the familiar; new fears are named by old labels; strange 
experience is reduced to the known” (2006: 79). 
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all denied being advised to stop taking ART.  Some had heard of churches where 
pastors advised stopping medication for a range of illnesses but they were largely 
critical of this stance.  For them, a belief in divine healing did not preclude the use of 
biomedicine.  Instead, some participants concluded that whilst waiting for their 
“miracle”, the safest course of action was to continue taking ART, whilst others 
believed that faith and ART worked together synergistically as a healing-complex248: 
I need God and medication.  It’s like if you’re sitting an exam.  God may lead you to 
read something before the exam and then you can answer the question.  But if you don’t 
even carry the textbook...how do you do it?   
(Bolade) 
There are numerous outcomes to HIV-positive women’s pursuit of divine healing within 
Pentecostal churches.  Some people believe that they have been cured of HIV through 
divine healing, although I did not encounter anyone who believed this during my 
study249.   Instead what was more widespread was the belief in other markers of divine 
intervention such as simplification of drug regimens250, an undetectable viral load on 
treatment, continued health, and the safe delivery of an HIV-negative child.  Women, 
many of whom had migrated from countries where maternal and child death due to HIV 
were commonplace, understandably saw this in itself as miraculous.  Many saw God 
operating through healthcare professionals and antiretroviral therapy and also believed 
that the power of prayer would augment the efficacy of their medication in a similar 
way to the use of other ritual objects within TCPM to bridge the distance between self 
and God in order to harness divine power. 
However, some women did not feel that they had experienced healing despite great 
personal investment in Pentecostalism.  The focus on personal efficacy within TCPM 
and the widespread belief that “your time will come” if you pray hard enough can lead 
to a sense of personal failure if the longed for transformation does not materialise. 
Within the church prolonged misfortune is perceived to be a result of ongoing demonic 
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 Also see Csordas on American Charismatics (1993: 28) and Engelke on Zimbabwean Apostolics 
(2004: 93) who both describe the compatibility and widespread use of biomedicine in Charismatic 
Christianity.   
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 I have encountered a small number of patients who believe they have been cured of HIV in my clinical 
practice and discontinue treatment, however this does not appear to be common during pregnancy.  The 
desire to secure an HIV-negative baby is likely to be an important motivation for women to continue their 
medication during pregnancy as discussed in Chapter Five.   
250
 Treatment simplification is the change from multiple tablets to a regimen with fewer pills.  As HIV 
medicine has evolved increasing numbers of co-formulated drugs (where multiple agents are combined in 
one tablet) have become available.  
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influence and evidence of a weak spiritual battle.  One pastor at an AIC church in 
London described HIV as posing particular challenges to those seeking deliverance.  
Firstly, medical technology limits biomedicine’s ability to assess whether someone has 
been cured: 
You know with other medical conditions, when people are prayed for and they are 
healed, they go and do a biopsy on them or do a blood test on them and say ‘OK the 
levels have changed, or whatever’. But with HIV we still don’t have anything other than 
checking the viral load. 
(Pastor of an AIC church in London) 
For this Pastor, relying on a test that states that a person has undetectable levels of virus 
but that the virus is still present prevents confirmation of divine healing.  Secondly she 
felt that some people living with HIV would not be cured despite intensive engagement 
with deliverance rituals and strong faith.  Her interpretation was that God had his 
reasons and this should be accepted without questioning, yet she was concerned that 
HIV was often interpreted within churches as a “rod from God”, a specific punishment 
for past sins that was not amenable to divine intervention.   
However, the women in my study were not prepared to accept HIV as a “rod from God” 
and actively engaged in seeking healing from HIV and for other misfortunes.  I will 
now conclude with a vignette as an illustrative example.    
6.6.1 Rhoda  
Rhoda was in her forties and had moved to the UK from Malawi in 1988 to join her 
husband.  In 1992 he fell ill and died of an HIV-related illness.  Shortly afterwards, 
Rhoda became unwell herself.   She was subsequently diagnosed with HIV and 
informed that her prognosis was poor.  Living in the UK on her own, she had found it 
hard to manage her grief for her husband and her anxieties about her future.  She had 
been brought up a Catholic but had friends who were involved in Charismatic Catholic 
Churches.  Aware of the emphasis on healing in these churches she decided to attend a 
Charismatic service and described herself as finding “so, so much peace” there.   Over 
the course of twenty years she attended a variety of Pentecostal churches, attracted by 
their “energetic” modes of worship but always moving if she felt she was not obtaining 
desired results.  An unemployed single mother, Rhoda’s most recent concerns were no 
longer her health but her poor housing and precarious finances.  A few years ago she 
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had become drawn to the TCPM:  
“I was watching the TV and I saw TCPM.   I’m looking for a job, I need serious prayer 
so I said I’ll go for deliverance.”   
She had found peace and strength through going there saying: 
 “I think it’s the testimonies […] I feel there is power in that Church.”   
Reflecting on nearly twenty years of living with HIV, Rhoda believed that her faith and 
religious practice had mobilised God’s power through both deliverance and the work of 
her doctors, and that her divine healing had manifested in her continued good health and 
that of her daughter.   
Rhoda was typical of many women I spoke to in that she had attended numerous 
churches, both charismatic and non-charismatic, to seek a desired outcome, whilst 
continuing to engage with biomedicine. In his description of the increasing 
commodification and diversity of religious faith in North America, Roof introduces us 
to the “spiritual marketplace” (Roof 2001).  With the rapid expansion of the Pentecostal 
faith globally, and the growing number of churches in London alone competing for 
members using increasingly sophisticated means, people are free to choose a church that 
they feel will cater to their needs251.  Furthermore, African women living with HIV in 
London are situated within a plural healthscape populated by biomedicine and a wide 
range of religious institutions, with a belief in divine healing an important but not 
singular resource in securing health and well–being.  Pentecostal faith did not serve as 
barrier to engaging with HIV services and interventions for the women in my study.     
There was no epistemological rupture in holding these two beliefs together as, for many 
women, the mechanisms of healing were of secondary consequence to efficacy (Last 
1981).  Whyte writes of the “pragmatics of uncertainty” (1997); when confronted with 
misfortune her participants in Uganda tried out various systems of healing ranging from 
divination to biomedicine.  The pursuit of alleviation of suffering was open-ended, with 
doubt inherent in all systems and outcomes indeterminate, allowing people to retain 
hope that if one system fails, then another may be effective.  Thus taking ART whilst 
striving for a divine healing is ultimately a pragmatic approach to make (in the words of 
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 Read’s ethnography of approaches towards mental illness in rural Ghana highlights the widespread 
hope among patients and their families for miraculous cures.  However, the longed for cure often did not 
materialise.  The ensuing scepticism was not directed towards miracles themselves, but towards the 
practitioners who had failed to deliver on their promise  (2012).   
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one of my participants) “the impossible become possible”. 
6.7 Conclusions 
In this chapter I have drawn upon observations from ethnographic fieldwork conducted 
at a diasporic Nigerian Pentecostal church on the outskirts of London.  As such, it is 
difficult to generalise to other Pentecostal churches in London with confidence, 
although my findings resonate with those of other authors who have conducted 
fieldwork in Pentecostal churches in a diverse range of settings (van Dijk 1997, Meyer 
1998a, Coleman 2000, Hunt 2002, Engelke 2004, Harris 2006, Adogame 2007). 
The impact of divine healing on engagement with HIV care has become increasingly of 
concern among professionals working within HIV, with a narrative of exploitation and 
harm within diasporic African Pentecostal churches emerging of late in sections of the 
British media.  In this chapter I have challenged these dominant negative 
representations of Pentecostalism within African migrant communities by exploring 
how migrant Africans, including pregnant women living with HIV,  actively engage 
with and use Pentecostal faith as a cultural resource in managing illness.  Adherents to 
Pentecostalism exist in a universe where all misfortune (ranging from immigration 
concerns to illness) is a demonic affliction necessitating spiritual warfare through a 
range of rich ritual practice centred on the power of the Word and the promise of 
transformation.  The belief in divine intervention and the discourse of transformation 
can foster hope and self-efficacy in the face of an incurable illness, whilst also serving 
to reduce stigma by attributing causation to an external force.  Furthermore, spiritual 
practice within the TCPM is deeply embodied by members and is a source of great 
personal empowerment and satisfaction.  Finally, the pragmatic orientation of TCPM 
and its willingness to engage with its congregation’s real life problems is part of its 
appeal as it recognises and addresses the social marginalisation faced by some of its 
members, providing the protection of a surrogate family and material assistance in times 
of hardship. 
There are valid critiques to be made of TCPM and churches similar to it.  The TCPM 
has been able to expand rapidly into a multi-million pound business empire within the 
space of a few years, currently running at significant profit.  Much of this comes in the 
forms of tithes from their members, some of whom are poverty-stricken and hoping for 
salvation from their current predicament.   However, in the course of my fieldwork I did 
not encounter anyone who had been adversely affected by their Pentecostal beliefs, nor 
 199 
did I find any evidence of Pentecostal faith as a pervasive barrier to engagement with 
HIV care.  The HIV-positive pregnant women I interviewed were extremely pragmatic 
and outcome-driven in their quest to secure a better future for themselves and their 
babies.  They occupied a plural healthscape populated by biomedicine and an array of 
Pentecostal churches, and were willing to draw upon a number of resources when 
managing life with HIV, with a belief in divine healing not precluding the use of ART.  
Instead their search for divine healing was often part of a larger quest to find solutions 
to multiple misfortunes, with their faith representing a vital source of hope, succour and 
resilience. 
Key points 
 Pentecostal Christianity (characterised by a direct personal experience of God 
and spiritual gifts such as speaking in tongues and divine healing) is one of the 
fastest growing religions both globally and in the UK. 
 The TCPM is an example of a rapidly expanding diasporic Nigerian Pentecostal 
churches with branches in London and elsewhere in the UK. 
 The TCPM, in line with conventional Pentecostal teachings, constructs a 
universe where misfortune, including illness, is caused by demonic forces that 
require battle within the spiritual plane. 
 Pentecostalism may hold particular appeal for migrants due to its pragmatic 
engagement with adherents’ problems. 
 Pentecostal cosmology and the promise of transformation can foster a sense of 
self-efficacy and hope, whilst at the same time reducing self-stigma by 
attributing misfortune to an external agent.   
 However, the vast majority of members use their church as one of a variety of 
resources in their healthscape in a pragmatic quest for a better future for 
themselves and their babies. 
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7  
           
Engaging with health services during pregnancy  
 
Summary 
In this chapter I focus on African HIV-positive women’s engagement with, and 
experience of, health services during pregnancy.  This second mixed methods chapter of 
the thesis uses data from the NSHPC to examine the relationship between maternal 
ethnicity, African region of birth and duration of residence in the UK, and late antenatal 
booking.  These quantitative findings are contextualised with ethnographic data 
exploring women’s attitudes towards and experiences of health services.  I also draw 
upon ethnographic data to specifically explore women’s experiences of maternity 
services at the time of delivery, an aspect of care that is not captured by surveillance 
data.   By weaving together these different strands, I aim to describe in detail African 
HIV-positive women’s use and experience of health services in the UK during 
pregnancy.   
7.1 Introduction 
In Chapter Five I explored the use of ART in pregnancy by African women living with 
HIV, concluding that most engaged well with treatment during pregnancy.  For a 
minority, important challenges included stigma and structural factors such as poverty, 
homelessness and lack of UK citizenship rights.  In Chapter Six, I challenged the 
perception of Pentecostal Christianity as a major barrier to taking ART, describing 
women’s pragmatic deployment of faith as part of a broader cultural system that 
addresses misfortune.  In this chapter I shift my focus from the use of ART to 
engagement with and experience of health services during pregnancy.  This is an aspect 
of HIV care that has been relatively overlooked in the literature on HIV and pregnancy 
as discussed in Chapter Two.    
When an HIV-positive woman becomes pregnant her engagement with clinical services 
will differ from that of an HIV-negative pregnant woman.  In the UK, pregnant women 
living with HIV are expected to attend a hospital-based antenatal clinic at least once or 
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twice a month, ideally to be seen by a specialist multidisciplinary team including an 
HIV physician, an HIV specialist midwife, an obstetrician and a paediatrician (Taylor et 
al. 2012).  In contrast, most pregnant women without complications will be seen 
between seven to ten times during their pregnancy, mainly by a midwife and often not 
in a hospital setting (National Institute for Health and Clinical Excellence 2008).  
During these numerous visits to the antenatal clinic, HIV-positive women have regular 
blood test monitoring, whilst the clinical team discuss options for mode of delivery and 
provide guidance about infant feeding.  HIV antenatal care also serves an additional 
function in that it presents an important opportunity to engage women in longer-term 
care, facilitating their return for follow-up after pregnancy.  Little is currently known 
about women’s use of HIV services during pregnancy, with even less work exploring 
women’s experiences.  This is a critical aspect of HIV and pregnancy, as experiences of 
clinical services during pregnancy are likely to influence how women access care and 
manage their HIV later in pregnancy and in the longer term.   
In this mixed methods chapter I first draw upon NSHPC data to examine late antenatal 
booking and its relationship with maternal ethnicity, African region of birth and 
duration of residence in the UK.  I then contextualise these quantitative findings with 
ethnographic data, mainly originating from my interviews within NHS clinics, in order 
to explore women’s attitudes towards and experiences of clinical services.  Finally I 
draw exclusively upon ethnographic data to specifically describe women’s experiences 
of maternity services around the time of delivery.  
7.2 Epidemiological data on late antenatal booking252 
UK guidelines state that all women should have their first antenatal care appointment, 
known as “antenatal booking”, by ten to thirteen weeks’ gestation (National Institute for 
Health and Clinical Excellence 2008, Department of Health 2009).  In the context of 
maternal HIV infection, timely initiation of antenatal care allows for early screening for 
maternal HIV infection (if a woman is not already diagnosed), prompt initiation of 
ART, planning of infant delivery and advice regarding avoidance of breastfeeding, all of 
which contribute to maternal and child health and minimisation of the risk of vertical 
transmission.  In this section I explore the association between late antenatal booking 
and: (i) maternal ethnicity, (ii) maternal African region of birth, and (iii) maternal 
duration of residence in the UK at conception (for African women).   
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 Some of this material appears in Tariq et al. 2012a. 
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The analysis was restricted to pregnancies with an actual date of delivery between 
January 2008 (when antenatal booking date started to be routinely collected by the 
NSHPC) and December 2010 or with an expected date of delivery (EDD) between those 
dates if the outcome was not a live or stillbirth.  Ectopic pregnancies and terminations 
of pregnancy (n= 78) were excluded, as it is unlikely that antenatal care would have 
been sought or indicated. Use of ART at conception was categorised as “yes with viral 
load <50 copies/ml”, “yes with viral load ≥ 50 copies/ml” and “no”253.  The analysis 
was stratified by whether a woman had been diagnosed with HIV (i) prior to or (ii) 
during the reported pregnancy, as these groups were not felt to be comparable.  There 
were few sequential pregnancies during this time period (270/3355) and therefore robust 
standard errors were not used.   EDD/year of delivery and parity were included in 
multivariable models a priori as confounders.  Other potential confounding variables 
considered included maternal age, history of injecting drug use, ART at conception, first 
CD4 in pregnancy and reporting region.  
“Early” booking was defined as reported antenatal booking before thirteen complete 
weeks’ gestation.  “Late” booking was defined as booking at thirteen weeks or more 
complete weeks’ gestation. This analysis excludes pregnancies in women who arrived 
in the UK after conception (n=87) as they would have been unlikely to have had the 
opportunity to access antenatal care during the first trimester254 of pregnancy.    The 
analysis was stratified by whether a woman had been diagnosed with HIV prior to or 
during the reported pregnancy. 
7.2.1 Results 
There were 3355 eligible pregnancies with a delivery date or expected delivery date 
between January 2008 and December 2010.  This analysis was based on 2481/3355 
(74.0%) pregnancies with data available on antenatal booking in 2349 women.  Missing 
antenatal booking date was associated with miscarriage, premature delivery, earlier time 
period and reporting region outside of London, (all p<0.001).  There was also an 
association between both white ethnicity and Eastern and Southern African region of 
origin and missing booking date (p< 0.05).  Demographic and clinical characteristics of 
the study population are presented in table 7.1.  Nearly 90% (89.1%) of pregnancies 
                                                             
253
 I created this composite variable as baseline viral load and ART at conception were collinear 
(correlation coefficient = -0.67).  The first viral load available during the reported pregnancy was used to 
create this variable.   
254
 Pregnancy is grouped into three trimesters.  The first trimester corresponds to week 1-12, the second to 
week 13-28 and the third to week 29 and beyond.   
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were in women who were of African ethnicity.   
Overall, antenatal booking was late (≥13 weeks’ gestation) in 46.8% (1162/2481; 95% 
confidence interval [CI]: 44.9%, 48.8%) of pregnancies, including 3.7% (92/2481; 95% 
CI: 3.0%, 4.5%) during the third trimester (≥28 weeks).   Of those booking late, the 
median gestational week of booking was 16.4 (interquartile range 14.3-20.4 weeks).  
Time of booking varied with timing of maternal HIV diagnosis.  Antenatal booking was 
late in 55.1% (357/648; 95% CI: 51.3%, 58.9%) of pregnancies in women diagnosed 
with HIV during the reported pregnancy compared with 43.9% (805/1833; 95% CI: 
41.6%, 46.2%) of those in women diagnosed before the reported pregnancy (p<0.001). 
On univariable analysis there was no evidence of an association between timing of 
booking and maternal age, injecting drug use or earliest CD4 count in pregnancy (all 
p>0.1, table 7.1) either in women diagnosed before or during the pregnancy. Year of 
EDD/delivery and reporting region were associated with late antenatal booking in both 
sub-groups (p<0.001).  Parity of 0 or 3 was associated with late booking, compared with 
parity of 1 or 2, in those diagnosed prior to the reported pregnancy (χ2trend test p<0.001).  
Among this group, late booking was also associated with not being on antiretroviral 
therapy at conception or having a detectable viral load on treatment at conception 
(p<0.001).   
There was an association between maternal ethnicity and timing of antenatal booking.  
In pregnancies where a woman was diagnosed with HIV prior to the reported 
pregnancy, 44.9% (736/1641) of African women booked late compared with 35.9% 
(69/192) of white British women (p<0.05).  This association was also seen in the group 
diagnosed during the reported pregnancy, with nearly 60% of African women (327/570) 
booking late for antenatal care compared with 38.5% (30/78) of white British women 
(p<0.05).   After adjusting for year of EDD/delivery, ART at conception, parity and 
reporting region, African ethnicity was associated with increased odds of late booking 
in women diagnosed with HIV prior to the reported pregnancy compared with white 
women (adjusted odds ratio [AOR] 2.03; 95% CI: 1.22, 3.40); p<0.05, table 7.2).  In the 
group diagnosed during the reported pregnancy the odds of late booking were also 
increased in women of African ethnicity (AOR 1.81; 95% CI: 1.04, 3.15; p<0.05, table 
7.2), when adjusted for year, parity and reporting region.   
Restricting the analysis to African women, there was no association either on 
univariable or multivariable analysis (adjusting for year, ART at conception, parity and 
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reporting region) between African region of origin and late booking among those 
diagnosed with HIV prior to the reported pregnancy (all p>0.1, table 7.3).  Looking at 
pregnancies in women diagnosed during the reported pregnancy, the odds of booking 
late were increased in both Southern African women (AOR 1.76; 95% CI 0.95, 3.25; 
p=0.073, table 7.3) and Middle African women (AOR 2.08; 95% CI: 0.98, 4.40; 
p=0.056, table 7.3) compared with Eastern African women (adjusting for year, parity 
and reporting region), although this was of borderline significance.    
Among African women who had been diagnosed with HIV before the reported 
pregnancy, a greater proportion of those who had arrived in the UK less than four years 
before conception (49.3%; 102/207) booked late compared with those who had been in 
the UK longer (42.5%; 366/862; p=0.076, table 7.4).  After adjusting for year, ART at 
conception, parity and reporting area women who had arrived in the UK less than four 
years prior to conception still had increased odds of booking late, although this was of 
borderline significance (AOR 1.34; 95% CI: 0.97, 1.85; p=0.080, table 7.4).  There was 
no evidence of an association between duration of residence in the UK and late booking 
among those diagnosed during the reported pregnancy after adjusting for year, parity 
and reporting region (AOR 0.68; 95% CI 0.43, 1.09; p>0.1, table 7.4). 
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Table 7.1: Demographic and clinical characteristics of women with pregnancies reported to the NHSPC by timing of antenatal booking, 2008-2010 
 Diagnosed with HIV prior to reported pregnancy Diagnosed with HIV during reported pregnancy 
 
 
ANC booking <13 
weeks, n (row %) 
n=1028 
ANC booking ≥13 
weeks, n (row %) 
n=805 
p-value
a
 
 
ANC booking <13 
weeks, n (row %) 
n=291 
ANC booking ≥13 
weeks, n (row %) 
n=357 
p-value
a
 
 
Ethnicity 
White British 
African 
 
123 (64.1) 
905 (55.2) 
 
69 (35.9) 
736 (48.9) 
 
0.019 
 
48 (61.5) 
243 (42.6) 
 
30 (38.5) 
327 (57.4) 
 
0.002 
African region of birth* 
Eastern Africa 
Southern Africa 
Western Africa 
Eastern Africa 
 
571 (56.4) 
47 (47.5) 
200 (55.1) 
87 (52.1) 
 
441 (43.6) 
52 (52.5) 
163 (44.9) 
80 (47.9) 
 
0.302 
 
135 (45.8) 
21 (33.9) 
76 (43.9) 
11 (27.5) 
 
160 (54.2) 
41 (66.1) 
97 (56.1) 
29 (72.5) 
 
0.072 
Duration of residence in the UK* 
шϰ years 
<4 years (before conception) 
 
496 (57.5) 
105 (50.7) 
 
366 (42.5) 
102 (49.3) 
 
0.076 
 
66 (38.8) 
73 (47.7) 
 
104 (61.2) 
80 (52.3) 
 
0.107 
Maternal age at delivery 
<25 years 
25-34 years 
шϯϱ years 
 
77 (59.7) 
550 (56.9) 
332 (55.2) 
 
52 (40.3) 
417 (43.1) 
270 (44.9) 
 
0.596 
 
43 (44.8) 
168 (46.5) 
50 (41.3) 
 
53 (55.2) 
193 (53.5) 
71 (58.7) 
 
0.606 
Year of EDD/delivery 
2008 
2009 
2010 
 
215 (48.2) 
377 (55.7) 
436 (61.4) 
 
231 (51.8) 
300 (44.3) 
274 (38.6) 
 
<0.001
b 
 
78 (34.7) 
127 (52.7) 
86 (47.3) 
 
147 (65.3) 
114 (47.3) 
96 (52.8) 
 
<0.001
b 
IDU 
No 
Yes 
 
1020 (56.0) 
8 (72.7) 
 
802 (44.0) 
3 (27.3) 
 
0.265 
 
291 (45.1) 
0 (0.0) 
 
354 (54.0) 
3 (100.0) 
 
0.117 
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Table 7.1 continued  
 Diagnosed with HIV prior to reported pregnancy Diagnosed with HIV during reported pregnancy 
 ANC booking 
<13 weeks, n (%) 
n=1028 
ANC booking ≥13 
weeks, n (%) 
n=805 
p-value
a
 
 
ANC booking <13 
weeks, n (%) 
n=291 
ANC booking ≥13 
weeks, n (%) 
n=357 
p-value
a
 
 
Earliest CD4 count
¶
, cells/µl 
шϯϱϬ 
200-249 
<200 
 
655 (57.9) 
235 (54.0) 
74 (50.0) 
 
476 (42.1) 
200 (46.0) 
74 (50.0) 
 
0.106 
  
130 (42.3) 
83 (47.4) 
49 (40.8) 
 
177 (57.7) 
92 (52.6) 
71 (59.2) 
 
0.447 
ART at conception 
Yes with earliest VL<50 copies/ml 
Yes ǁith earliest VL шϱϬ Đopies/ŵl 
No 
 
510 (61.0) 
81 (53.6) 
370 (48.9) 
 
326 (39.0) 
70 (46.4) 
386 (51.1) 
 
<0.001 
 
N/A 
 
N/A 
 
Parity 
0 
1 
2 
3 
 
 231 (66.6) 
381 (56.0) 
234 (53.3) 
114 (45.2) 
 
116 (33.4) 
300 (44.1) 
205 (46.7) 
138 (54.8) 
 
<0.001 
 
135 (44.6) 
87 (46.0) 
32 (38.1) 
18 (50.0) 
 
168 (55.5) 
102 (54.0) 
52 (61.9) 
18 (50.0) 
 
0.569 
Reporting areas 
London  
England (not London) 
Scotland, Wales, NI 
 
434 (58.0) 
401 (52.8) 
42 (44.2) 
 
314 (42.0) 
359 (47.2) 
53 (55.8) 
 
0.013 
 
82 (34.8) 
138 (50.7) 
18 (41.9) 
 
154 (65.3) 
134 (49.3) 
25 (58.1) 
 
0.001 
aObtained using χ2 test; bobtained using χ2 test for trend; *restricted to African women;  ¶first reported value in pregnancy.  ANC, antenatal care; EDD, expected date of 
delivery; IDU, likely route of HIV acquisition was maternal injecting drug use; ART, antiretroviral therapy; N/A, not applicable. 
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 Table 7.2: Univariable and multivariable analysis of the association between maternal ethnicity and late booking during pregnancy 
 Diagnosed with HIV prior to reported pregnancy Diagnosed with HIV during reported pregnancy 
 Univariable analysis Multivariable analysis, 
n=1469 
Univariable analysis Multivariable analysis, 
n=525 
 OR (95% CI) p-value AOR (95% CI) p-value OR (95% CI) p-value AOR (95% CI) p-value 
Ethnicity 
White British 
African 
 
1.00 
1.45 (1.06,1.98) 
 
 
0.018 
 
1.00 
2.03 (1.22,3.40) 
 
 
0.007 
 
1.00 
2.15 (1.33,3.50) 
 
 
0.002 
 
1.00 
1.81 (1.04,3.15) 
 
 
0.037 
Maternal age at delivery 
<25 years 
25-34 years 
шϯϱ years 
 
1.00 
1.12 (0.77,1.63) 
1.20 (0.82,1.77) 
 
0.595 
  
 
 
1.00 
0.93 (0.59,1.47) 
1.15 (0.67,1.98) 
 
0.007 
  
Year of EDD/delivery 
2008 
2009 
2010 
 
1.00 
0.74 (0.58,0.94) 
0.58 (0.46,0.74) 
 
<0.001 
 
1.00 
0.83 (0.64,1.09) 
0.59 (0.45,0.77) 
 
 
0.181 
<0.001 
 
1.00 
0.48 (0.33,0.69) 
0.59 (0.40,0.88) 
 
<0.001 
 
1.00 
0.50 (0.33,0.77) 
0.57 (0.36,0.90) 
 
 
0.002 
0.016 
Earliest CD4 count
¶
, cells/µl 
шϯϱϬ 
200-249 
<200 
 
1.00 
1.17 (0.94,1.46) 
1.38 (0.98,1.94) 
 
0.107 
 
 
 
 
 
1.00 
0.81 (0.56,1.18) 
1.06 (0.69,1.63) 
 
0.448 
  
ART at conception 
Yes with earliest VL<50 copies/ml 
Yes ǁith earliest VL шϱϬ Đopies/ŵl 
No 
 
1.00 
1.35 (0.95,1.92) 
1.63 (1.34,1.99) 
 
<0.001 
 
1.00 
1.32 (0.91,1.94) 
1.68 (1.34,2.10) 
 
 
0.147 
<0.001 
 
N/A 
 
 
 
N/A 
 
 
 
Parity 
0 
1 
2 
3 
 
1.00 
1.57 (1.20,2.05) 
1.74 (1.30,2.33) 
2.41 (1.73,3.37) 
 
<0.001 
 
1.00 
1.66 (1.23,2.24) 
1.82 (1.31,2.52) 
2.71 (1.86,3.95) 
 
 
0.001 
<0.001 
<0.001 
 
1.00 
0.94 (0.65,1.36) 
1.31 (0.80,2.14) 
0.80 (0.40,1.60) 
 
0.567 
 
1.00 
1.06 (0.70,1.61) 
1.62 (0.91,2.89) 
0.98 (0.46,2.07) 
 
 
0.766 
0.101 
0.951 
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Table 7.2 continued 
 Diagnosed with HIV prior to reported pregnancy Diagnosed with HIV during reported pregnancy 
 Univariable analysis Multivariable analysis,  
N=1469 
Univariable analysis Multivariable analysis, 
n=525 
 OR (95% CI) p-value AOR (95% CI) p-value OR (95% CI) p-value AOR (95% CI) p-value 
Reporting areas 
London  
England (not London) 
Scotland, Wales, NI 
 
1.00 
1.24 (1.01,1.52) 
1.74 (1.13,2.68) 
 
0.013 
 
1.00 
1.31 (1.05,1.64) 
1.98 (1.23,3.18) 
 
 
0.016 
0.005 
 
1.00 
0.52 (0.36,0.74) 
0.74 (0.38,1.43) 
 
0.001 
 
1.00 
0.54 (0.37,0.80) 
0.87 (0.42,1.79) 
 
 
0.002 
0.701 
¶First reported value in pregnancy. OR, odds ratio; CI, confidence interval; AOR, adjusted odds ratio: EDD, expected date of delivery; ART, antiretroviral therapy; VL, viral load; 
NI, Northern Ireland. 
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Table 7.3: Univariable and multivariable analysis of the association between maternal African region of birth and late booking during pregnancy 
(restricted to African women) 
 Diagnosed with HIV prior to reported pregnancy Diagnosed with HIV during reported pregnancy 
 Univariable analysis Multivariable analysis, 
n=1312 
Univariable analysis Multivariable analysis, 
n=537 
 OR (95% CI) p-value AOR (95% CI) p-value OR (95% CI) p-value AOR (95% CI) p-value 
African region of birth 
Eastern Africa 
Southern Africa 
Western Africa 
Middle Africa 
 
1.00 
1.43 (0.95,2.17) 
1.06 (0.83,1.34) 
1.19 (0.86,1.65) 
 
 
0.088 
0.662 
0.297 
 
1.00 
1.42 (0.86,2.32) 
1.22 (0.92,1.62) 
1.19 (0.82,1.74) 
 
 
0.169 
0.174 
0.366 
 
1.00 
1.65 (0.93,2.92) 
1.08 (0.74,1.57) 
2.22 (1.07,4.61) 
 
 
0.088 
0.701 
0.032 
 
1.00 
1.76 (0.95,3.25) 
1.16 (0.77,1.75) 
2.08 (0.98,4.40) 
 
 
0.073 
0.468 
0.056 
Maternal age at delivery 
<25 years 
25-34 years 
шϯϱ years 
 
1.00 
1.35 (0.86,2.13) 
1.48 (0.93,2.36) 
 
0.236 
  
 
 
1.00 
0.81 (0.46,1.42) 
1.09 (0.57,2.06) 
 
0.371 
  
Year of EDD/delivery 
2008 
2009 
2010 
 
1.00 
0.77 (0.60,0.99) 
0.58 (0.45,0.74) 
 
<0.001 
 
1.00 
0.90 (0.67,1.19) 
0.60 (0.45,0.80) 
 
 
0.449 
0.001 
 
1.00 
0.54 (0.36,0.80) 
0.59 (0.39,0.91) 
 
0.005 
 
1.00 
0.55 (0.37,0.84) 
0.66 (0.43,1.04) 
 
 
0.005 
0.071 
Earliest CD4 count
¶
, cells/µl 
шϯϱϬ 
200-249 
<200 
 
1.00 
1.20 (0.95,1.52) 
1.27 (0.89,1.81) 
 
0.183 
 
 
 
 
 
1.00 
0.68 (0.46,1.02) 
0.90 (0.58,1.41) 
 
0.176 
 
  
ART at conception 
Yes with earliest VL<50 copies/ml 
Yes ǁith earliest VL шϱϬ Đopies/ŵl 
No 
 
1.00 
1.36 (0.94,1.95) 
1.65 (1.33,2.03) 
 
<0.001 
 
1.00 
1.30 (0.87,1.93) 
1.58 (1.24,2.00) 
 
 
0.199 
<0.001 
 
N/A 
 
 
 
N/A 
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Table 7.3 continued 
 Diagnosed with HIV prior to reported pregnancy Diagnosed with HIV during reported pregnancy 
 Univariable analysis Multivariable analysis,  
n=1312 
Univariable analysis Multivariable analysis, 
n=537 
 OR (95% CI) p-value AOR (95% CI) p-value OR (95% CI) p-value AOR (95% CI) p-value 
Parity 
0 
1 
2 
3 
 
1.00 
1.57 (1.17,2.10) 
1.73 (1.26,2.36) 
2.17 (1.52,3.09) 
 
<0.001 
 
1.00 
1.73 (1.24,2.40) 
1.91 (1.34,2.70) 
2.59 (1.74,3.87) 
 
 
0.001 
<0.001 
<0.001 
 
1.00 
0.88 (0.60,1.29) 
1.46 (0.84,2.53) 
0.97 (0.44,2.14) 
 
0.375 
 
1.00 
0.92 (0.62,1.38) 
1.55 (0.88,2.71) 
1.08 (0.49,2.41) 
 
 
0.700 
0.128 
0.845 
Reporting areas 
London  
England (not London) 
Scotland, Wales, NI 
 
1.00 
1.34 (1.08,1.66) 
1.48 (0.90,2.45) 
 
0.236 
 
1.00 
1.44 (1.13,1.83) 
1.46 (0.85,2.51) 
 
 
0.003 
0.175 
 
1.00 
0.61 (0.42,0.89) 
0.88 (0.38,2.02) 
 
0.037 
 
 
 
 
¶First reported value in pregnancy. OR, odds ratio; CI, confidence interval; AOR, adjusted odds ratio: EDD, expected date of delivery; ART, antiretroviral therapy; VL, viral load; 
NI, Northern Ireland. 
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Table 7.4: Univariable and multivariable analysis of the association between maternal duration of residence in the UK at conception and late booking 
during pregnancy (restricted to African women) 
 Diagnosed with HIV prior to reported pregnancy Diagnosed with HIV during reported pregnancy 
 Univariable analysis Multivariable analysis, 
n=997 
Univariable analysis Multivariable analysis, 
n=313 
 OR (95% CI) p-value AOR (95% CI) p-value OR (95% CI) p-value AOR (95% CI) p-value 
Duration of residence in UK 
ш ϰ years 
< 4 years (before conception) 
 
1.00 
1.32 (0.97,1.78) 
 
 
0.076 
 
1.00 
1.34 (0.97,1.85) 
 
 
0.080 
 
1.00 
0.70 (0.45,1.08) 
 
 
0.107 
 
1.00 
0.68 (0.43,1.09) 
 
0.108 
Maternal age at delivery 
<25 years 
25-34 years 
шϯϱ years 
 
1.00 
1.47 (0.85,2.52) 
1.64 (0.94,2.84) 
 
0.197 
  
 
 
1.00 
0.96 (0.48,1.92) 
1.18 (0.53,2.59) 
 
0.782 
  
Year of EDD/delivery 
2008 
2009 
2010 
 
1.00 
0.69 (0.50,0.93) 
0.61 (0.44,0.83) 
 
0.007 
 
1.00 
0.69 (0.50,0.95) 
0.59 (0.43,0.83) 
 
 
0.025 
0.002 
 
1.00 
0.54 (0.32,0.92) 
0.54,0.31,0.96) 
 
0.036 
 
1.00 
0.56 (0.32,0.96) 
0.54 (0.30,0.97) 
 
 
0.034 
0.038 
Earliest CD4 count
¶
, cells/µl 
шϯϱϬ 
200-249 
<200 
 
1.00 
1.05 (0.79,1.40) 
1.34 (0.83,2.15) 
 
0.482 
 
 
 
 
 
1.00 
0.59 (0.35,0.99) 
0.62 (0.35,1.11) 
 
0.087 
  
ART at conception 
Yes with earliest VL<50 copies/ml 
Yes ǁith earliest VL шϱϬ Đopies/ŵl 
No 
 
1.00 
1.34 (0.86,2.09) 
1.62 (1.25,2.11) 
 
0.001 
 
1.00 
1.31 (0.83,2.07) 
1.56 (1.19,2.05) 
 
 
0.248 
0.001 
 
N/A 
 
 
 
N/A 
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Table 7.4 continued 
 
 Univariable analysis Multivariable analysis,  
n=997 
Univariable analysis Multivariable analysis, 
n=313 
 OR (95% CI) p-value AOR (95% CI) p-value OR (95% CI) p-value AOR (95% CI) p-value 
Parity 
0 
1 
2 
3 
 
1.00 
1.48 (1.02,2.14) 
1.56 (1.05,2.32) 
2.36 (1.52,3.68) 
 
0.002 
 
1.00 
1.57 (1.07,2.30) 
1.72 (1.14,2.58) 
2.56 (1.62,4.03) 
 
 
0.021 
0.009 
<0.001 
 
1.00 
0.80 (0.48,1.34) 
1.50 (0.70,3.18) 
0.72 (0.28,1.82) 
 
0.409 
 
1.00 
0.82 (0.49,1.39) 
1.44 (0.67,3.11) 
0.72 (0.27,1.88) 
 
 
0.466 
0.348 
0.501 
Reporting areas 
London  
England (not London) 
Scotland, Wales, NI 
 
1.00 
1.29 (0.99,1.69) 
1.52 (0.77,2.98) 
 
0.112 
 
 
 
 
 
 
1.00 
0.64 (0.39,1.04) 
1.41 (0.42,4.72) 
 
0.123 
 
 
 
 
 
¶First reported value in pregnancy. OR, odds ratio; CI, confidence interval; AOR, adjusted odds ratio: EDD, expected date of delivery; ART, antiretroviral therapy; VL, viral load; 
NI, Northern Ireland. 
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7.2.2 Summary of epidemiological analysis of late antenatal booking 
Nearly 50% of women diagnosed with HIV present to antenatal care beyond thirteen 
weeks of pregnancy, with African women being at higher risk of late booking than 
white British women.  I also found an association between late antenatal booking and 
Southern and Middle African region of birth and, for those diagnosed with HIV before 
the reported pregnancy, duration of residence in the UK, although these were of 
borderline significance.   It is hard to make comparisons with other studies as firstly 
there is no clear consensus on the definition of late antenatal booking and secondly the 
current UK target of before thirteen weeks’ gestation has only been introduced within 
the past three years.  However, the proportion of pregnancies in which booking was late 
in this analysis appears to be higher than in the overall antenatal population in England 
where late booking has been estimated at approximately 30%255.  It is also higher than 
rates of antenatal booking reported previously in HIV-positive women (Parisaei et al. 
2007, Jasseron et al. 2008).  The association between migrant African ethnicity and late 
antenatal booking has previously been reported in the context of HIV in France 
(Jasseron et al. 2008).  It also reflects the well-documented association between 
ethnicity, migration and late booking seen among pregnant women in general256.   
The impact of missing data on these analyses has been discussed in Chapter Three.  The 
analyses were limited by small numbers in comparison to the other analyses presented 
in this thesis as a result of booking date not being routinely collected by the NSHPC 
until 2008.   Furthermore, when booking dates were recorded it was difficult to be 
certain that this date corresponded to antenatal booking and not when the woman first 
attended the HIV antenatal service, which may be some time later257.  
                                                             
255
 Data obtained from NHS maternity statistics tables 2010-2011, England, available at 
http://www.hscic.gov.uk/pubs/maternity1011 (accessed 23 September 2013).  
256
 See Chapter Two for a detailed overview of literature on ethnicity, migration and antenatal booking. 
257
 Discussions with clinical colleagues revealed a lack of clarity regarding what constituted booking date 
and the fact that this date may not be easily available at the time of completing notification forms.   
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7.3 Ethnographic data on antenatal booking 
The analysis of national surveillance data has revealed that nearly 50% of women living 
with HIV book late for antenatal care in the UK with African women more likely to 
book late than white British women.  Late antenatal booking was not only common in 
women who were diagnosed with HIV during their pregnancy, and therefore unaware of 
their HIV status at the time of booking, but was also common in those who already 
knew their HIV status.   These findings draw attention to an apparent disparity in access 
to antenatal care among HIV-positive women.  Why is it that women living with HIV 
present late for antenatal care, and why are African women in particular more likely to 
book late?   
7.3.1 Engaging with antenatal care 
The majority of women who I interviewed (21/24) had presented to antenatal services 
before the end of their first trimester258.  As discussed in Chapter Five, African women 
in diaspora are situated within a transnational healthscape, having had extensive 
experience of biomedicine in their home countries.  My participants had predominantly 
come from urban elite settings where biomedicine carries prestige and cultural 
capital259.  Many had been pregnant before in Africa, and had sought hospital care 
during those pregnancies and antenatal care was therefore not a novel intervention.     
Women were also highly motivated to attend for antenatal care in the context of HIV, in 
much the same way as they were motivated to take ART as described in Chapter Five.  
To be a good mother entails securing a healthy HIV-negative baby and many women 
were anxious to attend for care early to ensure they were on the correct medication.  
Furthermore, as Browner and Press highlight in their study of prenatal care in the US 
(1997), women often find emotional reassurance through regular attendance and see 
technological interventions such as foetal ultrasound and stethoscope as a tool to forge 
intimacy with their unborn child.  This may have even more salience in the context of 
HIV, as touched upon in Chapter Five.   Women may perceive their HIV-positive 
pregnant bodies, carrying a risk of transmitting HIV and the potential toxicity of ART, 
as unreliable and requiring surveillance and monitoring.  Antenatal care therefore offers 
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 This is, of course, a reflection of the fact that women who engaged well with care were also likely to 
be more willing to participate in this study. 
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 Bourdieu’s concept of cultural capital extends the notion of capital beyond the economic sphere and 
into the sphere of culture.  Groups are defined and define themselves through a constellation of symbolic 
practices involved in the consumption of culture such as tastes in music, fashion and art (Bourdieu 1986). 
Here I see biomedicine as a cultural resource whose consumption marks groups as elite.   
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an opportunity for regular blood testing to monitor their clinical condition and foetal 
ultrasound scanning to check their baby’s wellbeing in the context of HIV and ART 
exposure. 
Women generally described the care they received from their HIV antenatal team in 
positive terms.  It was clear from these discussions that women particularly valued the 
fact that their healthcare professionals proactively situated their pregnancy in their daily 
lives, understanding the exigencies of lives often being lived in the margins.  For many, 
pregnancy was overshadowed by the oppressive realities of poverty, poor housing, food 
insecurity and insecure immigration status.   Attending antenatal care was an important 
step towards accessing practical support, especially if they had not been engaged in HIV 
care prior to their pregnancy, and was often the first time a professional had attended to 
their social needs.   This fits into Mol’s “logic of care” (2008) as outlined in Chapter 
Five, in which illness is addressed empathically and is situated within a broader context.  
Some women drew direct comparisons between the care they received by their specialist 
teams, and other clinical services they had come into contact with during their 
pregnancy.  Women were wary of interactions with non-specialist staff who often had 
limited knowledge of HIV and pregnancy, finding them poorly informed or 
judgemental.  In contrast, within the HIV antenatal clinic women felt that they were 
given time and support to understand pregnancy in the context of HIV without fear of 
being stigmatised, the interpersonal relationships with staff being defined by care: 
They [non-specialist staff] are not working because they love their job.  They just do 
their job [...]   If you do it with love, that’s different.  I think that’s the way with my 
midwife.  She is doing it because she loves it and really they can’t compare. 
(Rachel) 
The positive and trusting relationships built with HIV antenatal teams during pregnancy 
fostered confidence and encouraged many women to access antenatal care promptly 
during subsequent pregnancies.   
Some women had referred themselves directly to the specialist midwife who had cared 
for them in a previous pregnancy, which provided a quick and direct way into the 
antenatal system.  Women valued the close relationship they had fostered with their 
midwife, and often contacted them as soon as they realised they were pregnant.  This 
underlines the strength of specialist midwives not only in terms of the skills that they 
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bring to bear in their work but also the continuity of care they offer throughout 
pregnancy and sometimes across the course of a woman’s reproductive trajectory.  
However specialist midwives sometimes felt that their skills were overlooked by other 
members of NHS staff.  They described themselves as being poorly valued by 
colleagues in maternity services, often being pressurised to take on additional non-HIV 
related roles which took them away from their HIV work.  The potential erosion of their 
specialist role, in the context of widespread cuts in public sector funding and over-
stretched maternity services threatens to undermine the high standards of specialist 
antenatal care that HIV-positive women receive, potentially impacting upon women’s 
willingness to engage early in the antenatal process.   
7.3.2 Barriers to antenatal care access 
Late booking was rarely discussed during my interviews260, although HIV specialist 
midwives recognised late booking as a challenge and identified particular barriers to 
early booking for women living with HIV.  One was women’s fear that they may be 
judged for having had unprotected sexual intercourse.  Another was fear of toxicity of 
ART to their unborn child and a desire to avoid medication in the critical first twelve 
weeks of foetal development.  In a clinical setting where prevention of vertical 
transmission is paramount, women may not feel able to discuss their anxieties openly 
resulting in some women delaying access to care in an attempt to avoid judgement by 
healthcare professionals.  This raises concerns that despite interpersonal relationships 
with healthcare professionals being defined by patients as positive and supportive, there 
exists an underlying power structure that may constrain some women’s capacity to 
discuss their reproductive lives openly with healthcare providers.    
Unplanned pregnancy was common among the women I interviewed with eighteen of 
the twenty-four describing their pregnancies as such.  The two women who had 
presented late for antenatal care both described their pregnancies as unplanned and had 
not considered the possibility of pregnancy until second trimester.  For one participant, 
this pregnancy had come within a year of delivering her first child after a single episode 
of unprotected sex, placing great financial strain on her and her partner.  Her 
ambivalence towards her pregnancy resulted in her delaying seeking care until eighteen 
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 This can be partly explained by the fact that national guidelines for antenatal booking evolved over the 
course of this study, with the shift towards booking between ten to twelve weeks occurring from 2010.    
There has been an inevitable a time lag between the publication of guidelines and the evolution of clinical 
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weeks of pregnancy, explaining: 
I liked to put it deep down in me because I knew I was going to get stressed. 
(Audrey) 
Both of the women who had booked late were attending HIV outpatient services prior to 
becoming pregnant, which is of particular concern as it suggests that their sexual and 
reproductive health needs may not have been addressed adequately.   
However, these barriers do not explain why African women in particular were at greater 
risk of booking late antenatally.  It is likely that this reflects ethnic inequalities in 
antenatal care booking more broadly in the general obstetric population. A recent study 
conducted at Newham University Hospital261 found that almost 40% of pregnant women 
booked late for antenatal care beyond twelve weeks of pregnancy and that late booking 
was associated with non-white British ethnicity, inability to speak English and maternal 
birthplace outside the UK (Cresswell et al. 2013).   Qualitative interviews undertaken in 
this study reveal that factors contributing to this disparity included poverty and differing 
notions of what kind of care is required during pregnancy (Professor Angela Harden, 
University of East London, personal communication, 28 Feb 2012).  HIV antenatal care 
staff were conscious that their predominantly African clinic population may not 
subscribe to a biomedical view of pregnancy which may impact on their motivation to 
seek early antenatal care or may have culturally-defined reasons for delaying access to 
care262.   However, it is important to exercise caution when ascribing delays in antenatal 
booking to inherently different conceptions of pregnancy.  As discussed in Chapter 
Five, my participants had wide experience of biomedicine prior to migrating to the UK.  
Many had delivered children in hospitals in Africa, and clearly subscribed to a 
medicalised view of childbirth but early and regular attendance for antenatal care 
remains unusual throughout Sub-Saharan Africa (World Health Organisation 2006).   
Lack of adequate health infrastructure has precluded optimal antenatal care from 
becoming part of the ethno-obstetric system in many settings.  Some African women 
may not be aware of the opportunity or benefits of booking early in pregnancy, 
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 This study is of particular relevance to my work as it was conducted at one of my NHS fieldwork sites 
between 2008 and 2011. 
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 For example in their work in rural KwaZulu-Natal, Myer et al. describe how it is not is not deemed 
appropriate for a woman to seek care until she feels her baby move (2003).  Moreover, disclosing 
pregnancy to anyone outside the immediate family in the early stages, when the baby is viewed as 
particularly vulnerable, may be seen as inviting supernatural misfortune as revealed by recent work on 
barriers to antenatal care in Africans in West London (Martha Chinyoua, University of Northumbria, 
personal communication, 17 July 2012). 
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regardless of HIV status.  Late antenatal booking among African women living with 
HIV must therefore be placed in a wider context of disjunctures in obstetric 
healthscapes that manifest on migration.  This contributes to a broader discussion of 
disjunctures in transnational healthscapes as experienced by HIV-positive African 
women in diaspora, which is highlighted by women’s gratitude for access to ART in the 
context of global inequity in ART distribution as discussed in Chapter Five, and is 
developed further in Chapter Nine in discussions of global disparities in infant feeding 
advice.   
7.4 Experiences on the labour ward263 
During pregnancy, women living with HIV encounter many different parts of the NHS 
service, some of which are staffed by healthcare workers without expertise and 
specialist knowledge of HIV practice, attending appointments for foetal ultrasound 
scanning, blood tests, obstetric care, pharmacy and dentistry.  The majority of women in 
this study described high standards of care antenatally.   However, during their prenatal 
and postnatal interviews with me, some women reported isolated instances of sub-
optimal treatment ranging from carelessness to overt discrimination.  Some described 
inadvertent disclosure of their HIV status to family and friends.  Others were concerned 
that their medical information was being passed between healthcare professionals 
without their consent, some of whom may not need to know their HIV status, 
compromising their ability to manage HIV-related information.  A few women 
described being treated without kindness or consideration by staff who appeared busy, 
uninterested or judgemental, often attributing this to their HIV-status.  Furthermore 
some had experienced overt discrimination including one who had been denied dentistry 
care after revealing her HIV status.  Experiences of breaches of confidentiality and 
discrimination undermined some women’s trust in the healthcare system, prompting 
them to consider concealing their HIV status should they go into labour and find 
themselves being looked after by staff they had not met before.  This is of great concern, 
given that lack of disclosure may preclude important interventions during labour and 
postnatally to prevent vertical transmission.  
Experiences of poor care within maternity services264 were more common with eight of 
the fifteen women I spoke to postnatally describing poor treatment by staff.  
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 The findings in this section are drawn entirely from interviews with my participants.   
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 I use “maternity services” to refer to the care women receive during labour and in the immediate post-
partum period before being discharged home.  This is in contradistinction to antenatal services, which for 
the purposes of this study have been considered separately. 
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Experiences of poor care ranged again from neglect to frank discrimination, and were 
especially painful at this critical juncture in a woman’s journey to motherhood when she 
was likely to feel vulnerable and in need of support.  Before I continue, I would like to 
present two vignettes from my fieldwork.  My intention is not to romanticise these 
women’s suffering but to highlight important failures within the NHS system.  These 
vignettes provide an entry point into a wider discussion about poor maternity care 
experienced by African women living with HIV in the UK. 
7.4.1 Rachel  
Rachel, a 39-year-old Kenyan woman with French citizenship, had been diagnosed with 
HIV during her pregnancy on a routine antenatal screen.  Towards the end of her 
pregnancy, Rachel began to struggle to pay her rent and was facing eviction.  Despite 
being a French citizen and living in the UK for two years, she was not entitled to 
benefits as she had not been aware that she needed to register with the appropriate 
agencies. Her relationship with her controlling and verbally abusive partner had broken 
down during pregnancy and she received no support from him.   Rachel told her 
midwife about her housing and financial difficulties, but did not want this to be shared 
with social services.  However, social services were informed due to concerns about her 
child’s welfare.  They contacted Rachel four weeks before she was due to deliver, to 
inform her that they had no responsibility to care for her, only her baby.  She was 
advised to return to France to deliver, or face the possibility that the child might be 
placed into foster care whilst they try and find her accommodation.  During this time, 
Rachel felt under extreme pressure to return to France.  Practically, she could not 
envisage making a long journey to the South of France (where she had friends) whilst 
being thirty-six weeks pregnant.  However, she was frightened that her baby would be 
“taken” from her, convinced that this was part of a conspiracy to give her baby to a 
childless couple.   
Rachel had made plans to travel to France at this late stage of pregnancy when she woke 
one day, at home on her own, with severe abdominal pain and bleeding.  Unsure of who 
to contact at the hospital and frightened of further contact with services, she delayed 
seeking care until it was clear to her that things were going very badly wrong: 
“I was breaking and my baby was breaking.” 
Finally she contacted a community midwife who informed her to dial 999 as she was 
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too busy to come out to her.  When the ambulance arrived a paramedic attempted 
cannulation several times, unsuccessfully.   Rachel, in agonising pain and still without 
any treatment, begged to be taken to hospital but the paramedic team did not have a bed 
upon which to take her downstairs to the ambulance. Eventually she was carried 
downstairs, in great discomfort, by the paramedic team.    
When Rachel finally arrived at hospital, nearly an hour and a half later, it was too late.  
She had suffered a placental abruption265 and her baby was stillborn.  Whilst recovering 
in hospital, she was visited several times by social workers who continued to discuss her 
case with her, seemingly oblivious to the recent devastating events.  Some of these 
conversations took place in front of Rachel’s visitors, resulting in inadvertent disclosure 
of her HIV status.  When Rachel was discharged from hospital, she left with only £20 to 
buy food and advice to look for work as soon as possible.  Her church stepped in to pay 
for her son’s burial. 
Rachel was clear that the pressure she had been put under during her pregnancy had 
resulted in her son’s death:  
“he didn’t want to smell the dirtiness of this world and to feel the pollution and to see 
the wicked people, so he opened his eyes and then started to break”. 
7.4.2 Esther 
Esther was in her mid-30s and had recently delivered her third child since being 
diagnosed with HIV in 2006.   Originally from Ghana, she had been in the UK for 
eleven years and lived with her husband and children.  Her pregnancy had been largely 
uneventful and she felt she was well prepared having been through the process twice 
before.  However, this time her delivery had been a: 
 “horrible, horrible experience. Like a horrible movie; a horror movie.”   
Esther had planned to have a vaginal delivery so when she started getting contractions 
she went straight to her maternity unit.  On arrival her cervix was found to be 8cm 
dilated and she was taken straight up to the delivery suite.  Once there, she was 
informed that there were no midwives free and she was placed in a wheelchair in the 
main waiting area.  Esther’s contractions were becoming more and more frequent and 
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she was in considerable pain.  She was also alone, as her husband had stayed at home to 
care for her other two children.  Whilst waiting to be allocated a room, Esther was 
confronted by one of the midwives who put his hands to her face and asked her why she 
was shouting, chastising her for making so much noise.  Exhausted and in pain, Esther 
burst into tears.  After half an hour, she was given a room but offered no assistance in 
transferring from her chair to the bed.   
Finally a midwife arrived.  However Esther overheard her talking to a colleague outside 
describing her as “high, high risk”, seemingly with reference to her HIV, and 
expressing some reluctance to attend to her.  The midwife was told by her colleague that 
she was obliged to continue regardless of Esther’s “high risk” and reluctantly entered 
the delivery room.  Esther’s labour proceeded without complication.  After giving birth, 
she was handed her baby by the midwife without him being bathed, something that had 
been specified in her birth plan.  Furthermore, she was left alone in her soiled sheets and 
“a pool of blood”, her baby by her side.    No one came to check up on her in the three 
hours she waited in the delivery room. She was only given clean bedding and assistance 
in washing when the new day shift brought a new midwife who was shocked at the 
condition she had been left in. 
Esther described herself as having been “dehumanised” by events at the hospital that 
morning.  She felt betrayed by the very people she had entrusted her care to.  It had also 
stirred up similar emotions and anxieties to when she had first been diagnosed with HIV 
in 2006 and resulted in her feeling low after her son’s birth.  She eventually received a 
letter of apology from the NHS trust in response to a complaint and she was adamant 
that it would not stop her returning for HIV care at the same hospital.  However, two 
months later, she was still clearly profoundly affected by her experience:  
“when I think of the experience I just had…I wanted to have between four or five kids 
but when I came back I said to my husband ‘no, this is the end of it’”. 
7.4.3 Failures in care 
As demonstrated in both cases above, some women experience neglect in care within 
health services, especially maternity services, around the time of delivery.  This neglect 
was far ranging and included delays in reaching hospital, limited pain relief, being left 
alone at critical points during and after labour, and not being treated with kindness and 
respect.  Some women had noted that this had been different to previous experiences of 
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maternity services in the UK, and attributed this to staff shortages, some pointing to the 
well-publicised health sector cuts.  Many found it hard to ascertain whether their poor 
treatment was a direct result of their HIV-status or whether it reflected broader 
problems within British maternity services. 
A recent study revealed an increase in maternal morbidity in London between 2005 and 
2011 (Bewley et al. 2012), although the authors state that it is hard to know whether this 
was due to increasing complexity of cases or a decline in quality of services.  There is 
currently a recognised deficit in the maternity services workforce in the UK, with a 
particular problem in staff retention in London, which has resulted in huge pressures 
within the system (Royal College of Midwives 2011) and fragmentation of services 
(Bourke 2013).  A national review of maternity services across 152 NHS trusts 
identified significant problems with poor levels of staffing, lack of continuity of care 
and poor facilities (Healthcare Commission 2008).  A survey of women’s experiences 
of maternity care has shown a variability of services across the country.  Two of the 
NHS trusts that I conducted fieldwork within received average scores for their maternity 
services at the time of my fieldwork, although one scored badly in the domain 
pertaining to women being treated with kindness and respect266 (Care Quality 
Commission 2010).  The other centre I was based in had been scored below average in 
all aspects of care during and after delivery, most notably in trust in staff, being left 
alone during and after labour, and communication between staff and patients.  This 
same survey of 20,000 women in England identified that only 63% reported being 
treated with kindness in maternity services, whilst 8% reported not being able to obtain 
pain relief during labour. 
It is therefore important to place HIV-positive women’s experience of maternity 
services within a broader context of widespread difficulties in maternity care in general. 
There are also important ethnic disparities in care with studies showing that women 
from black and minority ethnic communities experience poorer levels of maternity care 
(Bharj et al. 2008)267.   A qualitative study of maternity care in women from black and 
minority ethnic communities demonstrated that experiences of racism and ethnic 
stereotyping were not uncommon (McCourt et al. 2000).  There has been very limited 
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 Data obtained from Survey of Women's Experiences of Maternity Care available at 
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 Between 2006 and 2008, maternal morbidity and mortality was higher in black African women than 
white British women (Centre for Maternal and Child Enquiries 2011).  Nineteen maternal deaths were 
reported in African-born women, the majority being in asylum seekers, refugees and new migrants.  
Again it is hard to establish whether this is due to poorer health within this group or poorer care. 
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qualitative research specifically into the experiences of maternity services within black 
African communities in the UK.   However, two studies with Somali women in London 
have also highlighted the prevalence of racism and ethnic stereotyping, as well as 
identifying lack of appropriate interpreting services as an important barrier to receiving 
good care (Bulman et al. 2002, McLeish 2005). 
Some of my participants certainly encountered worse care as a result of social 
marginalisation, highlighting how women come to embody structural inequalities in the 
form of suffering during labour recalling the earlier discussion of women’s embodiment 
of structural violence in terms of access to ART in Chapter Five.  Rachel had been 
aggressively pursued by social services in the latter stages of her pregnancy. Not only 
did she feel that this had contributed to her obstetric complications, but it also 
manifested in delays in her seeking care when things started to go wrong.  She was 
further disempowered by the fact that her partner had abandoned her, expressing doubt 
that social services would have got involved had he financially supported her.  Other 
women felt that their poor experience would have been avoided had they been 
accompanied by partners and friends who could have advocated on their behalf.  Their 
social isolation, often a result of stigma or fear of it, had made them particularly 
vulnerable to poor levels of care.  This echoes the work of both Martin (1987) and 
Jordan (1997) who have highlighted the central role of social networks in helping 
women in the US secure better standards of care and choice during labour.   Being alone 
and from a socially marginalised group that may be perceived to be less likely to 
complain made many women especially vulnerable to abuses of care: 
I think they treat you like dogs […] they are treating lots of people who are afraid to 
talk about them. 
(Rachel) 
Of the eight women who experienced poor care within maternity services at the time of 
delivery, two described overt discrimination as a result of their HIV-status.  Four others 
could not say for certain whether their experiences had been driven by stigma towards 
their HIV status, as this was often not made explicit by healthcare providers.  However, 
they were sensitive to the possibility that it was a result of being HIV-positive.  It is 
useful here to refer to the work of Scambler and Hopkins on stigma and epilepsy (1986) 
in which they make a distinction between enacted stigma, that is identifiable acts of 
discrimination, and felt stigma which is “more complex [and] refers principally to the 
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fear of enacted stigma, but also encompasses a feeling of shame” (Ibid.: 33).  Although, 
enacted stigma was not common, felt stigma was experienced by some participants 
resulting in anxiety and mistrust when entering maternity services. 
However, some women such as Esther had experienced enacted stigma within maternity 
services as a direct result of their HIV status.  Sandelowski’s metasynthesis of work on 
stigma in HIV-positive women highlights the centrality of felt and enacted stigma in the 
lives of women living with HIV (2004).  Studies have previously described 
discrimination towards HIV-positive women within maternity services, although this 
work is largely from the US or predates the HAART era (Prince et al. 1989, Green et al. 
2000, Tyer-Viola 2007).  A cross-sectional study of people living with HIV in East 
London found that almost one in ten women had experienced discrimination from 
healthcare providers within maternity services (Elford et al. 2008a) whilst recent work 
from Northern Ireland has revealed that HIV-related negative experiences of healthcare 
were commonly described by HIV-positive pregnant women (Kelly et al. 2012b). 
I was particularly struck by Esther’s story.  It seemed highly symbolic that she be left in 
soiled sheets and her own “high risk” blood, with her baby unwashed.  It appeared to be 
a remarkable dereliction of duty.  On one level it is easy to partly attribute this type of 
behaviour as instrumental stigma, driven by a fear of HIV transmission in staff who 
have limited knowledge and experience of caring for those living with HIV.  However, 
it is important to remember that stigma is created within a wider social context268.  
Collective representations of HIV have associated it with other discrediting attributes 
such as perceived sexual deviance and injecting drug use.  This symbolic violence 
operates on a pervasive level and often operates unnoticed and unremarked upon269.  
Furthermore, there is a synergistic effect between HIV-related stigma and other forms 
of social inequality such as ethnicity and immigration status, which can constrain 
people’s capacity to confront discrimination (Castro et al. 2005).  Stigma produces and 
reproduces power relations, and acts to serve the interests of a dominant group.  The use 
of stigmatising ethnic stereotypes within midwifery has previously been described 
(Bowler 1993).  Not only does it function as ‘shorthand’ in midwives’ decision-making 
about the type of care a patient requires, but it also protects against anxiety that may be 
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 Parker and Aggleton describe the notion of symbolic violence, with reference to Bourdieu, as it relates 
to HIV-related stigma (2003).   It is the process by which “symbolic systems” operate to serve the 
interests of dominant groups through the mobilisation of cultural resources in daily practice to legitimise 
structures of inequality through hegemony in almost intangible ways. 
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evoked by patients that present challenges.   I suggest that in this particular context 
some maternity care staff with little knowledge and experience of HIV may 
subconsciously employ negative stereotypes to serve their own interests in protecting 
themselves from anxiety. 
But how does stigma and discrimination operate in the case of the HIV-positive 
pregnant woman?  Much of what I have described thus far could apply to other services 
within healthcare.  Whilst recognising the importance of instrumental stigma and fears 
surrounding HIV transmission, it is important to note that these fears are exaggerated in 
the context of women being on ART and the low risk of HIV acquisition through 
occupational exposure.  So what else could be at play and what is it in particular about 
pregnancy and HIV that produces stigmatising attitudes?  Using the work of the social 
anthropologist Mary Douglas ([2002] 1966) and the psychoanalytic theorist Julia 
Kristeva (1982), I wish to explore the symbolic processes that may lie beneath the 
interactions between maternity care providers and HIV-positive women270.   
Esther’s experience in hospital suggests a deep-rooted fear of her “high-risk” blood 
manifesting in her midwife’s reluctance to care for her, clean her sheets or bathe her 
baby.  Esther’s blood was seen as polluting.    The notion of HIV as polluting was 
further reinforced by women’s own internalised stigma highlighted by repeated 
references to their disease or themselves as “disgusting” or “dirty”.  Douglas ([2002] 
1966), in her seminal work on pollution and taboo, laid bare the symbolic basis of 
pollution beliefs.  For Douglas the body is a representation of the social order at large, 
with the integrity of the body mirroring the integrity of the body politic.  Rules 
governing what constitutes bodily pollution and danger are therefore likely to symbolise 
deeper anxieties about threatened social structures.  The creation of domains of the pure 
and the polluting is an inherently symbolic process, and represent an attempt to impose 
order on experience.  If we set aside the instrumental reasons as to why HIV may be 
seen as polluting, we can try and engage with what other forces may be operating.  
Douglas writes: 
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exploring notions of breaching of bodily boundaries and symbolic ambiguity which I will be elaborating 
upon with reference to the HIV-positive labouring woman. 
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“The body is a model which can stand for any bounded system. Its boundaries can 
represent any boundaries which are threatened or precarious.” 
(Douglas [2002] 1966: 142) 
Bodily margins, like all margins, are dangerous as they stand at the border between one 
thing and another, constituting the most vulnerable part of what they attempt to contain.  
Green and Sobo (2000) note that fear of HIV-infection in healthcare workers through 
medical procedures was intensified if they involved “symbolically important areas […] 
such as the mouth and throat [and] the vagina” (Ibid.:127).  The authors attribute this to 
their social salience and use in fundamental processes such as communication and sex.  
However, they are also structures at the margins, which may imbue them with symbolic 
notions of danger.  The HIV-positive delivering woman is different to many other 
people living with HIV.  Her boundaries have been breached through the physiology of 
pregnancy271.  The woman herself may feel this in that the breaching of the boundaries 
between herself and her baby (the umbilical cord and the vaginal passage), become 
especially dangerous in the context of risk of vertical transmission.   
When confronted with dirt and disorder, we have two actions open to us.  We can either 
contain it, or we can reject it in an attempt to ward off danger (Yang et al. 2007).  This 
realm of the rejected that instils disgust and horror is termed the abject by Kristeva 
(1982).  Both Douglas and Kristeva see ambiguity at the heart of pollution and abjection 
respectively.  Douglas describes the dangers of the person “in a marginalised state” 
whose status cannot be defined ([2002] 1966: 118).  A prime example is the unborn 
child, not dead but not yet fully alive, who along with its pregnant mother is often 
viewed as dangerous in many cultures (Ibid.).  Kristeva’s notion of abjection is similar: 
“It is thus not lack of cleanliness or health that causes abjection but what disturbs 
identity, system, order.  What does not respect borders, positions, rules.  The in-
between, the ambiguous, the composite.” 
(Kristeva 1982: 4)  
I suggest that stigma towards HIV-positive pregnant women may arise as a combined 
product of the dangers inherent in the breaching of bodily margins, and their anomalous 
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lack of “rigid body boundaries” (2011: 127). 
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position in the symbolic order.  HIV-positive pregnant women disrupt simple binary 
oppositions.  They represent the idealised contained sexuality of the mother and the 
uncontained sexuality of people living with HIV, in dominant collective representations 
of HIV.  They appear, on the whole, well but are unwell.  They are the nurturing mother 
who has the potential to harm her child; the responsible mother and the irresponsible 
woman who risks bearing a child who may acquire HIV.  They embody life and death; 
joy and sorrow.  Furthermore, they are not quite separate enough.  Kristeva writes that 
the abject “lies there, quite close, but… cannot be assimilated” (Ibid.: 1).  The HIV-
positive mother does not fully occupy the position of other and is not quite “different 
enough” (Harris 2009: 41).  It is the combined power of ambiguity and recognition of 
self that invites abjection; a strategy that restores symbolic order by placing HIV-
positive mothers in the realm of the abject.   
In a study in 1992 Green and Sobo discovered that one of their participants had been 
“forced to sleep in sheets ‘all covered in blood’ after she gave birth” (2000: 125).  It 
seems remarkable that twenty years later I would be told similar stories.  However, a 
symbolic account of stigma, rather than a functional one, can help us understand the 
durability of these responses.  Childbirth can be a time when a woman feels especially 
vulnerable, and these experiences coming at this critical juncture in women’s transition 
into motherhood had considerable impact with many women crying as they spoke of 
what had happened to them.  These abuses within healthcare, whether frank 
discrimination or interactions that lack empathy and kindness, often remain invisible yet 
cause considerable suffering, violating the trust women have in healthcare professionals 
and  risking future engagement with services.  For my participants perceived stigma 
from healthcare professionals, a group which has the status of “wise” (Goffman [1990] 
1963)272, reified internalised notions of shame about their HIV-status and served to 
constrain women’s future reproductive decisions and their long-term engagement with 
healthcare services as a whole.  Healthcare professionals are, with good reason, 
expected to be informed about conditions such as HIV and to act with compassion and 
without judgement (Green et al. 2000: 132).  Given the position of power they occupy, 
their discriminatory behaviour may be especially corrosive. 
Despite these painful stories, none of the women who had disclosed receiving poor 
maternity care said that this would deter them from coming back for HIV care 
                                                             
272
 Goffman describes the “wise” as people who are do not have the discrediting attribute but have 
specialist knowledge or experience of working with the stigmatised.   
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postnatally; all of them seeing the HIV clinic as being completely separate from the 
maternity services.    
7.5 Conclusions 
In this chapter I have used a combination of national surveillance and ethnographic data 
to explore how women access and experience health services during pregnancy.  Nearly 
50% of women diagnosed with HIV do not present to antenatal care until beyond 
thirteen weeks of pregnancy, with African women being at higher risk of late booking 
than white British women.  This does not appear to be HIV-related per se, but rather a 
reflection of broader ethnic disparities in antenatal care access in general.  Unplanned 
pregnancy, cultural constructions of pregnancy, lack of knowledge of the importance of 
early booking and the effects of structural inequalities such as poverty and insecure 
immigration status, may also be important contributing factors.   
Once booked the majority of women describe good care within HIV antenatal services 
forging good relationships with healthcare providers.   However, some women 
described experiences of poor care within maternity services, which was more 
pronounced at the time of delivery.  This ranged from neglect, perhaps reflecting wider 
constraints within maternity services in general, to overt discrimination as a result of 
their HIV-positive status.  I have attempted to move beyond the instrumental nature of 
stigma through an exploration of deeper symbolic processes such as the breaching of 
bodily integrity and the notion of abjection in order to explain the persistence of stigma 
towards HIV among healthcare professionals in a post-HAART era.   
Key points 
 One in two HIV-positive women in the UK booked late for antenatal care 
between 2008 and 2010, with African women more likely to book late. 
 Late antenatal booking in HIV-positive African women is likely to reflect 
broader ethnic disparities in antenatal access in the UK due to a number of 
factors including poverty, lack of knowledge of services and cultural 
constructions of pregnancy. 
 The majority of women described positive experiences of HIV antenatal care. 
 Some women described poor care within maternity services, particularly around 
the time of delivery, ranging from neglect to overt discrimination. 
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8  
           
Returning to HIV services after pregnancy  
 
 
Summary 
In this chapter I explore the engagement with HIV services by African women for their 
own care after pregnancy.  In this third and final mixed methods empirical chapter of 
the thesis, I first use NSHPC data to examine the association between loss to follow-up 
from HIV care in the year after pregnancy and: (i) maternal ethnicity, (ii) maternal 
African region of birth, and (iii) maternal duration of residence in the UK at conception.  
I then contextualise these findings with ethnographic data to explore what facilitates 
engagement with HIV care after pregnancy, and why some women may find it hard to 
engage.  
8.1 Introduction 
In the previous chapter I explored the engagement with and experiences of health 
services during pregnancy.  I found that one in two HIV-positive women booked late 
for antenatal care, with African women more likely to book late than their white British 
counterparts.  However, once engaged in care most women described positive 
experiences with their HIV antenatal care team.   In contrast, a number of women 
described negative experiences of care within maternity services around the time of 
delivery, perhaps as a result of their HIV-positive status.   
HIV clinical care does not conclude with the end of pregnancy.  HIV is a chronic, if 
manageable, condition requiring long-term engagement with clinical services in order to 
access monitoring and treatment, if indicated.  It is important that women attend 
specialist HIV services after pregnancy to safeguard their own health, which also has a 
consequent effect on their dependent children and their risk of transmitting HIV 
sexually.  The transformation of HIV into a chronic condition has resulted in retention 
in care becoming a priority in the delivery of HIV services with recent UK standards 
recommending that ≥95% of people diagnosed with HIV should be accessing clinical 
services at least once a year (British HIV Association 2012).    Factors such as poor 
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experiences of maternity care and the responsibilities of looking after a baby may make 
it particularly difficult for a woman to access healthcare after pregnancy.  However, as 
discussed in Chapter Two, very little is currently known about the access to HIV 
services by women after pregnancy, especially within resource-rich settings such as the 
UK. 
In this final mixed methods empirical chapter of the thesis, I focus upon women’s 
engagement with HIV services after pregnancy.  First I use data from the NSHPC to 
examine the relationship between maternal ethnicity, African region of birth and 
duration of residence in the UK, and loss to follow-up from HIV care in the year after 
pregnancy.    I then contextualise these findings with ethnographic data, based mainly 
on interviews with pregnant women and their healthcare providers in order to explore 
women’s engagement with HIV services after pregnancy and possible barriers to 
accessing care. 
8.2 Epidemiological data on maternal loss to follow-up after pregnancy 
In this section I explore the association between loss to follow-up from HIV care in the 
year after pregnancy and: (i) maternal ethnicity, (ii) maternal African region of birth, 
and (iii) maternal duration of residence in the UK at conception (for African women).   
This analysis was restricted to pregnancies reported to the NSHPC with an EDD (if the 
outcome was not a live or still birth) or actual date of birth between January 2000 and 
December 2009. Pregnancies or attendances reported in Scotland were excluded from 
this analysis.  Up until recently, reports from Scotland were not linked over time and it 
was therefore not possible to track the same patient over time reliably.  Pregnancies 
were also excluded if it was documented that the woman had left the UK during her 
pregnancy273.  Year of EDD or date of delivery was included in all models as an a priori 
confounder.  Other potential confounders considered included maternal age, history of 
injecting drug use, time since diagnosis, last CD4 count and viral load in pregnancy, 
reporting region, outcome of pregnancy and gestation at delivery.    Robust standard 
errors were used to account for possible clustered effects in sequential pregnancies in 
the same mother.  This analysis is based on a matched dataset using data from the 
                                                             
273
 Only a small proportion (17.2%, 27/157) of women who were reported to have left the UK during their 
pregnancy appeared in subsequent SOPHID or NHSPC datasets and it was therefore reasonable to assume 
that if a woman left the country that she did not return.  
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NSHPC and the Survey of Prevalent HIV Infections Diagnosed (SOPHID)274.  Loss to 
follow up (LTFU) was defined as no documented attendance for HIV care at a NHS 
clinic in England, Wales or Northern Ireland during the calendar year after the end of 
pregnancy275.   This measure was selected as a result of new draft standards of HIV care 
by the British HIV Association (British HIV Association 2012) that defines loss to 
follow-up as not accessing clinical services for twelve months276.  For the purposes of 
this study LTFU was categorised as “No” or “Yes”.  It is likely that some women who 
were reported to the NSHPC as pregnant were not matched in SOPHID because they 
had never attended for HIV care in England, Wales or Northern Ireland.  There is a 
therefore a possibility of underestimating LTFU if these pregnancies are excluded.  To 
address this, two multivariable logistic regression models were built for each exposure 
variable.  In model 1 pregnancies in women that were not matched on the SOPHID 
dataset were excluded from analysis. In model 2 women who were not matched in the 
matching process were assumed to be lost to follow-up and coded as such.   
8.2.1 Results 
There were 8150 eligible pregnancies reported to the NSHPC between January 2000 
and December 2009, of which 7219 (88.6%) were in women who were matched with 
records in the SOPHID database.   
Eight pregnancies were in women who were known to have died in either the year of 
pregnancy or the year after, and they were excluded from analysis.  This analysis is 
therefore based on 7211 pregnancies in 5390 women.  Like previous analyses, nearly 
90% of pregnancies (6485/7211) were in African women.  Other demographic and 
clinical characteristics of the study population are presented in table 8.1.    
                                                             
274
 See Chapter Three for an overview of SOPHID and a description of the record linkage process (63-
65). 
275
 There is no standardised definition for loss to follow-up in HIV with numerous measurements used in 
studies such as varying lengths of time between outpatient appointments (Yehia, et al. 2012, Chi, et al. 
2011, Helleberg, et al. 2012). 
276
 It also allows comparison with previous studies on loss to follow-up in the overall HIV-positive 
population in the UK (Rice et al. 2011).   
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Table 8.1:  Demographic and clinical characteristics of women with pregnancies reported to 
the NHSPC in 2000-2009 by maternal follow-up in the calendar year following pregnancy 
 
 
 
 
Not LTFU by 1 year,  
n (row %) 
n=6309 
LTFU by 1 year,  
n (row %) 
n=902 
p-value* 
 
 
Ethnicity, n=7211 
White British 
African 
 
669 (92.2) 
5640 (87.0) 
 
57 (7.9) 
845 (13.0) 
 
<0.001 
Maternal age at delivery, n=7060 
<25 years 
25-34 years 
шϯϱ years 
 
808 (83.3)  
3853 (87.9) 
1556 (91.2) 
 
162 (16.7) 
530 (12.1) 
151 (8.9) 
 
<0.001 
Year of EDD/delivery, n=7211 
2000-2003 
2004-2006 
2007-2009 
 
1487 (86.2) 
2188 (86.5) 
2634 (89.1) 
 
238 (13.8) 
341 (13.5) 
323 (10.9) 
 
0.003 
IDU, n=7211 
No 
Yes 
 
6271 (87.5) 
38 (95.0) 
 
900 (12.6) 
2 (5.0) 
 
0.150 
Last CD4 count
¶
, cells/µl, n=6223 
шϯϱϬ 
200-249 
<200 
 
3339 (87.5) 
1544 (90.6) 
639 (91.2) 
 
478 (12.5) 
161 (9.4) 
62 (8.8) 
 
<0.001 
Last HIV viral load
¶
, copies/ml, 
n=6297 
<50 
шϱϬ 
 
 
3632 (90.9) 
1944 (84.6) 
 
 
366 (9.2) 
355 (15.4) 
 
 
<0.001 
Time since HIV diagnosis, n=6594 
>5 years 
1-5 years 
<1 years 
 
1199 (93.4) 
2100 (89.2) 
2510 (84.9) 
 
85 (6.6) 
254 (10.8) 
446 (15.1) 
 
<0.001 
Reporting region, n=6480 
London 
England (not London) 
Wales and Northern Ireland 
 
3043 (89.3) 
2564 (86.2) 
90 (90.0) 
 
363 (10.7) 
410 (13.8) 
10 (10.0) 
 
0.001 
Outcome of pregnancy, n= 7060 
Live birth 
Still birth 
Miscarriage/ectopic 
Termination 
 
5610 (87.9) 
65 (86.7) 
333 (90.2) 
209 (88.2) 
 
769 (12.1) 
10 (13.3) 
36 (9.8) 
28 (11.9) 
 
0.594 
Gestation at delivery
¶¶
, n=6416 
шϯ7 ǁeeks 
<37 weeks 
 
4833 (87.9) 
811 (88.4) 
 
666 (12.1) 
106 (11.6) 
 
0.634 
* Obtained using χ2 test. ¶ Last reported value in pregnancy. ¶¶ Restricted to live and still births.  EDD, 
expected date of delivery; IDU, likely route of HIV acquisition was maternal injecting drug use. 
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Overall, in 12.5% of pregnancies reported to the NSHPC women did not access HIV 
care in the year after pregnancy (902/7211; 95% CI: 11.7%, 13.3%)277.  This proportion 
rose to 22.5% (1833/6309; 95% CI: 21.6%, 23.4%) when unmatched records were 
included and coded as lost to follow-up.  Therefore the proportion of pregnancies where 
women were lost to follow-up in the subsequent year was likely to be between 12.5% 
and 22.5%.   
On univariable analysis there was an association between LTFU and ethnicity, younger 
maternal age at delivery, earlier year of EDD/delivery, higher maternal CD4 count at 
the end of pregnancy, detectable maternal viral load at the end of pregnancy, more 
recent maternal HIV diagnosis and pregnancy being reported in areas of England 
outside London (all p<0.05; table 8.1). There was no association between either 
injecting drug use as the route of HIV acquisition or outcome of pregnancy and LTFU 
(p>0.1). 
The percentage of LTFU varied over time rising from 9.0% in 2000 to a peak of 15.1% 
in 2003, falling to 11.1% in 2009 (p<0.05; figure 8.1).  Of the 902 women who did not 
return for HIV care in the year after pregnancy, 22.2% returned in the subsequent year.  
After excluding women who died during the study period, a total of 460 women who 
had been reported as pregnant to the NSHPC (6.4%; 95% CI: 5.8%, 6.9%) never 
returned for follow-up by the end of 2010.   
The proportion of women who returned for follow-up after pregnancy by the end of the 
study period (December 2010) decreased between 2000 and 2009 (χ2trend test p<0.001; 
figure 8.2).  However, this was mainly due to the fact that women who were pregnant 
earlier in the study period had greater opportunity to return for care by December 2010 
than those in later years.  To obtain a more accurate estimate, I looked at the proportion 
of pregnancies after which women did not return for HIV care in the five years after 
pregnancy, restricting this to pregnancies reported between 2000 and 2005.  Nearly 6% 
of women who were reported as pregnant between 2000 and 2005 did not return for 
HIV care in the five years after their pregnancy, excluding 28 women who died during 
this time period (183/3309; 5.5%; 95% CI: 4.8%, 6.3%).  The proportion lost to follow-
up at five years did not vary over time (p>0.1).  Loss to follow-up at five years was 
more common in women of African ethnicity than of white British ethnicity (6.1% vs. 
                                                             
277
 Some of these pregnancies were in sequential pregnancies in the same woman.  These were included in 
the analysis as independent observations with robust standard errors to account for clustering.  
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1.2%; p<0.001).  Among African women, a greater proportion of those from Western 
and Southern Africa and those who had arrived in the UK during conception did not 
return for HIV care in the 5 years following their pregnancy (all p<0.001).    
Figure 8.1: Trends over time in loss to follow-up in the calendar year following pregnancy, 
2000-2009 
 
LTFU, loss to follow-up; EDD, estimated date of delivery 
 
 
Figure 8.2: Trends over time in loss to follow-up to December 2010 
 
 
 
LTFU, loss to follow-up; EDD, estimated date of delivery 
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Returning to loss to follow-up in the year after pregnancy, a greater proportion of 
African women (13.0%; 845/6485) were lost to follow-up compared with women of 
white British ethnicity (7.9%; 57/726; p<0.001).  After adjusting for maternal age, year, 
last CD4 and viral load in pregnancy, time since HIV diagnosis and reporting area, 
African women were twice as likely as white British women to be lost to follow-up in 
the year subsequent to their pregnancy (AOR 2.17; 95% CI: 1.50, 3.14; p<0.001; table 
8.2, model 1).  This association persisted but was attenuated when I included women 
who had not been matched in the matching process (AOR 1.65; 95% CI: 1.27, 2.16; 
p<0.001; table 8.2, model 2). 
Restricting the analysis to pregnancies in African women, a significantly higher 
proportion of Southern African women (22.1%; 105/476) and Western African women 
(16.0%; 227/1415) did not return for HIV care in the year after pregnancy compared 
with women from Eastern Africa (11.0%; 432/3919) and Middle Africa (12.0%; 81/675; 
p<0.001).  After adjusting for maternal age, year, last CD4 and viral load in pregnancy, 
time since HIV diagnosis and reporting area, Southern African women were twice as 
likely as Eastern African women not to return for HIV care in the year after pregnancy 
(AOR 1.99; 95% CI: 1.48, 2.67; p<0.001; table 8.3, model 1). Western African women 
also had increased odds of being lost to follow-up in the year after pregnancy compared 
with Eastern African women (AOR 1.56; 95% CI: 1.25, 1.56; p<0.001; table 8.3, model 
1).    These associations were attenuated but remained significant when women who 
were not matched were included and coded as lost to follow-up (table 8.3, model 2).   
Among African women there was a difference in LTFU according to maternal duration 
of residence in the UK at conception.  A greater proportion of women who arrived in 
the UK after conception (23.9%; 76/318) and those who arrived less than four years 
prior to conception (13.2%; 246/1866) did not return for HIV care in the year after 
pregnancy compared with women who had resided in the UK for four or more years 
prior to conception (9.7%; 213/2203; p<0.001).  After adjusting for year, last CD4 and 
viral load in pregnancy, time since HIV diagnosis and reporting area, the odds of not 
returning to care in the year after pregnancy were similar for women who had arrived in 
the UK less than four years prior compared with those who had been in the UK for four 
or more years (AOR 1.11; 95% CI: 0.86, 1.44; p>0.1; table 8.4, model 1).  This 
remained the case when unmatched women were included in the analysis and coded as 
lost to follow-up (table 8.4, model 1).  However, women who had arrived in the UK 
after conception were over 1.5 times more likely to be lost to follow-up during the year 
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after pregnancy compared with those who had been in the UK for four or more years 
(AOR 1.60; 95% CI: 1.06, 2.42; p<0.05; table 8.4, model 1).  Again, the results were 
similar when women who were not matched across the datasets were included in the 
analysis (table 8.4, model 2).   
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Table 8.2: Univariable and multivariable analysis of the association between maternal ethnicity and loss to follow-up in the calendar year following 
pregnancy 
  Model 1 Model 2 
 Univariable analysis Multivariable analysis, n=5741 Multivariable analysis, 
n=6042 
 OR (95% CI) p-value AOR (95% CI) p-value AOR (95% CI) p-value 
Ethnicity 
White British 
African 
 
1.00 
1.76 (1.34,2.33)  
 
 
<0.001 
 
1.00 
2.17 (1.50,3.14) 
 
 
<0.001 
 
1.00 
1.65 (1.27,2.16) 
 
 
<0.001 
Maternal age at delivery 
<25 years 
25-34 years 
шϯϱ years 
 
1.00 
0.69 (0.57,0.83) 
0.48 (0.38,0.61) 
 
<0.001 
 
1.00 
0.73 (0.58,0.92) 
0.67 (0.50,0.91) 
 
 
0.009 
0.009 
 
1.00 
0.76 (0.63,0.92) 
0.82 (0.65,1.03) 
 
 
0.005 
0.086 
Year of EDD/delivery 
2000-2003 
2004-2006 
2007-2009 
 
1.00  
0.97 (0.81,1.16) 
0.77 (0.64,0.92) 
 
0.003 
 
1.00 
1.04 (0.82,1.31) 
0.97 (0.76,1.24) 
 
 
0.743 
0.820 
 
1.00 
0.91 (0.76,1.08) 
0.87 (0.72,1.04) 
 
 
0.288 
0.133 
IDU 
No 
Yes 
 
1.00 
0.37 (0.09,1.52) 
 
0.107 
    
Last CD4 count
¶
, cells/µl,  
шϯϱϬ 
200-249 
<200 
 
1.00 
0.73 (0.60,0.88) 
0.68 (0.51,0.89) 
 
<0.001 
 
1.00 
0.69 (0.56,0.84) 
0.50 (0.36,0.70) 
 
 
<0.001 
<0.001 
 
1.00 
0.84 (0.72,0.97) 
0.67 (0.53,0.84) 
 
 
0.020 
0.001 
Last HIV viral load
¶
, copies/ml 
<50 
шϱϬ 
 
1.00 
1.81 (1.55,2.12) 
 
<0.001 
 
1.00 
1.78 (1.47,2.16) 
 
 
<0.001 
 
1.00 
1.42 (1.23,1.64) 
 
 
<0.001 
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Table 8.2 continued 
  Model 1 Model 2 
 Univariable analysis Multivariable analysis, 
n=5741 
Multivariable analysis, 
n=6042 
 OR (95% CI) p-value AOR (95% CI) p-value AOR (95% CI) p-value 
Time since HIV diagnosis  
>5 years 
1-5 years 
<1 years 
 
1.00 
1.71 (1.32,2.20) 
2.51 (1.97,3.19) 
 
 
<0.001 
 
1.00 
1.54 (1.13,2.09) 
1.95 (1.43,2.67) 
 
 
0.006 
<0.001 
 
1.00 
1.58 (1.26,1.97) 
1.98 (1.58,2.49) 
 
 
<0.001 
<0.001 
Reporting region 
London 
England (not London) 
Wales and Northern Ireland 
 
1.00 
1.34 (1.15,1.56) 
0.93 (0.48,1.81) 
 
0.001 
 
1.00 
1.29 (0.36,0.70) 
1.28 (0.59,2.74) 
 
 
0.007 
0.532 
 
1.00 
1.47 (1.28,1.70) 
1.89 (1.16,3.09) 
 
 
<0.001 
0.010 
Outcome of pregnancy 
Live birth 
Still birth 
Miscarriage/ectopic 
Termination 
 
1.00  
1.12 (0.57,2.19) 
0.79 (0.55,1.12) 
0.98 (0.65,1.46) 
 
0.575 
 
 
 
 
 
  
Gestation at delivery 
шϯ7 ǁeeks 
<37 weeks 
 
1.00 
0.95 (0.76,1.18) 
 
0.634 
    
Model 1: Analysis includes only records that were matched in NSHPC and SOPHID datasets. 
Model 2: Pregnancies that were unmatched in SOPHID were recoded as lost to follow up. 
¶ Last reported test in pregnancy. OR, odds ratio; AOR, adjusted odds ratio: EDD, expected date of delivery; IDU, likely route of HIV acquisition was  
maternal injecting drug use. 
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Table 8.3: Univariable and multivariable analysis of the association between maternal African region of birth and loss to follow-up in the calendar year 
following pregnancy (restricted to African women) 
  Model 1 Model 2 
 Univariable analysis Multivariable analysis, n=4933 Multivariable analysis, 
n=5450 
 OR (95% CI) p-value AOR (95% CI) p-value AOR (95% CI) p-value 
African region of birth 
Eastern Africa 
Southern Africa 
Western Africa 
Middle Africa 
 
1.00 
2.28 (1.80,2.90) 
1.54 (1.30,1.83) 
1.10 (0.85,1.42) 
 
 
<0.001 
<0.001 
0.457 
 
1.00 
1.99 (1.48,2.67) 
1.56 (1.25,1.96) 
1.04 (0.74,1.47) 
 
 
<0.001 
<0.001 
0.824 
 
1.00 
1.60 (1.26,2.02) 
1.22 (1.02,1.47) 
0.85 (0.65,1.11) 
 
 
<0.001 
0.032 
0.234 
Maternal age at delivery 
<25 years 
25-34 years 
шϯϱ years 
 
1.00 
0.64 (0.52,0.78) 
0.45 (0.35,0.58) 
 
<0.001 
 
1.00 
0.74 (0.57,0.95) 
0.71 (0.52,0.98) 
 
 
0.020 
0.036 
 
1.00 
0.72 (0.59,0.89) 
0.81 (0.64,1.03) 
 
 
0.002 
0.092 
Year of EDD/delivery 
2000-2003 
2004-2006 
2007-2009 
 
1.00  
0.97 (0.80,1.16) 
0.76 (0.63,0.91) 
 
0.003 
 
1.00 
0.98 (0.77,1.25) 
0.90 (0.70,1.17) 
 
 
0.878 
0.435 
 
1.00 
0.88 (0.73,1.06) 
0.83 (0.68,1.00) 
 
 
0.194 
0.053 
Last CD4 count
¶
, cells/µl,  
шϯϱϬ 
200-249 
<200 
 
1.00 
0.73 (0.60,0.89) 
0.66 (0.50,0.88) 
 
<0.001 
 
1.00 
0.72 (0.58,0.88) 
0.51 (0.37,0.72) 
 
 
0.002 
<0.001 
 
1.00 
0.83 (0.71,0.97) 
0.66 (0.52,0.83) 
 
 
0.018 
0.001 
Last HIV viral load
¶
, copies/ml 
<50 
шϱϬ 
 
1.00 
1.85 (1.57,2.17) 
 
<0.001 
 
1.00 
1.86 (1.53,2.27) 
 
 
<0.001 
 
1.00 
1.44 (1.24,1.68) 
 
 
<0.001 
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Table 8.3 continued 
  Model 1 Model 2 
 Univariable analysis Multivariable analysis, 
n=4933 
Multivariable analysis, 
n=5450 
 OR (95% CI) p-value AOR (95% CI) p-value AOR (95% CI) p-value 
Time since HIV diagnosis  
>5 years 
1-5 years 
<1 years 
 
1.00 
1.70 (1.30,2.23) 
2.48 (1.93,3.20) 
 
<0.001 
 
1.00 
1.55 (1.12,2.14) 
1.80 (1.29,2.52) 
 
 
0.009 
0.001 
 
1.00 
1.65 (1.29,2.09) 
2.00 (1.56,2.56) 
 
 
<0.001 
<0.001 
Reporting region 
London 
England (not London) 
Wales and Northern Ireland 
 
1.00 
1.42 (1.22,1.66) 
1.18 (0.53,2.62) 
 
<0.001 
 
1.00 
1.40 (1.15,1.70) 
1.59 (0.70,3.62) 
 
 
0.001 
0.268 
 
1.00 
1.53 (1.31,1.78) 
2.28 (1.29,4.04) 
 
 
<0.001 
0.005 
Outcome of pregnancy 
Live birth 
Still birth 
Miscarriage/ectopic 
Termination 
 
1.00  
1.20 (0.61,2.37) 
0.74 (0.51,1.08) 
1.03 (0.69,1.54) 
 
0.392 
 
 
 
 
 
  
Gestation at delivery 
шϯ7 ǁeeks 
<37 weeks 
 
1.00 
1.03 (0.82,1.29) 
 
0.786 
    
Model 1: Analysis includes only records that were matched in NSHPC and SOPHID datasets. 
Model 2: Pregnancies that were unmatched in SOPHID were recoded as lost to follow up. 
¶ Last reported test in pregnancy. OR, odds ratio; AOR, adjusted odds ratio: EDD, expected date of delivery; IDU, likely route of HIV acquisition was maternal injecting 
drug use. 
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Table 8.4: Univariable and multivariable analysis of the association between maternal duration of residence in the UK at conception and loss to follow-up 
in the calendar year following pregnancy (restricted to African women) 
  Model 1 Model 2 
 Univariable analysis Multivariable analysis, n=3507 Multivariable analysis, 
n=3829 
 OR (95% CI) p-value AOR (95% CI) p-value AOR (95% CI) p-value 
Duration of residence in UK 
ш ϰ years 
< 4 years (before conception) 
Since conception 
 
1.00 
1.42 (1.17,1.72) 
2.93 (2.19,3.94) 
 
 
<0.001 
<0.001 
 
1.00 
1.11 (0.86,1.44) 
1.60 (1.06,2.42) 
 
 
0.425 
0.026 
 
1.00 
1.16 (0.95,1.42) 
1.65 (1.20,2.29) 
 
 
0.150 
0.002 
Maternal age at delivery 
<25 years 
25-34 years 
шϯϱ years 
 
1.00 
0.69 (0.53,0.89) 
0.51 (0.38,0.71) 
 
<0.001 
    
Year of EDD/delivery 
2000-2003 
2004-2006 
2007-2009 
 
1.00  
0.92 (0.73,1.16) 
0.78 (0.62,0.98) 
 
0.078 
 
1.00 
1.03 (0.76,1.39) 
1.03 (0.75,1.42) 
 
 
0.856 
0.843 
 
1.00 
0.94 (0.75,1.19) 
0.93 (0.73,1.19) 
 
 
0.617 
0.566 
Last CD4 count
¶
, cells/µl,  
шϯϱϬ 
200-249 
<200 
 
1.00 
0.68 (0.54,0.86) 
0.58 (0.40,0.83) 
 
<0.001 
 
1.00 
0.65 (0.50,0.83) 
0.39 (0.25,0.60) 
 
 
0.001 
<0.001 
 
1.00 
0.79 (0.65,0.96) 
0.55 (0.41,0.75) 
 
 
0.016 
<0.001 
Last HIV viral load
¶
, copies/ml 
<50 
шϱϬ 
 
1.00 
1.80 (1.48,2.20) 
 
<0.001 
 
1.00 
1.88 (1.48,2.40) 
 
 
<0.001 
 
1.00 
1.44 (1.20,1.73) 
 
 
<0.001 
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Table 8.4 continued 
  Model 1 Model 2 
 Univariable analysis Multivariable analysis, n=3507 Multivariable analysis, 
n=3829 
 OR (95% CI) p-value AOR (95% CI) p-value AOR (95% CI) p-value 
Time since HIV diagnosis  
>5 years 
1-5 years 
<1 years 
 
1.00 
1.75 (1.26,2.42) 
2.58 (1.90,3.52) 
 
<0.001 
 
1.00 
1.67 (1.14,2.46) 
1.93 (1.29,2.87) 
 
 
0.009 
0.001 
 
1.00 
1.78 (1.31,2.40) 
2.16 (1.59,2.95) 
 
 
<0.001 
<0.001 
Reporting region 
London 
England (not London) 
Wales and Northern Ireland 
 
1.00 
1.50 (1.24,1.83) 
2.45 (0.98,6.09) 
 
<0.001 
 
1.00 
1.35 (1.07,1.70) 
2.93 (1.15,7.46) 
 
 
0.012 
0.025 
 
1.00 
1.45 (1.21,1.74) 
2.47 (1.16,5.24) 
 
 
<0.001 
0.019 
Outcome of pregnancy 
Live birth 
Still birth 
Miscarriage/ectopic 
Termination 
 
1.00  
0.78 (0.28,2.20) 
0.67 (0.41,1.09) 
0.86 (0.50,1.48) 
 
0.348 
 
 
 
 
 
  
Gestation at delivery 
шϯ7 ǁeeks 
<37 weeks 
 
1.00 
0.97 (0.73,1.31) 
 
0.878 
    
Model 1: Analysis includes only records that were matched in NSHPC and SOPHID datasets. 
Model 2: Pregnancies that were unmatched in SOPHID were recoded as lost to follow up. 
¶ Last reported test in pregnancy. OR, odds ratio; AOR, adjusted odds ratio: EDD, expected date of delivery; IDU, likely route of HIV acquisition was  
maternal injecting drug use. 
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8.2.2 Summary of epidemiological analysis on maternal loss to follow-up after 
pregnancy 
In this analysis I have shown that 12.5% of women do not return for HIV care in the 
year after their pregnancy.  This is consistent with data in the general HIV-positive 
population in the UK (Rice at al. 2011).  African women were more likely than white 
British women not to attend for HIV care in the year after pregnancy in keeping with 
documented associations between Black African ethnicity and retention in care in UK 
studies of loss to follow-up in the HIV-positive population overall (Gerver et al. 2010, 
Rice et al. 2011, Clay 2013)278.    Looking at African women in more detail, women 
from Western and Southern Africa were at greater risk of being lost to follow-up than 
those from Eastern Africa, as were women who had arrived in the UK after conception.  
This will be explored in greater detail in the following section using ethnographic data. 
The limitations of the dataset linkage between NSHPC and SOPHID and associations 
with non-matching are discussed in detail in Chapter Three. Another important 
limitation of this analysis is in the interpretation of loss to follow-up among those who 
were matched.  We have no data on emigration, which may be an important reason for 
non-attendance for care279.  Deaths are almost certainly under-reported to SOPHID, 
however they are likely to be few in number and not a major contributory factor.  It is 
unlikely that patients would be seeking care in significant numbers within the private 
sector (Kupek et al. 1999) and it is therefore reasonable to assume that another 
explanatory factor in loss to follow-up is patient withdrawal from care.  
                                                             
278
 It also fits with findings from other parts of Europe and the US showing poorer retention in care for 
patients of non-white ethnicity (Hall, et al. 2012, Rebeiro, et al. 2013 ibid, Helleberg, et al, Thierfelder, et 
al. 2012, Fleishman, et al. 2012a). 
279
 A recent audit of adults in England, Wales and Northern Ireland with diagnosed HIV found that of 
2255 patients who did not access care in 2011, one in four had left the UK (Clay 2013). 
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8.3 Ethnographic data on loss to follow-up after pregnancy 
Discussions with clinical colleagues coupled with my own experiences of working in 
clinics with HIV-positive women, led me to initially question how effective HIV 
antenatal care is at fostering longer term engagement with HIV care: 
 
The antenatal clinic is a  very important front door for us for people to come through. 
(Helen, HIV physician) 
It has almost become received wisdom amongst clinicians that despite engaging women 
well in HIV care during pregnancy, it is not unusual for women to disappear after 
delivery, not to be seen in clinic again until they become pregnant again.    However this 
is not borne out by the quantitative findings presented in this chapter.  Although the 
12.5% loss to follow-up rate presented in the previous section is higher than the ≤5% 
attrition at one year recommended in the British HIV Association’s standards of care 
(2012), the key finding is that the majority of women do return for HIV care after their 
pregnancy.   
The quantitative data reveal disparities in loss to follow-up after pregnancy according to 
ethnicity, African region of birth and duration of residence in the UK.   African women, 
especially those from Southern and Western Africa and those who had arrived in the 
UK after conception, were more likely than white British women not to return to HIV 
care in the year after pregnancy.   One key explanatory factor is emigration but this 
information is unavailable in both the NSHPC and SOPHID datasets.  This is likely to 
contribute to the observed attrition post-pregnancy of women from Southern Africa due 
to the fact that South Africans are more commonly economic migrants as opposed to 
political asylum seekers and consequently may be more likely to be involved in circular 
migration between the UK and Africa (Owen 2009).  However, it is unlikely that 
emigration is the sole reason for some women failing to return for HIV care after 
pregnancy.  In this final section of this chapter I draw upon ethnographic data to explore 
access to HIV care after pregnancy.  I will pay particular attention to why African 
women (especially those from certain regions and those who have most recently arrived 
in the UK) are at greatest risk of defaulting from care, and what can be done to facilitate 
their return to HIV care after pregnancy. 
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8.3.1 Coming back 
Firstly, it is important to reiterate that the majority of women do return for HIV care in 
the year after their pregnancy.  Out of the twenty-three women I interviewed in NHS 
clinics, I knew of seventeen that had returned to their clinic within three months of 
delivering their baby280. The primary motivation for continuing to engage in HIV care 
beyond pregnancy was the safeguarding of their health.  The majority of women 
described their HIV infection in biomedical terms, explaining the importance of 
maintaining a good CD4 count.  I was struck by how often the spectre of death hovered 
over conversations with pregnant women and new mothers.  Many had lost friends and 
family to HIV-related illness, and feared the same fate despite having access to 
treatment in the UK.  Some had been diagnosed with HIV many years ago in an era 
when their life expectancy was limited, and may not have been aware of the 
improvements in prognosis with current ART.  Their uncertainties about survival were 
amplified by pregnancy and motherhood which, for many women like Grace, prompted 
rumination about their children’s futures: 
I just pray to God that he gives me a long life to take care of my children. Sometimes I 
am scared that I’m going to maybe die and leave my children. That’s what I think. 
 
The combination of fear of progression of disease and a biomedical conception of HIV 
was an important catalyst in the return of many women to HIV care postnatally.  
Women were keen to be monitored regularly by their clinical teams, through both 
medical consultations and routine blood tests.  Through this regular surveillance, 
women were able to keep informed about their clinical condition, restoring a degree of 
control over their HIV.  However rather than this “medical gaze” representing an 
exercise in biopower (Foucault [2003] 1963), engagement with HIV services and 
clinical monitoring were important resources for those living with HIV in the UK in 
confronting and managing anxieties about their and their families’ future survival.  For 
women who remained on ART after pregnancy for their own health, clinic attendance 
carried even more weight as it provided access to life-preserving medication.  Attending 
for care gave women emotional reassurance about their future, making them feel “safe” 
and allowing them the opportunity to fulfil their ambition to be mothers without the 
                                                             
280
 I interviewed fifteen women postnatally and was able to ascertain that they had returned for HIV care 
after delivery.  I spoke to a further two women who did not wish to be interviewed again but stated that 
they had returned for care.  I was unable to contact the remaining six women postnatally and therefore 
could not determine if they had returned to HIV services after their pregnancy. 
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pervasive fear that their children would grow up without them.  Engaging with HIV 
follow-up postnatally therefore serves a similar function to the use of ART during 
pregnancy as described in Chapter Five, sustaining hope and providing the means to 
generate a positive identity as a mother.  
When examining women’s experiences of antenatal care earlier in this chapter and in 
Chapter Five, I highlighted the importance of the interpersonal dimensions of care, 
framing it within Mol’s “logic of care” (2008).  Many women built strong relationships 
with their HIV antenatal care team that were founded upon trust and imbued with 
affective qualities.  This went a long way in fostering confidence in HIV clinical 
services as a whole, encouraging women to return for care, especially if they had been 
diagnosed during the current pregnancy and had limited experience of the hospital’s 
HIV service. For many women, being transferred back into the general HIV clinic 
involved moving their care from the team involved in the antenatal clinic to a different 
set of healthcare professionals.   The majority of women I interviewed had been 
diagnosed with HIV before their current pregnancy, and had attended the HIV clinic 
regularly prior to becoming pregnant.  For these women, a return to the general HIV 
service was an opportunity to re-engage with staff who they had built long term 
relationships with, one woman describing it as “like going back home, kind of”.  
Relationships with HIV specialist staff were characterised by care, with one woman 
telling me that her doctor was “doing her job with love”.  This was contrasted with staff 
in other disciplines who were felt not to be doing their job “from the heart” but “because 
they want to pay their bills and rent”.     
There were also practical ways in which women were encouraged to attend for follow-
up after delivering their baby.  For many, the arrival of a new baby heralded a period of 
upheaval especially if they were sole carers for their children.  In the midst of caring for 
children, women were at risk of forgetting appointments and valued reminders.  These 
prompts sometimes came from supportive partners, but often came from clinical staff, 
which made women feel valued and cared for.  In one NHS clinic, this process had 
recently been formalised with the development of a new specialist nurse clinic designed 
specifically to engage women in care postnatally and to work with those who failed to 
return to elucidate barriers.   In another clinic, women were provided with vouchers for 
formula feed and equipment by the general HIV clinic in the late stages of pregnancy 
and up to twelve months after delivery.  Staff noted that the introduction of this scheme 
had allowed women to become familiar with the general HIV clinic during pregnancy, if 
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they had not attended before, and incentivised them to return for follow-up.  Assistance 
with access to benefits and emergency funding provided further incentives for women to 
come back, demonstrating (as in Chapter Five) that engagement in medical care is often 
dependent on attending to the broader context of patients’ lives (Helman 1984, Mol 
2008).   
8.3.2 Staying away 
But what of those of don’t return for care after pregnancy?  Healthcare professionals 
regularly identified postnatal attrition as a major problem in their clinics.  The 
quantitative findings presented in this chapter challenge the common perception that 
women do not engage with HIV care after pregnancy.  One explanation for the 
discrepancy between clinicians’’ perceptions and the epidemiological data is that those 
working in healthcare are likely to preferentially recall cases where women have not 
returned.  Although none of the women I interviewed postnatally had disengaged from 
HIV care, many had heard of others who had or had opinions on what may prevent 
women from returning.  We have seen that a key determinant in a woman’s willingness 
to continue to engage in care is her experience of care during pregnancy.  When the 
relationship with healthcare professionals flounders, women’s trust in the healthcare 
system flounders with it.  The failures to maintain confidentiality, neglect of care and 
experiences of stigma and discrimination from healthcare professionals described in the 
preceding chapter, may instil fear in some women, discouraging them from returning 
for follow-up. As discussed earlier, HIV-related stigma often operates synergistically 
with other forms of exclusion such as racism, and gender and class inequalities.  African 
women living with HIV may experience greater levels of stigma and discrimination in 
health settings, and thus have more grounds to fear returning for care.   
Anxieties about stigma and discrimination were not just confined to the hospital setting.  
As explored in Chapter Five, HIV-related stigma is likely to vary between African 
communities, largely as a result of HIV prevalence, ART coverage and cultural factors 
such as the moralising influence of religion.  Evidence from the literature (Genberg et 
al. 2009, Winskell et al. 2011) and my fieldwork (see Chapter Five) suggests that 
stigmatising attitudes towards HIV may be more prevalent in West African 
communities.  Women from West Africa may therefore find disclosure of HIV status 
especially difficult.  Regular attendance for HIV care during pregnancy is facilitated by 
the fact that this is a common feature of all pregnancies in the UK, allowing a woman to 
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conceal her HIV status from those around her.  Attendance for care after pregnancy has 
ended, however, may prompt questions from partners and family that women may find 
difficult to answer.  This may be particularly difficult for women who have recently 
arrived in the UK or who have insecure immigration status, as they are often dependent 
on partners and family for financial support and their immigration papers as described 
in Chapter Five.  Lack of financial independence and citizenship rights compel women 
to manage information about their HIV-positive identity, fearing that disclosure will 
threaten an already precarious existence.  Facing the very real risk of abandonment and 
social ostracism, it is therefore unsurprising that some women may choose not to return 
to the HIV clinic when the stakes are so high.  The problem is compounded by the fact 
that the HIV clinic may be identifiable as such.  Some women made a clear distinction 
between HIV antenatal care and care after pregnancy.  In two of the hospitals I worked 
with, HIV antenatal care was provided in the hospitals’ general antenatal clinic.  
Women described their relief at being able to seek care in an environment that did not 
mark them out as HIV-positive, affording them privacy they may not experience in the 
general HIV clinic: 
In the antenatal clinic there were many of us.  No one knew why you were there.  Here 
[the HIV clinic] people see you.  There’s even a lady who works here who I know from 
college.  It was more private with my [specialist midwife].   
(Patience) 
Attending for follow-up at a clinic that is known to look after HIV-positive patients, 
may therefore compromise a woman’s ability to pass as HIV-negative and risks 
inadvertent disclosure and its attendant sequelae.    Of note, HIV exceptionalism was 
also felt by members of staff who spoke of its “separateness…its exclusivity…its 
secretiveness”.  One HIV physician commented on the location of the HIV clinic “on 
the back of the hospital”, perhaps symbolic of HIV medicine’s marginalisation as a 
discipline within the hospital.  This same physician enjoyed working in her HIV 
antenatal clinic as geographically she was situated within the hospital’s main building 
and worked with members of the hospital’s wider team.  If HIV clinicians find 
normalcy in working within the antenatal clinic, is it perhaps unsurprising that their 
patients share the same feelings.   The arrival of their baby heralded a time of great 
personal joy for women, especially as it allowed them to continue on a culturally 
defined life trajectory.  This excitement may result in HIV receding from women’s 
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lives, in some cases manifesting in denial of their HIV status.  The return to routine HIV 
care after pregnancy, often in a dedicated unit, may therefore function as a jarring and 
painful reminder of women’s HIV status at a precisely a point in their lives where they 
have achieved a degree of normalcy through motherhood. 
In Chapter Five, I explored the resilience women living with HIV demonstrate during 
pregnancy in terms of accessing care and taking ART.  Postnatally, some women may 
find themselves less motivated to attend for care for themselves, safe in the knowledge 
that they have secured an HIV-negative baby.  At this point, a woman’s own HIV 
disease may become relegated in the hierarchy of needs (Maslow 1943), submerged by 
the exigencies of day-to-day life as a migrant woman in London.  This may be 
especially the case for women who do not require ART for their own health after 
pregnancy.   Some women described not returning for follow-up after previous 
pregnancies as their ART had been stopped281.    They had felt that HIV care was 
intrinsically tied to the provision of ART and that stopping treatment was an indication 
that they were well and no longer required regular check-ups.  The link between ART 
and engagement in care is supported by data presented earlier (tables 8.2 - 8.4), 
revealing that women with higher CD4 counts at the end of pregnancy, who may have 
been advised to discontinue ART, were less likely to return for follow-up282.  
We have seen that African women, especially those who had recently arrived in the UK 
and who were also likely to have insecure immigration status, were at greater risk of not 
returning for HIV follow-up after pregnancy.  For many women interviewed, this was 
due to structural constraints.  Women who were in the asylum process and were waiting 
for a decision on their application faced the threat of being dispersed to other parts of 
the country.  As discussed earlier, continuity is an important factor in retaining women 
in care.   Having forged strong relationships with staff at their clinic, the thought of 
building trust in another centre was a source of great anxiety, with some women stating 
that they would be reluctant to attend a new service.  Those who existed outside the 
asylum system, either because they had entered the country illegally or had had their 
application for leave to remain rejected, had no entitlement to free HIV care following 
the delivery of their child283. Yet again, the structural violence described in Chapter 
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 Short term ART is used during pregnancy in women whose CD4 counts do not meet the threshold for 
continuing treatment. 
282
 The association between not being on ART and loss to follow-up has previously been reported in the 
overall HIV-positive population in the UK (Rice et al. 2011). 
283
 At the time of my fieldwork free HIV treatment was denied to undocumented migrants, some refused 
asylum seekers, those on visitor visas and visa overstayers.  The amendment to the Health and Social 
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Five, in the form of legal frameworks that legitimise unequal access to HIV care, comes 
to be embodied by HIV-positive migrant women.  Throughout my fieldwork and 
clinical practice I encountered high levels of destitution among women who had 
migrated to the UK, and this was most acute in those who did not have leave to remain.  
Poverty, especially in the context of new motherhood where precious resources are 
directed to providing for children, is an important barrier to accessing healthcare when 
faced with, at the very least, finding money to pay for transport costs, and at the very 
worst exorbitant bills for medical care.   
8.4 Conclusions 
In this chapter I have used data from the NSHPC and my ethnographic fieldwork to 
explore African women’s engagement with HIV services after pregnancy.  In contrast to 
the widespread clinical perception that women are lost to follow-up postnatally, nearly 
90% of women returned for HIV care after pregnancy, many motivated by the desire to 
secure a future for themselves and their family through maintaining good health.   Of 
the small proportion of women who did not return for HIV care, African women, 
especially those from Southern and Western African and those who arrived in the UK 
after conception, were at the greatest risk of being lost to follow-up.  Poor experiences 
of healthcare and the fear of being seen to attend a service known to provide care for 
those living with HIV may be important barriers as is the discontinuation of ART after 
pregnancy.  Structural constraints also play a central role whether it be the corrosive 
effects of poverty that relegate healthcare to the bottom of women’s hierarchy of needs 
or the structural violence of laws that denied access to ART to those without citizenship 
rights.  Again, the dual forces of stigma and structural violence act to constrain some 
African HIV-positive women’s access to healthcare and shape their experiences, placing 
their long term health and that of their babies’ at risk. 
Key points 
 Nearly 90% of HIV-positive women returned for follow-up in the year after 
pregnancy, mainly motivated by the desire to maintain their health and the good 
relationships they had fostered with their HIV antenatal teams. 
 Of the small proportion (12.5%) who did not return for HIV care, African 
                                                                                                                                                                                  
Care bill which removed charges for HIV treatment to all overseas visitors came into force in October 
2012 after my fieldwork had ended and therefore had no impact on my participants at the time of 
interview. 
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women, especially those from Southern and Western African and those who had 
arrived in the UK after conception, were at the greatest risk of being lost to 
follow-up.   
 Barriers to longer-term engagement in HIV care after pregnancy may include 
poor experiences of healthcare, fear of disclosure of HIV status and structural 
factors, especially the lack of provision of free HIV care to overseas visitors up 
until October 2012. 
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9  
           
Infant feeding among African women  
living with HIV in the UK 
 
Summary 
Current guidance in the UK advises HIV-positive women to avoid breastfeeding their 
children in order to minimise the risk of vertical transmission.  Although studies 
examining infant feeding decision-making among women living with HIV have been 
conducted in resource-poor settings, very little is known about how it affects women in 
countries such as the UK.  In this qualitative chapter I draw upon data from interviews 
with African women living with HIV and professionals involved in their care to explore 
decision-making about infant feeding in the context of HIV.  Embedding my analysis 
within a theoretical framework of the social construction of risk, I explore the structural 
and cultural context of decision-making about infant feeding.  I then discuss the impact 
of not breastfeeding on women, particularly focusing upon repercussions within the 
social domain and conclude by tracing emerging resistance in women to guidelines on 
infant feeding in the UK. 
9.1 Introduction 
Previous chapters of this thesis have explored how decisions about ART, access to 
health services and wider notions about health and illness among African women living 
with HIV in the UK are embedded within a complex sociocultural matrix. In these 
chapters, stigma, structural violence, faith and their location within transnational 
African communities emerge as important factors in shaping HIV-positive women’s 
experiences of pregnancy and their engagement with care. Breastfeeding is an important 
route of vertical transmission of HIV, with the risk estimated to be between 14 to 29% 
(Dunn et al. 1992), contributing to between one third and a half of all new HIV 
infections in children globally each year (World Health Organisation et al. 2007).  In 
this chapter I wish to build upon my analytic engagement with social factors by 
focusing on a different aspect of pregnancy and motherhood – infant feeding decision-
making.    
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The risk of vertical transmission postnatally varies depending on feeding patterns.  For 
reasons that are not fully understood, mixed feeding (which is feeding an infant breast 
milk and either non-human milk, other liquids or solids) (World Health Organisation 
2001a), carries a greater risk of HIV transmission than exclusive breastfeeding, defined 
as no other food or drink including water apart from breast milk (Coutsoudis et al. 
2001).  Exclusive formula feeding eliminates the risk of postnatal vertical transmission 
through feeding; however it requires access to affordable formula-feed, clean water and 
sterile equipment.   In resource-poor settings exclusive formula feeding presents 
significant operational challenges and has been shown to result in increased infant 
mortality secondary to diarrhoeal illness and malnutrition, when compared with 
exclusive breastfeeding (Iliff et al. 2005, Coovadia et al. 2007).   Current WHO 
guidelines on infant feeding and HIV (World Health Organisation 2001b) therefore 
advise that formula feeding be recommended to HIV-positive mothers if it is acceptable, 
feasible, affordable, sustainable and safe284.  In many resource-poor settings, these 
criteria are not met and women living with HIV are advised to exclusively breastfeed 
their infants for six months.  The use of maternal HAART has been shown to reduce the 
risk of vertical transmission through breastfeeding to between 0 and 5% (Kilewo et al. 
2009, Peltier et al. 2009, Homsy et al. 2010, Shapiro et al. 2010, The Kesho Bora Study 
Group 2011, Jamieson et al. 2012) and is recommended by the WHO for women who 
breastfeed in the context of HIV (World Health Organisation 2009b).   
In resource-rich settings such as the UK, widespread access to clean water and 
availability of formula-feed means that the risk of vertical transmission of HIV 
outweighs that of other infant morbidity such as malnutrition and diarrhoeal illness.  
Since 2001, UK guidelines have recommended exclusive formula feeding and the 
avoidance of breastfeeding for all women diagnosed with HIV (Lyall et al. 2001, 
Hawkins et al. 2005, BHIVA/CHIVA Guidelines Writing Group 2010, Taylor et al. 
2012).   Although current UK guidelines recognise that the risk of vertical transmission 
through breastfeeding is reduced through the use of maternal HAART, concerns remain 
about the small residual risk of transmission and the lack of data on long-term effects in 
infants of exposure to ART through breast milk.  Where a mother has an undetectable 
viral load on ART and chooses to breastfeed, UK guidance advises careful monitoring 
of both mother and child and cessation of breastfeeding by six months (Taylor et al. 
2012: 131).  This is the only situation currently in which breastfeeding in the context of 
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 This set of criteria is widely known by the acronym AFASS. 
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HIV is not viewed as grounds for automatic referral to child protection services (Ibid., 
131).  
Data I have extracted from the NSHPC dataset reveals very low rates of documented 
breastfeeding between 2000 and 2010 among women living with HIV in the UK 
(210/6608, 2.0%).   These data may be unreliable as breastfeeding history was not 
documented in over a third of infants and small numbers preclude further meaningful 
statistical analysis.   Furthermore, given the clear medical recommendation to 
exclusively formula-feed, women may not feel able to disclose that they have breastfed 
their infants.     However, the fact that seroconversion to HIV is extremely rare in 
infants who have had a negative test at birth (a marker of postnatal transmission) (Janet 
Masters, UCL Institute of Child Health, personal communication, 13 December 2011), 
coupled with the consistently low rate of vertical transmission in the UK (Townsend et 
al. 2013), suggest that the overwhelming majority of mothers in the UK who are 
diagnosed with HIV avoid breastfeeding.   
Although there is evidence that the majority of HIV-positive women in the UK adhere 
to UK guidelines, the avoidance of breastfeeding brings with it a host of other 
consequences.  During my fieldwork, women often raised the subject of infant feeding 
unprompted.  These sections of my interviews were often the most emotive, 
encompassing marked feelings of guilt, fear and despair.  Numerous studies conducted 
within resource-poor settings have highlighted the structural and sociocultural 
constraints experienced by HIV-positive women when making decisions about how to 
feed their babies (Moland 2004, Doherty et al. 2006, Blystad et al. 2009, Desclaux et al. 
2009, Koricho et al. 2010, Van Hollen 2011).  It is widely acknowledged that in many 
of these settings infant feeding decisions are highly conflicted (Hausman 2011: 2), 
whereas there is often an assumption that formula feeding is more acceptable and 
feasible in resource-rich settings285.  This assumption is reflected by the absence of 
literature emerging from resource-rich settings that engage with the realities of infant 
feeding decisions and HIV, with the notable exception of a recent but unpublished study 
conducted among HIV-positive mothers in Canada286.  To date, no work in the UK has 
explored the issue of infant feeding in the context of HIV systematically. 
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 For example Hausman’s assertion that formula feeding is “an accepted and ordinary practice in the 
United States and other industrialised countries [and that] women are not ostracized (or stigmatized as 
HIV-positive) as a result of feeding their babies with bottles” (2011: 191).    
286
 In this study of twenty-seven women in Ontario, Canada, the authors highlight how decisions about 
infant feeding by HIV-positive women are culturally, socially and politically contingent, and the 
difficulties encountered in avoiding breastfeeding (Greene, et al. 2012). 
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In this chapter I present the first ethnographic study in the UK to explore infant feeding 
decisions among HIV-positive mothers, with specific reference to African migrant 
women, drawing primarily upon interviews with African women living with HIV and 
professionals involved in their care.  Grounding my analysis in feminist writing on 
infant feeding and anthropological work on the social construction of risk, I aim to 
demonstrate how infant feeding decisions by HIV-positive women are generated within 
a social domain, and how the profoundly relational nature of this decision-making 
impacts on women socially in terms of stigma, social isolation and loss of social status.   
9.2 Theoretical frames 
Infant feeding (regardless of HIV) has become primarily a public health concern, 
reflecting the medicalisation of human life that is the hallmark of Foucauldian 
biopolitics (Foucault [2003] 1963).   Of course infant feeding, whether it be 
breastfeeding, formula feeding or feeding with other types of food, has important health 
and nutritional consequences.  However, this medicalisation has resulted in the 
biomedical aspects of feeding being privileged in contemporary discussions of infant 
feeding.  Furthermore, the portrayal of infant feeding as a health-related intervention 
invites it to be viewed as “value-neutral” (Hausman 2011: 37)287.   Yet, as highlighted 
by Linda Blum (1999) in her sociological analysis of the “ideologies of breastfeeding 
and motherhood” in the United States, the decision about how to feed your baby is 
rarely “value-neutral”.    Blum describes how dominant ideas on infant feeding are 
inextricably linked to the economic and political aims of the nation-state and the need to 
have productive mothers in the workforce and secure healthy future citizens288: 
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 In her analysis of the discursive construction of mothers living with HIV with particular reference to 
infant feeding, Hausman specifically places infant feeding in the context of Foucauldian biopower, 
describing the medicalisation of breastfeeding both in the United States (in the form of the 2004 U.S 
National Breastfeed Campaign) and the public-health response to the risk of vertical transmission through 
breastfeeding (2011).  Blum’s work on the sociohistorical construction of infant feeding in the United 
States as a legitimate state and public health concern in the early twentieth century is also relevant here 
(1999). 
288
 In this work, Blum also describes how the popularity of formula feeding in the US in the mid-
twentieth century coincided with increasing medical advances and interest in the scientific properties of 
milk, the rise of technological advances as emblematic of modernity and the growing role of women in 
the workplace.  In contradistinction, the resurgent popularity of breastfeeding in the US in the late 
twentieth century was underpinned by a broader feminist movement against the medicalisation of female 
bodies and the ‘back to nature’ messages of counterculture, as well as increasing medical evidence of the 
medical benefits of breast milk. 
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“Breastfeeding does not have inherent truth, but meanings determined out of power 
relations, various disciplining practices, and conflicting needs and interests, which are 
inherently political.” 
(Blum 1999: 200) 
This is echoed by work from South Africa revealing how breastfeeding is absorbed into 
ideologies of nation-state in KwaZulu-Natal, where women are exhorted to “breastfeed 
for a healthy nation” (Seidel 2000)289.  Furthermore breastfeeding, and by implication 
its counterpart formula feeding, are inherently social and invested with symbolic power 
as a “biosocial practice linked to other aspects of material life and their meanings [with] 
an important role in local cultural meaning systems” (Hausman 2011: 142).  As Donna 
Haraway so eloquently states, “breast milk is not the nature to the culture of Nestlé’s 
formula” (Haraway 1988: 209).  My aim in this chapter is to explore the meanings of 
breastfeeding and formula feeding among African women living with HIV in the UK, 
taking my starting point as both being “natural-technical objects, embedded in matrices 
of practical culture and cultural practice” (Haraway 1988: 209); biological substances 
imbued with signifying power in which “mind, body, and tool are on very intimate 
terms (Haraway 1991: 165). 
A second important theoretical frame for this chapter is the social construction of risk.  
Decisions about infant feeding in the context of HIV predominantly encompass 
questions about risk.  The risk of a child becoming infected with HIV, of a child not 
receiving adequate nutrition, of reduced bonding between mother and child, and a host 
of other social risks that will be explored in detail later in this chapter.  A dominant 
paradigm in the conceptualisation of risk within the public health arena is the technical 
approach to risk (Rhodes 1997, Tansey et al. 1999) which pertains to the calculation of 
risk in an effort to ensure safety (Rhodes 1997: 72).  The assumption underlying this 
approach is that decisions about risk are made by an individual, that these are rational 
choices underpinned by the utility principle290 (a cost versus benefit analysis), and that 
individuals are free to make these choices.    Those who do not subscribe to the 
consensus about dangers are thought to be irrational or poorly informed, requiring 
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 Seidel sees the global anti-formula milk action in the 1970s that was concentrated in many parts of 
Sub-Saharan Africa as an important influence in continuing emphasis on the importance of breastfeeding 
in this context (2000).   
290
 The utility principle is central to economic rationalism, which dominates twenty-first century global 
politics and asserts that individuals balance cost against benefits in order to maximise their personal 
advantage (Tansey et al. 1999). 
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education to redress these perceived poor choices (Douglas et al. 1983, Douglas et al. 
1990).  However, the technical approach has important limitations in that it fails to take 
into account the following: that humans are predominantly social beings and that 
decisions about risk are relational; that risk is socially constructed; and that issues of 
power may act to constrain people’s capacity to make choices.  The cultural theory of 
risk provides a more useful analytic entry point into thinking through decision-making 
about infant feeding in the context of HIV.  A key reference here is Douglas and 
Wildavsky’s “Risk and Culture” (1983) on the social construction of risk.  With specific 
reference to the predominance of concerns regarding environmental dangers in the 
contemporary United States, Douglas and Wildavsky do not ignore risk as fact but ask 
us to consider “on what basis are certain dangers guarded against and others relegated to 
secondary status” (Ibid.: 1)291.  How and why we come to see things as risky is not a 
value-neutral judgment centred upon costs and benefits, but instead is deeply socially 
embedded292.    Given the social construction of risk it therefore follows that decisions 
about what is risky and how to address this are predominantly social processes.  This is 
particularly important when considering decision making about health-related risks as 
“the credibility of health-related messages will (all) be influenced by the interactional 
context in which judgements are made” (Tansey et al. 1999: 72)293.  Douglas and 
Wildavsky highlight the importance of social context in addressing questions about risk: 
““The perception of risk is a social process.  All society depends on combinations of 
confidence and fear.  Learning about fear ought to afford a backdoor route for 
understanding confidence.  […] In addressing questions of acceptable risk without 
considering their social aspects, we could be speaking to the wrong problem.” 
(Douglas et al. 1990: 6) 
The social organisation of risk has been explored before within HIV, generating 
important insights into “high risk” behaviours.  Work addressing risk-taking behaviour 
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 Douglas and Wildavsky’s analysis of the social construction of risk builds upon Douglas’ previous 
work on pollution and taboo, which I drew upon in Chapter Seven when writing about stigma and 
discrimination experienced by women in maternity services.  In “Purity and Danger” ([2002] 1966) 
Douglas describes how the creation of the domain of the polluted is an inherently symbolic process with 
rules governing what constitutes bodily pollution and danger likely to symbolising deeper preoccupations 
with social structures.   
292
 For instance, Douglas and Wildavsky describe how preoccupations with environmental risks were 
borne of a particular time in history characterised by rapid technological innovation, changes in social 
structures, and growing suspicion of central institutions. 
293
 Tansey and O’Riordan’s 1999 review is a useful summary of the theoretical roots of cultural theory 
and risk and is application to health-risk management (1999). 
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among men who have sex with men, specifically barebacking294, has revealed that 
decisions to have sex without a condom are less about lack of awareness of health-risks 
and more bound up with concepts of masculinity, erotic fantasies, issues of power and 
emotional factors such as the building of trust and intimacy with sexual partners (Ridge 
1996, Ridge 2004).  Similarly, when looking at sexual and injecting risk-taking among 
people who use drugs in London, Rhodes found that risk-taking was again not borne out 
of poor knowledge but instead was shaped by the exigencies of illicit drug use, gender 
based violence, behavioural norms and the desire to forge intimate bonds (Rhodes et al. 
2005).   
Throughout this chapter I will be drawing upon these theoretical frames to explore the 
social meanings of both breastfeeding and formula feeding and how decisions that my 
participants made about feeding their babies were located within a social domain, rather 
than being based purely on a value-neutral rational assessment of risk versus benefits.   
My intention is that the understanding of the social dimensions of infant feeding 
decisions in the context of HIV will inform the development of support for women 
when making these difficult decisions.   
9.3 Breastfeeding as risk  
Current UK guidelines advise the complete avoidance of breastfeeding in women living 
with HIV (Taylor et al. 2012) in order to eliminate the risk of postnatal transmission of 
HIV and to avoid the unknown long term risk to infants of exposure to ART in breast 
milk.  Of the fifteen women I interviewed postnatally, only one described breastfeeding 
her infant295.  Of the remaining nine women who were not interviewed postnatally, all 
stated an intention to avoid breastfeeding completely.  My participants were 
knowledgeable about the risks of breastfeeding and emphasised the paramount 
importance of minimising the risk of HIV transmission to their child296.  Whilst not 
denying the reality of this risk, it is important to explore how the risk of breastfeeding in 
the context of HIV is socially organised.  For instance, why is breastfeeding prioritised 
as an important risk to the health of a child over other factors such as late antenatal 
booking297, which passes with virtually no comment?  
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 Anal intercourse without a condom. 
295
 This case will be discussed in detail later in the chapter. 
296
 This is echoed by work presented in Chapter Five on the importance of securing an HIV-negative child 
as a prime motivation to take ART during pregnancy. 
297
 In my overview of literature (Chapter Two) I described how late antenatal booking in the general 
obstetric population is associated with poorer maternal and infant outcomes.  I also presented data in 
 259 
In Chapters Five and Seven I highlighted how the HIV-positive pregnant female body 
may come to be viewed by professionals and mothers as unreliable, posing a threat to 
the safety of the foetus and requiring surveillance with procedures such as blood tests 
and foetal ultrasound imaging.  This manifestation of biopolitics extends into the 
construction of the postnatal HIV-positive body as potentially threatening, requiring 
regulation in terms of guidance to avoid breastfeeding, despite the risk of transmission 
for a woman stable on ART estimated to be low at between 0 and 5%.    This notion of 
the HIV-positive maternal body as a source of danger becomes embodied by women 
and is a source of distress: 
Because I was told that if you breastfeed [you can transmit HIV to the baby] I just felt 
like if I did anything with the baby maybe the baby will be in harm's way.  I was just 
scared of everything else so it caused quite a lot of stress for me.   I think that's how I 
actually managed to start having depression.  
(Charity) 
Women’s concerns about the risk they pose to their children echo the primacy of the 
foetus and child in biomedical discourse on reproduction298 and societal anxieties about 
the dangers mothers pose to their children.  The notion of breast milk as risky is not 
only biological fact but a social phenomenon constructed through interaction with 
professional institutions.  As Douglas and Wildavsky write: 
“In risk perception, humans act less as individuals and more as social beings, who have 
internalised social pressures and delegated their decision-making processes to 
institutions.  They manage as well as they do, without knowing the risks they face, by 
following social rules on what to ignore: institutions are their problem solving devices.” 
(Douglas et al. 1990: 80) 
In the Chapter Seven I explored the symbolic basis of stigma and discrimination 
towards HIV-positive women within maternity services. Using the work of Mary 
Douglas and Julia Kristeva, I argued that the pregnant HIV-positive woman occupies a 
                                                                                                                                                                                  
Chapter Seven demonstrating that nearly one in two HIV positive women in the UK presented late to 
antenatal care between 2008 and 2010. 
298
 Hausman draws a parallel between public health concerns in the US surrounding the transmission of 
West Nile Virus and the increasing medicalisation of the female reproductive body.  In this discourse, the 
technical approach to risk leads to an emphasis on risks of harm to the child, impelling women to 
subscribe to medical guidance and intervention in order to safeguard their children’s health despite little 
evidence that this posed a great risk (2011:70). 
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symbolically anomalous place challenging the simple binary oppositions of illness and 
health; death and life; joy and sorrow; responsibility and recklessness.  Furthermore the 
physical facts of pregnancy and lactation make the maternal body physically and 
symbolically permeable, collapsing the rigid boundaries of the human body and 
exacerbating fears about pollution.  Indeed the ambiguous nature of an HIV-positive 
mother’s breast milk renders it a pharmakon (Hausman 2011: 29), at once both 
nourishment and danger.  I suggest that the biomedical emphasis on an HIV mother’s 
breast milk as a dangerous substance, whilst rooted in biological fact, is informed by 
these symbolic meanings.   
The preoccupation with the maternal body as a site of potential danger is also reflected 
in wider concerns about the risks that woman may pose to their babies during pregnancy 
and motherhood, exemplified by recent medical guidance that women minimise risk 
through the avoidance of exposure to a host of everyday chemicals299.  This concern 
with environmental danger is in itself informed by the construction of environmental 
pollution as an important risk in contemporary society as described by Douglas and 
Wildavsky (1983).  In this discourse, a woman’s body ceases to exist in its own right 
and becomes uncoupled from other aspects of her life.  Her primary responsibility is to 
ensure the safety of her child by regulating and policing her own body, avoiding toxins 
and withholding her body from her child if that is not possible.  It is therefore 
unsurprising my participants presented the decision to avoid breastfeeding as a duty 
rather than choice, feeling that they would be ultimately responsible if their child 
became infected with HIV:   
I’m always thinking about it [breastfeeding]. I’m thinking […] like maybe I will just try 
[...]  but then I always have it in my head, ‘So what if something happens to the baby?’ 
Then it’s going to be something that I will never forgive myself for.’ 
(Matilda) 
9.4 Situating feeding decisions  
If decisions about infant feeding were wholly centred upon the avoidance of risk of 
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 A recently published scientific impact paper by the Royal College of Obstetrics and Gynaecology 
seeks to raise awareness of issues surrounding exposure to common chemicals (such as household 
cleaning products, herbal remedies, pesticides and personal care products) in pregnancy.  This paper 
concludes that in the absence of data about the risks that these chemicals pose that women should employ 
“a safety first approach, which is to assume there is risk present even when it may be minimal or 
eventually unfounded” (Royal College of Obstetricians and Gynaecologists 2013). 
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vertical transmission, we might expect decisions to be straightforward.  However, 
although almost all the women in this ethnography avoided breastfeeding their babies, 
the decision was often fraught and characterised by feelings of guilt, sorrow and fear.   
Breastfeeding can be an intensely enjoyable experience for women (Leff et al. 1994, 
Schmied et al. 1999) yet this pleasurable aspect of feeding is often overlooked.  Some 
participants mourned the loss of the physicality of breastfeeding: 
I didn’t like looking at women breastfeeding and sometimes I used to just put him [her 
son] on my breast even though there was nothing [no milk] there just to see how it 
would have felt. 
(Faith) 
The majority of work on breastfeeding comes from a biomedical and public health 
paradigm.  Studies that engage with women’s embodied experiences of breastfeeding 
remain rare.  Dominant notions of the asexual nurturing maternal body result in the 
muting of discussions of breastfeeding as a sensual and potentially erotic experience 
involving “intense physical exchanges: skin touching, hands stroking, holding and 
playing, bodies sharing, hormones pulsing, as well as an emotional relation of intimacy, 
care and often passionate engagement” (Bartlett 2005: 68)300.  On a broader level, this 
reflects a tendency to neglect pleasure in sexual and reproductive health research, 
especially among women (Hirsch 2007).   
In abstaining from breastfeeding my participants felt an acute sense of personal loss, 
often crying when discussing their decision to formula-feed and describing themselves 
as “sad”, “unhappy” and “devastated”.  It was clear that avoiding breastfeeding came at 
significant emotional cost: 
The big issue when I was diagnosed was thinking about not being able to breastfeed.  I 
mean it kind of disturbed me a lot [...]  With the first child it kind of hit me big time.  I 
used to cry about that; I used to cry about that you know. 
(Esther) 
Furthermore, the decision to abstain from breastfeeding was not an isolated event; rather 
it was a process that continued throughout infancy.  Women often found themselves 
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 Bartlett also outlines the sociohistorical factors that have led to the subjugation of maternal sexuality.  
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revisiting their decision either on feeding their baby or when questioned by others as to 
why there were not breastfeeding. This served as a painful and tangible reminder of 
their HIV-positive status: 
At times you want to forget this thing HIV.  If you keep explaining you have to tell lies 
[…] within yourself.  It’s a kind of emotional trauma. 
(Bolade) 
The structural marginalisation of some of my participants further contributed to the 
difficulties encountered in adhering to medical advice to avoid breastfeeding.  Women 
highlighted the work involved in formula feeding in terms of preparing equipment and 
feeds.  For those who were sole carers, often with other small children to look after, the 
demands of formula feeding without the support of a partner were especially great.  
Furthermore on migrating to the UK, many had left behind kinship networks at home 
that they could ordinarily draw support from.   The reality was that formula feeding 
their newborn baby was a solitary and laborious endeavour. 
An even greater challenge to the avoidance of breastfeeding was the significant cost of 
formula-feed and feeding equipment301.  As discussed in Chapter Five, destitution and 
food insecurity was common among my participants.  Those on low-incomes with 
secure immigration status qualified for state-funded financial assistance, which provides 
vouchers for the purchase of formula.  For those whose income level was not at the 
threshold of state-assistance, buying formula often put a strain on already stretched 
household finances: 
The formula is very expensive and you’re thinking, ‘Oh my God, if I was breastfeeding I 
wouldn’t be spending so much money on just buying milk all the time.’ At some point we 
[her and her partner] could not afford it [...]  it was so expensive. 
(Faith) 
Women with insecure immigration status and no recourse to public funds found 
                                                             
301
  Many studies from resource-poor settings illustrate how poverty renders the purchase of formula-feed 
impossible (Chivonivoni, et al. 2008, Thairu, et al. 2005, Hofmann, et al. 2009, Doherty, et al. 2006).  
This is especially the case for women who lack financial support from partners or families (Chisenga, et 
al. 2011, Seidel 2004 ).  Indeed, the corrosive effects of poverty extend beyond the family unit as women 
may find that clinic stocks of formula routinely run out (Doherty, et al. 2006). The structural constraints 
to formula feeding in resource-rich settings have up until now been overlooked.       
 
 263 
themselves in an even more precarious situation.  At the time of my fieldwork, the 
British HIV Association had released a position statement on infant feeding in the 
context of HIV in which they advised the provision of free formula to women without 
recourse to public funds through locally negotiated schemes (BHIVA/CHIVA 
Guidelines Writing Group 2010).  In reality the availability of such schemes was 
patchy, with one of my NHS fieldwork sites having no system in place to provide free 
formula and equipment to women who were unable to afford it302.  Women without 
secure immigration status were often forced into financial dependency on friends, 
family and partners, who were sometimes unaware of their HIV status, and were 
unwilling to provide financial assistance:  
I’ve had another woman who was living with a sort of relative who kept on at her for 
months.  She had no money, no resources.  She was an overstayer303 and she kind of had 
to stay there and put up with it but she [the relative] was always telling her that she was 
a bad mother and asking ‘why are you spending money on milk?’ when she hasn’t got 
any money. 
(Carol, HIV specialist midwife) 
Yet again, as seen in previous chapters, the structurally violent forces of poverty and 
immigration law combine to constrain the ability of women without secure immigration 
status to engage with important HIV-related health interventions, rendering their lives 
and those of their babies “bare” (Agamben 1998).   
In addition to the personal attachment to breastfeeding and the structural constraints 
outlined above, many participants expressed a strong belief in the superiority of breast 
milk over formula describing it as “important”, “the best”, “natural” and “good”. 
Breastfeeding was strongly identified with “African” culture by women: 
Sometimes I feel it’s so hard…that’s what really makes me feel sad when I look at my 
baby, as a black woman, because in our culture in Africa you’re supposed to breastfeed 
for two years.  
(Mariama) 
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 It will be interesting to see whether the recent publication of the British HIV Associations standards of 
care for people living with HIV, which explicitly states that free infant formula be provided to all women 
who cannot afford it,  results in a more consistent provision of support to mother living with HIV (British 
HIV Association 2012). 
303
 Someone who has remained in the UK beyond the expiry date of their visa. 
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In many regions of Sub-Saharan Africa breast milk is seen as superior to all other 
sources of infant nutrition (Moland 2004, Thairu et al. 2005, Chivonivoni et al. 2008, 
Moses et al. 2009).  Earlier in this chapter I drew upon work on infant feeding to 
highlight the fact that breast milk is not only a biological substance but also a symbolic 
object invested with social meaning (Haraway 1997, Blum 1999, Hausman 2011).   For 
example, among the Chagga in Northern Tanzania, breast milk is embedded within an 
elaborate symbolic network of bodily fluids and is seen as a powerful, “life-giving 
force”, the feminine counterpart to semen (Moland 2004).  Work conducted in Tanzania 
with Gogo women (Mabilia 2005) and with HIV-positive mothers in Malawi (Levy et 
al. 2010) illustrate how breastfeeding is often articulated in terms of its ‘naturalness’ 
and is understood to have unique nutritional qualities304.  This is highlighted in 
Hofmann’s ethnography of breastfeeding in rural Burkina Faso in which she draws our 
attention to the translation of siindji (the Djoula term for breast milk) as “the water that 
supports and preserves life” (2009).  An important contributing factor to the perception 
of breast milk as superior to infant formula throughout Sub-Saharan Africa is the highly 
contested issue of formula feeding throughout the continent in latter half of the 
twentieth century305.   Many of the women I interviewed grew up in African countries 
during the 1970s and 1980s, an era characterised by widespread efforts by activists, 
public health professionals and NGOs to educate communities about the benefits of 
breast milk and the dangers of formula.   
However to cast the cultural construction of breast milk as superior to formula as a 
purely African phenomenon is erroneous.  The pro-breastfeeding movement is both 
successful and international as exemplified by organisations such as the World 
Breastfeeding Alliance and La Leche League306. In resource-rich settings breast milk is 
idealised, cast in biomedical terms as optimal in terms of its immunological and 
nutritional qualities307.   In the UK it is the norm for most women to attempt to 
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 Also see Moland 2004, Buskens, et al. 2007, Pool, et al. 2001. 
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 Throughout the mid-twentieth century, multinational companies targeted resource-poor countries with 
aggressive marketing for infant formula.  However uptake of formula feeding was associated with 
increasing numbers of infant deaths secondary to diarrhoeal disease, malnutrition and dehydration as a 
result of lack of clean water. This led to the Nestlé Boycott from the 1970s onwards coupled with 
widespread education about the benefits of breast milk and the dangers of formula-feed, underpinned by a 
suspicion that Western institutions endorsing infant formula formed part of a grand narrative of post-
colonial exploitation (Baumslag, et al. 1995). 
306Both these international organisations seek to support and promote breastfeeding through both policy, 
and more locally through education and peer support programmes. For further information see their 
websites at  http://www.waba.org.my/ and http://www.llli.org/. 
307
 See Blum (1999) for a detailed description of the social organisation of breastfeeding in the United 
States and women’s experience of their bodies as “failing” if they are unable to meet this ideal.   
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breastfeed with rates of initial breastfeeding308 of 81% (The NHS Information Centre et 
al. 2011).  We therefore live in an era of globalised “ideologies of breastfeeding” (Blum 
1999) with women in diaspora being exposed to specific local articulations of this 
ideology in both their home countries and the UK.      
Women are also active agents in seeking information about infant feeding, drawing 
upon a host of sources including print media and the internet309.   Many of my 
participants had consulted books and the internet and had concluded that breastfeeding 
was superior to infant formula in terms of infant nutrition and long-term development.  
They were further exposed to pro-breastfeeding messages when attending for antenatal 
care.    Although my participants were seen by an HIV specialist antenatal team, 
geographically their clinics were located within the general hospital antenatal service.   
The high visibility of pro-breastfeeding posters and literature in general antenatal 
services, whilst understandable from a general public-health perspective, meant that 
HIV-positive women are often exposed to messages that were not tailored to their 
circumstances as HIV-positive expectant mothers.  The benefits of breast milk were 
reinforced within the antenatal classes that some of participants attended, which again 
were aimed at a predominantly HIV-negative group of women.   
African women living with HIV are therefore subjected to a variety of discourses that 
valorise breastfeeding.  For many, breastfeeding was intrinsically tied to a positive 
identity as both a mother and as a woman: 
I feel unhappy [about not breastfeeding].  But if I do not breastfeed, my baby might be 
okay. So I just accept it but in my heart it pains me because as a woman you have to 
breastfeed your baby.  
(Hope) 
Women described feelings of guilt and selfishness despite the fact that they were 
avoiding breastfeeding at great personal cost in order to safeguard the health of their 
baby.  Not only were their internal expectations of motherhood disrupted by avoiding 
breastfeeding, but they also had to contend with the expectations of those around them 
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 This definition includes all babies who were put to the breast at all, even if it was only once. 
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 A recent study from Leeds has revealed that “HIV breastfeeding” is entered as a Google search term 
approximately 2900 times a month with 320 of the searches originating in the UK.  The authors found 
that of the nineteen web pages, four were “pro-breastfeeding:” and did not make a clear distinction 
between resource-rich and resource poor settings.  Of more concern was the finding that three sites 
contained grossly misleading information about the ability of breast milk to destroy HIV (Durba, et al. 
2013).  
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either in the UK or on visits back home to Africa.  Some described how their decision to 
formula-feed had led them to be viewed by others as “selfish” or “bad” mothers.  Health 
professionals were acutely aware of the challenges their advice to avoid breastfeeding 
presented to the construction of a positive maternal identity: 
What does motherhood look like when it’s done well in the communities that have high 
rates of HIV?  It’s very hard to identify as a good mother if you follow the medical 
advice that I give out in many cases. 
(Helen, HIV antenatal specialist doctor) 
My participants subscribed to a global hegemonic notion of a good mother as a 
nurturing, selfless, breastfeeding mother.  In Goffman’s310 ([1990] 1963) terms, 
abstaining from breastfeeding “spoils” a woman’s identity as a good mother, both 
internally and externally, and places her in the realm of uncaring, selfish bad mothers, 
set apart from those who successfully adhere to the dominant cultural script: 
I think that maybe I am not a part of these people, I feel so bad when I see them [women 
who breastfeed]. 
(Grace) 
Breastfeeding was as a core component of motherhood that women had expected (and 
were expected) to perform, and had looked forward to.  Bury (1982) has described the 
“biographical disruption” that people with chronic illness encounter.  The long-term, or 
permanent, nature of chronic illness not only impacts upon a person’s physical self, but 
also presents a challenge to their sense of identity.  The onset of chronic illness brings 
with it a new world of symptoms, regimes, roles and meaning for an individual311. 
Pregnant women and mothers with living with HIV encounter a particular type of 
biographical disruption when confronted with infant feeding decisions.  When HIV 
interacts with pregnancy it disrupts their expected trajectory through motherhood 
meaning that the relationship between expectations of motherhood and motherhood as it 
is enacted in the context of HIV are no longer congruent.   
As touched upon earlier in this chapter, decisions about what is risky and how to 
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 See Chapter One (36-37) for a more detailed description of Goffman’s concept of spoiled identity.   
311
 Green and Sobo (2000) have elaborated upon this to describe the biographical disruption that results 
from HIV in terms of both physical symptoms in a pre-HAART era and the highly stigmatising nature of 
the disease.  
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address this are predominantly social processes.  For many of my participants, decisions 
about feeding their infants were socially embedded within their local social networks312. 
They described how it was the norm for families and members of their wider 
community to scrutinise and comment on mothers’ feeding decisions.  It was not 
uncommon for women’s decision to formula-feed to be greeted with suspicion, 
demands for justification and even physical encouragement to breastfeed: 
I am sure there are some who will breastfeed just to keep the family quiet because you 
would say to your mum, ‘Oh the baby doesn’t take to the breast very well’ and then they 
[mum] will probably show you how to do it wouldn’t they? So what do you do?  
(Cynthia, HIV peer-support professional) 
A central obstacle that women face when avoiding breastfeeding is that of disclosure of 
their HIV status.  Avoidance of breastfeeding not only marked women as “selfish” 
mothers but also functioned as a marker of HIV-positive status313, especially when 
coupled with other potential indicators: 
You always have to explain [...] that this baby is taking medication and then that you’re 
not breastfeeding.  So everything adds up and even if people don’t make comments you 
know it’s [suspicions about HIV-status] just going to be out there. 
(Faith) 
Although most women I interviewed had disclosed to their partner, it was rare that they 
had informed other members of their family of their HIV status, let alone anyone else.   
The deep-seated stigma within many African communities314 surrounding HIV led to 
the majority of women fearing the consequence of inadvertent disclosure of their 
status315. 
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 Studies from other settings (predominantly Sub-Saharan Africa) reveal how decisions about infant 
feeding extend beyond the mother-child dyad.  Although spouses play a large part in decision-making 
(Moses, et al. 2009, Kasinga, et al. 2008, Buskens, et al. 2007), it is important to recognise that extended 
family and other members of the community, especially elders and grandmothers, may contribute to 
feeding decisions (Pool, et al 2001, Buskens, et al 2007, Cames, et al. 2010). 
313
 Breastfeeding as a surrogate marker for HIV-positive status has been previously described by authors 
in various Sub-Saharan African settings (Moland, Sadoh, et al. 2009, de Paoli, et al. 2002, Blystad, et al. 
2009, Eide, et al. 2006, Kasinga, et al 2008, Doherty, et al. 2006). 
314
 The drivers of HIV-related stigma within African communities were discussed in detail in Chapter 
Five with reference to taking ART during pregnancy.   
315
 Work from South Africa reveals that pregnant women and new mothers suspected of being HIV-
positive may encounter mocking, social ostracism, abandonment, and physical violence (Doherty, et al 
2006, Visser, et al. 2008).  A study conducted by myself and colleagues in an East London HIV clinic  in 
2010  found that one in eight HIV-positive women had experienced intimate partner violence during 
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Although in the past HIV had many visible stigmata such as characteristic wasting or 
skin lesions, most people living with HIV with access to treatment will not be perceived 
as HIV-positive by those around them.  In Goffman’s terms they fall into the category 
of the “discreditable” ([1990] 1963: 14).  Given the level of stigma and taboo 
surrounding HIV in many African communities, my participants were often under 
considerable pressure to “pass” (Ibid: 58) by presenting an HIV-negative social identity.  
This required careful management of information so as to keep their HIV-status hidden, 
such as hiding medication and making excuses for visits to the doctor.  Many women 
described how public breastfeeding was the norm in their communities and that a 
woman who did not breastfeed her child would raise suspicions of HIV.  Therefore the 
mother/bottle-fed infant dyad functions as a potent and visible stigma symbol 
“especially effective in drawing attention to a debasing identity discrepancy” (Ibid.: 59), 
constraining a woman’s capacity to present an HIV-negative social identity. 
The decision to avoid breastfeeding therefore encompasses much more than the 
minimisation of risk of HIV transmission to the baby.  Transnational ideologies that 
valorise breastfeeding, structural barriers, a multiplicity of social meanings attached to 
breastfeeding and social pressure to conform to infant feeding norms place women in 
the unenviable position of balancing their needs with that of their child, demanding 
considerable resilience. 
9.5 Feeding decisions have social consequences 
Despite the difficulties women faced when avoiding breastfeeding, the majority of my 
participants managed to exclusively formula-feed their infants.  However, the social 
organisation of meaning of different modalities of infant feeding meant that the decision 
to avoid breastfeeding had repercussions within the social domain. 
Many women believed that breastfeeding was vital to bonding between mothers and 
their babies316.  Consequently they worried that not breastfeeding would result in 
decreased attachment between themselves and their child.  Breastfeeding was viewed as 
                                                                                                                                                                                  
pregnancy, although the association with HIV disclosure was not specifically explored (Dhairyawan, et 
al. 2013).   
316
 The belief that breastfeeding fosters emotional attachment between mother and child is widespread 
across many settings.  See for example Hoffman’s work in rural Burkina Faso (2009) and Buskens’ 
description of HIV-positive mothers’ attitudes towards breastfeeding in Namibia and Southern Africa 
(2007).  A questionnaire study conducted among mothers in the US has also provided evidence of 
increased bonding through breastfeeding (Britton, et al. 2006).  
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a central route through which mothers could pass love on to their child317: 
 
You transfer affection to the baby.  It’s like when partner goes on your breast.  It’s a 
kind of love you’re transferring.  You’re showing your love.  
(Bolade)  
My participants saw breastfeeding as the only way to secure a unique link with their 
children and to ensure their children “knew” them.  This was contrasted with formula 
feeding that “anybody at all can do for the baby”.  Breastfeeding is viewed in many 
communities as an important part of infant socialisation, transmitting maternal personal 
qualities (Mabilia 2005, Buskens et al. 2007, Hofmann et al. 2009), regulating infant 
behaviour (Seidel 2004) and strengthening kinship ties (Moland 2004).  This was 
echoed by my participants who felt that a child who was not breastfed would be less 
likely to show respect or feel a sense of familial obligation as they grow older: 
When a baby doesn’t breastfeed, it doesn’t listen to you.  The baby that breastfeeds, you 
know, they have more love than the baby who doesn’t [breast] feed.  
(Fatima) 
Breastfeeding has previously been explored through Mauss’ concept of the gift (Shaw 
2003, Mabilia 2005), emphasising breastfeeding as a socially embedded bodily practice.  
For Mauss the gift is as an important social interaction with three obligations; to give, to 
receive and to reciprocate ([2009] 1950).  It may seem antithetical to frame 
breastfeeding within a Maussian notion of gift as it is commonly perceived as natural, 
spontaneous and non-contractual; the ultimate symbol of maternal “corporeal 
generosity” (Shaw 2003).  However, for many of my participants there was a strong 
social expectation that they breastfeed their children, rendering it less a choice than a 
social obligation.  There was an expectation that breast milk would be given in return 
for a child’s love and respect, implying that breast milk had an active affective 
property318. Breastfeeding may be described as “generalised reciprocity”  (Sahlins 
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 See also Buskens’ description of breastfeeding as forging a “lifelong ‘love-link’” between mother and 
child in Southern Africa (2007), and Hoffman’s ethnography of infant feeding in Burkina Faso in which 
she emphasises the importance of breastfeeding as a way of sharing love (2009). 
318
 Also see Mabilia’s ethnography of breastfeeding among the Gogo women in Tanzania where 
breastfeeding appears on the surface to be an act of unconditional maternal altruism.  However, it exists 
within a system of social relations and meanings.  For Mabilia’s participants breastfeeding engenders an 
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1972), a form of supposed altruistic exchange, usually amongst kin, which carries an 
implicit acceptance of obligation that may be fulfilled in the future.    Breastfeeding not 
only ties a child to its mother by love, reinforcing familial obligation, but it also shapes 
women’s roles as mothers and structures relations with those around them319.  As HIV-
positive women exhorted by medical professionals to exclusively formula-feed, my 
participants were not only unable to assume the culturally-sanctioned role of the good 
breastfeeding mother, but they also found themselves isolated either because they were 
viewed with suspicion or because they withdrew from others for fear of disclosure and 
stigma.    This reconfiguration of breastfeeding through the Maussian notion of the 
“gift” allows us to see that women living with HIV, unable to participate in the gift-
exchange of breastfeeding, forgo important aspects of social interaction.  Avoiding 
breastfeeding disrupts the bond between mother and infant, threatens her reputation and 
status within her community, and weakens ties between the mother and her wider social 
network.     
Fear about disclosure of HIV status to friends, family and their wider social network 
was pervasive among my participants.  I have already highlighted how the 
mother/bottle-fed infant dyad functions as a potent stigma symbol within many of my 
participants’ communities, compromising women’s ability to pass as HIV-negative.    
Furthermore not breastfeeding significantly impacted on women’s self-esteem leading 
to feelings of inferiority or jealousy when encountering other mothers who were 
breastfeeding, who could otherwise have been an important part of their local support 
network.  The desire to avoid uncomfortable questions and the disclosure of their HIV-
positive status often resulted in varying degrees of social restriction in order to 
successfully manage information about themselves320, such as the participant below 
who had started attending church less since the birth of her child and avoided 
environments where her feeding decisions may be probed: 
My church members […] they ask questions too much […] so it is very hard 'cause they 
want to know everything.  They have a mothers’ room that you can go to with your baby 
                                                                                                                                                                                  
emotional and social bond between mother and child as well as structuring relations between the mother 
and her wider community.  Through breastfeeding Gogo women satisfy the expectations of those around 
them and secure their status within the community (2005). 
319
 Moland’s analysis of the cultural construction of breastfeeding among Chagga women in Tanzania 
highlights how breastfeeding strengthens women’s status in their community (2004).  Breastfeeding 
engenders respect and affords women social privileges during confinement such as more food and rest.  In 
contrast women who cannot breastfeed are seen as “useless” and forego any benefits attached to nursing.   
320
 Social isolation in an effort to prevent disclosure of HIV-status is a well-recognised aspect of HIV-
positive motherhood  (Desclaux, et al. 2009, Nuwagaba-Biribonwoha, et al. 2006, Blystad, et al. 2009, 
Cames, et al. 2010). 
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[...]  but when I went to church I didn’t want to go there. When everybody was there and 
feeding their baby [they ask] ‘why you don’t want to breast feed’? 
(Grace) 
This narrowing of the social sphere has previously been described by Green and Sobo 
(2000) in their study of the impact of HIV on identity and social relations. The threat 
HIV poses to someone socially is highly context-specific: 
“Who one is, where one is, and who one is with largely determines one’s perception and 
management of the social risk of being HIV positive, and dictate the extent to which 
HIV is incorporated publicly and privately into one’s identity.” 
(Green et al. 2000) 
My participants were migrant women living with HIV within communities where HIV 
remains highly stigmatised.  Their lives were often complicated further by poverty, 
insecure immigration status and lack of partner support.  I would argue that these 
women lack the social capital321 to be able to incorporate HIV into their public identity 
and have little choice but to isolate themselves in an effort to conceal the potent stigma 
symbol of the mother/bottle-fed infant dyad322. 
9.6 Emerging resistance 
Although the majority of my participants decided to avoid breastfeeding their baby, 
concerned about the risk of transmitting HIV to their baby, they were not wholly 
accepting of national guidance.  According to Emily Martin, the consciousness of 
opposition and resistance can take many guises ranging from “lament” and “non-action” 
through to “resistance” and “rebellion” (Martin 1987: 184-189).   Throughout this 
chapter I have foregrounded the considerable grief and distress experienced by my 
participants as a result of not breastfeeding their babies.  It is important to view this 
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 Here I am referring to Bourdieu’s definition concept of social capital as the benefits people gain from 
their participation within social networks.  Social capital is “the aggregate of the actual or potential 
resources which are linked to possession of a durable network of more or less institutionalized 
relationships of mutual acquaintance or recognition” (Bourdieu 1986: 248).. 
322
 Blystad and Moland (2009) have described how HIV-positive mothers in Tanzania and Ethiopia are 
unable to harness biosocial power from their HIV-positive status.  Poverty and other modes of social 
marginalisation function as barriers in the formation of a positive and empowering identification with 
HIV as is seen within HIV activism.  It is interesting to contrast these findings with those of Cecilia Van 
Hollen who found that HIV-positive mothers in Tamil Nadu were much less concerned about HIV 
disclosure (2011). She concludes that this is due to the low prevalence of HIV in Tamil Nadu and the low 
visibility of HIV, resulting in formula feeding not being a marker of HIV-positive status.   
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“lament” (Martin 1987: 184) as inchoate resistance as it suggests that women are not 
wholly accepting of the situation.  Others manifested resistance in the form of expressed 
ambivalence about medical advice to abstain from breastfeeding.  For some this centred 
around unresolved concerns about the long-term effects of not breastfeeding on their 
child’s health: 
They've [her children] got the energy.  I mean there's no difference between them and 
any other children that are being breastfed […] Well to me they don't look any different.  
But inside...I don't know what's going on inside.  
(Esther) 
For others their concern emanated from a mistrust of medical motives and a fear that 
professionals may be “lying”.  One woman framed this within a larger context of 
increasing and well-publicised public-sector cuts, suspicious that medical advice 
regarding infant feeding in HIV was driven by economics rather than patient need: 
Look at delivery [...]  why is it that they’re not saying that when you’re HIV you can just 
go straight to caesarean?  Because they will be thinking of saving money  ‘Oh yes, we 
can try normal [delivery] because we could save some money.’ [...] But when it’s got 
nothing to do with them [the hospital] saving anything then they are like ‘Don’t do it at 
all.’ [...] I am thinking if you were saving them money, say for example if it was 
compulsory for them to give formula, they would probably be encouraging women 
‘Okay, try to breastfeed up to this time’ just to see if they can save money.  But it’s 
[formula feeding] not costing them anything and it’s costing us.  Obviously no one is 
thinking about you.  
(Faith) 
Another source of doubt for the participant above, and for others, was the clear 
discrepancy between guidance on infant feeding in the UK, and guidance issued by the 
WHO for resource-poor settings.  In many resource poor settings, including many parts 
of Sub-Saharan Africa, HIV-positive mothers are advised to exclusively breastfeed their 
children as formula feeding is not is acceptable, feasible, affordable, sustainable and 
safe.  Women had knowledge of this discrepancy in public health guidelines through 
their own research on the internet and through the strong links they maintained with 
their home countries where they often knew of HIV-positive women who had been 
advised to breastfeed.   One woman’s experience of the global disparities in infant 
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feeding advice was more direct in that she had been advised to breastfeed on being 
diagnosed with HIV antenatally in Ghana, but on transferring her care to the UK to join 
her husband she had been informed that breastfeeding was risky and that she should 
exclusively formula-feed.   My participants’ location within diaspora gave them a 
unique vantage point of transnational disjunctures in public health policy, which 
sometimes led to confusion and frustration.  Furthermore, this stark contrast between 
guidelines presents a challenge to the authoritative knowledge of biomedicine, laying 
bare its inherent inconsistencies.  
During my fieldwork, only one woman disclosed to me that she was breastfeeding her 
child.  I present her story here to provide a deeper understanding of the factors 
underlying an HIV-positive mother’s decision to breastfeed against medical advice. 
9.6.1 Ruth 
Ruth, a Ugandan woman in her mid-twenties who migrated to the UK in 2001, had a 
six-month-old baby who was her second child.  She had been diagnosed several years 
before and already had a son who was HIV-negative.  Within months of delivering her 
son she had become pregnant again without planning to.  She had a partner, also HIV-
positive, who had been present at the birth of her youngest son but lived apart from her 
and provided little in the way of material and emotional support.  Instead, Ruth lived 
with her mother (a church Pastor who was aware of her daughter’s HIV status) and 
several other members of the extended family to whom Ruth had not disclosed.  Ruth’s 
social situation was precarious in that she did not have leave to remain in the UK and 
had no recourse to public funds.  She occasionally managed to find some work 
informally as a hairdresser but she was essentially financially dependent on her family 
to provide for herself and her two young children.  After her first pregnancy she had 
followed medical advice and had exclusively formula-fed her son.  However, on the 
birth of her second son Ruth had made the decision to both breastfeed and formula-feed, 
having been satisfied that her HIV was well-controlled: 
 “my doctor was telling me everything was OK with my blood, that it’s undetectable, so 
I said maybe I should just try.  I thought it was my decision.”   
She had found not breastfeeding in her first pregnancy “hard”, whereas breastfeeding 
by contrast was “easier, faster […] and it’s cheap”.  She also felt that this breastfeeding 
was better for her baby and that, as a mother, this was her decision to make.   The 
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confidence she had in this decision had been borne out by her baby’s HIV-negative tests 
up until that point and the fact that he was thriving: 
“at the end of the day, it was all good.”  
Ruth’s story is illustrative as it condenses many of the themes introduced in this chapter 
and provides us with an insight into the drivers of “resistance”323.   Again we see the 
limitations of the technical approach to risk that assumes that safety is paramount in the 
decisions people make about risk.  Ruth’s decision to breastfeed her child was 
underpinned by a complex set of factors including convenience, her belief in the 
nutritional superiority of breast milk, her understanding that having an undetectable 
viral load eliminated the risk of transmission324 and a desire to have agency in decision-
making about how to feed her child.  However, it was Ruth’s social marginalisation that 
loomed large in her narrative.  As a single mother with insecure immigration status she 
was financially and socially dependent on her family, many of who were unaware of her 
HIV status.     The decision to formula feed would have been met with suspicion, would 
have prompted questions or speculation about her HIV-status and would have been met 
with resistance in terms of financial assistance325.   The structural violence enacted 
through British immigration law had set in motion a chain of dependency.  As an HIV-
positive woman with two young children and no citizenship rights, breastfeeding 
incurred less social risk to herself and her young family than formula feeding by 
allowing her to present an HIV-negative identity to the wider world.  It was clear that 
the threat of poverty, homelessness and deportation were a greater risk to her child’s 
health than the small biological risk of vertical transmission.   
This narrative of resistance was hidden in that Ruth had not felt able to discuss her 
decision to breastfeed with her medical team “because they said I shouldn’t do it”, a 
striking example of the authoritative power of biomedicine326.  The lack of an open 
discussion about the possibility of breastfeeding had led to Ruth being unaware of the 
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 In Martin’s discussion of oppositional consciousness she defines resistance as “refusing to accept a 
definition of oneself and saying so, refusing to act as requested or required” (1987: 187). 
324
 As discussed earlier in the chapter, the risk of vertical transmission through breastfeeding is reduced 
through the use of maternal HAART but not eliminated.   
325
 It is important to note that Ruth attended a clinic that was not set up to provide access to free formula 
and equipment to HIV-positive mothers. 
326
 This concern was justified to some extent as when she finally informed her team, the revelation 
prompted a degree of anxiety in some team members who questioned Ruth’s parenting and sought advice 
from local child protection services.   
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risks attached to mixed-feeding327.  When she finally made the decision to disclose that 
she had been breastfeeding, she received support to wean safely and was offered further 
opportunities for her son to be HIV-tested.   
9.7 Conclusions 
The work presented in this chapter is the first in the UK to explore infant feeding 
decisions in women living with HIV, and is one of the first internationally to be 
conducted in a resource-rich setting.  It exposes as false the dichotomy between infant 
feeding decisions in resource-poor settings and those in resource-rich settings, where it 
is often assumed that the decision to formula feed will be more straightforward and 
acceptable.  Although the considerable infrastructure-related barriers to formula feeding 
faced by women in resource-poor settings may not be encountered in countries such as 
the UK, my participants were still subjected to economic constraints and dominant 
discourses that valorise breastfeeding.   Where this study differs from those conducted 
in other resource-poor settings is in its focus on women within the African diaspora.  
My participants’ location within diaspora gave them an acute awareness of transnational 
disjunctures in public health policy on infant feeding in the context of HV.  
Furthermore, the poverty and lack of citizenship rights that often accompany migration, 
forced some women into economic dependency on those around them, presenting a 
further challenge to their ability to adhere to their decision to formula feed.   
All but one woman I interviewed postnatally avoided breastfeeding their babies, 
however this decision came at great personal and social cost.  Rather than being 
decisions made by an individual solely to ensure safety (in this context to eliminate the 
risk of vertical transmission), decisions on how to feed their babies were highly 
relational in nature and were subjected to a range of competing concerns.  The 
consequences of not breastfeeding manifested clearly within the social domain, 
resulting in anxieties about bonding with their child, a restriction in the social sphere in 
order to avoid HIV disclosure, and the spoiling of a woman’s identity as a good mother 
with consequent loss of status and self-esteem.  Given the challenges that avoiding 
breastfeeding presents to migrant African women living with HIV, it is hardly 
surprising that there is emerging opposition on a spectrum from lament to overt 
resistance.   
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 Earlier in this chapter I described how mixed-feeding (that is breastfeeding in combination with other 
sources of food including formula) carries a greater risk of vertical transmission than either exclusive 
breast or formula feeding.   
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Despite the significant challenges, women continued to prioritise the needs of their child 
and avoided breastfeeding.  However, it is important to realise that the decision to 
breastfeed in the context of HIV is not an irrational one, but one based on minimising 
other risks, and is one that also is centred upon a mother doing what she thinks is best 
for her child.    As professionals we need to extend our notion of risk, which is informed 
by public health and the need to minimise vertical transmission, and appreciate risk in 
its multidimensional form. 
 
Key points 
 The majority of HIV-positive women adhere to current UK guidelines to 
formula feed exclusively. 
 Key difficulties encountered by women in avoiding breastfeeding are cultural 
notions of the superiority of breastfeeding, fears of disclosure of HIV status, 
financial cost and apparent transnational disjunctures in public health policy.   
 The decision to abstain from breastfeeding comes at significant personal and 
social cost to women and requires considerable support in order to create an 
enabling environment. 
 Some HIV-positive women will choose to breastfeed despite medical advice.  
These decisions are rarely irrational and are also centred on the health and 
wellbeing of their child.   Mothers who choose to breastfeed will require 
particular support in order to be able to do so safely and without judgment.   
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10  
           
Discussion  
 
Summary 
In this, the penultimate chapter of my thesis I present a synthesis of my quantitative and 
qualitative findings with reference to the overarching research question as well as the 
specific questions I posed in Chapter One.  I highlight how my research has generated 
new knowledge in key areas.  I conclude with a discussion of the strengths and 
limitations of my methodological approach in this thesis.   
10.1 Engagement with HIV services during and after pregnancy 
The overarching research question posed in this thesis is: how do African women living 
with HIV in the UK engage with HIV services and interventions during and after 
pregnancy?     This question arose because of the increasing number of pregnancies 
reported in women living with HIV in the UK, the overwhelming majority of whom 
were born in Sub-Saharan Africa.  It is a response to the dearth of literature on HIV and 
pregnancy that specifically engages with maternal-focused outcomes and lived 
experiences of women.   The thesis focuses on the relationship between outcomes and 
experiences of pregnancy among HIV-positive women in the UK, and maternal 
ethnicity, African region of origin and duration of residence in the UK.  To the best of 
my knowledge, this is the first time such research has been conducted in the UK. 
To answer the overarching research question (how do African women engage with HIV 
services and interventions during and after pregnancy?), I posed three specific questions 
in Chapter One: 
1. Are maternal ethnicity, African region of birth and duration of residence in the 
UK associated with:  
a. Not receiving ART during pregnancy 
b. Detectable maternal HIV viral load at delivery 
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c. Vertical transmission of HIV 
d. Late antenatal booking 
e. Loss to follow-up from HIV care in the year after pregnancy 
2. What are the mechanisms underlying associations between clinical and service 
outcomes, and maternal ethnicity, African region of birth and duration of 
residence in the UK? 
3. What are the experiences of African women living with HIV during and after 
pregnancy? 
I will now synthesise key findings from my research to answer these questions.  
10.2 Research question one  
My first question was: are maternal ethnicity, African region of birth and duration of 
residence in the UK associated with: not receiving ART during pregnancy; detectable 
maternal HIV viral load at delivery; vertical transmission of HIV; late antenatal 
booking; and loss to follow-up from HIV care in the year after pregnancy. 
 
10.2.1 Trends in pregnancies among women living with HIV 
In Chapter Four I showed that the number of reported pregnancies in women living with 
HIV in the UK has increased dramatically since 1990.  This is mainly a consequence of 
the widespread availability of HAART affording greater reproductive opportunity, but 
also the increased number of diagnoses of HIV in pregnancy as a result of the 
introduction of routine antenatal screening for HIV from 2000 and the increasing 
number of women, particularly from Sub-Saharan Africa, being diagnosed with HIV in 
the UK.   The number of women reported as pregnant stabilised at approximately 1400 
per year between 2006 and 2010328.  The overwhelming majority of HIV-positive 
women reported as pregnant between 1990 and 2010 were African. The proportion of 
women reported as pregnant to the NSHPC who were African increased between 1990 
and 2006 and then levelled off, partly reflecting the plateauing of immigration to the 
UK (including from Commonwealth nations) in recent years (Migration Observatory 
2011).  In 2010, 1351 pregnancies were reported in HIV-positive women in the UK.  
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 This is largely a result of a decrease in numbers of women newly diagnosed with HIV during 
pregnancy in recent years (Byrne, et al. 2013). 
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The largest number of pregnancies in HIV-positive women was reported in London; 
nearly all were in African women.  Outside London the proportion of pregnancies that 
were in African women was lower, although still high.   
Chapter Four explored, for the first time, pregnancy in different groups of HIV-positive 
African women in the UK from an epidemiological perspective.  The greatest 
proportion of pregnancies in African women was in those born in Eastern Africa.  
However, the proportion of pregnancies in women from Eastern Africa declined 
between 1990 and 2010, whilst the proportion in those from Western Africa 
(predominantly Nigeria) increased over the same time period.  This diversification in 
terms of African region of birth was also seen in the general adult HIV-positive 
population in the UK between 2001 and 2010 (Meaghan Kall, Public Health England, 
personal communication, 25 June 2012) and reflects underlying migration patterns to 
the England and Wales329.   
10.2.2 Key outcomes 
Almost all women in the analysis of NSHPC data presented in Chapter Five received 
ART during their pregnancy, in keeping with rates of ART uptake reported in the UK 
and Ireland as a whole ((Townsend et al. 2008b) and in Western Europe more widely 
(Mayaux et al. 2003, Bailey et al. 2011).  Using imputed viral load data I found rates of 
virological suppression of approximately 80%, similar to findings reported by other 
authors (Patel et al. 2007, Baroncelli et al. 2009, Burgard et al. 2010, Katz et al. 2010, 
Joao et al. 2012).  In the analysis in Chapter Five the rate of vertical transmission of 
HIV was low at just over 1%, which is similar to rates reported in other studies, 
including a previous analysis of NSHPC data (Townsend et al. 2008a, Warszawski et al. 
2008, Baroncelli et al. 2009, European Collaborative Study 2010, von Linstow et al. 
2010).  
In Chapter Seven I found that nearly one in two HIV-positive women booked late for 
antenatal care at thirteen weeks’ gestation or beyond.  My analysis is one of the largest 
studies to date to explore antenatal booking in HIV-positive women, and is the only one 
to focus on this in detail.  Only two previous studies, one from the UK (Parisaei et al. 
2007) and the other from France (Jasseron et al. 2011) have looked at antenatal booking 
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 According to the most recent Census there has been a greater increase in the number of residents in 
England and Wales who were born in Western and Central Africa compared to the increase in those born 
in Southern and Eastern Africa, as described in Chapter Four (115-116). 
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in women living with HIV, both reporting much lower rates.  However, these studies 
both used a different definition of late booking from my analysis (beyond twenty 
weeks’ gestation).   
Finally, I explored loss to follow-up from HIV care in the year after pregnancy using 
matched data from NSHPC and SOPHID.  The work I presented in Chapter Eight is the 
largest study to date to explore loss to follow-up from HIV services after pregnancy, 
and the first to use national surveillance datasets.  As such, it makes an important 
contribution to the broader literature that focuses on retention in HIV care and the 
treatment cascade in people living with HIV.  In this analysis I have shown that one in 
eight women do not return for HIV care in the year after their pregnancy.  This is 
consistent with data in the overall HIV-positive population in the UK (Rice et al. 2011)  
and is lower than rates reported in previous studies of loss to follow-up postnatally 
(Saulsbury et al. 2004, Lemly et al. 2007), both of which were smaller and used a 
definition of loss to follow-up that differed from mine.   
10.2.3 The association between maternal ethnicity, African region of birth and 
duration of residence in the UK, and key outcomes 
I now return to one of the key questions posed in this thesis:  are maternal ethnicity, 
African region of birth and duration of residence in the UK (which I will refer to in this 
chapter as “migration-related factors”) associated with key outcomes during and after 
pregnancy?  It is important to note from the outset that there has been almost no work to 
date looking at either maternal region of birth or duration of residence in the UK among 
migrant groups with regards to HIV and pregnancy, with the majority of work to date 
looking at either ethnicity or race (if conducted in the United States) alone. 
The key clinical and service-related outcomes I examined in Chapters Five and Seven 
were: not receiving ART in pregnancy, detectable maternal viral load at delivery, 
vertical transmission of HIV, late antenatal booking and loss to follow-up one year after 
pregnancy.   Overall I found no consistent association between any of the three 
migration-related factors and key outcomes.  Rather, the effect of migration-related 
factors varied according to outcome. 
Not receiving ART in pregnancy 
In Chapter Five I found no evidence of an association between African ethnicity and not 
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receiving ART during pregnancy330.   A new finding from my analysis was the disparity 
in receiving ART during pregnancy between different groups of African women. 
However, it is important to keep in mind that the overwhelming majority of women in 
all these groups did receive ART in pregnancy.  Women from Western Africa were 
more likely than Eastern African women not to receive ART in pregnancy, with 
Western African women, as well those from Middle Africa, also more likely to have 
declined treatment.  In addition, I have shown that African women who had arrived in 
the UK after conception were more likely not to receive ART in pregnancy than those 
who had been in the UK for four years or more.   
Detectable maternal HIV viral load at delivery 
Very few studies to date have looked at the impact of ethnicity, or indeed other 
migration-related factors, on maternal viral load at delivery.  Previous work has shown 
that migrant women (predominantly African) were as likely as non-migrant women to 
suppress virologically by delivery (Floridia et al. 2010, Izzo et al. 2011).  The findings 
presented in Chapter Five support this in that I also found no association between either 
ethnicity or African region of birth, and detectable maternal viral load at delivery.  A 
new finding is that African women who had arrived in the UK after conception had 
poorer outcomes, being at greatest risk of having a detectable viral load at delivery. 
Vertical transmission of HIV 
In Chapter Five I found no association between either ethnicity or African region of 
birth and vertical transmission, in keeping with findings reported by other authors 
including a previous analysis of NSHPC data (Jasseron et al. 2008, Townsend et al. 
2008a).  The rate of vertical transmission was elevated in pregnancies among women 
who had arrived in the UK after conception compared to those who had been in the UK 
for four or more years331.   
Late antenatal booking 
The work I present in Chapter Seven is the first study in the UK to explore in detail the 
                                                             
330
 Although one American study has demonstrated decreased uptake of ART in pregnancy in Black 
women compared to White women (Abatemarco, et al. 2008), my findings are consistent with those from 
a French cohort showing no association between Sub-Saharan geographical origin and uptake of ART in 
pregnancy (Mayaux, et al. 2003). 
331
 This was no longer statistically significant after adjusting for duration of ART, suggesting that the 
association between shorter duration of residence and vertical transmission was largely due to a shorter 
duration of treatment.  
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association between migration-related factors and late antenatal booking in women 
living with HIV. I have found an association between late booking and ethnicity, with 
African women approximately twice as likely to book late as white British women332, 
which is in keeping with previous findings from a French study (Jasseron et al., 2008).    
There was no evidence of an association between late antenatal booking and either 
African region of birth or duration of residence in the UK. 
Loss to follow-up after pregnancy 
Finally in Chapter Eight I explored maternal loss to follow-up one year after pregnancy.  
To date, all research on retention in HIV care postnatally among HIV-positive women 
has been conducted in Sub-Saharan Africa and has not explored the impact of 
migration-related factors.  The work I present in this thesis is the first from a resource-
rich setting to explore retention in care after pregnancy on a large scale.  To the best of 
my knowledge it is also the only study to date, regardless of pregnancy, to explore the 
heterogeneity between different groups of Africans with regards to retention in HIV 
care, identifying groups that may require particular support to engage with and access 
services.    
I have shown that African women are more likely than white British women not to 
attend for HIV care in the year after pregnancy.  This fits with findings in the overall 
HIV-positive population in the UK showing an association between Black African 
ethnicity and lower retention in care (Gerver et al. 2010, Rice et al. 2011, Clay 2013)333.   
Looking at African women in greater detail, I have shown that those from Western and 
Southern Africa were at greater risk of being lost to follow-up than those from Eastern 
Africa.  Furthermore, women who had arrived in the UK after conception were more 
likely not to return for follow-up in the year after pregnancy than those who had been 
resident for four or more years.  
In summary, I have explored the association between migration-related factors and a 
range of clinical and service-related outcomes in pregnancy (see table 10.1).  Key 
findings include the association between African ethnicity and both late antenatal 
booking and loss to follow-up after pregnancy; and the association between African 
region of birth and the receipt of ART in pregnancy and loss to follow-up after 
                                                             
332
 This reflects the well-documented association between ethnicity, migration and late booking seen 
among pregnant women in general as summarised in Chapter Two.   
333
 It also echoes work from other parts of Europe and the US, which show poorer retention in care for 
those of non-white ethnicity, as summarised in Chapter Two.   
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pregnancy.  A striking finding is the consistent association between arrival in the UK 
after conception and not receiving ART during pregnancy, detectable viral load at 
delivery, vertical transmission and loss to follow-up after pregnancy.  This is the first 
time that this particular group of women has been identified as vulnerable in analyses of 
observational data on HIV in pregnancy.   
 
Table 10.1: Summary table of association between maternal ethnicity, African region of 
birth and duration of residence in the UK, and key outcomes (Chapters Five, Seven and 
Eight) 
 African ethnicity African region of 
birth 
Arrival in the UK 
after conception 
Not receiving ART 
during pregnancy 
x   
Detectable viral 
load at delivery 
x x  
Vertical 
transmission 
x x  
Late antenatal 
booking 
 x N/A 
Loss to follow up 
after pregnancy 
   
 
10.3 Research question two 
My second question was: what are the mechanisms underlying the associations between 
clinical and service outcomes, and maternal ethnicity, African region of birth and 
duration of residence in the UK?  I explored this question using qualitative research 
methods.   My work comes from an anthropological tradition and engages 
ethnographically with previously unexplored areas such as how conditions of diaspora 
influence engagement with services, the role of Pentecostal churches in shaping 
attitudes towards illness, and the social construction of risk.  Furthermore, by deploying 
a conceptual framework of structural violence, I have situated my findings within a 
broader global literature on how unequal social arrangements come to be embodied by 
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people living with HIV (Farmer 2004, Fassin 2007). 
In this section I touch upon themes that contextualise the key quantitative findings 
summarised in section 10.2. 
10.3.1 Women engaging in care 
As shown in section 10.2.2, the findings from the epidemiological analyses are largely 
reassuring with high rates of receipt of ART in pregnancy, good levels of virological 
suppression, low rates of vertical transmission and the majority of women being 
retained in HIV care after pregnancy.  This suggests that women engage well with 
healthcare both during and after pregnancy.  This was borne out by findings from my 
ethnographic fieldwork.   
Women valued their HIV antenatal care highly, describing close relationships with a 
core group of professionals that they saw regularly through their pregnancy.  This 
fostered trust in the healthcare system as a whole and it gave women the confidence to 
return.  An important aspect of the care they received from their multidisciplinary HIV 
antenatal team was the fact that it was often situated within the context of day-to-day 
life as a migrant in London with support extending beyond the medical domain to 
address structural constraints through financial support and assistance with immigration 
matters.   
In Chapters Five, Seven and Eight I framed this engagement with healthcare 
professionals within the broader frame of African HIV-positive women’s lives and 
Mol’s “logic of care” (2008).  Mol contrasts the logic of care with the “logic of choice” 
which appears to be the dominant paradigm in contemporary healthcare delivery.  
Healthcare settings are increasingly subjected to market forces and choice, with people 
suffering ill health transformed from patients to consumers (Ibid.).  Underlying the 
principle of choice is the assumption that choices are made by autonomous individuals 
through the careful weighing up of advantages and disadvantages at a specific moment 
in time (Ibid.).  The logic of choice dictates that if a patient does not adhere to a certain 
intervention it is their individual responsibility.  The logic of care, on the other hand, 
views decision-making as embedded within a broader field of action and requiring 
constant recalibrating.  The implementation of the Health and Social Care Act 2012334, 
                                                             
334
 The Health and Social Care Act 2012 was an Act of Parliament implemented in the UK in April 2013, 
to widespread concern from the Royal Medical Colleges, precipitating the most extensive restructuring of 
the NHS since its inception.  Key underlying principles enshrined by the Act include opening up the NHS 
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with its enshrinement of patient choice as a driver of improvement of NHS care, 
therefore raises concern as it may lack core values inherent in the “logic of care” that 
have been instrumental in engaging the women in this study in HIV services during and 
after pregnancy.  
For many women in my ethnographic fieldwork biomedicine was not a technological 
innovation.  The majority were from urbanised elite backgrounds in Africa and had 
extensive experience of biomedicine in their home countries.  Biomedicine has 
successfully penetrated health settings internationally and has widespread prestige and 
purchase.  Inspired by Appadurai’s concept of –scapes (1996), I have deployed the 
neologism healthscape to capture the transnational flow of medical knowledge and 
technologies and their specific local articulations.  African women living with HIV in 
the UK exist within a global healthscape where biomedicine is highly visible and 
popular.  Seeking medical care for pregnancy and HIV was therefore not culturally 
alien.   
However, their vantage point within diaspora gave them an acute sense of disjunctures 
within the healthscape as it manifests in the UK and in Sub-Saharan Africa.  For some 
women, the knowledge that they could access services and interventions that may not be 
readily available in their home countries served as a motivating force to engage with 
HIV care.      
Finally, engagement with services and interventions, although often requiring 
considerable effort on the part of women, reduced the risk of vertical transmission and 
afforded women longer survival thus enabling them to achieve motherhood, a core 
component of their identities as women, whilst safeguarding their children’s health.   
10.3.2 Extending notions of risk to understand disparities    
Although the majority of women appeared to engage well with different aspects of care 
in analyses of NSHPC data, disparities in outcomes by migration-related factors were 
identified as summarised in 10.2.3.  The impact of ethnicity, African region of origin 
and duration of residence in the UK was complex and shifted according to which 
outcomes were considered.  However women who had arrived in the UK after 
                                                                                                                                                                                  
to the forces of competition and choice in order to drive quality improvement and value for money.  See 
"Factsheet C4" on choice and competition in the Act, published by the Department of Health and 
available at https://www.gov.uk/government/uploads/system/uploads/attachment_data/file/138269/C4.-
Factsheet-Choice-and-competition-270412.pdf (accessed 23 September 2013). 
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conception (many of who would have had insecure immigration status), and to a lesser 
extent women from Western Africa, emerged as groups who appeared to have poorer 
engagement with HIV care during and after pregnancy.   
I will now focus upon women from Western Africa and women with insecure 
immigration status, in order to summarise the challenges they may encounter in 
engaging with HIV services and interventions.  It is important to note that the 
challenges I describe here faced by Western African women and women with insecure 
immigration status are not confined to these groups and may extend not only to other 
groups of African women but also to HIV-positive women in general. However I have 
chosen to focus upon these two groups as they foreground many salient points from my 
ethnographic research. 
Western African women 
Women from Western Africa were more likely not to receive ART during pregnancy 
and were also more likely to have declined it.  Furthermore, Western African women 
(along with those from Southern Africa335) were also more likely to be lost to follow-up 
from HIV care in the year after pregnancy.  This was borne out by the experiences of 
healthcare professionals who identified women from Western Africa as being the 
hardest group of women to engage in care.   
Professionals often attributed poorer engagement with HIV care to the predominance of 
Pentecostalism within West African communities and widespread beliefs in divine 
healing.  However, this was not supported by findings from my ethnographic fieldwork.  
Beliefs in divine healing are situated in a wider cosmological framework in which all 
types of misfortune are addressed through spiritual warfare.  However, seeking a 
spiritual solution to misfortune does not preclude other approaches.  My work reveals 
that women draw upon their Pentecostal faith alongside biomedicine, in a pragmatic 
quest to manage life with HIV.  Pentecostalism not only offers succour in the form of 
material assistance and a sense of collectivity within a church, but is also an important 
resource in fostering hope and self-efficacy. 
A more important barrier to engaging with HIV care is likely to be the particularly high 
level of HIV-related stigma within West African communities cited by a number of my 
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 I was not able to recruit any participants from Southern Africa to interview and it is therefore difficult 
for me to comment further on increased rates of loss to follow-up one year after pregnancy in this group.   
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participants336.  Fear of disclosure of HIV status and consequent stigma and 
discrimination were common among Western African women.  Attendance for antenatal 
care was seen as a normal part of pregnancy.  However returning for care after 
pregnancy, especially in a clinic that was known to provide HIV care, risks 
compromising women’s ability to pass as HIV-negative, as does taking antiretroviral 
medication. 
HIV-related stigma was a common theme in my interviews with pregnant women 
regardless of their region of birth.  Although experiences and fears of stigma and 
discrimination are shared by many people living with HIV, I suggest that they may be 
more pronounced among African women in the diaspora.    A range of structurally 
violent factors including poverty, pervasive HIV-related stigma within migrant African 
communities, insecure immigration status and subsequent circumspection towards 
institutions, material dependency on partners and family in the absence of UK 
citizenship rights and experiences of intimate partner violence, all intersect to constrain 
the capacity of women to address HIV-related stigma.   Furthermore, the combination of 
these pernicious social forces may also make women more vulnerable to experiencing 
stigma and discrimination both within and outside of healthcare settings, with a 
consequent impact on the willingness of some to engage with care337. 
Women with insecure immigration status 
A vulnerable group of women identified in the quantitative analyses were those who 
had arrived in the UK after conception, many of whom are likely to have had insecure 
immigration status338.  For many women without secure immigration status, destitution 
and food insecurity were part of everyday life, with many unable to work due to 
restrictive immigration policies.   Their lives were dominated by their immigration 
status and the consequent structural violence that this brought in the form of poverty 
and housing crises.  In this context of chronic and extreme material insecurity, HIV and 
healthcare may fall lower and lower in the hierarchy of needs (Maslow 1943).  Some 
women were forced to depend on friends, family and sometimes violent partners, setting 
in motion a chain of further vulnerability.  Material dependency on family and partners 
                                                             
336Although HIV-related stigma and discrimination is a common experience for many people living with 
HIV, I suggest that they may be heightened within Western African communities where the epidemic is 
less established and HIV is historically less visible. See Chapter Five (164) for a discussion of regional 
variations in HIV-related stigma in Sub-Saharan Africa. 
337
 It is important to emphasise here that the majority of women engage well with HIV services and 
interventions during and after pregnancy.   
338
 The NSHPC does not collect data on immigration status. 
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often precluded HIV disclosure, resulting in anxieties about being seen to attend for 
HIV care and to take ART.   
Engagement in care was further compromised for some women by fears of being 
reported to immigration authorities and repeated demands for payment by hospitals, in 
contravention of Department of Health guidelines.  Furthermore, for the entire duration 
of my fieldwork anyone without secure immigration status in the UK was liable to incur 
charges for HIV treatment outside of pregnancy, posing an even greater barrier to 
treatment for an already marginalised and poverty-stricken group of people.   
The global financial crisis has ushered in a range of biting austerity measures across 
Europe.  In 2009 the World Health Organisation warned of the impact this would have 
on health and social care, stating that the world’s poorest and most marginalised 
populations would be most affected (World Health Organisation 2009a).  During my 
fieldwork between 2010 and 2011 the impact of austerity measures and cuts to welfare 
spending was evident in the increased workload placed on Body & Soul and similar 
voluntary sector organisations, and in the references made by some participants to 
government cuts as a possible reason for negative experiences of healthcare.   
As the financial crisis has deepened there has been a rise in xenophobic violence across 
Europe (Chauvin et al. 2013) and a resurgence in nationalist politics and far right 
movements.   In May of this year, the UK Independence Party (UKip), a right wing 
populist political party characterised by Eurosceptism and a tough line on immigration, 
won over 25% of the share of the vote in English local elections (Watt 2013).  This 
lurch to the right in British politics has resulted in the current government setting out 
policies that seek to curb the rights of migrants to social welfare and healthcare339 with 
the current Health Secretary vowing to restrict access to healthcare to all but those with 
permanent UK residency (Dominiczak 2013).   This has been accompanied by an 
increasingly robust and divisive policy approach to immigration perhaps best 
exemplified by the UK Border Agency’s recent deployment of vans displaying large 
adverts exhorting illegal immigrants to “Go home or face arrest”340.   
                                                             
339
 See the transcript of the Queen's Speech 2013 on the legislative programme for government available 
at https://www.gov.uk/government/speeches/the-queens-speech-2013. 
340This controversial pilot scheme was introduced in July 2013 in six boroughs of London known for their 
ethnic diversity (see http://www.ukba.homeoffice.gov.uk/sitecontent/newsarticles/2013/july/50-returns-
pilot, accessed 23 September 2013).  It has been widely criticised by civil liberties organisations as it has 
been viewed as operating racial profiling and deploying rhetoric reminiscent of fascist slogans in the 
1970s (see http://www.liberty-human-rights.org.uk/media/press/2013/press-advisory-stirring-up-tension-
and-division-in-the-uk-illegally-home-office-think-again.php, accessed 23 September 2013). 
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Measures such as these that target some of the most vulnerable and marginalised in our 
society are structurally violent acts, rendering the lives of migrants “bare” (Agamben 
1998).  The current political and economic climate raises concerns about whether HIV-
positive women without secure immigration status will be able to continue to overcome 
their fears and anxiety, as well as growing institutional barriers, to access the care they 
need to maintain their own health as well as that of their newborn babies. 
10.4 Research question three 
My third question was: how do African women living with HIV experience HIV 
services and interventions during and after pregnancy?   Here I summarise important 
experiences shared by many African women that emerged from my ethnographic 
fieldwork in relation to two key themes: maternity care and infant feeding.   
10.4.1 Negative experiences of maternity care 
Only one other recent study from the UK has engaged with women’s experiences of 
maternity services in the context of HIV (Kelly et al. 2012b).  This small study reported 
negative experiences of maternity services mainly as a result of lack of empathy.  
Although most women in my study described the care they had received antenatally in 
positive terms, eight of the fifteen women I interviewed postnatally described negative 
experiences of maternity care during labour and immediately afterwards, their 
experiences ranging from neglect to frank discrimination (Chapter Seven).  Some of my 
participants described episodes of overt discrimination as a result of their HIV status 
whereas others felt that the poor treatment they were experiencing was a result of their 
HIV-status.  Furthermore, lack of social support, poverty and anxieties about their 
immigration status rendered some of them more vulnerable to discrimination within 
maternity services and constrained their agency to address it when it occurred, 
highlighting again how stigma articulates with other modes of inequality in a synergistic 
fashion to create conditions of vulnerability (Castro et al. 2005).     
10.4.2 Infant feeding decisions 
The work I present in Chapter Nine is the first in the UK to explore infant feeding 
among HIV-positive women in the UK, specifically framing the analysis within cultural 
theories of risk.   It provides an entry point into the experiences of infant feeding among 
women living with HIV in resource-rich settings, an area that has previously been 
overlooked.    
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All but one of the women adhered to current UK guidelines to abstain from 
breastfeeding but this decision was fraught and complex, and deeply embedded within 
the social domain.  Firstly, on an operational level, the provision of free formula milk 
and sterilising equipment was not guaranteed across all NHS sites and placed women 
who were already destitute, and sometimes had no recourse to public funds, in the 
intolerable situation of not knowing how they would be able to feed their newborn 
babies.  Furthermore, women were subjected to transnational ideologies that valorise 
breastfeeding, which can make the decision to abstain particularly painful.  Their 
decision was further complicated by the conditions of diaspora in that they were well 
aware of the disjuncture between guidance in the UK, and guidance in African countries 
that promotes exclusive breastfeeding in the context of HIV.  
Formula feeding came at significant personal cost with many women experiencing 
anxieties about bonding and the health of their child and an acute sense of personal loss 
of the joys of breastfeeding.  It had also had significant repercussions in the social 
domain as the mother/bottle-fed child dyad functioned as a visible stigma symbol 
compromising a woman’s ability to present an HIV-negative self, often resulting in 
withdrawal from the social sphere to preserve confidentiality.   
10.5 Strengths and limitations of the study 
10.5.1 Quantitative methods 
The quantitative phase of this study was primarily based on data from the National 
Study of HIV in Pregnancy and Childhood, the UK and Ireland’s comprehensive 
surveillance programme for HIV in pregnancy and childhood, which has been running 
since 1986.  The great strength of the NSHPC is that it has national coverage and all 
women with diagnosed HIV-infection are eligible for inclusion341.   
One important limitation of using large surveillance datasets is that its primary objective 
is to provide a comprehensive overview of disease epidemiology, rather than to address 
specific research questions.  In order to maximise response rates and to facilitate data-
management there are necessary constraints on the amount of data that can be collected.  
There is no information on potentially important confounders such as immigration 
status, socioeconomic status, adherence to ART, disclosure of HIV status and maternal 
smoking history.  There may therefore be some residual confounding in my analyses.  
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 See Chapter Three (61) for a discussion of the strengths of the NSHPC study design.   
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Data were missing for many variables inevitably.  However on the whole this was 
minimal and for some variables was likely to be missing completely at random342 i.e. a 
result of someone simply overlooking a question on the notification form. 
10.5.2 Qualitative methods 
The fieldwork was conducted entirely in London, which has the greatest concentration 
of HIV clinical and support services.  However, it is reasonable to assume that 
challenges encountered by women in London, where support is likely to be greater than 
elsewhere in the UK, will be experienced by women elsewhere. 
The findings presented in this thesis should be interpreted with caution, as they may not 
reflect the experiences of women who do not engage well with HIV care either during 
or after pregnancy.   All women, except one, were recruited from NHS sites and were 
therefore attending for care.  Women who were poorly engaged in care were unlikely to 
consent to participate in a study, and those with complex pregnancies (either socially or 
medically) were often not approached by healthcare providers as understandably their 
social and medical needs were prioritised. Furthermore, I was unable to interview some 
women postnatally and therefore may not have captured the experiences of women who 
disengage from services after pregnancy.   
In order to explore the role of Pentecostalism in the lives of migrant Africans I 
conducted six weeks of fieldwork.  This was brief by necessity given the time 
constraints of a three-year mixed-methods PhD and has particular limitations when 
compared with the prolonged periods of immersion typical of most anthropological 
research.  A longer period of ethnographic fieldwork would have resulted in a deeper 
understanding of TCPM and may have given me more opportunity to encounter 
members and discuss HIV specifically.  It may have also resulted in greater access to 
members of the clergy.  Discussions with anthropologists conducting fieldwork within 
other Pentecostal churches in the UK revealed that older and more established churches 
were often more open to researchers. However, on reflection I feel that TCPM, a rapidly 
growing church attracting a large following often at the expense of the more established 
churches, is precisely where work such as mine needs to be located.   
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 The mechanisms and effects of missing data on my quantitative analyses are discussed in detail in 
Chapter Three (73-76).   
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10.6 Reflections on mixing methods 
In this thesis I have combined epidemiological and anthropological methods.  Although 
the use of mixed methods in health research is growing (O'Cathain et al. 2007), the 
combination of anthropology and epidemiology remains rare (Béhague et al. 2008).  
Rather than conducting primary data collection in my quantitative phase, I undertook 
secondary analysis using an existing national surveillance dataset.  There were therefore 
disjunctures between the quantitative and qualitative phases. I could not shape the 
quantitative data collection to reflect areas of interest that were explored in the 
qualitative phase such as the impact of Pentecostal Christian faith on clinical and 
service-related outcomes.   However, not only was this approach time efficient within 
the constraints of a three-year PhD, but also the size and coverage of the NSHPC 
dataset afforded me statistical power and the ability to generalise my quantitative 
findings that I would not have had had I conducted my own primary quantitative 
research.   
Certain conditions enabled the quantitative and qualitative data to be integrated, namely 
that both the NSHPC data and data from qualitative interviews were obtained from 
women attending for NHS care in the UK.  Furthermore, in view of the coverage and 
high case ascertainment within the NSHPC it is likely that the women I interviewed 
were already included in NSHPC data or would be in the future.  I therefore feel 
confident in extrapolating findings across both sources of data.  The disjuncture in 
datasets and type of data has presented difficulties at times in terms of achieving an 
integrated analysis and presentation (Bryman 2007).  However, despite these challenges 
I have been able to integrate quantitative and qualitative findings in three of the six 
empirical chapters in this thesis, and in this discussion chapter. 
The overarching research question posed in this thesis is: how do African women living 
with HIV in the UK engage with HIV services and interventions during and after 
pregnancy?  This encompasses questions about clinical and service-related outcomes as 
well as personal experiences and demands a range of research methods.  The 
combination of quantitative and qualitative methods has not only allowed me to get 
closer to a multidimensional account of pregnancy in migrant African women in the 
UK, but it has also allowed me to harness the strengths of different methodologies.  The 
quantitative data have provided a national view and generalisable results, and have also 
guided me in terms of my sampling and analysis in the qualitative phase.  The 
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qualitative data have added texture and context, allowing me to explore the mechanisms 
that underlie disparities in clinical and service-related outcomes.  Each approach 
generated insights that would not been possible without the other, such as women’s 
accounts of discrimination within maternity services and associations between ethnicity 
and loss to follow-up after pregnancy.  The mixed-methods approach in this study has 
therefore been instrumental in allowing me to answer my overarching research question. 
10.7 Conclusions 
The mixed methodological approach used in this study has provided a multidimensional 
account of the engagement with HIV services and interventions by HIV-positive 
African women in the UK during and after pregnancy.  My overarching research 
question was: how do African women living with HIV in the UK engage with HIV 
services and interventions during and after pregnancy? 
The findings from this study are largely reassuring in that they suggest that African 
women engage well with HIV care during pregnancy, and are motivated to return for 
their own care following the end of their pregnancy.  This is mainly due to their 
motivation to safeguard the health of their babies, and also to relationships that they 
build with their HIV antenatal team that fosters trust medical in systems.  However, 
some women reported negative experiences, particularly with regards to poor maternity 
care at the time of delivery and difficulties in abstaining from breastfeeding.   
I did identify disparities in engagement in care.  The association between maternal 
ethnicity, African region of birth and duration of residence in the UK with key 
outcomes is complex, although women who arrive in the UK after conception emerged 
as a vulnerable group in my analysis, as did Western African women to a lesser extent.  
Pentecostal beliefs in divine healing, although cited by professionals as a potential 
barrier to HIV care, do not appear to prevent the majority of African women from 
engaging with HIV services and interventions.  Instead, a complex constellation of 
cultural and structural factors such as stigma, concerns regarding disclosure of HIV 
status, poverty and lack of UK citizenship rights present a greater challenge to 
engagement with care, and may be felt disproportionately by certain groups of African 
women. 
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11  
           
Final reflections 
 
Summary  
The overarching research question posed in this thesis emerged from my experiences as 
an HIV physician working with pregnant migrant African women living with HIV and a 
desire to improve delivery of care to this group of patients.  In this final chapter I 
suggest an agenda for further research and make key recommendations for the 
collection of surveillance data, the delivery of clinical services, and the development of 
wider public policy.  In the fullness of time I hope that these recommendations lead to 
an improvement in the care of pregnant African women living with HIV in the UK. 
11.1 Overview of findings 
The overarching research question posed in this thesis is: how do African women living 
with HIV in the UK engage with HIV services and interventions during and after 
pregnancy?   
Except for the high proportion of women who booked for antenatal care beyond the 
current recommended timeframe, the findings from my analysis of NHSPC data in this 
thesis are very reassuring.  Almost all women in the UK diagnosed with HIV took ART 
in pregnancy, the vast majority achieving virological suppression by delivery with 
extremely low rates of vertical transmission, and the overwhelming majority returned to 
HIV services after their pregnancy.  This suggests that women are well engaged with 
HIV care during pregnancy, and are motivated to return for their own care following the 
end of their pregnancy.  Key motivating factors in women’s engagement with care were 
the importance of attaining normality through motherhood, safeguarding their newborn 
babies’ health, and relationships with their HIV antenatal team that fostered trust and 
confidence. 
Negative experiences of health services and interventions were reported by a number of 
women, the most important being poor care within maternity services around the time 
of delivery and difficulties encountered in abstaining from breastfeeding.  One of the 
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most vulnerable groups identified in my analyses were women who had arrived in the 
UK after conception, many of whom were likely to have had insecure immigration 
status.  For some of these women, the structurally violent and intersecting forces of 
poverty, economic dependence, stigma and lack of citizenship rights appeared to 
constrain their capacity to engage with HIV care during and after pregnancy. 
 
11.2 Future work 
The work presented in this thesis highlights important avenues for future research.  
The first area encompasses statistical approaches to the NSHPC dataset.  Due to the 
complexities of the NSHPC dataset structure I was unable to use emergent imputation 
methods to address the large amount of missing data on duration of residence data.  
Software now exists that could make this computationally possible and it would be 
useful to explore the feasibility and effects of imputing values in NSHPC analyses using 
variables with large amounts of missing data.   
A recommendation for future analysis of HIV epidemiological datasets more broadly, is 
for an awareness of the heterogeneity within broad ethnicity categories and the potential 
to identify differences through disaggregation.  One example of this is the analysis of 
loss to follow-up after pregnancy presented in Chapter Eight, which revealed disparities 
between different groups of African women.    It would be valuable to explore whether 
these associations are replicated in the overall adult HIV-positive population by 
disaggregating data on Black Africans, as it may allow us to identify groups that require 
particular support in engaging with HIV care. 
Moving on to specific analyses, I have identified late antenatal booking as a common 
feature of pregnancy in HIV-positive women, especially those from Africa.   Further 
studies specifically comparing initiation of antenatal care in HIV-negative and HIV-
positive women would help clarify whether late booking is specifically related to HIV 
itself.  As the number of reports with available data on antenatal booking increases, it 
will be possible to conduct further analyses exploring both later cut-off points for late 
antenatal booking, and the associations between late booking and clinical outcomes.  I 
also suggest that further qualitative work be undertaken to specifically explore late 
antenatal booking among HIV-positive women as late bookers were underrepresented in 
the work presented in this thesis.   
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The number of negative experiences of maternity services around the time of delivery 
reported by women in this study is of concern.  It is difficult to establish whether these 
experiences were due to pressures within maternity services in general or discrimination 
as a result of women’s HIV-status.  Further quantitative and qualitative work (including 
participant observation) with non-HIV specialist maternity care staff is required to 
elucidate knowledge of and attitudes towards HIV in order to identify and address 
potential gaps in professional development.   
Finally, the work I present in Chapter Six is the first in a UK setting to specifically 
explore Pentecostalism in the context of HIV, although it was brief by necessity. A 
more in-depth ethnographic study including comparisons with other diasporic churches 
would generate richer insights, especially into how HIV is constructed and addressed 
within the church.  Given the difficulties I encountered in gaining access to members of 
the clergy, I would suggest particular methodological considerations be given to how to 
approach working in churches such as the TCPM. 
11.3 Implications for practice and policy 
My primary aim in conducting this research was to generate findings that could be used 
to inform the delivery of services and improvement of healthcare to this group of 
women.  The findings from this study have implications for the collection of 
surveillance data, clinical practice and broader governmental policy in the UK.  It is to 
this that I now turn at the end of my thesis. 
One of the most vulnerable groups identified in the qualitative phase of this study were 
women who had insecure immigration status.  There are currently no data in the 
NSHPC on women’s immigration status, which could potentially be an important 
predictor of clinical and service-related outcomes.  However, collecting data on 
immigration status is particularly sensitive in a wider climate of increasingly hostile 
immigration policy.  Furthermore, additional questions on notification forms run the 
risk of reduced response rates.  A first step would be to consult the units that respond to 
the NSHPC on whether questions about immigration status would be acceptable and 
feasible.  The findings from my study also underline the importance of improving data 
collection on items that are currently poorly completed such as date of antenatal care 
booking, date of arrival in the UK, maternal viral load at delivery and breastfeeding.  
Improving the robustness of current NSHPC data collection is likely to have a greater 
impact on future research than the addition of new items.  With regards to the matched 
 297 
SOPHID/NSHPC dataset, I was limited in the conclusions I could draw by the lack of 
data on emigration.  A recent audit on loss to follow-up in HIV-positive adults (Clay 
2013) estimated that one in four patients not attending for care were known to have left 
the UK.  This suggests that such information is key to interpreting data on loss to 
follow-up from care, and may need to be collected routinely as part of SOPHID.  I 
would also like to underline the importance of continued close collaboration between 
surveillance programmes and their NHS respondents, as has been the case in the recent 
BHIVA audit, to improve our understanding of surveillance data. However, despite the 
limitations, the data from the matched SOPHID/NSHPC dataset have provided valuable 
insights and highlight the valuable contribution of matched large epidemiological 
datasets in formulating a more coherent picture of HIV in the UK. 
Work presented in Chapter Seven revealed that late antenatal booking and unplanned 
pregnancy were common in the context of HIV, suggesting failings in the delivery of 
sexual and reproductive healthcare to women living with HIV.  This emphasises the 
importance of addressing reproductive intentions and contraception regularly among 
those who are diagnosed (British HIV Association 2012) and informing women about 
the importance of prompt presentation to antenatal services in order to safeguard 
maternal and child health.   
Approximately one in eight women do not return for HIV care in the year after 
pregnancy.  It is important for healthcare professionals to reflect on how best to create 
conditions for women to be able to successfully engage with care.  The results from the 
qualitative phase of this research revealed that women engage with care if they feel that 
services have resonance and meaning in their lives.  Securing the health of their children 
was of overriding importance to all the women I interviewed during pregnancy.  I 
suggest that healthcare professionals encourage women to view ongoing engagement in 
care after pregnancy as an important step in maintaining both their health and their 
ability to look after their children.  It is also important to note how closely ART was 
coupled with returning for care after pregnancy in both the quantitative and qualitative 
analysis.  This may be an important reason to consider continuing ART after pregnancy, 
regardless of maternal CD4 count.   
Several women interviewed in this study gave accounts of negative experiences during 
pregnancy mainly with regards to poor care within maternity services and abstaining 
from breastfeeding.  This is important as not only is ensuring positive experiences of 
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care a key component of the NHS Outcomes Framework (Department of Health 2012b), 
but also because negative experiences may impact on future engagement with services.  
More work needs to be conducted within maternity services to ascertain levels of stigma 
towards HIV-positive women.  In the meantime the onus should be on those working 
within HIV services to provide training and education to non-specialist colleagues in 
order to address gaps in knowledge and stigmatising attitudes.   
With regards to infant feeding, healthcare professionals should continue to be aware of 
the difficulties encountered by women in adhering to current UK guidelines on formula 
feeding.  They have a responsibility to create an environment where women feel able to 
express their concerns and intentions openly and should be prepared to support the 
minority of women who will choose to breastfeed.  This is consistent with the current 
national guidelines on infant feeding and HIV in the UK, which although 
recommending formula feeding, acknowledges that some women will choose to 
breastfeed and will require support rather than an automatic referral to child protection 
teams (Taylor et al. 2012).  Finally, an important barrier to not breastfeeding is the 
patchy availability of free formula milk and sterilising equipment for those on low 
incomes.  This puts women in an intolerable position in terms of safeguarding the health 
of their babies.  I urge HIV centres with no clear provision for free formula and milk for 
their most vulnerable patients to address this as a priority in accordance with current 
standards of care for people living with HIV as outlined by the British HIV Association 
(British HIV Association 2012).    
Women from Western Africa and those who arrived in the UK after conception appear 
to be groups who have poorer engagement with HIV care due to a complex constellation 
of structural and cultural factors.  Healthcare professionals should be aware that women 
from these groups may have particular vulnerability in terms of stigma, disclosure, 
poverty, housing and immigration issues.  The importance of third sector agencies in 
this regard cannot be underestimated at this time of decreased public spending, 
especially peer-support programmes (such as the mentor mother scheme coordinated by 
Positive UK343) which have been shown to improve maternal and child outcomes 
internationally (McColl 2012).  
                                                             
343
 Positive UK, a London based charity that works with people living with HIV, provides information 
and workshops on all aspects of pregnancy as well as providing one-to-one support to women from others 
who have had a child whilst living with HIV.  See Positive UK's website for further information 
http://positivelyuk.org/women/. 
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The findings in this study also have implications for policy at a broader level.  Cuts in 
NHS spending will continue to erode the provision of maternity care in the UK resulting 
in increasing levels of dissatisfaction.  Lack of funding also threatens the position of 
specialist midwives who are increasingly being expected to take on other 
responsibilities, leaving them less time to provide the exemplary care that has been 
described in this thesis.  Furthermore, with choice being enshrined as a core value 
within the reorganised NHS, we are left to wonder whether this brings with it a set of 
market-derived values that fail to engage flexibly and compassionately with the 
complexity of healthcare in chronic illness. 
The ongoing economic crisis and ensuing austerity cuts have prompted a predictable 
surge in anti-immigrant rhetoric and legislation amongst the political classes in the UK.  
This will fuel anxiety and further marginalise an already vulnerable group of people.  
An important and welcome development during the course of my research has been the 
change in NHS charging rules, allowing all patients free ART regardless of immigration 
status.  This has removed an important and corrosive barrier to long-term engagement 
with HIV services in the UK. With this in mind, the government’s recent pledge to 
restrict migrants’ access to benefits and healthcare is of deep concern.  By stripping the 
most vulnerable in society of their rights, we render their lives “bare” (Agamben 1998) 
and constrain their capacity to look after their health. 
11.4 Final thoughts 
I began this thesis by recounting Pauline’s engagement with HIV services during and 
after her pregnancy.  My clinical experience of working with patients such as Pauline 
has undoubtedly been the main driving force in the development of this study.  As a 
doctor who has worked closely with HIV-positive migrant African women for over ten 
years, and as the daughter of a migrant mother who received poor care within maternity 
services in the 1970s, I am not a dispassionate observer but an advocate who seeks to 
address health inequities.  I embarked on this study wanting to know more about how 
African women in the UK engage with HIV care during and after pregnancy in order to 
improve clinical practice.  It soon became apparent that the complex and 
multidimensional nature of this research question demanded a combination of 
methodological approaches.  Conducting mixed methods research at doctoral level as 
researcher has been challenging, demanding an in-depth knowledge of a range of 
methodological approaches as well as an engagement with literature from a wide range 
of disciplines.   Furthermore, throughout the duration of my research I have found 
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myself “betwixt and between” roles (Turner 1967: 93), as both an 
epidemiologist/anthropologist and as a clinician/researcher.  However my ambiguous 
position at disciplinary margins has been transformative, not only in the knowledge I 
have been able to generate but also in the skills I have acquired that can now be applied 
to other similarly complex questions within public health.   
As I reach the end of this thesis, I would like to emphasise that the vast majority of 
pregnant African migrant women living with HIV in the UK engage well with HIV 
services and interventions during and after pregnancy, resulting in low rates of vertical 
transmission.   They describe good relationships with their HIV antenatal teams and 
most return to HIV services after pregnancy.  On the one hand this reflects well on the 
multi-disciplinary antenatal HIV teams and provides evidence of best practice that can 
be used to inform other parts of NHS HIV services. However, these good outcomes are 
mainly down to the efforts of HIV-positive women to engage well with interventions, 
sometimes at great personal cost, and are a testament to their resilience and love for 
their babies.  I would like to end my thesis by paying tribute to them. 
